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Abstract 
 
Lateral epicondylitis (LE) is one of the most common lesions of the arm. Physiotherapy 
is a conservative treatment that is usually recommended for LE patients and a wide 
array of physiotherapy treatments is used. Two of the most common physiotherapy 
treatments for LE are Cyriax physiotherapy and supervised exercise programmes. More 
recently physiotherapists are able to use a new modality called polarised polychromatic 
non-coherent light (Bioptron light) for the management of LE. The clinical value of 
these treatments for LE is not known. The aim of this project was to investigate the 
clinical use and clinical effectiveness of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) for the 
treatment of LE. Systematic review (Chapter 2) found that there was strong evidence for 
the short-term effectiveness of acupuncture for LE. It also found that there was strong 
evidence that four physiotherapy modalities, low power laser light, ultrasound, 
extracorporeal shock wave therapy, and pulsed electromagnetic field therapy were not 
effective treatments for the management of LE. There was insufficient evidence 
available for other treatments used for LE, such as iontophoresis and home exercise 
programmes, to judge their effectiveness. Chapter 2 recommended that more evidence is 
needed for Cyriax physiotherapy, supervised exercise programmes and polarised 
polychromatic non-coherent light (Bioptron light). It is necessary to establish optimal 
protocols for these treatments before a suitable clinical trial can be designed. A critical 
literature review (Chapter 3) found that treatment protocols for Cyriax physiotherapy, 
supervised exercise programmes and polarised polychromatic non-coherent light 
(Bioptron light) were mainly derived from the views of advocates of these treatments, 
based on their personal experience. Two preliminary clinical studies were conducted to 
pilot the use of treatment protocols derived from the critical review in Chapter 3 on 
overuses injuries that were similar to LE and were regularly presented to the clinic 
(Chapter 4). In the first study (section 4.3) Cyriax physiotherapy did not reduce the pain 
in patellar tendinopathy, while the supervised exercise programme did. In the second 
study (section 4.4) polarised polychromatic non-coherent light (Bioptron light) reduced 
nocturnal pain and paraesthesia in carpal tunnel syndrome (CTS). The findings of these 
two pilot studies should be interpreted cautiously because the number of patients  
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Abstract 
 
included in the patellar tendinopathy was small and in the CTS study it was not possible 
to attribute changes to the light per se because the study lacked a control group. Before 
the effectiveness of these protocols could be tested, a questionnaire survey was 
conducted to establish the current clinical practices of these physiotherapy treatments 
for LE. This survey was based on the self-reporting of chartered physiotherapists in 
Athens using these treatments in their clinical practice (Chapter 5). It may be 
confidently assumed that the results of the questionnaire present a representative view 
of current clinical practice of Cyriax physiotherapy, a supervised exercise programme 
and polarised polychromatic non-coherent light (Bioptron light) on LE at least as these 
treatments are applied in Athens. How much this reflects usage in the rest of the Greece, 
Europe, or even the world, is yet to be seen by extending the research. When the 
effectiveness of Cyriax physiotherapy, a supervised exercise programme and polarised 
polychromatic non-coherent light (Bioptron light) for LE was compared, the three 
treatments reduced pain and improved function at the end of the treatment and at any of 
the follow-up time points (Chapter 6). Whether this is due to placebo effects is not 
known.  The supervised exercise programme produced the largest effect in the short, 
intermediate and long term (Chapter 6). This finding suggests that, of the three 
treatments, the supervised exercise programme should be used as a first treatment 
option when physiotherapists manage LE patients (Chapter 6; Chapter 7). If this is not 
possible, Cyriax physiotherapy and polarised polychromatic non-coherent light 
(Bioptron light) may be suitable (Chapter 6; Chapter 7). Although the three treatments 
are promising interventions for the management of patients with LE, further research is 
warranted to investigate and confirm the effectiveness of Cyriax physiotherapy, 
supervised exercise programmes and polarised polychromatic non-coherent light 
(Bioptron light) in the treatment of impairment and disability resulting from LE. 
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Chapter 1: Introduction 
 
1.1 Introduction 
Lateral epicondylitis (LE) is one of the most common lesions of the arm and results in 
considerable morbidity and financial cost (patients lose many days of their work and 
spend a lot of money for the management of LE) because LE is a condition that is 
difficult to treat and is prone to recurrent boots (Labelle et al., 1992; Notteboom et al., 
1994; Vicenzino and Wright, 1996; Vicenzino, 2003; Korthals-de Bos et al., 2004; 
Hong et al., 2004). LE without the appropriate treatment may last for several weeks or 
months, with the average duration of a typical episode reported to be between 6 months 
and 2 years (Murtagh, 1988; Hudac et al., 1996). In some cases, the condition may last 
for 48 months or more (Murtagh, 1988). It remains unknown whether spontaneous 
recovery of LE occurs or patients learn to live with the symptoms of LE after that 
period. If spontaneous recovery occurs in some patients, these patients will not stop to 
be symptomatic because the degenerative changes can cause dysfunction. LE is usually 
defined as a syndrome of pain in the area of lateral epicondyle (Haker, 1993; Vicenzino 
and Wright, 1996; Assendelft et al., 2003; Trudel et al., 2004; Hong et al., 2004). The 
pain can be reproduced by a therapist in three ways including: (i) digital palpation on 
the facet of the lateral epicondyle, (ii) resisted wrist extension and/or resisted middle-
finger extension with the elbow in extension, and (iii) gripping (Haker, 1993; Noteboom 
et al., 1994; Plancher et al., 1996; Vicenzino and Wright 1996; Peters and Baker, 2001; 
Assendelft et al., 2003). Apart from pain, patients have decreased function (Vicenzino 
and Wright, 1996; Trudel et al., 2004; Hong et al., 2004). Both the previously reported 
complaints, pain and decreased function, may affect activities of daily living such as 
shaking hands, grasping, lifting, knitting, handwriting, driving a car and using a 
screwdriver. Over 40 different methods for treating LE have been reported in the 
literature (Kamien, 1990; Goguin and Rush, 2003; Hong et al., 2004). These include 
nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroid injections, many 
physiotherapy treatments, cast immobilasation, braces, a plethora of surgical operations 
and nutritional supplements (Labelle et al., 1992; Wright and Vicenzino, 1997; Sevier 
and Wilson, 1999; Sevier and Wilson, 2000). These treatments have different theoretical 
mechanisms of action, but all have the same aim: to reduce pain and improve function 
(Sevier and Wilson, 1999; Sevier and Wilson, 2000; Nirschl and Ashman, 2003). 
                                                                                                                            Chapter 1 
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However, such a variety of treatment options suggests that the optimal treatment 
strategy is not known, and more research is needed to establish the most effective 
treatment in patients with LE.  
 
Conservative treatment is advocated as the primary choice of treatment for LE (Nirschl, 
1992; Noteboom et al., 1994; Wright and Vicenzino, 1997; Pienimaki, 2000; Gorguin 
and Rush, 2003; Nirschl and Ashman, 2003; Trudel et al., 2004). It is believed that such 
treatment consisting of one or more components can give good clinical results in the 
majority of LE patients, since only 5%-10% of patients with LE require surgery 
(Nirschl, 1992; Noteboom et al., 1994; Gorguin and Rush; Nirschl and Ashman, 2003). 
But the effectiveness of available conservative medicinal treatments — NSAIDs and 
corticosteroid injections — for LE is controversial (Assendelft et al., 1996; Smidt et al., 
2002a; Green et al., 2002a). Due to this, other conservative treatments such as 
physiotherapy are recommended and used (Stasinopoulos and Johnson, 2004a). 
Physiotherapy is a conservative treatment that is usually recommended for LE patients 
(Sevier and Wilson, 1999; Sevier and Wilson, 2000; Baskurt et al., 2003; Trudel et al., 
2004) and a wide array of physiotherapy treatments are used: electrotherapeutic 
modalities, exercise programmes, soft tissue and manual techniques (Sevier and Wilson, 
1999; Gorguin and Rush, 2003). However, the sheer variety of physiotherapy treatments 
with such different theoretical mechanisms of action suggests that the optimal 
physiotherapy treatment strategy is not known and more research to establish the most 
effective physiotherapy treatment in LE patients is needed. 
 
 Indeed, a cursory search of the literature revealed a systematic review published in 
1992 that concluded that there was a lack of scientific evidence supporting 
physiotherapy treatments for LE (Labelle et al., 1992). Three recently published 
systematic reviews by Smidt et al (2003), Trudel et al (2004) and Bisset et al (2005) 
confirm these early findings and demonstrate the importance of improving the current 
physiotherapy management of LE.   
 
Two of the most common physiotherapy treatments for LE are Cyriax physiotherapy 
and exercise programmes (Wright and Vicenzino, 1997; Sevier and Wilson, 1999; 
Pienimaki, 2000; Sevier and Wilson, 2000; Gorguin and Rush, 2003). In general, there 
are two types of exercise programmes for the management of common musculoskeletal 
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conditions: home exercise programmes and exercise programmes carried out in a 
clinical setting. This division of exercise programmes was first presented on 
tendinopathies such as LE (Stasinopoulos and Johnson, 2004b). A home exercise 
programme is commonly advocated for LE patients because it can be performed any 
time during the day without requiring the supervision from a physiotherapist. However, 
the difficulty with home exercise programmes is how patients comply with the regimen 
(Stasinopoulos and Johnson, 2004b) because patients may carry out the home exercise 
programmes incorrectly not only in the technique but also in the frequency of session, 
sets and repetitions. This difficulty can be managed by the exercise programmes 
performed in a clinical setting under the supervision of a physiotherapist. For the 
purposes of this report, “supervised exercise programme” will refer to such 
programmes. More recently physiotherapists are able to use a new modality called 
polarised polychromatic non-coherent light (Bioptron light) for the management of LE 
(Stasinopoulos and Johnson, 2004c). Although the clinical value of these treatments for 
LE is not known, these treatments are recommended for the management of LE. 
 
Cyriax physiotherapy is a manual therapy, customized for each patient on the basis of 
the patient’s verbal description of the pain experienced during the procedure. Cyriax 
physiotherapy is administered in a clinical setting by experienced physiotherapists in the 
technique (Chapter 3) with treatment consisting of three sessions per week for four 
weeks (Cyriax, 1982; Verhaar et al., 1996; Kesson and Atkins, 1998). A session 
consists of 10 minutes of deep transverse friction (DTF) and one instance of Mill’s 
manipulation, which is performed immediately after the DTF (Cyriax, 1982). DTF is a 
specific type of connective tissue massage applied precisely to the soft-tissue structures 
such as tendons (Cyriax, 1982; Chamberlain, 1982; de Bruijn, 1984; Noteboom et al., 
1994; Selvier and Wilson, 1999; Selvier and Wilson, 2000). Mill’s manipulation is a 
passive movement performed at the end of the elbow-extension range, i.e. it consists of 
a minimal amplitude high-velocity extension thrust at the elbow once the full range of 
elbow extension has been taken up (Cyriax, 1982; Kushner and Reid, 1986; Kesson and 
Atkins, 1998). It is postulated that Cyriax physiotherapy can result in both symptomatic 
pain relief and tissue healing (Chapter 3). Research is needed to translate the 
physiological effects of Cyriax physiotherapy into clinically meaningful results and vice 
versa. 
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Exercise programmes are commonly used treatments that demand the active 
participation of the patient. Such programmes are individualised on the basis of the 
patient’s report of pain experienced during the procedure. Exercise programmes are 
administered in clinical settings and/or homes. The treatment regimen of home exercise 
programmes is usually daily, once or twice, for at least three months based on patellar 
and Achilles tendinopathy studies (Niesen-Vertommen et al., 1992; Alfredson et al., 
1998; Mafi et al., 2001; Silbernagel et al., 2001; Ohberg et al., 2004; Purdam et al., 
2004; Roos et al., 2004). The treatment regimen of supervised exercise programmes is 
at least three times per week for four weeks based on one patellar tendinopathy study 
(Stasinopoulos and Stasinopoulos, 2004). The main explanations for this difference in 
the treatment regimen of exercise programmes may be the compliance of patients and/or 
the clinical route/routine. Exercise programmes for tendinopathies such as LE usually 
consist of slow, progressive eccentric exercises and static stretching exercises of the 
injured tendon (Stanish et al., 1986; Fyfe and Stanish, 1992; Stanish et al., 2000; Khan 
et al., 2002). Three sets of eccentric exercises with at least ten repetitions in each set are 
usually recommended (Stanish et al., 1986; Fyfe and Stanish, 1992; Noteboom et al., 
1994; Hawary et al., 1997; Selvier and Wilson, 1999; Stanish et al., 2000; Selvier and 
Wilson, 2000). Six repetitions of static stretching exercises of the “injured” tendon are 
usually performed, three before and three after the eccentric exercises, with each 
stretching lasting 30-45 seconds (Stanish et al., 1986; Fyfe and Stanish, 1992; Stanish et 
al., 2000). It is reported that exercise programmes are used to promote tissue healing 
(Chapter 3). Research to translate the physiological effects of exercise programmes into 
clinically meaningful results and vice versa is needed. 
 
Manufacturers of polarised polychromatic non-coherent light (Bioptron light) claim that 
the waves of this light move in parallel planes (polarization), cover a wide range of 
wavelengths (480nm-3400nm) including visible light and part of the infrared range 
(polychromy), and are not synchronized (incoherency). The polarised polychromatic 
non-coherent light (Bioptron light) treatment course is standardized. Polarised 
polychromatic non-coherent light (Bioptron light) should be administered at least three 
times per week for four weeks in a clinical setting, six minutes each time and that it 
does not require specific operating skills (Monstrey et al., 2002a; Monstrey et al., 
2002a; Iordanou et al., 2002; Medenica and Lens, 2004; Stasinopoulos et al., 2005). The 
probe emitting polarised polychromatic non-coherent light (Bioptron light) should be 
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held at a 90o angle (perpedicular) 5-10 cm above the clean bare skin of the “injured” site 
in order to achieve the best therapeutic effect (Monstrey et al., 2002a; Monstrey et al., 
2002a; Iordanou et al., 2002; Medenica and Lens, 2004; Stasinopoulos et al., 2005). It is 
claimed that polarised polychromatic non-coherent light (Bioptron light) has 
biostimulative effects assisting tissue healing at the cellular level (Chapter 3). Research 
is needed to determine whether claims about physiological effects of polarised 
polychromatic non-coherent light (Bioptron light) translate into clinically meaningful 
results and vice versa. 
 
The aim of this project was to investigate the clinical use and clinical effectiveness of 
Cyriax physiotherapy, a supervised exercise programme and polarised polychromatic 
non-coherent light (Bioptron light) for the treatment of LE.  
The objectives of the project were to:   
1. Establish the clinical effectiveness of treatments available to physiotherapists to 
manage pain and functional impairment associated with LE by conducting a systematic 
review of published clinical trials in order to find which of the available physiotherapy 
treatments has evidence supporting claims of effectiveness (Chapter 2). 
2. Establish treatment protocols for Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) for the 
management of pain and functional impairment on LE. These protocols would be based 
on:   
 information provided in clinical trials included in chapter 2 
 the claims of manufacturers and anecdotal reports from therapists, gathered in 
the course of a critical review of the literature  (Chapter 3). 
3. Pilot the use of treatment protocols of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light), as derived 
from the critical review in chapter 3 on overuse injuries similar to LE that are regularly 
presenting to the clinic (Chapter 4). 
4. Conduct a questionnaire-based survey to establish the current clinical practices for 
Cyriax physiotherapy, a supervised exercise programme and polarised polychromatic 
non-coherent light (Bioptron light) in the treatment of LE, based on the self-reporting of 
chartered physiotherapists in Athens who are using these treatments in their clinical 
practices (Chapter 5). 
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5. Determine the clinical effectiveness of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) on LE by 
conducting a controlled clinical trial (Chapter 6). 
6. Make recommendations for the use of these treatments in clinical practice (Chapter 
7). 
 
However, before conducting a systematic review of published clinical trials to establish 
the clinical effectiveness of treatments available to physiotherapists for the management 
of pain and functional impairment associated with LE, it is important to understand why 
it has proved difficult for previous workers to establish effective treatments for LE. 
 
1.2 The difficulty of establishing effective treatments for LE  
1.2.1 Difficulties with nomenclature 
A cursory search through existing literature reveals a plethora of terms that have been 
used to describe LE (Vicenzino and Wright, 1996; Vicenzino, 2003; Nirschl and 
Ashman, 2003; Gorguin and Rush, 2003; Hong et al., 2004). These include (i) tennis 
elbow (TE), (ii) extensor tendonitis, (iii) extensor tendinosis, (iv) extensor tendinopathy 
and (v) lateral epicondylalgia. However, it was the description of hypothetical condition 
by Morris of “lawn tennis arm” in 1882 (Gellman, 1992; Haker, 1993) that instigated 
the use of the term LE in medicine. 
 
The term “lateral epicondylitis” (LE) refers to the site of injury and the pathology of this 
condition (Gellman, 1992; Sevier and Wilson, 1999). The term “tennis elbow” (TE) 
refers to the cause of this condition, the motions entailed in the game of tennis (Plancher 
et al., 1996; Peters and Baker, 2001). The term “extensor tendonitis” refers to the 
pathology of the afflicted wrist extensor tendons (Gorguin and Rush, 2003). The term 
“extensor tendinosis” refers to the pathology of the afflicted wrist extensor tendons 
based on histopathological studies (Almekinders and Temple, 1998; Maffulli et al., 
1998; Khan et al., 1999). The term “extensor tendinopathy” refers to the painful overuse 
of wrist extensor tendons without implying pathology (Almekinders and Temple, 1998; 
Maffulli et al., 1998; Khan et al., 1999; Cook et al., 2000; Khan et al., 2000a; Khan et 
al., 2000b; Khan et al., 2002). Finally, the term “lateral epicondylalgia” refers to the 
symptoms of this condition without implying pathology (Vicenzino and Wright, 1996; 
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Wright and Vicenzino, 1997; Vicenzino, 2003; Silcock and Rivett, 2004; Waugh, 
2005). 
 
This variety of terms suggests that there is disagreement by workers in this field as to 
which is the most suitable. Physicians commonly use the terms LE and TE for clinical 
diagnosis and patients consequently know the condition by one of these two terms. LE 
is actually an inappropriate term to describe this condition because the primary 
pathology of LE is degenerative rather than inflammatory (section 1.2.2). In addition, 
the site of LE pathology is not over the lateral epicondyle, but just below of it, on the 
facet of lateral epicondyle. The term TE on the other hand is misleading since it implies 
that the condition is caused by only one activity, playing tennis. In fact, the term TE is 
now used to describe pain and functional impairment in the area of the elbow that has a 
wide variety of causes including occupational activities such as hammering, gardening 
and secretarial work (Kivi, 1982; Noteboom et al., 1994; Olliviere and Nirschl, 1996; 
Plancher et al., 1996; Almekinders and Temple, 1998; Haahr and Andersen, 2003a; 
Baskurt et al., 2003; Haahr and Andersen, 2003b; Paoloni and Murrell, 2004; Waugh et 
al., 2004). However, while making the recommendation that some future researcher 
should review the terminology to resolve the problem of inconsistency, this report will 
employ the term LE because this is the most common used term to describe this 
condition in medicinal literature (Smidt et al., 2003; Trudel et al., 2004).  
 
1.2.2 Difficulties with pathophysiology 
Considerable confusion concerning the actual location of LE has existed since the 
introduction of the term about a century and a half ago.  The exact location of the 
pathophysiological changes was unknown for decades, since many structures around the 
elbow— the tendons of the wrist extensor muscles and possibly the anconeous muscle, 
the bursae, the radial collateral and annual ligament, the radiohumeral synovial fringe, 
the radiohumeral joint, the radial head and radial nerve — have been described in the 
pathogenesis of LE based on theoretical hypotheses and mechanisms through clinical 
examination and diagnosis (Cyriax, 1936; Coonrad and Hooper, 1973; Noteboom et al., 
1994; Vicenzino and Wright, 1996; Peters and Baker, 2001). This problem seems now 
to have been resolved, because the structure most commonly reported as being 
responsible for LE is the origin of the extensor carpi radialis brevis (ECRB) tendon on 
the basis of surgical findings (Nirschl and Petrone, 1979; Lee, 1986; Nirschl, 1992; 
                                                                                                                            Chapter 1 
 8 
Regan et al., 1992; Verhaar et al., 1993; Jobe and Ciccoti, 1994; Potter et al., 1995; 
Kraushaar and Nirschl, 1999; Nirschl and Ashman, 2003).  
 
There was also some debate as to the pathogenesis of LE. At first LE was classified as 
an inflammatory process and physicians attributed the pain of LE to inflammation 
(Kraushaar and Nirschl, 1999; Sevier and Wilson, 2000). However, great progress has 
been made in this area, especially in the last two decades, and it has been found that the 
LE condition is a degenerative process that occurs when the ECRB has failed to heal 
properly after an injury or after repetitive microtrauma resulting from overuse (Nirschl, 
1989; Doran et al., 1990; Regan et al., 1992; Leadbetter, 1992; Nirschl, 1992; Verhaar 
et al., 1993; Chard et al., 1994; Potter et al., 1995; Teitz et al., 1997; Kraushaar and 
Nirschl, 1999; Nirschl and Ashman, 2003). This finding was confirmed by 
histopathological investigations of biopsied materials. These investigations (Nirschl and 
Pettrone, 1979; Nirschl, 1992; Regan et al., 1992; Leadbetter, 1992; Verhaar et al., 
1993; Potter et al., 1995; Teitz et al., 1997; Järvinen et al., 1997; Kraushaar and Nirschl, 
1999; Alfredson et al., 2000) have resulted in a host of new findings:  
 The tendon is dull, gray and friable.  
 The total amount of collagen is decreased, since breakdown exceeds repair. 
 The amounts of proteoglycans and glycosaminoglycans are increased, 
possibly in response to increased compressive forces associated with the 
repetitive motion. 
 The ratio of Type III to Type I collagen is abnormally high.  
 The normal parallel bundled fiber structure is disturbed; the continuity of the    
collagen is lost with disorganized fiber structure and evidence of both 
collagen repair and collagen degeneration.  
 Microtears, mucoid and hyaline degeneration, calcification and collagen 
fiber separations are seen. Many of the collagen fibers are thin, fragile, and 
separated from each other.  
 The number of fibroblast cells is increased; the tenocytes look different, with 
a more blast-like morphology (the cells look thicker, less linear). These 
differences show that the cells are actively trying to repair the tissue.   
 The vascularity is increased, evidence of an immature repair process.  
 Inflammatory cells are usually not seen in the tendon.  
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 Electronic microscopic observations have shown alterations in the size and 
shape of mitochondria in the nuclei of the tenocytes. 
 
Based on these findings, physicians have begun to develop new or alternative theories 
about the source of pain associated with LE. Physicians believe that the pain of LE 
probably comes partly from the physical injury itself (separation of collagen fibers and 
mechanical disruption of tissue) and partly from irritating non-inflammatory 
biochemical substances that are produced as part of the injury process (Khan et al., 
1999; Khan et al., 2000b). The biochemical substances probably irritate the pain 
receptors in the tendon and surrounding area (Khan et al., 1999; Khan et al., 2000b). 
The mechanism of pain associated with LE is yet to be confirmed by researchers and is 
beyond the scope of the present project.  
 
Future research, although beyond the scope of this project, may also determine whether 
knowledge of the pathophysiology of LE may be translated to clinical effectiveness and 
vice versa.  
 
1.2.3 Difficulties with etiology 
It is commonly accepted that LE is the effect of overuse, over-stress or over-exertion of 
the extensor tendons of the wrist, especially ECRB, by quick, continuously 
monotonous, repetitive and/or strenuous activities of the wrist (Kivi, 1982; Kamien, 
1990; Noteboom et al., 1994; Olliviere and Nirschl, 1996; Pienimaki et al., 1996; 
Plancher et al., 1996; Vicenzino and Wright, 1996; Almekinders and Temple, 1998; 
Haahr and Andersen, 2003a; Haahr and Andersen, 2003b; Paoloni and Murrell, 2004; 
Waugh et al., 2004).  
 
If this were the only cause of LE, it would beg the question: why do researchers not face 
this cause and establish an effective treatment for LE? The answer is simple: the 
etiology of LE remains relatively unknown and unexplored because LE is a 
multifactorial condition in nature and, although the overuse of the wrist is the main 
cause, it is not the only one. Other factors that play a significant role in the etiology of 
LE can be age, sex, poor vascular supply of ECRB, anatomical variation such as 
differences in alignment and range of motion, decreased flexibility and cervical spine 
dysfunction. 
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Even though some studies showed that LE occurs most commonly in those between 30 
and 60 years of age (Nirschl and Pettrone, 1979; Kivi, 1982; Hamilton, 1986; Kitai et 
al., 1986; Kannus et al., 1989; Verhaar, 1994; Vicenzino and Wright, 1996) and occurs 
with equal frequency in both sexes but is more severe in women (Allander, 1974; Kivi, 
1982; Hamilton, 1986; Vicenzino and Wright, 1996; Waugh et al., 2004), no studies 
were found to show a relation between LE and poor vascular supply of ECRB, 
anatomical variation, or decreased flexibility (Almekinders and Temple, 1998). It has 
been purported that cervical spine dysfunction may contribute to the etiology of LE 
(Lee, 1986; Vicenzino et al., 1996; Cleland et al., 2004) but cervical spine dysfunction 
and LE are two different conditions while the symptoms of cervical spine dysfunction 
may mimic LE pain (section 1.2.5) 
 
Overall, a determination of the causes of LE requires further research since, if clinicians 
were to understand the etiology of LE, firstly an effective treatment for LE might be 
more easily established and secondly LE might be more easily prevented. Such research 
is beyond the scope of this project. 
 
1.2.4 Difficulties with epidemiology 
The epidemiology of LE is the aspect of this condition that has been investigated in 
most detail, and it is clear that LE is a common clinical problem. It is generally accepted 
that the occurrence of LE is expressed as either an incidence or a prevalence rate 
(Vicenzino and Wright, 1996). The incidence rate of LE (the rate at which new cases 
appear over a year) is approximately 4-7 per 1000 patients per year in general practice 
(Kivi, 1982; Hamilton, 1986; Verhaar, 1994). The annual prevalence (the number of 
existing cases at a given time) of this condition is 1-3% in the general population 
(Allander, 1974; Kivi, 1982; Verhaar, 1994). Tennis players have been reported to 
account for 5-8% of all LE patients, and between 40-50% of all tennis players will be 
afflicted with this condition at some time during their career (Nirschl, 1986; Noteboom 
et al., 1994; Overend et al., 1999).  
 
Factors such as age, gender, stress loads on the elbow and the interaction between these 
factors have been postulated to influence the incidence and prevalence rates of LE. 
Although LE occurs at all ages, the peak prevalence of LE is between 30 and 60 years 
(Nirschl and Pettrone, 1979; Kivi, 1982; Hamilton, 1986; Kitai et al., 1986; Kannus et 
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al., 1989; Verhaar, 1994; Vicenzino and Wright, 1996) because these are the most 
productive (creative) ages. The proportion of those afflicted by LE is not influenced by 
the sex of the patient, but the disorder appears to be of longer duration and severity in 
females (Allander, 1974; Kivi, 1982; Hamilton, 1986; Vicenzino and Wright, 1996; 
Waugh et al., 2004) because females are weaker than males in physical characteristics 
such as strength. Finally, LE is almost invariably experienced in the dominant arm 
(Nirschl and Pettrone, 1979; Kivi, 1982; Hamilton, 1986; Vicenzino and Wright, 1996) 
because this is the arm that is mainly used and is under stress in every day activities. 
 
If research in this area is to help clinicians establish an effective treatment for LE, it 
must be sustained and in depth. Future surveys of the occurrence rates of LE should 
carefully attend to methodological issues such as differences in sampled populations, 
the classification of included and excluded cases, and the validation of such cases by 
trained health care personnel. Such research is beyond the scope of this project. 
 
1.2.5 Difficulties with diagnosis 
Although the diagnosis of LE is simple with the clinical picture fairly uniform, many 
conditions mimic LE pain, and thus the physicians can be easily misdiagnosed as LE, 
which complicates the prospect of optimal treatment for LE. These conditions include 
osteochondritis dissecans, cubital osteoarthritis, radial-tunnel syndrome, rheumatoid 
arthritis, severe cervical spondylosis or cervical radicular syndrome, painful shoulder or 
rotator cuff tendinopathy and increased neural tension (Nirschl, 1992; Gellman, 1992; 
Haker, 1993; Noteboom et al., 1994; Plancher et al., 1996; Vicenzino and Wright, 1996; 
Peters and Baker, 2001; Goguin and Rush, 2003; Nirscl and Ashman, 2003). However, 
an experienced clinician with LE patients can easily distinguish the pain of LE from the 
pain of other conditions that mimic LE pain. 
 
A cursory survey of the existing literature reveals a plethora of diagnostic tests that have 
been used to diagnose LE (Halle et al., 1986; Gellman, 1992; Nirschl, 1992; Haker, 
1993; Noteboom et al., 1994; Plancher et al., 1996; Kraushaar and Nirschl, 1999; Peters 
and Baker, 2001; Goguin and Rush, 2003; Nirscl and Ashman, 2003). These include (i) 
palpation on the facet of lateral epicondyle, where the ECRB tendon originates (Figures 
1.1 and 1.2), (ii) the Tomsen test (Figure 1.3), (iii) resisted middle finger extension 
(Figure 1.4), (iv) the Mill’s test (Figure 1.5), (v) the handgrip dynamometer test (Figure 
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1.6), (vi) resistance supination with the elbow in flexion and in extension (Figure 1.7), 
(vii) the chair test (Figure 1.8), and (viii) the coffee-cup test (Figure 1.9). 
 
Although any therapist conducting one or more of these tests can reproduce the pain of 
LE, such a plethora of diagnostic tests suggests that the most variable and valid test for 
LE is not known. However, clinicians do not use all these tests to diagnose LE. They 
would normally palpitate the facet of the lateral epicondyle and one or two of the tests 
listed above, with tests (ii) to (v) being the most commonly used (Gellman, 1992; 
Haker, 1993; Noteboom et al., 1994; Plancher et al., 1996; Peters and Baker, 2001; 
Goguin and Rush, 2003). For this reason, to identify LE patients, similar diagnostic tests 
were used in our controlled clinical trial described in chapter 6. Future research might 
investigate these various and possibly inconsistent diagnostic tests, since different 
approaches to diagnosis of LE may lead to different choices of treatment for LE. 
 
In the vast majority of LE patients the diagnosis is based on history and physical 
examination. Radiological investigation such as magnetic resonance imaging (MRI) or 
ultrasound examinations can add information in diagnosis, for example if the ECRB is 
the only affected structure or other structures such as supinator or extensor digitorum 
communis are also involved. Although such as investigation can help clinicians to 
modify their treatment in order to obtain the best therapeutic effects, it is not routinely 
obtained. 
 
1.2.6 Difficulty with conservative treatments 
Clinicians regarded LE as an inflammatory condition and recommended management 
with anti-inflammatory treatments such as NSAIDs and corticosteroid injections. 
However, it is now known that the LE condition is not an inflammatory process but a 
degenerative one (section 1.2.2) and clinicians must ask themselves how efficacious 
treatments using these medicinal conservative approaches actually can be.  
 
Systematic reviews of the literature failed to turn up evidence not convincingly 
supporting the long-term effectiveness of injections (Assendelft et al., 1996; Smidt et 
al., 2002a). Definite conclusions cannot be drawn due to the lack of high quality studies. 
A recently systematic review found some support for the use of NSAIDs to relieve LE 
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pain at least in the short term; however, there was, insufficient evidence either to 
recommend or to discourage the use of NSAIDs (Green et al., 2002a). 
 
Some narrative reviews report cases, although they do not provide details of the nature 
of the cases, in which NSAIDs and corticosteroid injections provide short-term but 
rapid symptom relief (Almekinders and Temple, 1998; Cook et al., 2000; Assendelft et 
al., 2003; Mellor 2003) It is believed that NSAIDs and corticosteroid injections are 
effective treatments in patients with a short duration (less than six weeks) of LE (Hay et 
al., 1999; Smidt et al., 2002b). Clinicians should accept that, at least until data appear 
demonstrating otherwise, that these two kinds of treatments do not provide significant 
long-term benefit in tendinopathy such as LE (Astrom and Westlin, 1992; Almekinders 
and Temple, 1998; Hay et al., 1999; Cook et al., 2000; Smidt et al., 2002). Given the 
known deleterious effect of corticosteroid injections into tendon and their inhibition of 
collagen repair when administered in the area of tendons, this treatment has lost favor 
(Unverferth and Olix, 1973; Price at el., 1991; Nirschl, 1992; Kraushaar and Nirschl, 
1999; Khan et al., 1999; Khan et al., 2000a). Moreover, the use of NSAIDs can cause 
gastrointestinal problems that impede the healing process (Khan et al., 1999; Khan et 
al., 2000a; Riley et al., 2001; Khan et al., 2002). Therefore, the clinical use and 
effectiveness of these two treatments for LE are controversial. There remains a need for 
more effective, yet conservative and less hazardous, treatments.  
 
Physiotherapy is a conservative treatment that is commonly used to manage patients 
with LE (Sevier and Wilson, 1999; Sevier and Wilson, 2000; Baskurt et al., 2003; 
Trudel et al., 2004). Physiotherapy treatments whose only role is to reduce 
inflammation may not prove helpful to treat patients with LE. Physiotherapy treatments 
that reverse the pathophysiology of LE may be effective for the management of this 
condition.  
 
1.3 Summary 
Though LE is a common clinical condition and physiotherapy a common form of 
treatment, there appears to be a lack of evidence for the effectiveness of physiotherapy 
interventions. This may be due to the difficulty of establishing nomenclature, 
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pathophysiology, etiology, epidemiology, diagnosis and conservative treatment of the 
condition. 
 
It is important to systematically review existing clinical trial evidence to establish the 
clinical effectiveness of treatments available to physiotherapists to manage the pain and 
functional impairment associated with LE. This information will provide future 
treatment strategies for LE in the present project. 
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Figure 1.1 
 
ECRB origin 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Nirschl (1992) 
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Figure 1.2 
 
Pain with palpation on the facet of lateral epicondyle (ECRB tendon origin) 
 
 
 
 
 
 
Adapted from URL www.sportsinjuryclinic.net 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                            Chapter 1 
 17 
Figure 1.3 
 
 Tomsen test 
Pain with resisted wrist extension, with the elbow in full extension, forearm pronated 
and the wrist extended about 30o, giving the resistance at the heads of the second and 
third metacarpal bones 
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Figure 1.4 
 
Pain with resisted middle finger extension 
Pain with resisted middle finger extension with the elbow in extension, forearm 
pronated and the wrist in neutral position 
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Figure 1.5 
 
Mill’s test 
Pain with full passive flexion of the wrist with the elbow in extended position and the 
forearm pronated 
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Figure 1.6 
 
Handgrip dynamometer test 
Pain and decrease in grip strength when the patient is asked to squeeze the hand 
dynamometer 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Adapted from Peters and Baker (2001) 
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Figure 1.7 
 
Pain with resistance supination 
Pain with resistance supination and the elbow in flexion (A) should be less than the pain 
with resistance supination and the elbow in extension (B). If the pain is equally severe 
with the elbow flexed and extended, then operative intervention is more likely to be 
needed 
 
 
        (A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         (B) 
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Figure 1.8  
 
Chair test 
Pain when the patient is asked to lift a chair with the shoulder adducted, elbow extended 
and forearm pronated 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Peters and Baker (2001) 
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Figure 1.9 
 
Coffee cup test 
Pain when the patient is asked to grasp or pinch with the wrist in extension 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                     Chapter 2 
 24 
Chapter 2: A systematic review to establish the effectiveness 
of physiotherapy for lateral epicondylitis 
 
2.1 Introduction 
LE is a widespread condition that causes pain and reduced function in affected patients 
(Chapter 1). Although therapists can easily make a diagnosis of LE using common tests 
that reproduce the symptoms, the “ideal” treatment for LE remains unknown (Chapter 
1). This may be due to the difficulty of establishing nomenclature, pathophysiology, 
etiology, epidemiology, diagnosis and conservative treatment of LE (Chapter 1). 
Physiotherapy including electrotherapeutic and non-electrotherapeutic interventions is 
the most commonly used non-operative treatment for LE (Sevier and Wilson, 1999; 
Sevier and Wilson, 2000; Baskurt et al., 2003; Trudel et al., 2004; Hong et al., 2004); 
pain relief and restoration of function are its primary objectives (Gorguin and Rush, 
2003; Trudel et al., 2004). However, the optimal physiotherapy treatment strategy 
remains unknown and more research is required to establish the most effective 
physiotherapy treatment. 
 
The need for more research on the efficacy of available physiotherapy treatments for 
this condition was supported by an earlier systematic review (Labelle et al., 1992). 
Labelle et al (1992) evaluated the clinical effectiveness of treatment methods used not 
only by physiotherapists but by physicians in general, for the treatment of patients with 
LE. Eighteen randomised controlled trials (RCTs) conducted prior to 1990 were 
included in the Labelle et al (1992) review. Physiotherapy had been used in seven of 
these eighteen RCTs. Because of the poor methodology of some of the studies 
reviewed, the authors concluded that there was not enough scientific evidence to favor 
any particular type of treatment for LE. They called for RCTs with proper 
methodological design to demonstrate the efficacy of different treatments utilized for 
LE. Other systematic reviews have attempted to determine the clinical effectiveness of 
physiotherapy treatments alone such as extracorporeal shock-wave therapy (Buchbinder 
et al., 2002) and acupuncture (Green et al., 2002b). However, conclusions could not be 
drawn from these reviews due to the low number of studies included.  
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Thus, to date Labelle et al (1992) remains the only published systematic review that 
examines the clinical effectiveness of physiotherapy in the management of LE. Several 
new RCTs have been published since, however, and an updated systematic review is 
required to evaluate the clinical effectiveness of available physiotherapy treatments. 
 
The term “clinical effectiveness” requires attention. It may be defined as the provision 
of high quality treatments or services in a way that allows the recipient(s) to achieve the 
maximum health gain (Chartered society of Physiotherapy, 2002). Clinical effectiveness 
is evaluated through RCTs, which provide the best evidence for the effectiveness of a 
treatment (McNeely et al., 2003). Therefore in order to review the effectiveness of 
physiotherapy treatments it was necessary to conduct a systematic review of RCTs. 
 
A narrative review was not conducted because, rather than address a particular issue in 
depth, narrative reviews deal with a broad range of issues related to a given topic 
(Mulrow, 1987). Narrative reviews are appropriate for describing the history or 
development of a problem and its management, but the connection between clinical 
recommendations and evidence in narrative reviews is often tenuous, incomplete, or — 
worse still — based on a biased citation of studies (Cook et al., 1997). The aim of 
systematic reviews, on the other hand, is to answer specific, often narrow, clinical 
questions in depth, and therefore to increase our precision in estimating treatment 
effects and risks (Mulrow, 1994). Systematic reviews address sharply defined clinical 
questions and may constitute a more reliable means of integrating existing information 
and providing clinicians with data for making rational decisions and providing optimal 
health care (Mulrow, 1994; Mulrow et al., 1997; Cook et al., 1997). Although 
demanding and time consuming, they constitute a more efficient scientific technique, 
one that tends to minimize error and bias (Cook et al., 1997; Egger and Smith, 1997). 
 
2.2 Aim 
The aim of this systematic review was to establish the clinical effectiveness of 
treatments available to physiotherapists for the management of the pain and functional 
impairment associated with LE. This would also enable me to identify which 
physiotherapy treatments lack evidence to determine their effectiveness. 
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2.3 Methods 
2.3.1 Search strategy  
Computerized searches using Medline (from 1966 to October 2002), Embase (from 
1988 to October 2002), Cinahl (from 1982 to October 2002), Index to Chiropractic 
literature (from 1992 to October 2002), Chirolars (from 1994 to October 2002) and 
SportDiscus (from 1990 to October 2002) were performed. Only English language 
publications were retrieved. The search terms used individually or in various 
combinations were: “tennis elbow”, “lateral epicondylitis”, “lateral epicondylalgia”, 
“extensor tendinopathy”. “extensor tendonitis”, “extensor tendinosis”, “rehabilitation”, 
“treatment”, “management”, “physiotherapy, “randomised control trials”. Additional 
reports were also sought from the reference sections of papers retrieved, by contacting 
experts in the field, and from the Cochrane Collaboration clinical trial register (last 
search: October 2002). Unpublished reports and abstracts were not included in the 
review.  
 
2.3.2 Selection of studies 
To be included in the present review, a study had to fulfill the following conditions: it 
had to be a randomised control trial (RCT), with or without follow-up, that included 
subjects aged 18 years old and above who were treated for LE. For the purposes of this 
review, LE was defined as a syndrome of pain in the area of the lateral epicondyle. It 
had to be stated that the pain could be reproduced by a therapist in three ways including 
(i) digital palpation on the facet of the lateral epicondyle, (ii) resisted wrist extension 
and resisted middle finger extension with the elbow in extension, and (iii) gripping 
(Haker, 1993; Noteboom et al., 1994; Plancher et al., 1996; Vicenzino and Wright, 
1996; Peters and Baker, 2001). The treatment had to be any type of physiotherapy and 
evaluated against at least one of the following: (i) placebo; (ii) no treatment; (iii) another 
treatment, either conservative (physical therapy intervention or medicinal) or operative. 
RCTs in which the physiotherapy was given as part of the treatment, that is, in 
combination with non-steroid anti-inflammatory drugs (NSAIDs) and/or ultrasound 
and/or exercise programmes and/or bracing, or RCTs in which physiotherapy was given 
in combination with physical therapy treatments such as ultrasound, exercise 
programmes and light therapy, were excluded since it would be impossible to know 
how the physiotherapy component contributed to the results. However, the effectiveness 
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of these management strategies has not been assessed previously in the literature. This 
review sought data for one of the following two primary outcome measures: pain 
(scales, tests or description words) and function (scales, tests or description words). 
 
The titles and abstracts of all studies were assessed according to the above eligibility 
criteria. If it was absolutely clear from information provided in the title and/or abstract 
that the study was not relevant, it was excluded. If this was unclear from the available 
abstract and/or the title, the full text article was retrieved. This review was not blind as 
to the studies’ authors, places of publication or results. Claims that there are differences 
between judgements of trial outcome between blinded and unblinded reviews have not 
been supported by experimental evidence which has shown little consistency in 
direction or magnitude of bias (Berlin, 1997; Moher et al., 1998). The content of all full 
text articles were assessed according to the selection criteria. 
 
2.3.3 Methodological Quality 
The Chalmers’ scale was used to score methodological quality in line with the previous 
published systematic review by Labelle et al (1992). Chalmers’ scale was validated and 
tested for reliability by Berard et al (2000). The version used in the present study 
consists of two evaluation forms, with 29 individually scored items, allowing for a 
maximum score of 100. The first form consists of 15 scored items and assesses the 
study’s design by giving particular importance to the blinding of the study in respect to 
patients and physicians, and to the presence and method of randomisation of the patients 
and, where applicable, of the physicians (Table 2.1). The second form consists of 14 
scored items and evaluates the quality of the data analysis, the statistical analysis and 
the presentation of results (Table 2.2). 
 
2.3.4 Data abstraction and Analysis 
The data extracted consisted of demographic data including characteristics of 
participants (e.g., age, gender, previous treatments, duration of disorder and etc), 
outcomes (type of outcome measure and instrument), interventions (type, dose or 
intensity, frequency, and duration) and raw data for all outcomes.  
 
It was not possible to perform a meta-analysis because the data were statistically and 
clinically too heterogeneous. I therefore chose to vote count trial outcome as positive or 
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negative. The votes were summarized using a rating system for levels of evidence. The 
findings were organized and placed within themes that reflected the objectives of the 
review. The rating system consisted of four levels of scientific evidence that have been 
used previously in systematic reviews of back pain (Linton and Van Tulder, 2001) and 
that are based on the quality and the outcome of the studies: 
 Level A—Strong evidence: consistent findings from multiple RCTs. 
 Level B--Moderate evidence: one RCT or consistent findings from multiple 
non-randomised controlled trials (NRCTs). 
 Level C—Limited evidence: only one NRCT 
 Level D—No evidence: no RCTs or NRCTs 
 
As NRCTs were not included in this review, level C became irrelevant and therefore 
only three levels remained: strong, moderate and no evidence. 
 
2.4 Results 
2.4.1 Trial flow 
Examination of the titles and abstracts of “hits” identified 48 studies that could meet the 
potential inclusion criteria. Of these studies, 21 failed to meet all inclusion criteria when 
the full text was considered (Table 2.3), leaving 27 eligible RCTs to be included in the 
review (Table 2.4). Most investigation into LE concentrated on the effectiveness of light 
therapy that employed low-power laser light (LPLL) (9 studies), of ultrasound (5 
studies), of acupuncture (5 studies) and of extracorporeal shock wave therapy (ESWT) 
(4 studies). A few studies had investigated the effectiveness of other physiotherapy 
treatments such as pulsed electromagnetic field therapy (2 studies), iontophoresis (1 
study), Cyriax physiotherapy (1 study) and home exercise programme (1 study). The 
home-exercise programme study qualified as an ultrasound study because it compared 
the effectiveness of home exercise programmes to that of ultrasound. Taking all these 
together, 28 qualifying studies were identified. 
 
2.4.2 Description of included studies 
The characteristics of included studies are presented in Table 2.4. Randomisation 
procedures were stringently performed and well reported in all studies. Eleven studies 
had adequate blinded-outcome assessors (Deveraux et al., 1985; Chard and Hazleman, 
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1988; Molsberger and Hille, 1994; Pienimaki et al., 1996; Rompe et al., 1996; Speed et 
al., 2002; Haake et al., 2002a; Crowther et al., 2002; Runeson and Haker, 2002; Fink et 
al., 2002; Tsui and Leung, 2002). One study gave adequate details in respect to blinding 
of patients (Haake et al., 2002a). Four studies had adequately blinded the therapist(s) 
(Basford et al., 2000; Haake et al., 2002a; Fink et al., 2002; Runeson and Haker, 2002). 
All studies reported the dropping-out of patients when such was the case, but not the 
reasons for these drop-outs. Side effects were also reported in all studies where they 
occurred. Only three studies (Molsberger and Hille, 1994; Basford et al., 2000; Haake et 
al., 2002a) stated the power calculations for the sample size. 
 
2.4.3 Methodological quality rating of studies  
Table 2.4, in the column “quality score”, shows the evaluation for the 27 included 
clinical trials. The table expresses the results as percentages of the maximum possible 
score and allows for items that were not applicable to every study and which were 
therefore excluded from the calculations. If the score of the study is below 40% (0-39), 
the design of the study is of low quality; if the score of the study is 40–69%, the design 
of the study is satisfactory; if the score of the study is 70% and over the design of the 
study is of high quality. 
 
The average scores for the 27 trials were 50.6%, with a minimum of 15% for the 
weakest study design (Brattberg, 1983), and a maximum of 75% for the strongest design 
(Haake et al., 2002a). The majority of studies had a satisfactory quality design, and two 
studies exceeding 70% (Haake et al., 2002a; Fink et al., 2002). Studies were classified 
into groups according to the LE treatment studied.  
 
2.4.3.1 Light therapy 
Nine studies evaluated the effectiveness of light therapy using LPLL for the treatment 
of LE. In all these studies, pain and function were measured using a variety of outcome 
measures. Eight out of nine studies compared the effects of LPLL with placebo LPLL 
(Lundeberg et al., 1987; Haker and Lundeberg, 1990b; Haker and Lundeberg, 1991b; 
Haker and Lundeberg, 1991c; Vasseljen et al., 1992; Krasheninnikoff et al., 1994; 
Papadopoulos et al., 1996; Basford et al., 2000). In all these studies, the probe of 
placebo LPLL irradiated the same points with the probe of LPLL, but it was inactive, so 
that no light was emitted. Details of the LPLL application are presented in Table 2.4.  
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Six out of these eight studies found that LPLL was no more effective for the 
management of LE than placebo LPLL, as assessed by any of the outcome measures 
(Lundeberg et al., 1987; Haker and Lundeberg, 1990b; Haker and Lundeberg, 1991b; 
Krasheninnikoff et al., 1994; Papadopoulos et al., 1996; Basford et al., 2000). Based on 
the reported findings, the reviewer agrees with the conclusion reached by the authors of 
these six studies. One of these six studies was a low-quality study (33%) (Lundeberg et 
al., 1987). The others were studies of satisfactory quality, with the scores ranging from 
41% to 64%.  
 
On the other hand, the findings of two studies suggested that LPLL is significantly 
better than placebo LPLL in short term, and that it reduces pain and improves the 
function of LE patients (Haker and Lundeberg, 1991c; Vasseljen et al., 1992). Based on 
the reported findings, the reviewer agrees with the conclusion reached by the authors of 
these two studies. Both studies were satisfactory-quality studies with quality scores of 
50% (Haker and Lundeberg, 1991c) and 58% (Vasseljen et al., 1992), respectively.  
 
Finally, one study in which LPLL was compared with a combination of physical 
therapy treatments (ultrasound and deep transverse friction) found that LPLL was an 
ineffective treatment in patients with LE (Vasseljen et al., 1992). Based on the reported 
findings, the reviewer agrees with the conclusion reached by the authors of this study. 
Vasseljen et al (1992) study was a satisfactory quality study with quality score 61%.  
A total of seven studies provide strong evidence (Level A) that LPLL is an ineffective 
treatment for LE patients in either the short or long term (Table 2.5).  
 
On the other hand, no studies were found to investigate the effectiveness of other forms 
of light therapy such as those employing polarised, polychromatic non-coherent light 
(Bioptron light) for the treatment of LE and the effectiveness of this modality must be 
classified as Level D (Table 2.5). 
 
2.4.3.2 Ultrasound 
Five studies assessed the effectiveness of ultrasound on LE. Pain and function were 
measured in all these studies using a variety of outcome measures. Three out of five 
studies compared ultrasound with placebo ultrasound (Binder et al., 1985; Lundeberg et 
al., 1988; Haker and Lundeberg, 1991a). In all these studies placebo ultrasound and 
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ultrasound were applied in the same manner; however, during the application of placebo 
ultrasound, the machine was turned off. Details of the application of ultrasound are 
presented in Table 2.4.  
 
Just one of these three studies found that ultrasound could decrease the pain and 
improve the functional status of LE patients (Binder et al., 1985). Based on the reported 
findings, the reviewer agrees with the conclusion reached by the authors of these three 
studies. The study that showed positive effects of ultrasound was a low-quality study 
with a quality score of just 36% (Binder et al., 1985), while the other two studies were 
satisfactory-quality studies with quality scores of 46% (Lundeberg et al., 1988) and 
54% (Haker and Lundeberg, 1991a), respectively. 
 
One study comparing ultrasound therapy with the epicondylitis clasp found no 
significant difference in the results of the two treatments (Holdworth and Anderson, 
1993). Based on the reported findings, the reviewer agrees with the conclusion reached 
by the authors of this study. This study was of satisfactory quality, with a quality score 
42%. 
 
One study compared ultrasound with a home exercise programme (Pienimaki et al., 
1996). The home exercise programme consisting of slow progressive strengthening 
(isometric and isotonic contractions) and static stretching exercises, was demonstrated 
to be a more effective treatment for LE than was ultrasound. Based on the reported 
findings, the reviewer agrees with the conclusion reached by the authors of this study. 
The Pienimaki et al (1996) study was of satisfactory quality, with a quality score 68%.  
 
Overall, there is strong evidence (Level A) that ultrasound is an ineffective treatment in 
LE patients (Table 2.5), since a total of four studies showed that ultrasound resulted in 
no improvement for patients. 
 
2.4.3.3 Acupuncture 
Five studies evaluated the effectiveness of acupuncture for the treatment of LE. Pain 
and function were the outcome measures in all studies, which used a variety of outcome 
measures. The exception was one study, which only measured pain (Molsberger and 
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Hille, 1994). Details of the application of acupuncture in all studies are presented in 
Table 2.4. 
 
Two out of these five studies compared acupuncture with placebo (Molsberger and 
Hille, 1994) and sham acupuncture (Fink et al., 2002), respectively. In the Molsberger 
and Hille study (1994) using the placebo acupuncture, a pencil-like probe was used to 
stimulate a point 1.5 cm lateral to T3 (mock acupuncture) for five minutes, 1 treatment 
in total. In the Fink et al. study (2002), six needles were used for sham acupuncture. The 
needles were inserted in the same way as in acupuncture, but investigators used 
puncture sites that were at least five cm from the classical acupuncture points and their 
interconnecting meridians but were also clear of painful pressure points (Ah-Shi or 
trigger points).  
 
These two studies found that, for any outcome measures, acupuncture was a more short-
term effective treatment for the management of LE than placebo and sham acupuncture 
respectively. Based on the reported findings, the reviewer agrees with the conclusion 
reached by the authors of these two studies. The design of one of these two studies was 
satisfactory, with a quality score of 41% (Molsberger and Hille, 1994) and the other 
study was of high quality, with a score of 73% (Fink et al., 2002).  
 
Two other studies compared two different types of acupuncture. One study (Haker and 
Lundeberg, 1990a) compared deep acupuncture with superficial acupuncture and the 
other (Tsui and Leung, 2002) compared electro-acupuncture with manual acupuncture. 
These studies found that, for the management of LE, deep acupuncture and electro-
acupuncture respectively were more short-term effective treatments than superficial and 
manual acupuncture for any outcome measures. Based on the reported findings, the 
reviewer agrees with the conclusion reached by the authors of these two studies. Both 
studies had a design of satisfactory quality, with quality score s of 43% (Haker and 
Lundeberg, 1990b) and 46% (Tsui and Leung, 2003), respectively.  
 
A final study compared acupuncture with corticosteroid injection (Brattberg, 1983). 
Brattberg (1983) reported that, for the management of LE, acupuncture was a more 
effective treatment than steroid injection for any outcome measures. Based on the 
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reported findings, the reviewer agrees with the conclusion reached by the authors of this 
study. However, Brattberg (1983) was a low-quality study, with a score of 15%. 
 
Thus, strong evidence (Level A) supports the acupuncture as a short-term effective 
treatment for LE patients (Table 2.5). A total of five studies showed positive results. 
 
2.4.3.4 ESWT 
Four studies assessed the effectiveness of extracorporeal shock-wave therapy (ESWT) 
for the treatment of LE. Pain and function were the outcomes measured in two studies 
(Rompe et al., 1996; Haake et al., 2002a), while only pain was measured in the other 
two studies (Speed et al., 2002; Crowther et al., 2002).  Details of the application of 
ESWT in all studies are presented in Table 2.4. 
 
Three out of the four studies compared ESWT with sham ESWT (Rompe et al., 1996; 
Speed et al., 2002; Haake et al., 2002a). Within each study, the ESWT and the sham 
ESWT were applied in the same way. In the Rompe et al (1996) study, sham ESWT 
was given as 10 impulses of 0.08 mJ/mm2; in the Haake et al (2002a) study, 
polyethylene foil was filled with air and fixed with ultrasound gel to the front of the 
coupling cushion, thus totally reflecting the shock waves; in the Speed et al (2002) 
study, the sham ESWT was given as 0.04 mJ/mm2.  
 
Two of these three studies found that, for any outcome measure, ESWT was a no more 
effective treatment for the management of LE than sham ESWT (Speed et al., 2002; 
Haake et al., 2002a). Based on the reported findings, the reviewer agrees with the 
conclusion reached by the authors of these two studies. One study was of satisfactory 
quality, with a score of 53% (Speed et al., 2002) and the other study was of high quality, 
with a quality score of 75% (Haake et al., 2002a).  
 
On the other hand, a single study reported that ESWT could reduce the pain and 
improve the functional status of LE patients (Rompe et al., 1996). Based on the reported 
findings, the reviewer agrees with the conclusion reached by the authors of this study, 
which was of satisfactory quality, with a score of 55%. 
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Finally, a study compared the effectiveness of ESWT with steroid injection for the 
treatment of LE. This study found that the injection resulted in a greater reduction in 
pain than the ESWT (Crowther et al., 2002). Based on the reported findings, the 
reviewer agrees with the conclusion reached by the authors of this study. This was a 
satisfactory-quality study, with a quality score of 55%. 
 
Overall, there is strong evidence (Level A) that ESWT is an ineffective treatment for 
patients with LE (Table 2.5), since a total of three studies supported this finding. 
 
2.4.3.5 Pulsed electromagnetic field therapy 
Two studies assessed the effectiveness of pulsed electromagnetic field therapy in the 
treatment of LE by measuring pain and function using a variety of outcome measures. 
In both studies, pulsed electromagnetic field therapy was compared with placebo 
dummy coils (Deveraux et al., 1985; Chard and Hazleman, 1988). Details of the 
application of pulsed electromagnetic field therapy are presented in Table 2.4. The 
results of both studies indicated that, for the treatment of LE, pulsed electromagnetic 
field therapy was not significantly better than placebo dummy coils for any outcome 
measure. Based on the reported findings, the reviewer agrees with the conclusion 
reached by the authors of these two studies, which were of satisfactory quality, with 
scores of 65% (Deveraux et al., 1985) and 43% (Chard and Hazleman, 1988) 
respectively. Therefore there is strong evidence (Level A) that pulsed electromagnetic 
field therapy is an ineffective treatment for LE (Table 2.5). 
 
2.4.3.6 Iontophoresis 
One study evaluated the effectiveness of iontophoresis for the treatment of LE by 
comparing iontophoresis with placebo iontophoresis (Runeson and Haker, 2002). 
Iontophoresis and placebo iontophoresis were applied in the same way, but in placebo 
iontophoresis, the patient was administered saline instead of daxamethasone sodium 
phospate. Details of the application of iontophoresis are presented in Table 2.4. The 
results of the Runeson and Haker (2002) study showed that iontophoresis could not 
reduce the pain and improve the functional status of LE patients better than placebo 
iontophoresis. Based on the reported findings, the reviewer agrees with the conclusion 
reached by the authors of this study. This was a satisfactory study, with a quality score 
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of 55%. Therefore, there is moderate evidence (Level B) that iontophoresis is an 
ineffective treatment for patients with LE (Table 2.5). 
 
2.4.3.7 Cyriax physiotherapy 
One study assessed the effectiveness of Cyriax physiotherapy for the treatment of LE 
(Verhaar et al., 1996). In the Verhaar et al (1996) study, Cyriax physiotherapy was 
compared with corticosteroid injection. In the short-term follow-up (six weeks after the 
end of treatment), corticosteroid injection had significantly greater reduction in pain and 
in the improvement of function than Cyriax physiotherapy. The authors of the study 
concluded that there was no significant difference between the treatments in long-term 
follow up (1 year after the end of treatment) but did not report whether the treatments 
were effective or ineffective and the reviewer was unable to make a further 
determination. This was a satisfactory-quality study (Verhaar et al., 1996) with a quality 
score of 44%.  However, due to lack of sufficient information of the included study 
(Verhaar et al., 1996), it was concluded that no evidence (Level D) exists for the 
effectiveness of Cyriax physiotherapy in the treatment of LE (Table 2.5). 
 
2.4.3.8 Exercise programmes 
One study compared a home exercise programme with ultrasound (Pienimaki et al., 
1996). This study has been previously reported herein (section ultrasound, 2.4.3.2). 
There is moderate evidence (Level B) that the home exercise programme can be an 
effective treatment in patients who suffer from LE (Table 2.5). 
 
No studies that investigated the effectiveness of a supervised exercise programme were 
found. Therefore, there is no evidence (Level D) for the effectiveness of this treatment 
on LE (Table 2.5). 
 
2.5 Discussion 
A wide array of physiotherapy treatments has been recommended for the management 
of LE. The present review found strong evidence for the short-term effectiveness of 
acupuncture for LE. It also found that there was strong evidence that four physiotherapy 
interventions, LPLL, ultrasound, ESWT and pulsed electromagnetic field therapy, were 
not effective treatments for LE. There was not sufficient evidence to judge the 
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effectiveness of other treatments such as iontophoresis and home exercise programmes. 
Finally, there was no evidence available for the effectiveness of Cyriax physiotherapy, a 
supervised exercise programme and polarised polychromatic non-coherent light 
(Bioptron light). It appeared most appropriate then to investigate the clinical use and 
effectiveness of Cyriax physiotherapy, a supervised exercise programme, and polarised 
polychromatic non-coherent light (Bioptron light). 
 
The systematic review conducted by Labelle et al (1992) could not determine the 
effectiveness of physiotherapy for LE due to small number of available studies (i.e. 7). 
Three recently published systematic reviews by Smidt et al (2003), Trudel et al (2004) 
and Bisset et al (2005) included a larger numbers of studies (i.e. 23, 31 and 28, 
respectively) but they concluded that there was insufficient evidence to support the 
effectiveness of physiotherapy treatments for LE. Reading the systematic review by 
Bisset et al (2005) carefully and in depth, they drew the same conclusions with the 
present systematic review about the effectiveness of physical therapy interventions for 
the management of LE. However, Bisset et al (2005) did not report evidence for the 
effectiveness of polarised polychromatic non-coherent light (Bioptron light). This lack 
of evidence probably occurred because Bisset et al (2005) did not experiment on this 
form of light therapy. The results obtained by Smidt et al (2003) and Trudel et al (2004) 
contrast with the results of the present review and the systematic review by Bisset et al 
(2005).  This may be attributed to the different methods of data analysis employed by 
the reviews. In the present systematic review, a vote counting procedure was used and 
the results were summarized using a rating system for levels of evidence; Smidt et al 
(2003) performed a meta-analysis. Trudel et al (2004) also used a vote-counting 
procedure to summarize the results obtained by using a rating system for levels of 
evidence. However, the rating system for levels of evidence in the Trudel review was 
fundamentally different from the rating system for levels of evidence used in the present 
systematic review. Trudel et al (2004) used the Sackett’s level of evidence, while in the 
present study the Linton and Van Tulder (2001) level of evidence was used. On the 
other hand, Bisset et al (2005) also performed a meta-analysis, using studies with at 
least 40% quality in a modified Pedro scale. 
 
The most important aspect of a systematic review may be the authors’ quality 
assessment of the included studies. If the raw material is flawed then the conclusions of 
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systematic review cannot be trusted (Egger et al., 2001). Traditionally, one of the corner 
stones of systematic reviews has been to base conclusions on the outcome of trials with 
the best-rated methodology (Bjordal, 2003). The choice of a quality scale may also 
dramatically affect the final results and conclusions of systematic reviews (Juni et al., 
1999; Herbert et al., 2001) Though a number of scales have been developed, many have 
not been fully validated (Moher et al., 1999) and many include items that may not be 
related to the internal validity of a trial (Moher et al., 1995; Juni et al., 2001). In the 
present review, the Chalmers’ scale was used to assess the quality of the included trials. 
The Chalmers’ scale has been validated and tested for reliability by Berard et al (2000). 
 
Overall, the studies covered in this review rated well on Chalmers’ scale of quality. 
However, methodological shortcomings such as lack of (i) adequate allocation 
concealment; (ii) blinding of participants, assessors and therapists; (iii) standardised 
outcome measures; (iv) power analysis; (v) recruitment strategies; (vi) long term 
follow-up; (vii) reasons for drop-outs; and (viii) clear descriptions of interventions, 
were present. Many of the studies failed to provide adequate allocation concealment and 
some failed to blind the participants, assessors administering the interventions, or the 
assessors measuring outcomes. There is empirical evidence that inadequate methods of 
allocation concealment produce more generous estimates of the effects of treatments 
(Schulz et al., 1995; Moher et al., 1998). This potentially skews the findings of a 
systematic qualitative review in favour of the treatment under consideration (Schultz et 
al., 1995; Altman and Schultz, 2001). Other meta-analyses have found that lack of 
blinding can significantly bias treatment results (Gam et al., 1993). Although some 
interventions such as exercise programmes and Cyriax physiotherapy may be difficult to 
blind due to the manner of their application, it should be possible for trials to be blind 
with respect to the assessors. In addition, a number of trials were labelled “double 
blind”, but they failed to provide any details of the blinding status of groups involved in 
the trials. The failure to use standardised outcome measures was another area of deficit. 
Too many different outcome measures, with their differences in validity, reliability and 
responsiveness, complicate the comparison of the effects of treatments and the 
interpretation of effectiveness. The lack of power analysis becomes an important issue 
in studies that fail to report any difference between interventions. There is a risk of the 
type II error (Wright and Vicenzino, 1997), i.e. it becomes difficult to determine 
whether the results are due to the fact that no treatment effect exists or to the fact that 
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the study lacked sufficient statistical power to detect any small but clinically important 
therapeutic effect (Stratford et al., 1993). Recruitment strategies were also often not 
described, making it difficult to generalise the results. Many of these studies failed to 
provide adequate long-term follow-up. Although patients may be mainly interested in a 
fast recovery, if a treatment’s initial advantage is sustained in long-term follow-up, this 
will provide definite evidence for its effectiveness. Failure to give reasons for subject 
drop-outs was another shortcoming of the studies. The outcome of a study can be much 
influenced by the large numbers of dropouts. This is even more problematic if the drop-
out is selective (Koes, 2004). It is possible, however, to deal with selective follow-up in 
the analysis phase of a study. Additional analysis using a ‘worst case analysis’ could be 
carried out (Koes, 2004). Finally, a study’s lack of discussion of clinical and practical 
issues relating to the interventions themselves, including clear descriptions of the 
techniques, dosage, and progression as well as training or experience requirements, 
makes it difficult to replicate study interventions. Future research is recommended to 
resolve these issues. 
 
LPLL has during the last fifteen or twenty years attracted much interest as it is applied 
to common musculoskeletal conditions such as LE (Wright and Vicenzino, 1997). 
Helium-neon (HeNe) and gallium arsenide (GaAs) are the two most common types of 
LPLL (Prentice, 1999). LPLL application is ideally done with light contact to the 
affected site and/or to the acupuncture points and should be perpendicular to the target 
(Prentice, 1999). LPLL is primarily used in practice to relieve pain and stimulate tissue 
healing at the cellular level (Baxter et al., 1991; Simunovic et al., 1998; Sevier and 
Wilson, 2000; Pienimaki, 2000). However, in the literature there is no agreement on the 
optimal treatment for pain relief with regard to the intensity, frequency, wavelength and 
the peak pulse (Sevier and Wilson, 2000). The present review and the review by Bisset 
et al (2005) revealed strong evidence (Level A) that LPLL is an ineffective treatment for 
LE. This is in accordance with the systematic review by Gam (1993), which concluded 
that LPLL has no effect on pain in musculoskeletal syndromes, and with the RCT by 
Mulcahy (1995), which concluded that LPLL acts primarily as a placebo. Contradicting 
these findings, one meta-analysis found that the effectiveness of LPLL treatment in 
treating tendinopathy was dependant on a range of application parameters such as dose 
0.1-3 J/cm2, power density 5-21 mW/ cm2 and frequency 3-5 times per week (Bjordal et 
al., 2001). In the present review and others (Gam et al., 1993; Smidt et al., 2003; Trudel 
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et al., 2004; Bisset et al., 2005), it has been difficult to test for dose response due to poor 
reporting of parameters and a dearth of clinical studies comparing the effectiveness of 
different physical-therapy-treatment parameters. However, LPLL cannot be ruled out as 
a subject of research; its dose-response modality and its optimal-treatment dosage for 
the management of LE and other musculoskeletal conditions may not as yet have been 
determined. 
 
Polarised, polychromatic, non-coherent light (Bioptron light) has recently appeared on 
the market for the treatment of a wide range of medical conditions including LE. Details 
of the rationale behind the use of polarised, polychromatic non-coherent light (Bioptron 
light) are presented in chapter 3 (section 3.6). This review found no evidence (Level D) 
to support the effectiveness of polarised, polychromatic non-coherent light (Bioptron 
light) in patients with LE. The extent of clinical use of polarised polychromatic non-
coherent light (Bioptron light) is not known although novel modalities like it are 
attractive to practitioners working in rehabilitation settings. Therefore, further research 
to investigate the effectiveness of this modality is required.   
 
Ultrasound is a commonly used modality among physical therapists for the management 
of soft tissue injuries such as LE (Naslund, 2001). For LE, this modality can be applied 
continuously or pulsed over the origin of the common extensor tendon (Sevier and 
Wilson, 2000). Pulsed ultrasound at low intensities (mean 0.5 W/ cm2) is commonly 
referred to in practice for soft tissue repair, because it has been found to have beneficial 
effects on collagen synthesis (Dyson and Suckling, 1978; Khan et al., 2000a). 
Ultrasound is primarily used for analgesia assisting tissue healing with the pulsed more 
than continuous ultrasound (Halle et al., 1986; Stratford et al., 1989; Kochar and Dogra, 
2002). However, there is no agreement in the literature on the optimal treatment dosage 
of this modality for pain relief (Klaiman et al., 1998). This review and the systematic 
review by Bisset et al (2005) found strong evidence (Level A) that ultrasound is an 
ineffective modality as a sole treatment for patients with LE. Six reviews, four narrative 
and two systematic, accord with this finding, reporting that ultrasound is not an effective 
treatment approach for pain treatment (Falconer et al., 1990; Reitman and Esses, 1995; 
Balint and Szebenyi, 1997; Fedorczyk, 1997; Van der Heijden et al., 1997; Van der 
Windt et al., 1999). However, further research into the use of this modality cannot be 
ruled out: it is a dose-response modality and its optimal-treatment dosage for the 
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management of LE and other musculoskeletal conditions may not as yet have been 
determined. 
 
The use of acupuncture is constantly growing in the Western world, but it has long been 
used with good results in China (Naslund, 2001). Acupuncture is recommended for a 
plethora of medical conditions (Wright and Vicenzino, 1997). One of these conditions is 
LE (Wright and Vicenzino, 1997; Sevier and Wilson, 2000). In acupuncture, needles are 
usually used. They are placed at acupuncture points dictated by traditional Chinese 
medicine (Sevier and Wilson, 2000). TENS and LPLL can also be used for acupuncture 
but no so common as needles. Acupuncture is mainly used for symptomatic pain relief 
(Pienimaki, 2000; Fink et al., 2002; Trinh et al., 2004). The improvement of function is 
related to the short-term analgesia and not to the promotion of tissue healing. However, 
the optimal acupuncture treatment to obtain pain alleviation is still unknown (Trinh et 
al., 2004). The findings of the present review and the systematic review by Bisset et al 
(2005) provide strong evidence (Level A) for the short-term effectiveness of 
acupuncture for LE patients. A recently published systematic review accords with this, 
reporting strong evidence to support the use of acupuncture on LE, especially in short-
term (Trinh et al., 2004). However, further research is required to determine which 
acupuncture type is the most effective, in which dosage, and if this treatment can 
produce long-term effects. 
 
ESWT is a relatively new treatment for the management of common tendon problems 
such as LE (Haake et al., 2002b). ESWT consists of single pressure pulses of 
microsecond duration that can be focused on a site of tissue damage, i.e. the origin of 
the common extensor tendon for LE (Speed et al., 2002). In practice, ESWT is mainly 
used for symptomatic pain relief (Krischek et al., 1999; Maier et al., 2001; Wang and 
Chen, 2002; Melegati et al., 2004). However, the optimal treatment protocol to achieve 
pain reduction remains uncertain (Rompe et al., 2004; Chung and Wiley, 2004)). This 
review and the review by Bisset et al (2005) found strong evidence (Level A) that 
ESWT is an ineffective treatment for the management of LE. A recently published 
systematic review revealed conflicting findings about the effectiveness of ESWT in the 
management of LE (Stasinopoulos and Johnson, 2005). In addition, two recently 
published RCTs found that the ESWT is not beneficial in the treatment of LE (Melikyan 
et al., 2003; Chung and Wiley, 2004). On the other hand, positive effects of ESWT on 
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LE were found by two recently published RCTs (Rompe et al., 2004; Pettrone and 
Leftan, 2005) and by a recently published systematic review in German language 
(Rompe et al., 2005). Specifically, Rompe et al (2004) found the ESWT an effective 
treatment in tennis players who suffered from LE. Based on the results of the previously 
reported studies there is chaos about the effectiveness of ESWT and definite conclusions 
cannot be drawn. Research on ESWT must be continued in order to determine the 
optimal treatment dosage of ESWT for the management of LE and which population of 
LE patients ESWT can treat effectively.  
 
Pulsed electromagnetic field therapy is an accessory electrotherapeutic modality for the 
management of a variety of medicinal conditions (Pienimaki, 2000). This kind of 
therapy had good results in the treatment of ununited fractures (Bassett et al., 1982) and 
rotator cuff tendinopathy (Binder et al., 1984).  Pulsed electromagnetic field therapy is 
recommended for tendon disorders such as LE to promote tissue healing and reduce 
pain by inference  (Deveraux et al., 1985). The findings of the present review and of the 
systematic review by Bisset et al (2005) indicated strong evidence (Level A) that pulsed 
electromagnetic field therapy is an ineffective intervention for the management of LE. 
There is no objective evidence that clearly supports the therapeutic value of this 
modality for many of the conditions for which this is recommended such as LE. 
However, research with this treatment must be continued until it is possible to draw 
definite conclusions about its effectiveness on LE. 
 
Iontophoresis is another “recommended” physiotherapy modality for the management 
of LE (Sevier and Wilson, 2000; Pienimaki, 2000). It is claimed that iontophoresis 
works by transmitting medication into the underlying tissues using a very low electrical 
current (Demirtas and Oner, 1998; Sevier and Wilson, 2000; Runeson and Haker, 2002; 
Baskurt et al., 2003). It can be used as an alternative to injections without the traumatic 
effects of injections, with no pain for the patient and no risk of infection (Wright and 
Vicenzino, 1997; Demirtas and Oner, 1998; Sevier and Wilson, 2000; Baskurt et al., 
2003).  Iontophoresis is recommended for symptomatic pain relief (Sevier and Wilson, 
2000; Baskurt et al., 2003). However, the optimal protocol to obtain the pain relief 
remains unknown (Sevier and Wilson, 2000). The present review and the review by 
Bisset et al (2005) revealed moderate evidence (Level B) that iontophoresis offers no 
benefit in patients with LE. This finding is supported by a recently published and well-
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designed RCT about iontophoresis for LE (Nirschl et al., 2003). However, more 
research is required to determine if there is evidence for iontophoresis’ effectiveness for 
LE in appropriate dosage, although there is the claim that it should only be considered 
as part of the overall management of the patient as with all pharmacological agents 
(Demirtas and Oner, 1998). 
 
Cyriax physiotherapy, consisting of deep transverse friction and Mill’s manipulation, is 
currently used extensively for the management of LE (Stasinopoulos and Johnson, 
2004d). Details of the rationale behind Cyriax physiotherapy are presented in chapter 3 
(section 3.4). The present review found one study to show at least moderate evidence of 
the effectiveness of Cyriax physiotherapy for LE. However, the present review reports 
no evidence (Level D) for the effectiveness of Cyriax physiotherapy for LE, because the 
results of the Cyriax physiotherapy study (Verhaar et al., 1996) were not presented well 
and leave the reader with several questions. Further research is required if scientific 
evidence for the effectiveness of Cyriax physiotherapy for LE is to be determined.  
 
Exercise programmes are a common physiotherapy treatment for LE patients (Sevier 
and Wilson, 1999; Sevier and Wilson, 2000; Pienimaki, 2000). The rationale behind 
exercise programmes is presented in chapter 3 (section 3.5). The goal of exercise 
programmes is to return the patient to full function with no pain (Sevier and Wilson, 
1999; Sevier and Wilson, 2000). This review found moderate evidence (Level B) for the 
effectiveness of home exercise programmes for LE. The present review found no 
evidence (Level D) to support the effectiveness of supervised exercise programmes for 
LE. It might be argued that exercise programmes are only for home use. Home exercise 
programmes have been used in some previously published clinical trials as the sole 
treatment approach or as a part of a treatment programme (Pienimaki et al., 1996; 
Drechsler et al., 1997; Svelnlov and Adolfsson, 2001; Kochar and Dogra, 2002; Smidt 
et al., 2002b; Struijs et al., 2003; Struijs et al., 2004). The major advantage of home 
exercise programme is that patients carry them out independently, saving time for both 
patient and therapist (Stasinopoulos and Johnson, 2004b). However, it is difficult to 
monitor patient compliance in home exercise programmes. Patients need a 
physiotherapist to monitor the administration and progress of the programme and 
exercise programmes are consequently better performed in clinical settings under the 
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supervision of physiotherapists (Stasinopoulos and Johnson, 2004b). Further research is 
required to investigate the effectiveness of supervised exercise programmes on LE. 
 
Due to the nature of this review (a PhD dissertation), the focus was on studies written in 
the English language. For the same reason, the researcher personally determined the 
selection criteria of included studies. Although the quality of the majority of included 
studies was found satisfactory on Chalmers’ scale, they had some shortcomings such as 
insufficient blinding in respect to patients and therapists and a lack of power-statistical 
analysis. Chalmers’ scale was validated and tested for reliability by Berard et al (2000) 
but one wonders whether Chalmers’ system for rating methodological quality can 
adequately assess the true methodological quality of physiotherapy trials. Two possible 
explanations will be presented below to answer this issue. 
 
One explanation is that some of these criteria (such as blinding in respect to therapists 
and patients) seem to be irrelevant and unrealistic for physiotherapy trials. Failure to 
meet these criteria does not affect the methodological quality in physiotherapy studies. 
Another explanation is that the Chalmers’ scale does not fully express the true 
methodological quality of physiotherapy trials. It would therefore be useful to compare 
the results derived from using Chalmers’ scale with those obtained by using other scales 
such as those of Pedro or Jadad (Smidt et al., 2003). In respect of the included studies, a 
correlation between the scores achieved by these scales would be significant.  
 
In addition, the rating system for levels of evidence of the present review does not 
specify the kind of studies required, whether of high or low quality, to achieve a rating 
as “strong evidence”. It might be wrongly assumed that a rating system for levels of 
evidence does not require a rating of methodological quality. In fact, if strong evidence 
is found for the effectiveness of a treatment, we must know what kind of studies, 
whether they were of high or low quality, this finding was based on. If these studies 
were of low quality, the effectiveness of this treatment would be controversial and more 
research with well-designed studies would be required. On the other hand, if the finding 
was based on high-quality studies, this treatment could be recommend as an “ideal” 
treatment for the investigated condition. In short, a methodological-quality rating is 
required in any rating system that assesses levels of evidence. This issue could be 
avoided if the results of the present review had been compared with other rating systems 
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that measure levels of evidence, systems such as the one developed by Van Tulder et al 
(1997), which requires high-quality studies to achieve strong evidence for the 
effectiveness of a treatment. Such a comparison would allow us to determine whether 
any correlation existed between the two compared level-of-evidence rating systems as 
applied to the effectiveness of the treatments included in the present study. However, a 
recently published meta-analysis and systematic review (Bisset et al., 2005) confirmed 
the conclusions of the present review and therefore the findings of the present review 
are valid and can be trusted. 
 
2.6 Conclusion     
This review showed that there was strong evidence for the short-term effectiveness of 
acupuncture for LE. It also found that there was strong evidence that four physiotherapy 
modalities, LPLL, ultrasound, ESWT and pulsed electromagnetic field therapy were not 
effective treatments on LE. Other treatments used for LE such as iontophoresis and 
home exercise programmes had insufficient evidence available to judge the results of 
their effectiveness. However, all the previously reported physiotherapy treatments for 
LE cannot be refuted or recommended as ideal treatment for LE, because the optimal 
treatment protocols are unknown. Additional well-designed RCTs are needed to provide 
definite conclusions for the effectiveness of these LE-treatment modalities. Finally, this 
review found no evidence for the effectiveness of Cyriax physiotherapy, supervised 
exercise programmes and polarised polychromatic non-coherent light (Bioptron light) 
for LE. This is rather strange because Cyriax physiotherapy and a supervised exercise 
programme appear to be used extensively by physiotherapists for treating LE. In 
addition, polarised polychromatic non-coherent light (Bioptron light) is a new modality, 
which is gaining popularity for treating LE. Therefore, it is important to investigate the 
clinical use and effectiveness of Cyriax physiotherapy, supervised exercise programmes 
and polarised polychromatic non-coherent light (Bioptron light) as treatments for LE. 
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Table 2.1 
 
Evaluation form A adapted from Chalmers et al. (1981) showing the 15 items 
scored to evaluate the study design of a clinical trial 
 
 
 
 
 
0-2: 0= no information available; 1=some information available; 2= all information  
             available 
0-3: 0= no information available; 1.5=some information available; 3= all information  
             available 
0-4: 0= no information available; 2=some information available; 4= all information  
             available 
0-8: 0= no information available; 4=some information available; 8= all information  
             available 
0-10: 0= no information available; 5=some information available; 10= all information  
             available 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Items Possible points 
Description of selection of subject was adequate 0-3 
Description of patients screened was provided 0-3 
Inclusion criteria for study included 0-2 
Exclusion criteria for study included 0-2 
Withdrawals and reason for withdrawal were described 0-3 
Randomisation was blinded 0-12 
Patients were blinded to treatment group 0-9 
Investigators were blinded to treatment group 0-9 
Power calculations (sample size requirements) 0-5 
Adequacy of randomisation was evaluated 0-4 
Adequacy of blinding was evaluated 0-3 
Compliance with treatment has assessed 0-3 
Measure of outcome of active therapy was made 0-2 
 Total possible score 60 
Items Possible points 
Description of selection of subject was adequate 0-3 
Description of patients screened was provided 0-3 
Inclusion criteria for study included 0-2 
Exclusion criteria for study included 0-2 
Withdrawals and reason for withdrawal were described 
 
0-3 
Therapeutic regimen definition 0-3 
Control appearance 0-2 
Randomisation was blinded 0-10 
Patients were blinded to treatment group 0-8 
Investigators were blinded to treatment group 0-8 
Power calculations (sample size requirements) 0-4 
Adequacy of randomisation was evaluated 0-4 
Adequacy of blinding was evaluated 0-3 
Compliance with treatment has assessed 0-3 
Measure of outcome of active therapy was made 0-2 
 Total possible score 60 
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Table 2.2 
 
Evaluation form B adapted from Chalmers et al. (1981) showing the 14 items 
scored to evaluate the data analysis of a clinical trial. 
 
 
 
 
Items Possible points 
Dates of study description 0-2 
Results of randomisation 0-2 
Post type 2 estimate 0-3 
Confidence limits 0-3 
Time series analysis 0-2 
Timing of evens 0-4 
Correlation 0-2 
Statistical analysis 0-4 
P value 0-2 
Withdrawals 0-4 
Handling withdrawals 0-4 
Side effects 0-2 
Retrospective evaluation 0-3 
Presentation of results 0-3 
 Total possible score 40 
 
0-2: 0= no information available; 1=some information available; 2= all information  
             available 
0-3: 0= no information available; 1.5=some information available; 3= all information  
             available 
0-4: 0= no information available; 2=some information available; 4= all information  
             available 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                     Chapter 2 
 47 
Table 2.3 
 
Studies excluded from review with reasons 
 
 
No randomisation performed 
 
Abbott J, Patla C, Jensen R. (2001). The initials effects of an elbow mobilization with 
movement technique on grip strength in subjects with lateral epicondylalgia. Manual 
Therapy, 6 163-169. 
 
Halle J, Franklin R, Karalfa B. (1986). Comparison of four treatment approaches for 
lateral epicondylitis of the elbow. Journal of Orthopaedic and Sports Physical Therapy, 
8 62-69. 
 
Johannsen F, Gam A, Hauschild B, Mathiesen B, Jensen L. (1993). Rebox: an adjunct 
in physical medicine? Archives of Physical Medicine and Rehabilitation, 74 438–440. 
 
Krischek O, Hopf C, Nafe B, Rompe J. (1999). Shock-wave therapy for tennis and 
golfer’s elbow-1 year follow up. Archives of Orthopaedic and Trauma Surgery, 119 62-
66. 
 
Maier M, Steinborn M, Schmitz C, Stabler A, Kohler S, Veihelmann Am Pfahler M, 
Refior H. (2001). Extracorporeal shock wave therapy for chronic lateral epicondylitis-
prediction of outcome by imaging. Archives of Orthopaedic and Trauma Surgery, 121 
379-384. 
 
Simunovic Z, Trobonjaca T, Trobonjaca Z. (1998). Treatment of medial and lateral 
epicondylitis-tennis and golfer’s elbow-with low lever laser therapy: A multicenter 
double blind, placebo controlled clinical study on 324 patients. Journal of Clinical 
Laser Medicine and Surgery, 16 145-151. 
 
Solverborn A. (1997). Radial epicondylalgia (tennis elbow): treatment with stretching 
and forearm band. A prospective study with long term follow up including range of  
 
                                                                                                                                                     Chapter 2 
 48 
Table 2.3 (continued) 
 
motion measurements. Scandinavian Journal of Medicine and Science in Sports, 7 229-
237. 
 
Stratford P, Levy D, Gauldie S, Miseferi D, Levy K. (1989). The evaluation of 
phonophoresis and friction massage as treatments for extensor carpi radialis tendinitis: a 
randomized controlled trial. Physiotherapy Canada, 41 93-99. 
 
 
Laboratory studies 
 
Vicenzino B, Collins D, Wright A. (1996). The initials effects of a cervical spine 
manipulative physiotherapy treatment on the pain and dysfunction of lateral 
epicondylalgia. Pain, 68 69-74. 
 
Vicenzino B, Paungmali A, Buratowski S, Wright A. (2001). Specific manipulative 
therapy treatment for chronic lateral epicondylalgia produces unique characteristic 
hypoalgesia. Manual Therapy, 6 205-212. 
 
Wang C, Chen H. (2002). Shock wave therapy for patients with lateral epicondylitis of 
the elbow: A one to two year follow up. American Journal of Sports Medicine, 30 422-
425. 
 
 
Combination of treatments 
 
Burton AK. (1988). A comparative trial of forearm strap and topical anti-inflammatory 
as adjuncts to manipulative therapy in tennis elbow. Manual Medicine, 3 141–143. 
 
Demirtas N, Oner C. (1998). The treatment of lateral epicondylitis by iontophoresis of 
sadium salicylate and sodium diclofenac. Clinical Rehabilitation, 12 23-29. 
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Table 2.3 (continued) 
 
Drechsler W, Knarr J, Mackler L. (1997). A comparison of two treatment regimens for 
lateral epicondylitis: a randomised trial of clinical interventions. Journal of Sport 
Rehabiliation, 6 226-234. 
 
Dwars BJ, Feiter P, Patka P, Haarman HJThM. (1990). Functional treatment of tennis.  
A comparative study between an elbow support and physical therapy. Sports Medicine 
and Health, 237-241. 
 
Kochar M, Dogra A. (2002). Effectiveness of a specific physiotherapy regimen on 
patients with tennis elbow. Physiotherapy, 88 333-341.  
 
Rompe J, Riedel C, Betz U, fink C. (2001). Chronic lateral epicondylitis of the elbow 
(tennis elbow)-prospective comparison of low energy wave therapy with low energy 
shock wave therapy plus manual therapy of the cervical spine. Archives of Physical 
Medicine and Rehabilitation, 82 578-582. 
 
Smidt N, Windt D, Assendelft W, Deville W, Bos I, Bouter L. (2002b). Corticosteroids 
injections, physiotherapy, or a wait and see policy for lateral epicondylitis: a 
randomised controlled trial. Lancet, 359 657-662. 
 
Svernlov B, Adolfsson L. (2001). Non-operative treatment regime including eccentric 
training for lateral humeral epicondylalgia. Scandinavian Journal of Medicine and 
Science in Sports, 11 328-334. 
 
 
General soft tissue injury (not exclusively LE) 
 
Klaiman M, Shraded J, Danoff J, Hicks J, Pesce W, Ferland J. (1998). Phonophoresis 
versus ultrasound in the treatment of common  musculoskeletal conditions. Medicine 
and Science in Sports and Exercise, 30 1349-1355. 
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Table 2.3 (continued) 
 
Vecchini L, Grossi E. (1984). Ionization with diclofenac sodium in rheumatic disorders: 
a double-blind placebo-controlled trial. Journal of International Medical Research, 12 
346–350. 
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Characteristics of included studies 
 
 
 
Study Patients 
No. of subjects (n)  
Sex M/F  
Age (ys) 
Duration of 
symptoms 
Interventions 
Type (n) 
Time 
Frequency 
Outcomes 
measures 
when administered 
Author(s) 
conclusion 
Reviewer 
conclusion 
Quality      
   score 
(%) 
Lundeberg et al. 
(1987) 
n=57 31M 26F 
25-62 ys 
Symptoms at least 
three months 
Ga-As pulse 
wave laser (19) 
Vs He-Ne 
continuous laser 
(19) Vs placebo 
laser (19). Laser 
was applied at 
surface of skin 
for 60sec in each 
acupuncture 
point which were 
Li 10,11,12 SJ 
5,10, SI 4,8, 
H3,4, P3. No 
reported dose 
2 treatments per 
week, 10 
treatments totally 
over 5-6 weeks 
Pain VAS  
Lifting test 
Grip strength 
Measurements taken 
at baseline, end of 
treatment and three 
months after the end 
of treatment  
 
Laser was no 
significant 
better than 
placebo at the 
end of 
treatment and 
at follow ups 
Laser not 
effective 
33 
Haker & 
Lundeberg (1990) 
n=49 28M 21F 
24-70 ys 
Symptoms for at 
least one month 
Ga-As laser (23) 
Vs placebo laser 
(26). 
Laser was 
Lifting test 
Grip strength 
Subjective reports of 
improvement. 
No statistical 
significant 
differences 
between the 
Laser not 
effective 
50 
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applied in 
L1,10,11,12,Lu5,
SJ5 points for 30 
in each point 
with wand held 
1mm from skin 
and dose 0.36 
J/point. 2-3 times 
per week, 10 
treatment totally 
Measurements taken 
at baseline, end of 
treatment three 
months and twelve 
months after the end 
of treatment. 
groups at the 
end or at the 
follow-ups 
Haker & 
Lundeberg (1991b)  
n=58 43M 15F 
33-65 ys 
Symptoms for at 
least one month 
Ga-As, He-Ne 
laser (29) Vs 
placebo laser 
(29). 
Probe was used 
to radiate the 
area over LE for 
eight minutes. 
Then pen laser 
was applied to 
acupuncture 
points LI11,12 
for two minutes 
per point. 3 times 
per week, 10 
treatments in all 
Pain with diagnostic 
tests 
Grip strength 
Lifting test 
Subjective 
assessment 
Measurements taken 
at baseline, end of 
treatment, 1, 3 and 12 
months after the end 
of treatment. 
No significant 
difference 
between laser 
and placebo 
laser at the end 
of treatment or 
at follow-ups. 
Laser not 
effective 
50 
Haker & 
Lundeberg (1991c)  
 
n=49  31 M 18F 
22-66ys 
Symptoms for at 
least one month 
Ga-As laser (25) 
Vs placebo  
laser (24). Laser 
was applied to 
one point at 
anterior aspect of 
LE and five 
points around 
this site at 1.5-2 
Pain with diagnostic 
tests 
Lifting test 
Grip strength 
Patient assessment 
Measurements taken 
at baseline, end of 
treatment, 3 months 
and 12 months after 
Laser better 
than placebo at 
the end of 
treatment and 
at 3-month 
follow up. 
Laser effective at 
the end of 
treatment and at 
3-month follow 
up. 
50 
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cm. Each point 
was treated for 
30 sec with laser 
held 1mm from 
skin and dose 
0.36 J/point. 2-3 
treatments per 
week, 10 
treatments totally 
the end of treatment  
Vasseljen et al. 
(1992)  
n=30 15M 15 F 
25-63 ys. Symptoms 
duration for at least 
one month 
Infrared laser 
(15) vs placebo 
laser (15). 
Laser was 
applied 10 
minutes in the 
painful site with 
3.5J/cm2, three 
times per week, 
8 treatments 
totally. 
Pain on VAS 
Lifting test 
Grip strength 
Goniometric 
measurements of 
wrist flexion 
Patient assessment. 
Measurements taken 
at baseline, end of 
treatment and at four 
weeks after the end 
of treatment 
Laser better 
than placebo 
laser, but as 
sole treatment 
its 
effectiveness 
is 
controversial 
Laser effective  58 
Vasseljen (1992)  
 
n=30 13M 17F 
25-70 ys 
Symptoms for at 
least one month 
Ga-As laser (15) 
Vs traditional 
physiotherapy 
(ultrasound and 
deep transverse 
friction) (15). 
Laser was 
applied 10 
minutes in the 
painful site with 
dose 3.5J/cm2, 
three times per 
week, 8 
treatments 
Pain on VAS 
Lifting test 
Grip strength 
Goniometric 
measurements of 
wrist flexion 
Patient assessment. 
Measurements taken 
at baseline, end of 
treatment and at four 
weeks after the end 
of treatment 
Traditional 
physiotherapy 
better than 
laser 
Traditional 
physiotherapy 
better than laser 
61 
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totally. 
Ultrasound 
1Mhz 1.5 W/cm2 
pulsed, 
stationary head 
for seven 
minutes and deep 
transverse 
friction at the 
origin of ECRB 
as advocated by 
Cyriax for ten 
minutes. 
All treatments 
were given three 
times per week, 
8 treatments in 
all. 
Krasheninnikoff et 
al. (1994)  
 
n=36 19F 17M 
 37-64 ys 
Symptoms at least 
four weeks 
Ga-Al-As laser 
(18) Vs placebo 
laser (18). Laser 
was 
applied to tender 
points on lateral 
epicondyle and 
in forearm 
extensors for 120 
seconds (3.6 
J/point). 
Two times per 
week, 8 
treatments totally 
Pain on VAS and 
four point verbal 
scale pain score 
Grip strength 
Tender points on LE 
and in forearm 
extensors 
Measurements taken 
at baseline, end of 
treatment, 10 weeks 
after the last 
treatment 
No statistical 
significant 
difference 
between laser 
and placebo 
laser 
Laser not 
effective 
41 
Papadopoulos et 
al. (1996) 
n=29 10 M 19F 
mean age 45.3 ys. 
Symptoms for at 
Ga-Al-As laser 
(14) Vs placebo 
laser (15). 
Pain VAS 
Function with Marcy 
wedge 
No statistical 
significant 
differences 
Laser not 
effective 
48 
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least one month, 
with mean 25 weeks  
Laser was 
applied to the 
most tender spot 
for 60 seconds.  
Three times per 
week for two 
weeks 
Measurements taken 
at baseline and end of 
treatment. 
between laser 
and placebo 
laser 
Basford et al 
(2000)  
n= 47 28F 19M 
Mean age 45ys 
Symptoms for at 
least one month 
Laser (23) Vs 
placebo laser 
(24). Laser was 
applied 60 
seconds at seven 
sites along 
forearm (three 
sites 
immediately 
above, at and 
below LE, at 
distal wrist 
extensors, volar 
wrist, two sites 
on medical 
epicondyle with 
12.24 J/point 
Three times per 
week for four 
weeks. 
VAS pain 
Grip strength 
Pinch strength 
Tenderness on 
palpation 
Measurements taken 
at baseline, 6th 
treatment, end of 
treatment and one 
month after the end 
of treatment 
No statistical 
significant 
differences 
between the 
groups at the 
end of 
treatment or at 
follow-up 
Laser not 
effective 
64 
Binder et al. 
(1985) 
n=76 28M; 48 F Age 
29-65 ys 
Symptom duration at 
least one month 
Ultrasound  (38) 
Vs placebo 
ultrasound (38). 
Pulsed 
ultrasound 1:4; 
1.0 Mhz; 1-
2W/cm2 5-10 
min on the 
Pain VAS  
Lifting test 
Grip strength 
Measurements taken 
at baseline, every two 
weeks until the end 
of treatment, 1 month 
and one year after the 
Ultrasound 
better than 
placebo 
Ultrasound 
effective 
36 
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affected area 
12 treatments (2-
3 times per 
week) for 4-6 
weeks 
end of treatment 
Lundeberg et al. 
(1988)  
n=99 53M 46F 
age 21-68 ys 
Symptom duration at 
least one month 
Ultrasound (33) 
Vs placebo 
ultrasound (33) 
Vs rest (33). 
Ultrasound 
continuous 1Mhz 
1W/cm2 10 
minutes on the 
affected area 
10 treatments 2 
per week for 4-6 
weeks 
Pain VAS 
Pain with 
diagnostic tests 
Lifting test 
Grip strength 
Patient satisfaction 
Measurements taken 
at baseline, 1 month, 
three months and 12 
months after the end 
of treatment 
No significant 
difference 
between 
ultrasound and 
placebo. 
Significant 
difference 
between 
ultrasound and 
rest 
Ultrasound= 
placebo 
Ultrasound better 
than rest 
46 
Haker and 
Lundeberg (1991a) 
n=43  23M 20F 
age 34-67.2 ys 
Symptoms for at 
least one month 
Ultrasound (21) 
Vs placebo 
ultrasound (22). 
Pulsed 
ultrasound 1 
Mhz, 1:4; 1 
W/cm2, 2-3 times 
weekly at the 
tender site, 10 
treatments in all. 
Each treatment 
10 minutes 
Pain with diagnostic 
tests 
Lifting test 
Grip strength 
Global improvement 
Measurements taken 
at baseline, end of 
treatment, 3 and 12 
months after the end 
of treatment 
No statistical 
significant 
differences 
between the 
groups. 
Ultrasound not 
effective 
54 
Holdworth & 
Anderson (1993) 
n=36 16M 20F 
age 21-66 
For at least one 
month 
Phonophoresis 
Vs epicondylitis 
clasp. 
Continuous 
ultrasound 3 
Mhz, 1.5 W/cm2  
Pain VAS 
Lifting test 
Patient assessment 
Measurements taken 
at baseline, end of 
treatment, 1, 3 and 6 
No difference 
between the 
treatments at 
the end of 
treatment and 
at the follow-
Ultrasound not 
effective 
42 
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3 times per 
week, 12 
treatments in all. 
Epicondylitis 
clasp for one 
month 
months after the end 
of treatment 
ups. 
Pienimaki et al. 
(1996)  
n=39 14M 25F 
33-53 ys 
Symptom duration at 
least three months 
Home exercise 
programme (20) 
Vs ultrasound 
(19) 
Home exercise 
group: 
progressive slow 
repetitive wrist 
and forearm 
stretching 
muscle 
conditioning, 
occupational 
exercises 10 reps 
for 2-3 sets for 
each exercise 4-6 
times per day for 
6-8 weeks 
Ultrasound 
group: pulsed 
ultrasound 1:5 
1Mhz 0.3-0.7 
W/cm2 10-15 
minutes on the 
affected site 2-3 
times per week 
for 6-8 weeks 
Pain and function 
assessment using 
VAS and 
questionnaire 
Isokinetic testing of 
wrist 
Grip strength 
Measurements taken 
before and after the 
treatment  
Exercise 
programme 
more effective 
that ultrasound 
Exercise 
programme more 
effective that 
ultrasound 
68 
Brattberg  (1983) n=60 40M 20F 
Age 30-60ys 
Steroid injection 
(26) Vs 
Pain using a six point 
scale from worse to 
Acupuncture 
was better than 
Acupuncture 
effective  
15 
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Persistent LE acupuncture 
(34). 
Acupuncture was 
applied to L5 LI 
10,11,12 TI1 
points with 
needles for 15 
minutes. 2 
treatments per 
week for four 
weeks. No 
details of 
injections 
no pain 
Measures were taken 
1,3,6,12 months after 
the end of treatment  
 
injection at the 
end of 
treatment and 
at any follow-
up point 
Haker & 
Lundeberg (1990b) 
n=80 50M 30F 
25-70 ys 
Symptom duration at 
least one month 
Deep 
acupuncture (44) 
Vs superficial 
acupuncture 
(36). 
Deep 
acupuncture: 
Needles inserted 
corresponding to 
traditional 
Chinese 
acupuncture 
(LI10, LI11, 
LI12, Lu5, SJ5), 
inserted to depth 
of 1.25–2.5 cm; 
all rotated to 
illicit The Chi 
every five min 
during 20 min 
Superficial 
acupuncture: 
Pain with diagnostic 
tests 
Grip strength 
Lifting test 
Global measure of 
improvement 
Measurements taken 
at baseline, end of 
treatment, 3 months 
and 12 months after 
the end of treatment 
After 10 
treatments 
smaller 
number in 
traditional 
group suffered 
pain than in 
superficial 
group. No 
significant 
difference in 
any follow up 
point. 
Deep 
acupuncture 
effective in 
short-term 
43 
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Needles inserted 
superficially at 
same points as 
deep 
acupuncture 
treatment group; 
20 min; The Chi 
not 
obtained 
2-3 times per 
week 10 
treatments at all 
Molsberger & 
Hille (1994)  
n=48 Symptom 
duration at least two 
months 
Acupuncture Vs 
placebo 
Acupuncture. 
Acupuncture 
group: Needle on 
fibulatibial joint 
of homolateral 
leg, inserted 2 
cm; needle 
manipulated 
until felling of 
dull pressure and 
warmth; 5 min  
Placebo group: 
Pencil-like probe 
stimulated a 
point 1.5 cm 
lateral to T3 
(mock 
acupuncture); 
five min 
1 treatment 
 
Pain point scales 
were measured 
before, after and 12 
hours after the end of 
treatment  
Acupuncture 
better than 
placebo  
Acupuncture 
effective 
41 
                                                                                                                                                                                            Chapter 2: Table 2.4  
 
 
 60 
Fink et al.  (2002)  
 
n=45  
Symptom duration at 
least 3 months 
Acupuncture 
(23) Vs sham 
acupuncture (22) 
Acupuncture: six 
needles in Ash 
point, LI10, 
LI11, Lu5, LI4, 
SJ5; twisting 
needles until a 
De Qi sensation 
was induced; 25 
min  
Sham 
acupuncture: six 
needles: 
Puncture sites 
five cm away 
from the classic 
points and their 
interconnecting 
meridians and 
also clear of 
painful pressure 
points(Ah-Shi or 
trigger points), 
25 min 
 2 times per 
week for 2 
weeks 
Grip strength 
Pain VAS at rest, 
motion and resisted 
movement with a six 
point verbal rating 
scale (0-6) 
Functional 
impairment was 
measured with the 
Dash questionnaire 
Measurements taken 
at baseline, 2 weeks 
and 2 months after 
the end of treatment 
Acupuncture 
better than 
sham  
Acupuncture 
effective 
73 
Tsui & Leung  
(2003)  
n=20 
Chronic LE 
Manual 
acupuncture (10) 
Vs electro-
acupuncture 
(10).  
The acupuncture 
Pain VAS 
Grip strength 
Measurements taken 
at baseline and end of 
treatment 
Electro 
acupuncture is 
superior to 
manual 
acupuncture in 
treating LE 
Electro 
acupuncture is 
more effective 
than manual 
acupuncture 
46 
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points GB34 and 
ST38 were used 
in both groups. 
In the manual 
acupuncture 
group the needle 
was retained for 
20 minutes after 
the Deqi 
sensation 
obtained. In the 
electro- 
acupuncture 
group electrical 
stimulation with 
4 pulses/second 
frequency was 
applied  and 
treatment lasted 
for 20 minutes. 6 
treatments in 2 
weeks 
 
patients 
Rompe et al. 
(1996) 
n=100 42M 58F 
26-61 ys 
Symptoms for more 
than 12 months 
ESWT (50) Vs 
sham ESWT 
(50). 
 ESWT:  1000 
impulses of 
0.08mJ/mm2. 
Sham ESWT: 10 
impulses of 0.08 
mJ/mm2. ESWT 
and sham ESWT 
were 
administered at 
Pain VAS 
Pain with diagnostic 
tests 
Grip strength 
Global improvement 
Measurements taken 
at the end of 
treatment and at 3, 6 
and 24 weeks after 
the end of treatment 
ESWT more 
effective than 
ESWT placebo 
at the end of 
treatment and 
at follow-ups 
ups 
ESWT better 
than placebo 
ESWT 
55 
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the anterior 
aspect of the 
lateral 
epicondyle and 
at three points 
around this site 
at a radius of 1.5 
to 2 cm at a 
frequency of 3Hz 
at intervals of 
one week. 20-30 
minutes each 
session 
 
Haake et al. (2002) n=271 128M 143F 
Mean age 46.9+-8.5 
and 46.3+-9.6 
chronic LE 
ESWT (134) Vs 
sham ESWT 
(137). 
ESWT was 
applied three 
times in three 
weeks with 2000 
pulses and a 
energy flux 
density to be 
0.07-
0.09mJ/mm2. 
Sham ESWT 
was given in the 
same regimen, 
but a 
polyethylene foil 
filled with air 
and fixed with 
ultrasound gel in 
front of the 
Pain VAS 
Pain with diagnostic 
tests 
Grip strength 
Roles and Maudsley 
Score 
Measurements taken 
at the end of 
treatment, six weeks 
and 12 weeks after 
the end of treatment 
No significant 
difference 
between 
ESWT and 
placebo 
therapy at the 
end of 
treatment and 
at follow-ups. 
ESWT not 
effective 
75 
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coupling cushion 
totally reflected 
the shock waves. 
Speed et al. (2002)  n=75 33 M 42F 
26-70 ys 
Symptoms for at 
least 3 months 
ESWT (40) 
versus sham 
ESWT (35). 
ESWT was 
applied using 
1500 pulses at 
0.18mj/mm2. 
Sham ESWT 
was applied 
using 0.04 
mj/mm2. 20-30 
minutes each 
session. Three 
times in a month.  
Pain VAS 
Measurements taken 
at baseline and one 
month after the end 
of treatment 
No significant 
difference 
between the 
two groups. 
ESWT not 
effective 
53 
Crowther et al. 
(2002) 
n=73 38M 35F 
27-69ys 
Symptoms for at 
least 4 months 
ESWT (48) Vs 
corticosteroid 
injection (25) 
Injection in the 
origin of ECRB 
using 20 mg of 
triamcinolone 
made up to 1.5ml 
with 1% 
lignocaine using 
an aseptic 
technique. 
ESWT in the 
origin of ECRB 
2000waves 
maximum 
0.1MJ/mm2 three 
times at weekly 
Pain VAS 
Measurements taken 
at baseline, six weeks 
and three months 
after the end of 
treatment  
Injection was 
more effective 
treatment than 
ESWT at the 
end of 
treatments and 
at follow-ups 
ESWT less 
effective than 
corticosteroid 
injection 
56 
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intervals 
Deveraux et al. 
(1985) 
n=30 17M 13F 
Treatment group 
43.7+-2 and in 
placebo group 43.9 
+-2.5 
Symptom duration at 
least three months 
Pulsed 
electromagnetic 
field therapy 
regime (15) Vs 
placebo dummy 
coils (15) 
8 hours per day 
1-2 sessions per 
day for eight 
weeks 
Pain induced by 
lifting 
Incremental lifting 
test 
Pain with wrist 
dorsiflexion 
Effect on work 
Pain on routine daily 
tasks 
Tenderness over 
lateral epicondyle 
Grip strength 
Thermal gradient 
Measurements taken 
at baseline and every 
two weeks during the 
treatment period  
No significant 
differences 
between the 
groups 
Pulsed 
electromagnetic 
field therapy not 
effective 
      65 
Chard & 
Hazleman (1988) 
n=55 22M 23F 
22-68ys Symptom 
duration at least three 
months 
Pulsed 
electromagnetic 
field therapy 
regimen (23) Vs 
placebo dummy 
coils (22) 
8 hours per day 
for six weeks 
Pain VAS  
Grip strength 
Patient assessment 
Measurements taken 
at baseline and at the 
end of treatment 
No significant 
differences 
between the 
groups 
Pulsed 
electromagnetic 
field therapy not 
effective 
43 
Runeson & Haker 
(2002) 
n=64 41M 23F 
age 22-64ys 
Pain at least for one 
month  
Iontophoresis 
(33) Vs placebo 
iontophoresis 
(31). 
Iontophresis was 
applied with the 
IOMED device 
using 0.4% 
daxamethasone 
Pain with diagnostic 
tests 
Grip strength 
Measurements taken 
at baseline, end of 
treatment, 3 months 
and six months after 
the end of treatment 
No statistical 
significant 
difference 
between 
iontophoresis 
and placebo 
iontophoresis 
at the end of 
treatment and 
Iontophoresis not 
effective 
55 
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sodium phospate. 
The placebo 
group received 
saline. Current 
was 4mA. This 
was given four 
times for 2 
weeks, 10 
minutes each 
time 
at the follow-
ups. 
Verhaar et al. 
(1996) 
n=106 59M 47 
Mean age 43ys 
Symptoms duration 
no specified 
Corticosteroid 
injections Vs 
Cyriax 
physiotherapy 
Injection group: 
one injection and 
patients were 
then seen two 
and four weeks 
after the start of 
treatment and a 
second or third 
injection was 
given. 
Cyriax 
physiotherapy 
was given (deep 
transverse 
friction and 
Mill’s 
manipulation) 
for four weeks 
12 treatments, 
totally  
Severity of pain 
Occurrence of pain 
Subjective loss of 
grip strength 
Grip strength 
Pain with diagnostic 
tests 
Result rating 
Patient satisfaction 
level 
Resumption of labor 
Measurements taken 
at baseline, 6 weeks 
and 52 weeks after 
the end of treatment 
Corticosteroid 
injection better 
than Cyriax at 
6-week 
assessment no 
significant 
differences in 
one year 
follow-up 
Corticosteroid 
injection better 
than Cyriax at 
six weeks. No 
difference 
between the two 
treatments at 
long term follow 
up. Maybe both  
not effective. 
This is not 
specified 
44 
Abbreviations next page  
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M=male; F=female; VAS=visual analogue scale; n=number of patients; DASH=disabilities of the arm, shoulder, and hand; yr=years; 
reps=repetitions; ESWT=extracorporeal shock-wave therapy; He=Helium; Ne=Neon; Ga=Gallium; As=Arsenide; Al=Aluminium; 
W=watts; cm=centimeters; mm=millimeters; J=joule; min=minutes; LE= lateral epicondylitis; ECRB=Extensor carpi radialis brevis; Mhz= 
megahertz; Vs=versus  
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Table 2.5 
 
Evidence of effectiveness for physiotherapy treatments for the treatment of LE 
 
 
 
 
Treatment Evidence Effective Ineffective 
LLPL Level A  ++ 
Polarised polychromatic non-coherent light 
(Bioptron light) 
Level D  
?? 
 
?? 
Ultrasound Level A  ++ 
Acupuncture Level A ++  
ESWT Level A  ++ 
Pulsed electromagnetic field therapy Level A  ++ 
Iontophoresis Level B   ?? 
Cyriax physiotherapy Level D ?? ?? 
Home exercise programme Level B ??  
Supervised exercise programme Level D ?? ?? 
++ = Strong evidence, but further well-designed studies are needed in order to draw  
         definite conclusions for recommendations. Acupuncture is a short-term effective  
         treatment. 
?? = More research 
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Chapter 3: A critical review of the literature to establish 
treatment protocols based on the claims of manufacturers and 
anecdotal reports from therapists for Cyriax physiotherapy, a 
supervised exercise programme and polarised polychromatic 
non-coherent light (Bioptron light) for the management of the 
pain and functional impairment of lateral epicondylitis 
                                                                                                                                                                                                                                                                                                                                                                                                                                 
3.1 Introduction 
The systematic review conducted in the previous chapter found strong evidence for the 
short-term effectiveness of acupuncture for LE. It also found strong evidence that four 
modalities, LPLL, ultrasound, ESWT, and pulsed electromagnetic field therapy were 
not effective physiotherapy treatments for the management of LE. There was 
insufficient evidence to determine the effectiveness of other treatments (e.g. 
iontophoresis and home exercise programmes). The systematic review also revealed the 
possibility that treatments may have been incorrectly administered, since optimal 
treatment protocols are unknown and that this may have been accounted for the lack of 
effects in these RCTs. Chapter 2 recommended that more evidence is needed for Cyriax 
physiotherapy, supervised exercise programmes, and polarised polychromatic non-
coherent light (Bioptron light). However, it is necessary to establish optimal protocols 
for them before a suitable clinical trial can be designed. Chapter 2 provided information 
only for the treatment protocol of Cyriax physiotherapy on LE, because this 
physiotherapy treatment was used in one RCT (Verhaar et al., 1996).   
 
3.2 Aim 
This chapter discusses a critical review of literature in an attempt to establish treatment 
protocols for Cyriax physiotherapy, supervised exercise programmes, and polarised 
polychromatic non-coherent light (Bioptron light), for the management of pain and 
functional impairment associated with LE.  
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3.3 Methods 
An electronic search for clinical studies was carried out in six databases: Medline (from 
1966 to December 2002), Embase (from 1988 to December 2002), Cinahl (from 1982 to 
December 2002), Index to Chiropractic literature (from 1992 to December 2002) 
SportDiscus (from 1990 to December 2002) and Chirolars (from 1994 to December 
2002). A search took a very broad approach in order to capture all published material 
from any source including any clinical study, review, and letters to editors of journals. 
The following key words were used individually or in various combinations:  “tennis 
elbow”, “lateral epicondylitis”, “lateral epicondylalgia”, “extensor tendinopathy”, 
“extensor tendonitis”, “extensor tendinosis”, “rehabilitation”, “treatment”, 
“management”, “protocol”, “optimal protocol”, “Cyriax physiotherapy”, “exercise 
programme”, “exercise therapy”, “polarized light”, “polarized light therapy”, “Bioptron 
light”, “claims”, “experts’ claims”, “manufacturers’ claims” and “clinicians’ claims”.  
 
Only English language publications were considered. Other references were attempted 
to identify from existing reviews, books and other papers cited in the publications 
searched. Additional reports were sought from the reference sections of papers that were 
retrieved, from contacting experts in the field, from the Cochrane Collaboration clinical 
trial register (last search December 2002) and from internet sites such as 
www.bioptron.com. Unpublished reports and abstracts were included in the review. 
 
Treatment protocols would be developed using the following criteria: 
(i) Methodological quality of the clinical study. Studies that report a treatment protocol        
     that is effective will be given credence.  
(ii) Clinical observations will be given greater credence over theoretical papers. 
(iii) Credibility of particular commentators, authors and experts. 
 
3.4 Cyriax physiotherapy 
A review of the literature revealed that Cyriax physiotherapy for treating LE consists of 
DTF and Mill’s manipulation (Cyriax, 1982; Kesson and Atkins, 1998). Mill’s 
manipulation is performed immediately after the DTF (Cyriax, 1982). No literature was 
found to contradict this Cyriaxs’ approach (Stasinopoulos and Johnson, 2004d). DTF 
and Mill’s manipulation have been administered separately for LE in previously 
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published studies (Burton, 1988; Stratford et al., 1989; Dwars et al., 1990; Vasseljen, 
1992; Drechsler et al., 1997; Smidt et al., 2002b; Struijs et al., 2003; Struijs et al., 
2004). In all these studies, Cyriax physiotherapy was not administered but components 
of Cyriax physiotherapy were administered as advocated by Cyriax (1982). Cyriax 
(1982) claimed that, if clinicians intended to use Cyriax physiotherapy in treating 
patients with LE, it could only be considered Cyriax physiotherapy in treating patients 
with LE if the two therapy components were used together in the order mentioned, 
rather than separately or in another order. Cyriax physiotherapy consists of DTF only in 
the rest tendinopathies (Cyriax, 1982). The reasons why Cyriax physiotherapy is applied 
in a different way between LE and rest tendinopathies will be discussed in chapter 7. 
Both components of Cyriax physiotherapy are based on the clinician’s experience and 
the patient’s verbal feedback; for this reason, these two components cannot be given in 
a standardized way. Cyriax physiotherapy treatment is individualised on the basis of the 
patient’s description of pain experienced during the procedure. If the patient reports too 
much pain the therapist reduces the intensity of DTF/Mill’s manipulation. Cyriax 
(1982) and Kesson and Atkins (1998) stated that Cyriax physiotherapy was 
administered to patients three times per week for four weeks (a month).  
 
3.4.1 DTF  
DTF is a specific type of connective tissue massage applied precisely to the soft-tissue 
structures such as tendons, in the case of LE to the ECRB tendon (Cyriax, 1982; 
Chamberlain, 1982; de Bruijn, 1984; Noteboom et al., 1994; Selvier and Wilson, 1999; 
Selvier and Wilson, 2000; Wright and Sluka, 2001). Although some practitioners using 
this technique maintain that the word “friction” is technically incorrect and would be 
better replaced by the word “massage” (Kesson and Atkins, 1998; Sevier and Wilson, 
1999), this project uses “friction” because this is the term advocated by Cyriax. DTF 
was developed in an empirical way by Cyriax and is currently used extensively in 
rehabilitation practice (Noteboom et al., 1994; Selvier and Wilson, 1999; Selvier and 
Wilson, 2000) because it is believed that the application way of DTF can really help in 
the management of collagen tissue (section 3.4.4). However, the experience of Cyriax is 
an unreliable tool to determine the effectiveness of DTF (Ernst, 1995) and therefore 
more research in the form of well-designed clinical trials is needed to determine its 
effectiveness.  
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DTF advocates claim that DTF should be administered only at the exact site of the 
lesion, with the depth of the DTF that is tolerable to the patient; relief cannot otherwise 
be expected (Cyriax, 1982; Chamberlain, 1982; de Bruijn, 1984; Kesson and Atkins, 
1998). However, to find the exact site of lesion, the correct clinical diagnosis, the 
anatomical knowledge and palpation skills of the physical therapist must be 
considerable (Cyriax, 1982; Kesson and Atkins, 1998).  In addition, the depth of DTF to 
reach and benefit the target issue is dependent upon the irritability of the lesion and the 
verbal feedback from the patient (Cyriax, 1982; Chamberlain, 1982; Kesson and Atkins, 
1998; Selvier and Wilson, 1999; Selvier and Wilson, 2000). 
 
Advocates claim that DTF should be administered transversely across the longitudinal 
orientation of the fibre of the specific structure involved. It is claimed that this kind of 
DTF application assist tissue healing (section 3.4.4). This is unlike superficial massage, 
which is given in a longitudinal direction, parallel to the vessels. Superficial massage is 
said to enhance circulation and the return of fluids (Cyriax, 1982; Kesson and Atkins, 
1998). It is also claimed that the therapist’s fingers and patient’s skin should move as a 
single unit when DTF is performed; otherwise subcutaneous fascia could lead to blister 
formation or subcutaneous bruising due to friction (Chamberlain, 1982). The most 
efficient way to achieve the movement of the therapist’s fingers and patient’s skin as a 
single unit during the DTF application is to apply the DTF in two directions. Pressure is 
first directed down onto the structure and maintained whilst the transverse sweep is 
applied (Kesson and Atkins, 1998).  
 
It is generally recommended that DTF be applied for 10 minutes every other day or at a 
minimum interval of 48 hours, preparing the tendon for Mill’s manipulation (Cyriax, 
1982; Chamberlain, 1982; Kesson and Atkins, 1998; Selvier and Wilson, 1999; Selvier 
and Wilson, 2000). Only empirical evidence does support the above suggested times. 
However, increasing the time of DTF application clinicians claim that this method 
places a considerable strain on the hands of the treating clinician, who find it exhausting 
(Stratford et al., 1989; Vasseljen, 1992; Noteboom et al., 1994; Selvier and Wilson, 
1999; Selvier and Wilson, 2000; Wright and Sluka, 2001). The considerable strain on 
the hands of the treating clinician may result in the loose and no correct application of 
the technique or increase the possibility of injury. In addition, in the application of DTF 
daily the lesion would be tender from the previous day’s encounter to tolerate adequate 
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treatment. Over the years, the technique has unfortunately developed a reputation for 
being very painful for the patient (Ingham, 1981; Woodman and Pare, 1982; de Bruijn, 
1984). However, pain during DTF application is usually the result of a wrong 
indication, a wrong technique, an unaccustomed amount of pressure, or a combination 
of the above three and usually results from the administration of DTF by a 
physiotherapist inexperienced with this technique (Cyriax, 1982; Chamberlain, 1982; 
Kesson and Atkins, 1998). It is claimed that if DTF is administered by a physiotherapist 
experienced with this technique, one who has a certification or diploma in orthopaedic 
medicine based on Cyriax principles, DTF will not be at all a painful experience for the 
patient (Cyriax, 1982; Chamberlain, 1982; Kesson and Atkins, 1998).  
 
Absolute contraindications to DTF are few. DTF should never be applied to active 
infections, bursitis and disorders of nerve structures, ossification and calcification of the 
soft tissues, and active rheumatoid arthritis. Care must be taken if there is fragile skin or 
if the patient is currently undergoing anticoagulant therapy (Cyriax, 1982; Chamberlain, 
1982; de Bruijn, 1984; Galloway et al., 1992; Kesson and Atkins, 1998). These 
contraindications are overcome if  (i) clinicians diagnose the condition correctly 
(bursitis, active rheumatoid arthritis, disorders of nerve structures and anticoagulant 
therapy); (ii) a plain X-ray of the affected structure has been taken (in the suspicion of 
ossification and calcification of the soft tissues) and (iii) clinicians check the skin for 
infections. 
 
3.4.1.1 Recommendations for the application of DTF for the treatment of LE 
It is claimed that, for the treatment of LE, DTF should be applied as in the following 
manner (Cyriax, 1982; Kesson and Atkins, 1998). The patient should be positioned 
comfortably on a bed with the elbow on a pillow fully supinated and in ninety degrees 
of flexion. The therapist should stand at the side of the affected elbow to locate the 
inferior-lateral aspect of the lateral epicondyle to identify the area of tenderness. The 
therapist applies DTF with the side of the thumb tip, applying pressure using the thumb 
in a posterior direction to the origin of ECRB tendon. The therapist maintains this 
pressure whilst imparting DTF and holding the other side of the patient’s elbow to 
establish counter-pressure (Figure 3.1). The DTF is administered for ten minutes to 
prepare the tendon for the Mill’s manipulation. 
 
                                                                                                                            Chapter 3 
 73 
3.4.2 Mill’s manipulation 
Mill’s manipulation is defined as a passive movement performed at end of the elbow-
extension range, i.e. it is a minimal amplitude high-velocity extension thrust at the 
elbow once the full range of elbow extension has been taken up (Cyriax, 1982; Kushner 
and Reid, 1986; Kesson and Atkins, 1998; Selvier and Wilson, 1999; Selvier and 
Wilson, 2000). Cyriax (1982) claims that Mill’s manipulation should be performed 
immediately after the DTF, otherwise the effectiveness of Mill’s manipulation could be 
reduced. Several authors stated that Mill’s manipulation was the most common 
manipulative technique among physical therapists (Kushner and Reid, 1986; Selvier and 
Wilson, 1999; Selvier and Wilson, 2000) because Mill’s manipulation was the only 
known manipulative technique for the management of musculoskeletal injuries in the 
extremities. Although mobilization with movement developed by Mulligan is a new 
manipulative technique for the management of extremities’ injuries, Mill’s 
manipulation remains one of the most common manipulative techniques for 
musculoskeletal disorders. 
 
It is claimed that Mill’s manipulation is conducted once only at each treatment session 
since it is not a comfortable procedure for the patient (Cyriax, 1982; Kushner and Reid, 
1986; Kesson and Atkins, 1998). In addition, Cyriax claims that Mill’s manipulation 
should be performed when the patient has a full range of passive elbow extension 
(Cyriax, 1982). If the patient has limitations of passive elbow extension, the 
manipulative thrust is said to affect the elbow joint rather than the ECRB tendon, 
possibly causing a traumatic arthritis (Cyriax, 1982; Kesson and Atkins, 1998). 
Moreover, traumatic arthritis is also said to be a risk if Mill’s manipulation is performed 
poorly by physical therapists who fail to maintain full wrist flexion during the 
application of Mill’s manipulation. In that case the thrust is said to be absorbed mainly 
by the elbow joint. Finally, it is claimed that during the application of Mill’s 
manipulation, the patient must avoid leaning away, either forwards or sideways from 
therapist, because this will reduce the tension on the ECRB tendon (Cyriax, 1982; 
Kushner and Reid, 1986; Kesson and Atkins, 1998). 
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3.4.2.1 Recommendations for the application of Mill’s manipulation for the treatment 
of LE 
Cyriax (1982) recommended that Mill’s manipulation for LE is administered as follows. 
The patient should be positioned on a chair with a backrest. The clinician stands behind 
the patient and supports the patient’s arm under the crook of the elbow with the 
shoulder joint abducted to ninety degrees and medially rotated. The forearm will 
automatically fall into pronation. The clinician places the thumb of his or her other hand 
in the web space between the patient’s thumb and index finger and fully flexes the 
patient’s wrist and pronates the forearm. The clinician moves the hand supporting the 
crook of the elbow onto the posterior surface of the elbow joint and, whilst maintaining 
full wrist flexion and pronation, fully extends the patient’s elbow, then applies a 
minimal amplitude high-velocity thrust by simultaneously side-lexing the clinicians 
own body away from his or her arms and pushing smartly downwards with the hand 
over the patient’s elbow (Figure 3.2). 
 
3.4.3 Recommendations for the application of Cyriax physiotherapy for the treatment 
of LE 
Cyriax physiotherapy for LE should consist of 10 minutes of DTF followed 
immediately by one instance of Mill’s manipulation (Figure 3.3). Cyriax physiotherapy 
should be administered in a clinical setting by a physiotherapist experienced in 
providing this treatment and having a certificate or diploma in orthopaedic medicine 
based on Cyriax principles. DTF and Mill’s manipulation should be delivered as 
described in sections 3.4.1.1 and 3.4.2.1, three times per week for four weeks. Cyriax 
physiotherapy treatment is individualised by the patient’s description of the pain 
experienced during the procedure. In the only previously published RCT of Cyriax 
physiotherapy, the therapy was administered in a manner identical to Cyriaxs’ views 
(Verhaar et al., 1996).  
 
3.4.4 How Cyriax physiotherapy works 
It has been postulated that Cyriax physiotherapy can be used for both symptomatic 
relief of pain and promotion of tissue healing. Although the exact mode of action of 
Cyriax physiotherapy to achieve the previously reported goals is not known, some 
theoretical explanations have been put forward in respect to DTF mainly. 
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3.4.4.1 Pain relief 
A number of hypotheses have been proposed to explain the pain relief that is said to 
follow the application of DTF as part of Cyriax physiotherapy. 
 
Pain relief during and after DTF application may be due to modulation of the 
nociceptive impulses at the level of the spinal cord: the‘‘gate control theory ’’. Pressure 
stimulates low-threshold mechanoreceptors in the skin that reduces the excitability of 
the nociceptor terminals on the central nervous system by presynaptic inhibition, 
effectively “closing the gate” on the pain (Goats, 1994; Gregory et al., 2003). The 
greater the mechanoreceptor stimulation, the greater the level of pain suppression 
(Bowsher, 1988; Wells, 1988). Quite simply, rubbing a painful spot reduces pain, 
enabling the application of DTF to be graded in depth, specific to individual lesions, 
and thus to produce its beneficial effects (Kesson and Atkison, 1998). 
 
According to Cyriax (1982) the application of DTF can produce vasodilatation and 
increase blood flow to the affected area (hyperemia). It may be hypothesised that 
hyperemia appears to diminish pain by firstly facilitating the removal of chemical 
irritants such as Lewis’ P substance, probably due to release of histamine (Chamberlain, 
1982) and secondly through diffuse noxious inhibitory controls (de Bruijn, 1984; 
Melzack and Walls, 1988), a descending pain suppression mechanism that releases 
endogenous opiates (Chamberlain, 1982; Walker, 1984; Galloway et al., 1992; Goats, 
1994). The latter are inhibitory neurotransmitters that diminish the intensity of the pain 
transmitted to higher centers (Goats, 1994). 
 
3.4.4.2 Tissue healing 
It is now generally recognised that internal and external mechanical stress applied to the 
repair tissue is the main stimulus for remodeling immature and weak scar tissue with 
fibres oriented in all directions and through several planes into linearly rearranged 
bundles of connective tissue (Hardy, 1989). Therefore, during the healing period, the 
affected structures should be kept mobile by using them normally. However, because of 
pain, the tissues cannot be moved to their full extent. This problem can be solved by the 
application of DTF. DTF imposes rhythmical stress transversely to the remodeling 
collagenous structures of the connective tissue and thus reorients the collagen in a 
longitudinal fashion with the result of enhancing tensile strength (Chamberlain, 1982; 
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de Bruijn, 1984; Galloway et al., 1992).  Tensile strength is the maximum stress or load 
sustained by a material (Kesson and Atkins, 1998). Tensile strength is related to a 
balance between the synthesis and lysis of collagen, the development of collagen cross-
links and the orientation of collagen fibres in the existing weave (Kesson and Atkins, 
1998).  
 
In this way, DTF can produce therapeutic movement by breaking down the strong 
cross-links or adhesions that have formed on the “injured” structure, tendon in this case 
(Chamberlain, 1982; Walker, 1984; Galloway et al., 1992; Goats, 1994). DTF achieves 
this effect by softening scar tissue and mobilizing the cross-links between the mutual 
collagen fibres and the adhesions that link still-healing connective tissue and the 
surrounding tissues (Chamberlain, 1982; Walker, 1984; Galloway et al., 1992; Goats, 
1994). 
 
Similar to the previously reported aim of DTF, the purpose of Mill’s manipulation when 
it is performed correctly by experienced therapists with this technique is to elongate the 
scar tissue by rupturing adhesions within the tenooseous junction, thus making the area 
mobile and pain free (Cyriax, 1982, Kushner and Reid, 1986; Kesson and Atkins, 
1998). Experimental evidence to support the previously reported claim is lacking. 
 
3.5 Supervised exercise programmes 
Exercise programmes are used extensively for the physical management of LE 
(Noteboom et al., 1994; Selvier and Wilson, 1999; Kraushaar and Nirschl, 1999; Selvier 
and Wilson, 2000; Wright and Sluka, 2001). Such programmes consisting of 
strengthening exercises and especially of eccentric contractions (section 3.5.1.1) offer 
adequate rehabilitation for tendinopathies but many patients with patellar tendinopathy 
do not respond to this prescription alone (Cannell et al., 2001). Home exercise 
programmes consisting of both strengthening and stretching exercises have shown good 
clinical results in tendinopathies similar to LE (Niesen-Vertommen et al., 1992; 
Alfredson et al., 1998; Mafi et al., 2001; Silberhagel et al., 2001) because tendons must 
not only be strong but flexible as well. Despite the lack of trials to investigate the 
effectiveness of supervised exercise programmes on tendinopathies, the literature on 
this subject suggests that strengthening and stretching exercises are the main 
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components of supervised exercise programmes (Noteboom et al., 1994; Selvier and 
Wilson, 1999; Selvier and Wilson, 2000). 
 
3.5.1 Strengthening exercises 
There are essentially three forms of musculotendinous contractions that strengthen soft-
tissue structures such as tendons: (i) isometric, in which the muscle resists an applied 
force and the muscle-tendon unit length is constant (no work); (ii) concentric, in which 
the muscle resists an applied force and the muscle-tendon unit shortens (positive work) 
and (iii) eccentric, in which the muscle resists an applied force and the muscle-tendon 
unit lengthens (negative work) (Stanish et al., 1986; Stanton and Purdam, 1989; Fyfe 
and Stanish, 1992; Pienimaki, 2000). Of these three forms of contractions, most 
therapists agree that eccentric contractions appear to have the most beneficial effects for 
the treatment of LE (Stanish et al., 1986; Selvier and Wilson, 1999; Kraushaar and 
Nirschl, 1999; Selvier and Wilson, 2000; Stanish et al., 2000; Cook et al., 2000; Khan et 
al., 2000a; Khan et al., 2002). Eccentric training is associated with greater strength 
development than both concentric and isometric contractions (Stanton and Purdam, 
1989; Fyfe and Stanish, 1992; Kellis and Baltzipoulos, 1995; Hawary et al., 1997). 
Increasing the tendon strength the chance of eccentric overload injury decreases 
(Stanton and Purdam, 1989; Kellis and Baltzopoulos, 1995; Stanish et al., 2000). 
Eccentric exercises as components of a home exercise programme have been shown to 
have positive effects on tendinopathies (Niesen-Vertommen et al., 1992; Alfredson et 
al., 1998; Mafi et al., 2001; Silberhagel et al., 2001). Moreover, therapists advocate 
eccentric exercises only for the “injured” tendon and not for all tendons in the relevant 
anatomic region, because the tensile strength of the injured tendon should be increased 
(section 3.5.4). This procedure was followed in previously published trials on 
tendinopathies (Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 
2001; Silberhagel et al., 2001). In the case of LE, eccentric training should be performed 
for the extensor tendons of the wrist, including the ECRB tendon, which LE most 
commonly affects (Stanish et al., 1986; Fyfe and Stanish, 1992; Khan et al., 2000a; 
Cook et al., 2000; Stanish et al., 2000; Khan et al., 2002), because the origin of extensor 
tendons of the wrist (including the ECRB) is common in the relevant anatomical area 
and it is impossible to be isolated and strengthened only the affected ECRB tendon. 
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3.5.1.1 Eccentric exercises 
The three principles of eccentric exercises are: 1) the load (resistance), 2) the speed 
(velocity) and 3) the frequency of contractions.  
 
3.5.1.1.1 Load (resistance) 
One of the main principles of eccentric exercises is increasing the load (resistance) on 
the tendon progressively. Increasing the load clearly subjects the tendon to greater stress 
and forms the basis for the progression of the programme. Indeed, this principle of 
progressive overloading forms the basis of all physical-training programmes. Therapists 
believe that the load of eccentric exercises should be increased according to the 
patients’ symptoms, otherwise the possibility of re-injury is high (Stanish et al., 1986; 
Noteboom et al., 1994; Hawary et al., 1997; Selvier and Wilson, 1999; Kraushaar and 
Nirschl, 1999; Selvier and Wilson, 2000; Stanish et al., 2000; Khan et al., 2000a; 
Wright and Sluka, 2001; Khan et al., 2002). The load of eccentric exercises was 
increased according to the patients’ symptoms in previously published trials on 
tendinopathies ((Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 
2001; Silberhagel et al., 2001) because the opposite has shown poor results (Jensen and 
Di Fabio, 1989). The rate of increase of the load cannot be standardized among patients 
during the treatment period because each patient does not have the same endurance in 
the pain. Furthermore, anecdotal evidence in the form of discussion with therapists 
suggested that they did not have a protocol to account for how the injured tendon, which 
is loaded eccentrically, gets back to a starting position without experiencing concentric 
loading. Although eccentric training develops greater strength than concentric training 
as mentioned above in order to demonstrate the real effects of eccentric exercises, 
clinicians would need ways to avoid concentric loading of the tendon, otherwise the 
effectiveness of eccentric exercises may become controversial in the future. One 
approach would be to use the non-injured extremity in order to return the injured 
extremity to the starting position (passive return). This approach was followed in 
Alfredson et al (1998) trial.  
 
3.5.1.1.2 Speed (velocity) 
Another basic principle to ensure the success of eccentric exercises is the speed 
(velocity) of contractions. Stanish et al (1986), Fyfe and Stanish (1992) and Stanish et al 
(2000) state that the speed of eccentric training should be increased in every treatment 
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session, so that increasing the speed also increases the load on the tendon to simulate 
the mechanism of injury better, which usually occurs at relatively high velocities. 
Following this approach in a trial, patients with patellar tendinopathy continue to 
complain of pain at the end of the treatment (Jensen and Di Fabio, 1989). However, 
other therapists claim that eccentric contractions are performed at a slow velocity to 
avoid the possibility of re-injury (Krushaar and Nirschl, 1999; Selvier and Wilson, 
1999; Selvier and Wilson, 2000; Pienimaki, 2000; Khan et al., 2000a; Wright and 
Sluka, 2001; Khan et al., 2002). Eccentric exercises were performed at slow speed in 
every treatment session in previous studies giving good clinical results (Niesen-
Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; Silberhagel et al., 
2001). In contrast to traumatic events, which produce rapid eccentric forces, low-
velocity eccentric loading presumably does not exceed the elastic limit of the tendon 
and generates less injurious heat within the tendon assisting tissue healing and avoiding 
the possibility of re-injury (Kraushaar and Nirschl, 1999). Therapists and previously 
published trials of home exercise programmes on tendinopathies (Niesen-Vertommen et 
al., 1992; Alfredson et al., 1998; Mafi et al., 2001; Silberhagel et al., 2001) do not 
define the “slowness” of eccentric exercises. The most likely explanation for this lack of 
definition is the claim that in order to avoid pain, patients perform the eccentric 
exercises slowly because the development of speed should be based always on the 
endurance of patients in pain. Nevertheless, when a supervised exercise programme 
treatment protocol is developed, the “slowness” of eccentric exercises should be 
defined. Failure to do so will make it difficult for therapists to replicate the exercise 
programme and put it into practice. Based on a home exercise programme, which was 
given as part of a physiotherapy treatment for the management of LE, the patients 
performed each repetition counting to thirty (Dwars et al., 1990). 
 
3.5.1.1.3 Frequency of contractions 
The third principle of eccentric exercises is the frequency of contractions. Sets and 
repetitions can vary in literature, but therapists claim that three sets of ten repetitions, 
with the elbow in full extension, forearm in pronation and with the arm supported, can 
normally be performed without overloading the injured tendon, as determined by the 
patient’s tolerance (Stanish et al., 1986; Fyfe and Stanish, 1992; Noteboom et al., 1994; 
Hawary et al., 1997; Selvier and Wilson, 1999; Kraushaar and Nirschl, 1999; Stanish et 
al., 2000; Selvier and Wilson, 2000). Although three sets of eccentric exercises have 
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been performed in previously published trials of home exercise programmes on 
tendinopathies (Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 
2001; Silberhagel et al., 2001), more repetitions in each set were used in these studies. 
The most likely explanations for the difference in the repetitions of eccentric 
contractions between therapists’ claims for LE and previously conducted trials on the 
rest tendinopathies may be the different type of exercise programmes (home versus 
supervised) and the different amount of strength that the tendon needs to achieve its aim 
(Achilles and patellar tendons versus EBRC tendon). Therapists recommend one-minute 
rest intervals between each set (Stanish et al., 1986; Pienimaki, 2000). Although there is 
lack of evidence to support the previously reported rest interval, it is claimed essential 
to define and accept this rest interval in order to avoid the possibility of tendon re-injury 
(increase of temperature, fatigue). In addition, the rest interval between the sets should 
be defined, so that the exercise programme can be replicated by therapists. Therefore, 
this period of time will be used in our trial (Chapter 6). 
 
If the affected arm is not supported, therapists claim that patients complain of pain in 
other anatomical areas distant from elbow joint, areas such as the shoulder, neck and 
scapula (Hawary et al., 1997; Selvier and Wilson, 1999). Furthermore, therapists claim 
that the elbow has to be in full extension and the forearm in pronation, because, in this 
position, the best strengthening effect for the extensor tendons of the wrist is achieved 
(Selvier and Wilson, 1999; Pienimaki, 2000). However, there is no information about 
the treatment regimen of supervised exercise programmes, that is, the number of 
sessions and frequency of treatment (MacPherson et al., 2002) for the performance of 
these eccentric exercises. The literature offers information about treatment regimens 
only for home exercise programmes based on studies for other tendinopathies (Niesen-
Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; Silberhagel et al., 
2001). However, one cannot be based on treatment regimen of home exercise 
programmes in order to develop the treatment regimen of supervised exercise 
programmes on LE. The two exercise programmes differ not only in the environment 
that they are conducted but also in the compliance of patients.  
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3.5.1.2 Recommendations for the application of eccentric exercises for the treatment 
of LE 
Based on the above evaluation, eccentric exercises for LE should be performed with 
elbow supported on the bed in full extension, forearm in pronation, wrist in extended 
position (as high as possible) and the hand hanging over the edge of the bed (Figure 
3.4). In this position, patients flex their wrist slowly counting to thirty until to achieve 
full flexion (Figure 3.5) and then return to the starting position with the help of the other 
hand (Figure 3.6). Patients are instructed go ahead with the exercise even if they 
experience mild pain. However, they are instructed to stop the exercise if the pain 
becomes disabling. They perform 3 sets of 10 repetitions at each treatment session, with 
one-minute rest intervals between each set. When patients are able to perform the 
eccentric exercises without experiencing any minor pain or discomfort, the load is 
increased using free weights (Figures 3.7 and 3.8). However, no literature could be 
found to explain the treatment regimen of the eccentric exercises. This issue will be 
explored by conducting a survey of existing practitioners’ reports of their use of a 
supervised exercise programme for the treatment of LE (Chapter 5).  
 
The starting positions and final positions of eccentric exercises cannot properly be 
standardized for patients, nor can the increase of the load and the degree of mild or 
disabling pain because all these are individualized by patients’ descriptions of pain 
experienced during the procedure. 
 
3.5.2 Stretching exercises 
Even though a variety of stretching techniques such as ballistic, static and 
proprioceptive neuromuscular facilitation has been proposed to increase flexibility, 
there is a concern as to what stretching techniques and/or procedures should be used for 
optimal gains in flexibility. Flexibility has been defined as the range of motion possible 
about a single joint or through a series of articulations (Alter, 1996; Prentice, 1999). 
Therapists claim that static stretching, an extremely effective and simple stretching 
procedure, is the most widely used stretching technique (Hubley et al., 1984; Stanish et 
al., 1986; Fyfe and Stanish, 1992; Noteboom et al., 1994; Stanish et al., 2000; Selvier 
and Wilson, 2000; Shrier and Gossal, 2000; Feland et al., 2001). This kind of stretching 
technique has been used as component of home exercise programmes in previously 
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published trials on tendinopathies (Jensen and Di Fabio, 1989; Niesen-Vertommen et 
al., 1992; Alfredson et al., 1998; Mafi et al., 2001; Silberhagel et al., 2001). 
 
3.5.2.1 Static stretching exercises 
Static stretching is defined as passively stretching a given muscle-tendon unit by 
placing it in a maximal position of stretch slowly and sustaining it there for an extended 
period of time (Sandy et al., 1982; Taylor et al., 1990; Smith, 1994; Bandy et al., 1997; 
Webright et al., 1997; Selvier and Wilson, 2000). This maximal stretching position is 
determined by the moderate discomfort and/or pain that the patient experiences 
(Prentice, 1999; Shrier and Gossal, 2000; Stanish et al., 2000). Static stretching 
exercises are individualized by patient feedback as to the discomfort and/or pain 
experienced during the procedure. This approach was followed in previously published 
trials on tendinopathies similar to LE (Jensen and Di Fabio, 1989; Niesen-Vertommen 
et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; Silberhagel et al., 2001). 
Performing the static stretching slowly it is impossible for the stretch reflex that causes 
contraction of the muscle tendon unit instead of relaxation to be stimulated. 
Furthermore, the resistance of the muscle tendon unit in slow static stretching is less 
than in a quick static stretching because muscle tendon unit is a viscoelastic structure 
with result its elongation.  
 
Therapists’ advocate static stretching exercises only for the “injured” tendon and not for 
all tendons in the anatomic region. Similar to this, static stretching exercises were 
advocated for the “injured” tendon in previously published trials on Achilles 
tendinopathy (Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; 
Silberhagel et al., 2001). In addition, the “injured” tendon may be tight with decreased 
tensile strength and the stretching technique can reverse this (section 3.5.4). On the 
other hand, in Jensen and Di Fabio (1989) patellar tendinopathy study static stretching 
exercises were described for quadriceps and hamstrings. The reason why static 
stretching exercises are applied in a different way between patellar and rest 
tendinopathies will be discussed in chapter 7. In the case of LE, static stretching should 
be performed for the ECRB tendon, the site most commonly affected by LE (Stanish et 
al., 1986; Stanish et al., 2000; Khan et al., 2002). The best stretching position result for 
the ECRB tendon is achieved with elbow in extension, the forearm in pronation and the 
wrist in flexion and an ulnar deviation according to the patients’ tolerance (Selvier and 
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Wilson, 1999). In contrast with the strengthening exercises that it was not possible to be 
isolated the ECRB tendon, in stretching exercises the ECRB tendon can be isolated 
following the previously reported technique. 
 
Recommendations for the optimal time for holding this stretching position vary, ranging 
from as little as 3 seconds to as much as 60 seconds (Herling, 1981; Sandy et al., 1982; 
Smith, 1994; Bandy et al., 1997; Webright et al., 1997). Therapists believe that a stretch 
for 30 to 45 seconds is the most effective for increasing tendon flexibility (Stanish et al., 
1986; Fyfe and Stanish, 1992; Bandy et al., 1997; Selvier and Wilson, 1999; Shrier and 
Gossal, 2000; Selvier and Wilson, 2000; Stanish et al., 2000). Several studies have 
indicated that holding a stretch for 30-45 seconds is the most effective for increasing 
tendon flexibility (Medding et al., 1987; Lentell et al., 1992; Bandy, 1994; Bandy et al., 
1997). Stretches lasting for longer than 45 seconds seem to be uncomfortable for 
patients without better results (Sandy et al., 1982; Madding et al., 1987; Lentell et al., 
1992; Smith, 1994; Bandy, 1994; Bandy et al., 1997; Webright et al., 1997). This time 
period is sufficient for the Golgi tendon organs to begin responding to the increase in 
tension. The impulses from the Golgi tendon organs can override the impulses coming 
from the muscle spindles, allowing to the muscle tendon unit to reflexively relax after 
the initial reflex resistance to the change in length (Prentice, 1999). Lengthening the 
muscle tendon unit and allowing it to remain in a stretched position for an extended 
period of time is unlikely to produce any injury to the muscle tendon unit. This time 
period was followed in previously published trials on tendinopathies (Jensen and Di 
Fabio, 1989; Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; 
Silberhagel et al., 2001) 
 
Although the first stretch repetition results in the greatest increase in muscle-tendon unit 
length (Taylor et al., 1990; Alter, 1996; Prentice, 1999; Selvier and Wilson, 1999; 
Selvier and Wilson, 2000; Shrier and Gossal, 2000), a static stretch should be repeated 
several times per treatment session, because Taylor et al (1990) found that more than 
80% of a muscle-tendon unit length can be obtained after the fourth repetition of a static 
stretch.  Stanish et al (1986), Fyfe and Stanish (1992) and Stanish et al (2000) claim that 
6 repetitions of static stretching exercises should be performed in each treatment 
session, dividing those into an equal number of repetitions, three before and three after 
the eccentric training. This approach of static stretching has been used in the majority of 
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previously published trials on tendinopathies (Niesen-Vertommen et al., 1992; Mafi et 
al., 2001; Silberhagel et al., 2001). Clinicians suggest a 15 to 45-second rest interval 
between each repetition (Selvier and Wilson, 1999; Shrier and Gossal, 2000). The 
reasons why the above rest interval was followed in the trial stated in chapter 6 were 
reported previously in the eccentric exercise section (3.5.1.1.3). However, there is no 
information about the treatment regimen for static stretching exercises on LE in a 
supervised exercise programme. As was described in the eccentric exercises section, 
this information is available only for home exercise programmes. 
 
Logically, it seems that increasing tissue temperature before stretching would increase 
the flexibility of muscle-tendon unit; however many therapists believe that stretching 
with or without a warm-up yields the same results (Smith, 1994; Shrier and Gossal, 
2000). Therefore, in previously published studies the home exercise programmes for the 
management of tendinopathies were used without a warm up (Jensen and Di Fabio, 
1989; Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; 
Silberhagel et al., 2001). 
 
3.5.2.2 Recommendations for the application of static stretching exercises for the 
treatment of LE 
Based on the previously reported evaluation, static stretching exercises for LE should be 
applied slowly with elbow in extension, forearm in pronation and wrist in flexion and 
ulnar deviation according to the patients’ tolerance (Figure 3.9), in order to achieve the 
best stretching position result for the ECRB tendon, which is the “injured” tendon in 
LE. This position should be held for 30 to 45 seconds, three times before and three 
times after the eccentric exercises at each treatment session with a 30-second rest 
interval between each procedure. The treatment regimen of static stretching exercises 
will be resolved by surveying existing practitioners’ reports on their own use of 
supervised exercise programmes for LE (Chapter 5). The static stretching exercises will 
be individualized by the patient’s description of the discomfort and pain experienced 
during the procedure. 
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3.5.3 Recommendations for the application of a supervised exercise programme for 
the treatment of LE  
A supervised exercise programme for LE should be given as 3 sets of 10 repetitions of 
slow progressive eccentric exercises of wrist extensors. Before and after the eccentric 
exercises, the patient should carry out 3 repetitions of static stretching exercises of the 
ECRB tendon for 30 to 45 seconds each repetition (Figure 3.10). The eccentric and 
static stretching exercises should be delivered as described above (sections 3.5.1.1. and 
3.5.2.2). The supervised exercise programme should be individualized through the 
patient’s description of discomfort and pain experienced during the procedure. A survey 
of practitioners to determine their own use of supervised exercise programmes for the 
treatment of LE will be conducted in chapter 5. 
 
3.5.4 How supervised exercise programmes work 
In clinical practice, the exercise programme is predominately used for the promotion of 
tissue healing. It has been suggested that pain relief will occur concomitantly with 
progression of repair, that is, the patient’s pain will reduce as healing progresses. The 
elucidation of the mechanisms through which exercise programme can alter pain in 
tendinopathies remains fragmentary.  
 
It seems that the eccentric training induced remodeling of the injured tendon. It is likely 
that specific eccentric training drills result in tendon strengthening by stimulating 
mechanoreceptors in tenocytes to produce new collagen and thus help reverse the 
tendinopathy cycle (Leadbetter, 1992). Collagen production is probably the key cellular 
phenomenon that determines recovery from tendon injuries (Khan et al., 2000; Khan et 
al., 2002; Ohberg et al., 2004).  
 
The eccentric training regimen may improve collagen alignment of the tendon and 
stimulate collagen cross-linkage formation, both of which increase the size of fibres 
(hypertrophy) and the ultimate strength of tendons (tensile strength) (Hawary et al., 
1997; Khan et al., 2000; Khan et al., 2002; Ohberg et al., 2004) as supported by 
experimental studies on animals (Vilata and de Campos Vidal, 1989). Eccentric training 
may induce a response that normalizes the high concentrations of glycosaminoglycans 
(Ohberg et al., 2004). Ohberg et al (2001) found that, during eccentric training, the 
blood flow is stopped in the area of damage and this leads to neovascularisation, the 
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formation of new blood vessels, which improves blood flow and healing in the long 
term. 
 
The improvement of the fibre arrangement, the normalization of the high concentrations 
of glycosaminoglycans and the neovasularisation possibly result in decreased tendon 
thickness in the injured point where scar tissue has already formed (Ohberg et al., 
2004). However, if the decrease of tendon thickness during eccentric training can be 
associated with the decrease of tendon pain is unknown. 
 
It has also been proposed that the positive effects of exercise programmes for tendon 
injuries may also be attributable to the effect of stretching, with a “lengthening” of the 
muscle-tendon unit, orientation of the new collagen fibres and consequently less strain 
experienced during joint motion (Alfredson et al., 1998). Stretching may strengthen the 
tendon or make it more resistant to strain and increase the range of motion of the 
relevant joint (Stanish et al., 2000). 
 
3.6 Polarised polychromatic non-coherent light (Bioptron light) 
LPLL is a commonly used light-therapy modality among physiotherapists for the 
management of common musculoskeletal disorders such as tendinopathies (Baxter et 
al., 1991). The effect of LPLL on wound healing has been investigated in many studies 
during the last two decades with conflicting results (Medenica and Lens, 2003). 
Polarised polychromatic non-coherent light (Bioptron light) is another form of light 
therapy (Chapter 2) that is commonly used to treat wound healing in dermatology and 
plastic surgery (Monstrey et al., 2002a; Monstey at al., 2002b; Iordanou et al., 2002). 
Manufacturers claim that polarised polychromatic non-coherent light (Bioptron light) 
can be used in the treatment of common musculoskeletal disorders such as LE but 
experimental support is lacking.  
 
Available literature is predominately in the form of manufacturers pamphlets. 
Polarisation seems to be the most important characteristic of polarised polychromatic 
non-coherent light (Bioptron light) (Table 3.1) because the polarised polychromatic 
non-coherent light (Bioptron light) owes its proposed mode of action in this 
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characteristic (section 3.6.2). LPLL and polarised, polychromatic non-coherent light 
(Bioptron light) differ in their characteristics of radiation (Table 3.2).  
 
Three devices are commercially available to deliver polarised, polychromatic non-
coherent light (Bioptron light): (i) the Bioptron 2, (ii) the Bioptron Pro and (iii) the 
Bioptron Compact III. According to the manufacturer’s user guide, these three devices 
do not differ in output characteristics. However, according to experts in dermatology 
and plastic surgery (Monstrey et al., 2002a; Monstey at al., 2002b; Iordanou et al., 
2002), the Bioptron 2 seems to be the most commonly used device in practice to deliver 
the polarised, polychromatic non-coherent light (Bioptron light).  
 
Bioptron 2 (Figure 3.11) is a product from Harrier Inc. USA, and was developed in 
Switzerland. The emission of light may be administered in one-minute steps and 
controlled by an integrated soft-start/soft-stop electronic switch. When the treatment 
with Bioptron 2 is over, there is a characteristic sound (beep tone). The output 
characteristics of Bioptron 2, according to the manufacturers’ user guide, are: light 
wavelength = 480-3400 nm; degree of polarization = 95%; specific power density = 
40mW/cm2; energy density = 2.4J/cm2. Bioptron 2 is approved by the FDA (USA), 
TGA Australia, EEC and carries an ISO 9001 certificate and EN 46001 as a patented 
medically-approved product. 
 
Manufacturer literature recommends that the Bioptron 2 device should be used in 
practice as follows: The probe of Bioptron 2 is held at a 90o angle (perpendicular) 5-10 
cm above the clean bare skin of the “injured” site as this is claimed to achieve maximal 
penetration of light. The regimen is six minutes of stimulation for at least three times 
per week for four weeks. Following this protocol, the polarised polychromatic non-
coherent light (Bioptron light) was found to be an effective treatment for patients with 
deep dermal burns (Monstrey et al., 2002a; Monstrey et al., 2002b) and ulcers (Iordanou 
et al., 2002). However, there is lack of evidence to support the effectiveness of this 
protocol in common musculoskeletal injuries such as LE. 
 
The manufacturer claims that there are no side effects for the use of polarised, 
polychromatic non-coherent light (Bioptron light) because there is no ultra-violet light 
in the Bioptron spectrum so there is no tanning or heat effect on the skin. No reports of 
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adverse effects were found in conducted trials (Monstrey et al., 2002a; Monstrey et al., 
2002b; Iordanou et al., 2002). Manufacturers also claim that polarised, polychromatic 
non-coherent light (Bioptron light) is not harmful to the eyes, or to pregnant women or 
to patients with pacemakers. No prophylactic measures for both, therapists and patients, 
were taken in conducted trials (Monstrey et al., 2002a; Monstrey et al., 2002b; Iordanou 
et al., 2002). In addition, pregnant women and patients with pacemakers were not 
excluded from the trials (Monstrey et al., 2002a; Monstrey et al., 2002b; Iordanou et al., 
2002). Finally, the polarised polychromatic non-coherent light (Bioptron light) cannot 
cause cancer because it is known that the dangerous wavelength of light is below 250 
nm and the wavelength of polarised polychromatic non-coherent light (Bioptron light) is 
outside of this range (480-3400nm). The lack of side effects and contraindications of the 
polarised polychromatic non-coherent light (Bioptron light) is supported by the 
conducted trials (Monstrey et al., 2002a; Monstrey et al., 2002b; Iordanou et al., 2002) 
and confirmed by the approval of the FDA (USA), TGA Australia, EEC, the ISO 9001 
certificate and EN 46001 as a patented medically-approved product. 
 
3.6.1 Recommendations for the application of polarised polychromatic non-coherent 
light (Bioptron light) for the treatment of LE 
Based on the manufacturer’s claims and on one unpublished report (Stasinopoulos, 
1990), polarised polychromatic non-coherent light (Bioptron light) therapy should be 
used in a clinical setting in line with manufacturers guidelines as follows: The probe of 
Bioptron 2 should be held at a 90o angle 5-10 cm above the clean bare skin of the lateral 
condyle (i) from the upper surface (anterior) with the elbow in extension and the 
forearm in supination (3.12) and (ii) from the lateral surface with the elbow in 900 of 
flexion and the forearm in pronation (3.13). Next, the probe of Bioptron 2 should be 
held at a 90o angle 5-10 cm above the clean bare skin of the bellies of the extensors 
muscles of the wrist with the elbow in 900 of flexion and the forearm in mid-position of 
pronation-supination (3.14). The polarised polychromatic non-coherent light (Bioptron 
light) therapy should last six minutes in each position, 18 minutes totally. Treatment 
regimen of polarised polychromatic non-coherent light (Bioptron light) therapy should 
be three times per week for four weeks (Figure 3.15). The polarised polychromatic non-
coherent light (Bioptron light) treatment is standardised during the treatment period. 
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3.6.2 How polarised polychromatic non-coherent light (Bioptron light) works 
LPLL has a biostimulating effect (Mester et al., 1971). Biostimulation is the reactivation 
of cell functions that allows regenerative processes to take place again (Monstrey et al., 
2002a). This effect is directed to those cells that have been damaged or do not function 
efficiently any more (Monstrey et al., 2002b). A considerable amount of research has 
been performed to determine which of LPLL characteristics was the most important for 
the biostimulation effect (Mester et al., 1971; Fenyo, 1984; Mester et al. 1985; Karu, 
1987). Several different LPLL with varying monochromatic outputs were equally 
successful, showing that the wavelength played no role in the healing effects (Mester et 
al., 1971; Mester et al. 1988). Coherent (in-phase) and incoherent (out of phase) light 
can cause the same biostimulative effects (Karu et al., 1987). Polarisation appears to be 
the key factor in biostimulation (Fenyo, 1984; Kertesz et al., 1982). The polarised 
polychromatic non-coherent light (Bioptron light) is a truly polarised light that could 
induce biostimulative effects in living cells similar to LPLL. The way that polarised 
polychromatic non-coherent light (Bioptron light) obtains biostimulative effects is not 
known and is based on a variety of proposed mechanisms. Both parts, visible and 
infrared, of the electromagnetic spectrum of polarised polychromatic non-coherent light 
(Bioptron light), can explain these mechanisms. These lead to the same final 
photoresponse, but start the cascade of metabolic events at different cellular levels that 
assist tissue healing. 
 
One proposed mechanism of action of biostimulation is the absorption of visible light 
energy by the mitochondria (Karu, 1989). This may cause a chain of molecular events 
leading to an increase in cell energy and activation of nucleic acid synthesis, which is 
essential for tissue repair (Medenica and Lens, 2003). 
 
The second mechanism is obtained by the infrared portion of the light spectrum 
(Medenica and Lens, 2003). In a hypothetical physical model for biostimulation, the cell 
membrane was stated to be the site of stimulation (Kertaesz et al., 1982). In this 
hypothesis the polarised polychromatic non-coherent light (Bioptron light) interacts 
with the polar heads of the lipid double layer of the cell membrane in which the 
biologically active proteins are incorporated. Due to the interaction with polarised 
polychromatic non-coherent light (Bioptron light), structural changes may occur to give 
the membrane a reordered distribution of the surface changes and to modify the lipid 
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protein connections. This conformation change may influence the cellural processes 
connected with the cell membrane: receptor function, energy production, immune 
responses and enzyme reactions (Kertesz et al., 1982). 
 
Different biological effects have been reported after polarised light radiation, including 
the stimulation of cell proliferation (especially in fibroblasts), the release of growth 
factors and the enhancement of collagen synthesis (Kertesz et al., 1982; Fenyo, 1984; 
Kubasova et al., 1988; Bolton et al., 1992). It can be suggested that the tensile strength 
of tendons can be improved indirectly through the previously reported observations. 
 
Another mechanism that might be responsible for the polarised polychromatic non-
coherent light (Bioptron light) therapy’s therapeutic effect is the local peripheral 
vasodilation, which improve blood flow and the delivery of oxygen to the soft tissue 
area, facilitating the transport of nutrients needed for soft tissue healing (Medenica and 
Lens, 2003). 
 
3.7 Conclusion 
Treatment protocols for Cyriax physiotherapy, supervised exercise programmes and 
polarised polychromatic non-coherent light (Bioptron light) for the management of the 
pain and functional impairment associated with LE were developed in this chapter. 
Cyriax physiotherapy consists of 10 minutes of DTF and one instance of Mill’s 
manipulation, which is performed immediately after the DTF. The supervised exercise 
programme consists of slow progressive eccentric exercises of wrist extensors (3 sets of 
ten repetitions with 1-minute rest interval between each set) and of static stretching 
exercises of the ECRB tendon (3 repetitions before and 3 repetitions after the eccentric 
training for 30-45 seconds each repetition with a 30-second rest interval between each 
procedure). The probe emitting polarised polychromatic non-coherent light (Bioptron 
light) should be held at a 900 angle 5-10cm above the bare skin of the lateral condyle 
(anterior and lateral surface) and the bellies of extensors muscles of the wrist, for six 
minutes each position, 18 minutes totally. All treatments are administered in a clinical 
setting. The treatment regimen of Cyriax physiotherapy and polarised polychromatic 
non-coherent light (Bioptron light) is three times per week for four weeks. The 
treatment regimen of supervised exercise programmes will be defined in chapter 5 by 
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conducting a survey of existing practitioners’ reports of their use of a supervised 
exercise programme for the treatment of LE. Cyriax physiotherapy and supervised 
exercise programmes are individualised on the basis of the patient’s report of pain 
experienced during the procedure. A physiotherapist with certificate or diploma in 
Orthopaedic medicine based on Cyriax principles should be applied Cyriax 
physiotherapy. It has been postulated that Cyriax physiotherapy can be used for both 
symptomatic relief of pain and promotion of tissue healing. In clinical practice, exercise 
programmes are predominately used for the promotion of tissue healing. It has been 
reported that polarised polychromatic non-coherent light (Bioptron light) has 
biostimulative effects assisting tissue healing at the cellular level. Two preliminary 
clinical trials to pilot the use of these treatment protocols on overuse injuries similar to 
LE that are regularly presenting to the clinic are described in the next chapter. 
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Figure 3.1 
 
Deep transverse friction (DTF) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Cyriax (1982) 
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Figure 3.2 
 
Mill’s manipulation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Kesson and Atkins (1998) 
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Figure 3.3 
 
Recommended treatment protocol for Cyriax physiotherapy for the treatment of 
LE 
 
 
                                                Cyriax physiotherapy 
 
 
 
 
 
                                         10 minutes of DTF per session                               
 
 
 
 
 
 
                                                     
                                    Mill’s manipulation once per session 
 
 
 
 
 
 
 
 
                                                         Three times per week 
 
 
 
 
 
 
 
 
 
                                                        1 month 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                            Chapter 3 
 95 
Figure 3.4 
 
Starting position of slow eccentric strengthening exercises of wrist extensors 
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Figure 3.5 
 
Final position of slow eccentric strengthening exercises of wrist extensors 
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Figure 3.6  
 
Return to starting position with the help of the other hand 
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Figure 3.7 
 
Starting position of slow eccentric strengthening exercises of wrist extensors using 
resistance 
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Figure 3.8 
 
Final position of slow eccentric strengthening exercises of wrist extensors using 
resistance 
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Figure 3.9 
 
Static stretching exercises of ECRB tendon 
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Figure 3.10 
 
Recommended treatment protocol for a supervised exercise programme for the 
treatment of LE 
 
Supervised exercise programme 
 
 
 
3 repetitions of static stretching exercises of ECRB tendon for 30-45 seconds each 
stretching with 30 seconds rest between each stertching 
 
 
 
Eccentric strengthening exercises of 
wrist extensors tendons 
 
 
 
 
Load                   Speed      Frequency of contractions 
                      progressive               Slow        3 sets of 10 repetitions 
                     according to                                     1-minute rest 
                       patients                                           between each set 
                      allowance 
 
 
 
  
3 repetitions of static stretching exercises of ECRB tendon as described previously 
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Figure 3.11 
 
Bioptron 2 
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Figure 3.12 
 
First position of polarised polychromatic non-coherent light (Bioptron light) 
application 
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Figure 3.13 
 
Second position of polarised polychromatic non-coherent light (Bioptron light) 
application 
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Figure 3.14 
 
Third position of polarised polychromatic non-coherent light (Bioptron light) 
application 
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Figure 3.15 
 
Recommended treatment protocol for polarised polychromatic non-coherent light 
(Bioptron light) for the treatment of LE 
 
Polarised polychromatic non-coherent light 
 
 
 
Use Bioptron 2 device 5-10 cm above the skin 
 
 
 
To the lateral condyle from the upper surface (anterior) with the elbow in extension and 
the forearm in supination for six minutes 
 
 
To the lateral condyle from the lateral surface with the elbow in 900 of flexion and the 
forearm in pronation for six minutes 
 
 
 
To the bellies of the extensors muscles of the wrist with the elbow in 900 of flexion and 
the forearm in mid position of pronation-supination for six minutes 
 
 
 
Three times per week 
 
 
 
1 month 
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Table 3.1 
Manufacturer’s explanation in the characteristic of polarized, polychromatic non-
coherent light (Bioptron light). 
 
 
 
Polarisation 
 
Its waves move on parallel planes. In this device polarization reaches a degree of 
approximately 95%, which narrows and concentrates the beam. 
Polychromy 
Polychromatic light contains a wide range of wavelengths, including visible light and 
a part of infrared range. The wavelength of this device’s light ranges from 480nm to 
3400nm. This electromagnetic spectrum does not contain ultraviolet radiation. 
Incoherency 
This device’s light is incoherent or out of phase light. This means the light waves are 
not synchronized. 
 Source: www.bioptron.com/characteristics/index.php 
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Table 3.2 
Comparison of polarized, polychromatic non-coherent light (Bioptron light) with 
LPLL 
 
Polarized, polychromatic non-
coherent light (Bioptron light) 
LPLL Comments 
polychromatic light with a wide 
range of wavelengths (480nm-
3400nm) using visible light and 
a part of infrared range 
monochromatic light with single 
wavelength (632.8nm or 904nm 
the most common) using visible or 
infrared light 
It is claimed that polarised 
polychromatic non-coherent 
light (Bioptron light) with a 
longer wavelength has a greater 
penetration than LPLL 
incoherent or out of phase light coherent or sychronised light No difference in biostimulative 
effects. Phase of light is not the 
key factor in biostimulation 
truly polarized light for practical purposes polarized 
light (Baxter 1996) 
Polarisation is the key factor in 
biostimulation (Kertesz et al., 
1982; Fenyo, 1984). Polarised 
polychromatic non-coherent 
light (Bioptron light) is a truly 
polarised light, while LPLL is 
polarised light for practical 
purposes. Thus, it is claimed that 
polarised polychromatic non-
coherent light (Bioptron light) 
have better biostimulative 
effects than LPLL 
energy density constant 
(2.4J/cm2) 
Energy density ranges from 1 
J/cm2 to 4J/cm2 , but sometimes 
needing higher dosages up to 32 
J/cm2  (Low and Reed, 2000). 
Energy density is calculated 
according to the condition  
Optimal energy density is 
unknown. In polarised 
polychromatic non-coherent 
light (Bioptron light) almost the 
mean rate of the range 0.5 J/cm2 
and 4 J/cm2 is used, without 
needing calculation. However, 
we do not know if this is the 
optimal energy density 
No specific user skills for 
handling 
need specific user skills for 
handling and protective goggles 
Polarised polychromatic non-
coherent light (Bioptron light) 
can be used by inexperienced 
therapists with this modality. Its 
usage is easy 
No contraindications Many contraindications such as, 
pregnancy, cancer, peacemaker etc 
It is claimed that polarised 
polychromatic non-coherent 
light (Bioptron light) can be 
used for all patients 
Large diameter of the beam small diameter of the beam Polarised polychromatic non-
coherent light (Bioptron light) 
can radiate a large surface of the 
body 
Expensive  Expensive Polarised polychromatic non-
coherent light (Bioptron light) is 
less expensive than LPLL 
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Chapter 4: Preliminary clinical studies on the effectiveness of 
Cyriax physiotherapy, a supervised exercise programme and 
polarised polychromatic non-coherent light (Bioptron light) 
on overuse injuries  
 
4.1 Introduction 
The recommended treatment protocols for Cyriax physiotherapy, a supervised exercise 
programme, and polarised polychromatic non-coherent light (Bioptron light) were 
derived from the views of advocates of these treatments, based on their personal 
experience with the treatment and on the putative physiological mechanisms that the 
treatment addresses (Chapter 3). The effectiveness of these protocols was tested on 
overuse injuries that were similar to LE regularly presenting to the clinic. The first study 
was a controlled clinical trial that evaluated the effectiveness of Cyriax physiotherapy 
and a supervised exercise programme in patellar tendinopathy, commonly referred to as 
“jumper’s knee”. The second study was a prospective open, uncontrolled clinical trial 
that assessed the effectiveness of the polarised polychromatic non-coherent light 
(Bioptron light) treatment protocol in idiopathic carpal tunnel syndrome. 
 
4.2 Aim 
The aim of the studies described in this chapter was to pilot the use of treatment 
protocols for Cyriax physiotherapy, a supervised exercise programme and polarised 
polychromatic non-coherent light (Bioptron light), as derived from the critical literature 
review in chapter 3 on overuse injuries similar to LE that are regularly presenting to the 
clinic. 
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4.3 A controlled clinical trial to compare the effects of Cyriax 
physiotherapy, a supervised exercise programme and ultrasound in the 
reduction of pain in patellar tendinopathy 
 
4.3.1 Introduction 
Patellar tendinopathy or jumper’s knee causes significant morbidity in professional and 
recreational sports people, particularly those participating in sports involving repeated 
jumping and landing, rapid acceleration and deceleration, cutting moves and kicking 
(Nichols et al., 1991; Molnar and Fox, 1993); examples are basketball, volleyball, 
soccer, tennis, high jump, long jump, fencing and track (Blazina et al., 1973; Fornage 
and Rifkin, 1988; Raatikainen et al., 1994; Hamilton and Purdam, 2004). Patellar 
tendinopathy is most commonly characterized by pain at the inferior pole of the patella, 
although pain can also be at the tibial attachment and the attachment of the tendon to the 
superior pole of the patella (Blazina et al., 1973).  
 
There is no correlation between intrinsic factors, such as malalignment of the extensor 
mechanism, the Q angle, or biomechanical derangements, and the incidence of jumper’s 
knee (Ferretti, 1986; Cook et al., 2001). The principal factors that lead to its 
development are hard playing surfaces, increased frequency of training sessions with 
repetitive eccentric movement, and tight hamstring and quadriceps (Ferretti, 1986; 
Stanish et al., 2000; Hamilton and Purdam, 2004).  
 
The pathology of jumper’s knee shows the presence of degeneration of the tendon with 
collagen disorientation, disorganization and fibre separation by increased mucoid 
ground substance, vascularity and cellularity. Cellularity results from the presence of 
fibroblasts and myofibroblasts, not inflammatory cells (Khan et al., 2000a). Due to the 
absence of inflammatory cells, the term patellar tendonitis as diagnosis seems 
inappropriate. Patellar tendinosis refers to pathology of the patellar tendon and is the 
best diagnostic term. The term patellar tendinopathy refers to painful overuse tendon 
without implying pathology; it is ideal for clinical diagnosis.  
 
Many forms of physical therapy have been proposed for the management of patients 
with patellar tendinopathy. Physical therapy treatment involves manual techniques such 
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as Cyriax physiotherapy (DTF), modalities such as LPLL, ultrasound, transcutaneous 
electrical nerve stimulation (TENS), etc., exercise programmes and bracing. 
Nevertheless, there are a limited number of studies on the conservative treatment of 
patellar tendinopathy. Cyriax physiotherapy, supervised exercise programmes and 
ultrasound are three commonly used physiotherapy treatments for patellar tendinopathy. 
However, the clinical value of these treatments for patellar tendinopathy is unknown. 
Chapter 2 found strong evidence that ultrasound is an ineffective treatment for LE, and 
perhaps for conditions similar to LE such as patellar tendinopathy. Ultrasound is a 
commonly used treatment modality in physiotherapy and the ineffectiveness identified 
in chapter 2 may be due to the lack of optimal treatment dosages. 
 
4.3.2 Aim 
The aim of the present study was to compare the effects of Cyriax physiotherapy, a 
supervised exercise programme and ultrasound in the reduction of pain in patients with 
patellar tendinopathy. 
 
4.3.3 Methods 
A controlled, monocenter trial was conducted to assess the effectiveness of Cyriax 
physiotherapy, a supervised exercise programme and ultrasound in a clinical setting 
over a 15-month period. A parallel group design was used in case the treatment 
intervention cured the condition. A cross-over design is limited in this regard because if 
patients are cured they do not have the opportunity to receive the other treatments 
following cross over (Johannsen et al., 1993). Two investigators were involved in the 
study: 1) The primary investigator was a qualified physiotherapist (DS) who 
administered the treatments and 2) the co-investigator was a specialized rheumatologist 
(IS) who evaluated the patients to confirm the diagnosis and also assessed all baseline 
and follow up measurements. The co-investigator (IS) was blind to the patients’ therapy 
group and did not treat patients at all. 
 
4.3.3.1 Participants and recruitment 
Thirty patients, all recreational athletes who had been clinically diagnosed with patellar 
tendinopathy by the co-investigator (IS), took part in this study. They were selected 
from patients referred to our clinic (Rehabilitation and Rheumatology Centre, located in 
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Athens) during the season 2001-/2002. The patients were either self-referred or referred 
by their physician or physiotherapist. All patients were new cases to our clinic. 
 
4.3.3.2 Inclusion criteria 
The inclusion criteria for the study, which have been used in similar previously 
published trials (Jensen and Di Fabio, 1989; Cannell et al., 2001), were: 
  Tenderness with palpation over the inferior pole of the patella 
  No history of trauma to the knee 
  Minimum duration of symptoms three months 
  Unsuccessful conservative treatment before entering the study, but not in the     
            preceding one month 
 No other current knee or lower extremity problems including anterior knee pain, 
muscle strains and hip or ankle injuries 
 Positive decline squat test. 
 
4.3.3.3 Ethical consideration  
The procedure was explained to patients and informed consent was obtained from all of 
them. The co-investigator (IS), who was the manager of the clinic, approved the study 
and authorized access to clinic patients.  
 
4.3.3.4 Sequential allocation 
The patients were allocated to three groups by sequential allocation. For example, the 
first patient with patellar tendinopathy was assigned to the Cyriax physiotherapy group, 
the second patient with patellar tendinopathy to the supervised exercise-programme 
group, the third patient with patellar tendinopathy to the ultrasound group, the fourth 
patient with patellar tendinopathy to the Cyriax physiotherapy group, the fifth patient 
with patellar tendinopathy to the supervised-exercise-programme group and so on. 
Patients were able to drop out from the study at any stage and without reason. 
 
All patients were instructed to rest during the treatment period. Patients were asked to 
refrain from taking anti-inflammatory medication throughout the course of study. 
Patient compliance to this request was monitored using a treatment diary.  
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4.3.3.5 Treatment intervention 
All treatment interventions were performed in our centre. The primary investigator (DS) 
administered all treatments. DS is a qualified physiotherapist with about 7 years 
experience in the management of common musculoskeletal disorders such as patellar 
tendinopathy. In addition, DS is a physiotherapist experienced in the application of 
Cyriax physiotherapy. He holds a Certificate in Orthopaedic Medicine on Cyriax 
principles (Appendix I). All patients received three treatments per week for four weeks. 
 
4.3.3.5.1 Cyriax physiotherapy 
The treatment protocol of Cyriax physiotherapy in patellar tendinopathy consists of 
DTF. DTF was applied to the patellar tendon as advocated by Cyriax (1982) 
continuously for 10 minutes. Details of DTF application are presented in chapter 3 
(section 3.4.1). The Cyriax physiotherapy treatment was individualised on the basis of 
the patient’s description of pain experienced during the procedure. 
 
4.3.3.5.2 Supervised exercise programme 
The supervised exercise programme consisted of static stretching exercises of 
quadriceps and hamstring, and eccentric exercises of patellar tendon. Static stretching 
exercises were performed as described for LE (section 3.5.2.1) before and after the 
eccentric exercises adapted in patellar tendinopathy. Details about the static stretching 
exercises in patellar tendinopathy can be found in the study by Jensen and Di Fabio 
(1989).  
 
In the eccentric exercises, patients carried out three sets of 15 repetitions of unilateral 
squat. The squat was performed at a slow speed at every treatment session. At the 
beginning, the load consisted of the body weight only and patients were standing with 
all their body weight on the injured leg. As they moved from the standing to the squat 
position (about 600 of knee flexion), the quadriceps muscle and patellar tendon by 
inference were loaded eccentrically; no following concentric loading was done, as the 
non-injured leg was used to get back to the start position. Patients were told to go ahead 
with the exercise even if they experienced mild pain. However, they were told to stop 
the exercise if the pain was disabling. When the squat was pain-free, patients increased 
the load by holding weights in their hands. Between each set there was a 2-minute rest.  
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The supervised exercise programme treatment was individualised on the basis of the 
patient’s description of pain experienced during the procedure. 
 
4.3.3.5.3 Ultrasound 
The ultrasound treatment was standardised during the treatment period as follows: The 
10 patients in the ultrasound group received local pulsed ultrasound from 0.4 to 0.8 
W/cm2 from a RT-20 ultrasonic machine (RT-20, Pagani, Italy). The pulse ratio was 
1:4, the duration of pulse 2 ms and frequency 1 MHz. The ultrasound head was applied 
to the patient’s skin, using an ultrasonic coupling medium. The radiated area was over 
the inferior pole of the patella. Treatment time was 10 minutes.  
 
4.3.3.6 Outcome measures 
Patients were asked to describe the status of their pain from the following alternatives: 
worse, no change, somewhat better, much better, no pain. This scale was designed by 
the investigators in order to determine the effectiveness of each therapy. Each patient 
was evaluated at the end of the four-week course of treatments (week 4). Follow-up 
recordings were made at one month after the end of the treatment (week 8) and three 
months after the end of the course of treatments (week 16).  
 
4.3.3.7 Statistical analysis 
Patients in each group were placed into one of the two pain-response categories. The 
first category included those who reported their pain to be worse, no change, or slightly 
better; the second category included those reporting that they were much better or had 
no pain. The chi-square test (alpha=/0.05) was used to determine whether patients in the 
two categories were equally distributed across the three groups. This test was used 
because (i) there were three different (independent) subject groups; (ii) the data was 
nominal and (iii) the assumptions for a valid chi-square analysis were met. These 
assumptions were: 1. data was frequency counts; 2. observations were independent of 
one another; 3. expected and observed frequencies were equal one another and 4. the 
sample size was adequate. 
 
4.3.4 Results 
All patients completed the study, including the two follow-ups (Figure 4.1). Ten 
patients (5 men, 5 women), mean age 26.24±4.17 (21-33) years, were entered into the 
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Cyriax physiotherapy group. Ten patients (7 men, 3 women), mean age 28.12±2.03 (21-
31) years, were entered into the supervised exercise programme group. Ten patients (6 
men, 4 women), mean age 29.17±3.76 (22-33) years, were entered into the ultrasound 
therapy group. The basketball was the most common sport among the patients (Table 
4.1). 
 
Chi-square analysis showed significant differences in the distribution of pain-response 
categories across the groups at the end of treatment (Table 4.2), one-month follow-up 
(Table 4.3) and three-month follow-up (Table 4.4). It can be concluded that the 
supervised exercise programme was statistically significantly better than the other two 
treatments. There were no significant differences between Cyriax physiotherapy and 
ultrasound. 
 
4.3.5 Discussion 
The results obtained from this controlled clinical trial are novel, since to date there is no 
existing data to compare the effectiveness of Cyriax physiotherapy, supervised exercise 
programmes and ultrasound in the reduction of pain in patellar tendinopathy. The results 
of the present study showed that the supervised exercise programme was the most 
effective treatment in the reduction of pain in patellar tendinopathy.  
 
Home exercise programmes have shown good clinical results in rest tendinopathies such 
as Achilles tendinopathy (Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi 
et al., 2001; Silbernagel et al., 2001). In all previously published trials, a home exercise 
programme was conducted daily, once or twice, for a period of three months. In the 
present study, the supervised exercise programme was conducted three times per week 
for four weeks. It is obvious that a supervised exercise programme can reduce pain in 
tendinopathies in a shorter period than a home exercise programme. This difference 
may be due to the supervised nature of such programmes, which are able to achieve a 
high degree of patient compliance. However, in order to establish strong evidence for 
the effectiveness of these two exercise programmes for tendon disorders, a future well-
designed future clinical trial is needed to compare their effectiveness.  
 
Recently, Purdam et al (2004) suggested that the eccentric squat for the management of 
patellar tendinopathy should be performed on a 250 decline board. This was suggested 
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because passive and active calf tension have the potential to reduce demand on the knee 
extensors in the squat by limiting forward angulation of the tibia approaching the limit 
of ankle dorsiflexion (Purdam et al., 2004). However, no significant differences were 
found between decline and flat squat for the management of patellar tendinopathy in a 
recently published RCT (Young et al., 2005).  Flat squat was called in Young et al 
(2005) trial the squat that was followed in the present pilot study.  Therefore, an 
exercise programme consisting of flat squat can be an effective treatment for patellar 
tendinopathy. 
 
Although Cyriax physiotherapy is currently used extensively in rehabilitation practice 
and especially in conditions such as patellar tendinopathy, the results of the present 
study do not support its use. Moreover, previously published trials provide little support 
for the effectiveness of Cyriax physiotherapy on overuse injuries (Schwellnus et al., 
1992; Pallechia et al., 1994; Verhaar et al., 1996). Prentice (1999) claims that if Cyriax 
physiotherapy does not decrease the pain in patellar tendinopathy patients after 4 or 5 
treatments, this treatment approach is unlikely to resolve the problem. However, the 
experience of Prentice is not a reliable tool to determine the effectiveness of Cyriax 
physiotherapy. There is a clear need for future well-designed clinical trials to establish if 
there is strong evidence for the effectiveness of Cyriax physiotherapy on overuse 
injuries. Finally, the major drawback of Cyriax physiotherapy is that the application of 
this treatment placed a considerable strain on the hands of clinicians, who find it 
exhausting (Chapter 3). 
 
Pulsed ultrasound at low intensities and 1 MHz frequency has been shown to have 
beneficial effects on collagen synthesis and on the tensile strength of tendons (Dyson 
and Suckling, 1978; Khan et al., 2000a). Similar parameters were used in this study. 
Although ultrasound is a common clinical modality, the majority of published trials 
have shown that it is not effective as a sole treatment for tendinopathies (Lundeberg et 
al., 1988; Haker and Lundeberg, 1991; Pienimaki et al., 1996). The results of the 
present study, supporting the results of previously published studies in tendon injuries 
area as well as the findings of chapter 2, showed that ultrasound produced poor results 
in patients with patellar tendinopathy. 
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The results of the present study should be interpreted cautiously because this study did 
not use a randomised design, the subjects’ numbers were small, no power analysis was 
conducted and there was lack of a placebo/no treatment group. Furthermore, outcome 
measures of unknown validity were used, the compliance of patients was not monitored 
when they were away from the clinic and the “slowness” of eccentric exercises was not 
defined.  In addition to the weaknesses discussed, structural changes in the tendon that 
related to treatment interventions were not demonstrated; the improvement in 
quadriceps strength following one of the three treatment interventions was not 
measured; and the long-term effects of these treatments were not investigated. All these 
issues will be discussed in chapter 7. 
 
4.3.6 Conclusions 
The present study was an attempt to find out if three commonly used physiotherapy 
treatments could reduce the pain in patients with patellar tendinopathy. The results 
showed that the supervised exercise programme was a better treatment than Cyriax 
physiotherapy and ultrasound at the end of the treatment as well as at the follow-ups. 
However, due to the shortcomings of the present pilot study described above, future 
controlled studies are needed to establish the effects of these three treatments in patellar 
tendinopathy.  
 
4.4 A prospective open and uncontrolled clinical trial to evaluate the 
effectiveness of polarised polychromatic non-coherent light (Bioptron 
light) in the reduction of nocturnal pain and paraesthesia in idiopathic 
carpal tunnel syndrome 
 
4.4.1 Introduction 
Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve at the 
level of the carpal tunnel and is by far the most common of all peripheral nerve 
entrapments (Szabo, 1998). The CTS patient often presents with symptoms of nocturnal 
pain and numbness, weakness or clumsiness in holding small objects and paraesthesia in 
the median nerve distribution of the hand (Donatelli and Wooden, 2000; Boscheinen-
Morrin and Conolly, 2001). Despite many suggested causes of CTS, the most common 
presentation of CTS is idiopathic with no discernible underlying pathology (Schkind et 
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al., 1990; Thurston, 2000). The most likely explanation is an overuse phenomenon of 
the hand as in process workers or housewives (Donatelli and Wooden, 2000; Thurston, 
2000; Boscheinen-Morrin and Conolly, 2001). Other cases of CTS result from trauma 
and from metabolic and endocrinal abnormalities (Detmars and Housin, 1986; Thurston, 
2000). Phalen’s test and Tinel’s sign are two commonly used provocative tests to help 
in the clinical diagnosis of CTS, but these two tests are not absolutely diagnostic despite 
being positive in about two-thirds of patients with this syndrome (Gerr and Letz, 1998). 
Electrophysiological studies measuring median nerve function are the only objective 
way to show the nerve deficit (Johnson, 1993; Gerr and Letz, 1998; Szabo, 1998). 
 
Benefit from non-surgical treatment, however, seems to be limited. Conservative 
treatments such as splints, injections, gliding exercises and ultrasound have been used to 
reduce nocturnal pain and paraesthesia associated with CTS, although these approaches 
have produced variable outcomes (Giele, 2001). For example, splints and carpal bone 
mobilization have been shown to be ineffective (Tal-Akabi and Rushton, 2000; Walker 
et al., 2000; Manente et al., 2001) and results with gliding exercises and ultrasound have 
been conflicting (Hunter et al., 1995; Ebenbichler et al., 1998; Oztas et al., 1998). 
Finally, there are recently clinicians’ claims that neural mobilization (mobilization of 
the median nerve) can reduce the symptoms, nocturnal pain and paraesthesia, in patients 
with CTS (Kostopoulos, 2004).  
 
The findings of a recently published RCT indicated that light therapy using LPLL could 
be an effective treatment for CTS (Naeser et al., 2002). Polarised polychromatic non-
coherent light (Bioptron light) is the other form of light therapy. Research is required to 
determine if polarised polychromatic non-coherent light (Bioptron light) can also give 
good clinical results in CTS.  
 
Polarised polychromatic non-coherent light (Bioptron light) has recently appeared on 
the market for the treatment of a wide range of medical conditions including CTS. 
However, descriptions of the effects of this modality are often theoretical or lacking. 
And even if these effects exist in laboratory models, it by no means follows that they 
will translate into clinically meaningful effects. Although novel modalities like 
polarised polychromatic non-coherent light (Bioptron light) are attractive to 
practitioners working in rehabilitation settings, the extent of its clinical usefulness is not 
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known. No studies were found on the clinical effectiveness of polarised polychromatic 
non-coherent light (Bioptron light) for CTS. The present trial was the first study in 
which polarised polychromatic non-coherent light (Bioptron light) was used to manage 
nocturnal pain and paraesthesia associated with idiopathic CTS. 
 
4.4.2 Aim 
The aim of this study was to assess the effectiveness of polarised polychromatic non-
coherent light (Bioptron light) in the reduction of nocturnal pain and paraesthesia in 
idiopathic CTS. 
 
4.4.3 Methods 
An uncontrolled monocenter trial was performed to gauge the effectiveness of polarised 
polychromatic non-coherent light (Bioptron light) in a clinical setting over 18-month 
period. Two investigators were involved in the study: 1) The primary investigator who 
administered the treatment was a qualified physiotherapist (DS) with about seven years 
of experience in the management of common overuse injuries such as CTS using the 
polarised polychromatic non-coherent light (Bioptron light) and 2) the co-investigator 
was a physiotherapist (EK) who performed all baseline and follow-up assessments, was 
blind to the patients’ therapy group, and did not treat patients at all. 
 
4.4.3.1 Participants and recruitment 
Twenty-five patients, 22 female and 3 male, with clinically-suspected CTS that had 
been referred to our clinic over a year (from mid-2001 to mid-2002) were invited and 
subsequently completed this open prospective uncontrolled clinical trial. All patients 
were new cases to our clinic. The mean age of patients was 47.4 years (range 34-58). 
CTS was diagnosed by using standard electrophysiological criteria, which were motor 
distal-latency and sensory-antidrotic nerve-conduction velocity. The patient population 
had a mean duration of CTS of 5.2 months (range 3-11).  
 
4.4.3.2 Inclusion/exclusion criteria  
Inclusion criteria for the study were unilateral idiopathic CTS, mild to moderate 
nocturnal pain and paraesthesia lasting more than three months (Hunter et al., 1995; 
Ebenbichler et al., 1998; Oztas et al., 1998; Tal-Akabi and Rushton, 2000; Walker et al., 
2000; Manente et al., 2001).  
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Exclusion criteria were secondary entrapment neuropathies, systematic diseases with 
increased risk of CTS, electroneurographic or clinical signs for axonal degeneration of 
the median nerve, previous treatment with physical-therapy modalities for CTS, history 
of steroid injections into carpal tunnel, regular analgesic or anti-inflammatory drugs 
(Hunter et al., 1995; Ebenbichler et al., 1998; Oztas et al., 1998; Tal-Akabi and 
Rushton, 2000; Walker et al., 2000; Manente et al., 2001). 
 
4.4.3.3 Ethical consideration  
The procedure was explained to patients and informed consent was obtained from all of 
them. The manager of the centre (IS) approved the present study and authorized access 
to clinic patients 
 
4.4.3.4 Drop-out rate 
Patients were able to drop out from the study at any stage and without reason and would 
immediately receive the standard care (polytherapy such as NSAIDs, polarised 
polychromatic non-coherent light (Bioptron light), ultrasound, LPLL, gliding exercises, 
neural mobilization and nocturnal splint with the wrist in the neutral position) for CTS 
as provided by the clinic. If patients reported moderate or severe symptoms two to three 
months after the end of the treatment, an alternative form of treatment was offered for 
their condition.  
 
4.4.3.5 Polarised polychromatic non-coherent light (Bioptron light) treatment 
intervention 
Patients attended the clinic three times each week over a four-week period for each 
polarised polychromatic non-coherent light (Bioptron light) treatment. The primary 
investigator (DS) administered the polarised polychromatic non-coherent light 
(Bioptron light) as monotherapy, following the advice provided in the manufacturer’s 
user guide (Chapter 3, section 3.6). The polarised polychromatic non-coherent light 
(Bioptron light) treatment was standardised during the treatment period. 
 
A Bioptron 2 device* was used to deliver the polarised polychromatic non-coherent 
light (Bioptron light). Bioptron 2 is the most common polarized polychromatic non-
                                                 
* Harrier Inc. USA 
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coherent light (Bioptron light) device in practice (Chapter 3, section 3.6). The output 
characteristics of Bioptron 2 were reported in chapter 3 (section 3.6). Patients sat 
upright with the arm placed on an adjacent bed with the elbow in extension and 
supination. The probe of Bioptron 2 was held at a 90o (perpendicular) angle 5-10 cm 
above the clean bare skin of the carpal tunnel as this is claimed to achieve maximal 
penetration of light for exactly six minutes (Figure 4.2).  A 'beep' signified the end of 
the 6-minute treatment. 
 
All patients were asked to avoid activities that irritate their hand and to refrain from 
taking analgesic medication for any condition during the course of study. Patient 
compliance to this request was monitored using a treatment diary. Patients were given 
no additional treatment for CTS until the six-month follow-up assessment.  
 
4.4.3.6 Outcome measures 
Outcome measures were the patient's self-report of nocturnal pain and paraesthesia 
respectively using a verbal 5-point categorical rating scale (worse, no change, slightly 
better, much better, no pain or paraesthesia). Outcome measures were taken at the end 
of the treatment (week 4) and at the six-month follow-up after the end of treatment 
(week 28).  
 
4.4.3.7 Data analysis 
Due to preliminary nature of the trial and the lack of control groups data was analysed 
using descriptive statistics. Descriptive statistics are always appropriate, though for 
analyzing results from an experiment when a hypothesis has been tested, the inferential 
statistics is the branch of statistics that is commonly used to show some kind of 
difference between groups. However, some times this kind of statistics is not possible to 
be performed. One of these occasions is the present study, because no statistical test was 
found to determine the difference between three dependent samples with nominal data.   
 
4.4.4 Results 
No patients requested to withdraw from the study and all patients provided data at the 6-
month follow-up. 
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4.4.4.1 Nocturnal pain 
Twenty-three out of 25 patients (92%) reported that their pain had improved at the end 
of the course of polarised polychromatic non-coherent light (Bioptron light) treatments 
(Table 4.5). Of these 23, 5 reported that they no longer experienced nocturnal pain, and 
12 reported that their nocturnal pain was ‘much better’. At 6-month follow-up, all 
patients reported that their pain had improved, with 9 reporting no nocturnal pain and 13 
reporting that their nocturnal pain was ‘much better’ (Table 4.5). 
 
4.4.4.2 Paraesthesia 
Twenty-one out of 25 patients (84%) reported that their paraesthesia had improved at 
the end of the course of polarised polychromatic non-coherent light (Bioptron light) 
treatments (Table 4.6). Of these 21 patients, 3 reported that they no longer experienced 
paraesthesia, and 13 reported that their paraesthesia was ‘much better’. At 6-month 
follow-up, 23 out of 25 patients reported that their paraesthesia had improved, with 7 
reporting no paraesthesia and 14 reporting that their paraesthesia was ‘much better’ 
(Table 4.6). 
 
4.4.5 Discussion 
The data from this preliminary prospective open and uncontrolled clinical trial in 
patients with idiopathic CTS suggests that a course of polarised polychromatic non-
coherent light (Bioptron light) treatments given in 6-minute sessions three times per 
week for four weeks may reduce the self-report of nocturnal pain and paraesthesia when 
compared to baseline data. However, the absence of a placebo (sham)/no treatment 
group means that we cannot be certain that these findings were due to the polarised 
polychromatic non-coherent light (Bioptron light) treatment intervention itself rather 
than to natural fluctuations in symptoms, resolution of the idiopathic CTS, use of 
medication not reported to the investigators, and/or expectation of treatment success 
associated with receiving a medicinal intervention. The possibility that patients reported 
prolonged improvement at the 6-month follow-up in order to please the investigator 
cannot also be discounted, as there was no placebo (sham)/no treatment control group.  
 
However, it must be noted that none of the patients wanted to discontinue polarised 
polychromatic non-coherent light (Bioptron light) in favor of conventional polytherapy. 
We must entertain the reasonable probability that symptom reduction was a real 
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phenomenon. For this reason, the finding that a high proportion of patients report long-
term improvement with polarised polychromatic non-coherent light (Bioptron light) 
given as a monotherapy merits dissemination, as the conservative management of 
idiopathic CTS still remains controversial. Some patients self-manage idiopathic CTS in 
the initials stages by reducing activities of the hands and/or task modification for one or 
two months in order to reduce symptoms. However, this approach is effective in less 
than 10% of patients (McCabe, 2002). For most patients CTS is managed in the initial 
stages by conservative treatment and by surgery if conventional treatment fails (Giele, 
2001; McCabe, 2002).  
 
The findings of the present preliminary trial should encourage the design of a RCT with 
sufficient power and validated outcome measures to determine the effectiveness of 
polarised polychromatic non-coherent light (Bioptron light) against a valid placebo and 
LPLL. It is also needed to confirm or refute the manufacturer’s recommendations for 
the application of polarised polychromatic non-coherent light (Bioptron light) in CTS, 
because the traditional use is not a reliable tool to determine the effectiveness of a 
treatment (Ernst, 1995). Finally, studies are needed to find out the analgesic effects of 
polarised polychromatic non-coherent light (Bioptron light) as well as to investigate the 
role of polarised polychromatic non-coherent light (Bioptron light) as physical therapy 
intervention for the management of common musculosceletal and / or orthopaedic 
conditions.  
 
4.4.6 Conclusions 
Polarised polychromatic non-coherent light (Bioptron light), applied as monotherapy in 
the current preliminary prospective open clinical trial, indicated a positive clinical effect 
in nocturnal pain relief and paraesthesia ability of idiopathic CTS. However, this study 
is limited by the lack of a control group and valid outcome measures. These 
shortcomings will be discussed in chapter 7. Future well-designed RCTs are required to 
investigate the absolute and relative effectiveness of polarised polychromatic non-
coherent light (Bioptron light) and to objectively evaluate recommendations for its 
routine use in clinical practice. 
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4.5 Conclusion 
The findings of these two preliminary clinical studies indicate that the supervised 
exercise programme and polarised polychromatic non-coherent light (Bioptron light) 
may reduce the symptoms in patellar tendinopathy and CTS, respectively. Cyriax 
physiotherapy consisting of DTF only did not reduce the pain in patients with patellar 
tendinopathy. However, future well-designed studies are required to confirm and further 
explore these findings, because methodological shortcomings were not absent from 
these two pilot studies. A questionnaire-based survey of the self-reports of chartered 
physiotherapists in Athens who are using the above-three treatments was conducted in 
order to establish their current clinical practice (Chapter 5). 
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Figure 4.1 
Flowchart of patellar tendinopathy study 
3 months symptoms 
Previous conservative treatment 
1-month therapy free interval 
 
 
Eligible patients (n=30) 
 
 
 
              Cyriax physiotherapy        Supervised exercise programme                 Ultrasound 
                        (n=10)                                       (n=10)                                             (n=10) 
 
 
 
            End of treatment (week 4)            End of treatment (week 4)               End of treatment (week 4) 
                         (n=10)                                       (n=10)                                             (n=10) 
 
 
 
                      Success                                      Success                                               Success 
 
 
                  Yes             No                        Yes             No                                   Yes             No 
                 (n=2)          (n=8)                     (n=8)          (n=2)                               (n=1)          (n=9)  
 
 
 
                 1-month follow-up (week 8)        1-month follow-up (week 8)   1-month follow-up (week 8) 
                       (n=10)                                        (n=10)                                                   (n=10) 
 
 
 
                      Success                                      Success                                                    Success 
 
 
 
                 Yes             No                             Yes             No     Yes             No 
                    (n=2)          (n=8)                         (n=10)        (n=0)                                        (n=0)        (n=10) 
 
 
 
             3-month follow-up (week 16)        3-month follow-up (week 16)               3-month follow-up (week 16) 
                            (n=10)                                       (n=10)                                                        (n=10) 
 
 
                                            
                           Success                                      Success                                                        Success 
 
 
                     Yes             No                             Yes             No     Yes             No 
                    (n=2)          (n=8)                         (n=10)        (n=0)                                        (n=0)        (n=10) 
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Figure 4.2 
Application of polarised polychromatic non-coherent light (Bioptron light) with 
Bioptron 2 device for the treatment of CTS 
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Table 4.1 
 
Sports of patients (n) 
 
 
  
Cyriax physiotherapy 
Supervised exercise 
programme 
 
Ultrasound 
Basketball 5 4 3 
Soccer 1 3 2 
Running 2 1 2 
Volleyball 1 2 2 
Tennis 1 0 1 
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Table 4.2 
 
Frequency and percentage of pain response categories across groups at the end of 
the treatment 
 
 
 
 Worse/no 
change/slightly better 
  
Much better/no pain 
 
 Frequency % Frequency % 
Cyriax 
physiotherapy 
 
8 
 
80 
 
2 
 
20 
Supervised exercise 
programme 
 
2 
 
20 
 
8 
 
80 
Ultrasound 9 90 1 10 
 
X2=12.21, p<0.01 
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Table 4.3 
 
Frequency and percentage of pain response categories across groups at one-month 
follow-up 
 
 
 
 Worse/no 
change/slightly better 
  
Much better/no pain 
 
 Frequency % Frequency % 
Cyriax 
physiotherapy 
 
8 
 
80 
 
2 
 
20 
Supervised exercise 
programme 
 
0 
 
0 
 
10 
 
100 
Ultrasound 10 100 0 0 
 
 
X2=23.2, p<0.001 
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Table 4.4 
 
Frequency and percentage of pain response categories across groups at three-
month follow-up 
 
 
 
 Worse/no 
change/slightly better 
  
Much better/no pain 
 
 Frequency % Frequency % 
Cyriax 
physiotherapy 
 
8 
 
80 
 
2 
 
20 
Supervised exercise 
programme 
 
0 
 
0 
 
10 
 
100 
Ultrasound 10 100 0 0 
 
X2=23.2, p<0.001 
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Table 4.5 
 
Nocturnal pain in CTS (n(%)) 
  
 
 
 End of treatment  Six-month follow-up  
Worse  0 0 
No change  2 (8%) 0 
Slightly better  6 (24%) 3 (12%) 
Much better  12 (48%) 13 (52%) 
No pain  5 (20%) 9 (36%) 
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Table 4.6 
 
Paraesthesia in CTS (n(%)) 
 
  
 End of treatment  Six-month follow-up  
Worse  0 0 
No change  4 (16%) 2 (8%) 
Slightly better  5 (20%) 2 (8%) 
Much better (n) 13 (52%) 14 (56%) 
No paraesthesia  3 (12%) 7 (28%) 
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Chapter 5: A questionnaire survey to establish current 
clinical practice of Cyriax physiotherapy, a supervised 
exercise programme and polarised polychromatic non-
coherent light (Bioptron light) for the management of pain 
and functional impairment on lateral epicondylitis in Athens 
 
5.1 Introduction 
Chapter 2, which reports on a systematic review of RCTs that was conducted to 
establish the clinical effectiveness of physiotherapy for LE, provided information only 
on the treatment protocol of Cyriax physiotherapy for application to LE. Chapter 3 
reports on a review of the published literature discussing the appropriate way to apply 
Cyriax physiotherapy, a supervised exercise programme, and polarised polychromatic 
non-coherent light (Bioptron light). The purpose was to establish possible treatment 
protocols for a clinical trial that would determine the relative effectiveness of these 
treatments for LE. These recommended protocols were derived from the views of 
advocates for the various therapies, based on their personal experience of using the 
treatment and on the putative physiological mechanisms that the treatment might rely 
upon. Two preliminary clinical studies were conducted to pilot the use of treatment 
protocols derived from the critical review in chapter 3 on overuse injuries that are 
similar to LE and were regularly presenting to the clinic (Chapter 4). The findings of 
these two pilot studies should be interpreted cautiously due to methodological 
shortcomings as mentioned in chapter 4. In the first study (section 4.3), Cyriax 
physiotherapy was administered by a therapist who was the investigator of the present 
project (DS) and was based on Cyriax principles. Cyriax physiotherapy did not reduce 
the pain in patellar tendinopathy. In the same study, the supervised exercise programme 
was administered by the investigator of the project (DS) with a resulting reduction in 
the pain of patellar tendinopathy. In the second study (section 4.4), polarised 
polychromatic non-coherent light (Bioptron light) was administered by the investigator 
of the project (DS) with a resulting reduction in the nocturnal pain and paraesthesia of 
idiopathic CTS. As a preliminary to investigating the effectiveness of these protocols in 
treating LE, a questionnaire survey was conducted to establish the current clinical 
practice of Cyriax physiotherapy, supervised exercise programmes, and polarised 
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polychromatic non-coherent light (Bioptron light) for the management of LE. This 
questionnaire was designed to record the self-reports of chartered physiotherapists in 
Athens who were using these treatments in their clinical practices.  
 
Questionnaire surveys have been used to establish current clinical practice using LPLL 
(Baxter et al., 1991) and cryotherapy (Johannsen and Langberg, 1997; Kerr et al., 1999). 
Surveys can quickly gather views of large number of people spread over large 
geographic areas, and they are less intrusive and cheaper than interviews or other forms 
of practice such as observation (Thomas and Nelson, 1996; Hicks, 1999; Domholdt, 
2000; Berg and Latin, 2004). The present survey administered, a questionnaire designed 
by the investigator of the project (DS) to Greek chartered physiotherapists who worked 
in Athens. 
 
5.2 Aim 
The aim of this questionnaire survey was to establish current clinical practice of Cyriax 
physiotherapy, a supervised exercise programme, and polarised polychromatic non-
coherent light (Bioptron light) for the management of pain and functional impairment 
associated with LE, through the self-reports of chartered physiotherapists of Athens.  
 
 5.3 Methods 
5.3.1 Design of questionnaire 
No validated instrument (questionnaire) existed for the purpose of assessing the self-
reports of physiotherapists on their management of LE using either the Cyriax 
physiotherapy, the supervised exercise programme, or polarized polychromatic non-
coherent light (Bioptron light). Therefore, the investigator of the present project (DS) 
designed a questionnaire (Appendix II) based on previously published questionnaires 
that established the current clinical practice of physiotherapy treatments such as LPLL 
and cryotherapy (Baxter et al., 1991; Johannsen and Langberg, 1997; Kerr et al., 1999). 
In addition, experts in this field were contacted and their comments on the draft 
questionnaire design sought. The final questionnaire comprised: (i) background 
information; (ii) the beliefs and opinions of respondents who worked with LE regarding 
signs, symptoms and management of LE; and (iii) the self-reports of respondents who 
worked with LE using Cyriax physiotherapy, a supervised exercise programme, and 
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polarised polychromatic non-coherent light (Bioptron light) in their own clinical 
management of LE. 
 
5.3.1.1 Background information  
Respondents were asked to report on how many years they had practiced, their area of 
specialisation, and if they worked with patients with LE. The last information was 
particularly important as this was used to exclude respondents who never saw LE 
patients in their practice. 
 
5.3.1.2 Respondents’ beliefs about signs, symptoms and management of LE 
In this section the respondents who worked with LE patients were asked to report on 
which of the below terms (such as LE, lateral epicondylalgia, extensor tendinosis, 
extensor tendonitis and extensor tendinopathy) was in their opinion the most commonly 
used to describe the TE condition. Respondents in this section were also asked to report, 
according to their belief, (i) if the ECRB was the most commonly affected structure of 
LE, (ii) if LE patients complained of pain during digital palpation conducted by 
therapists, (iii) if LE patients complained of pain during gripping and (iv) if resistance 
of the wrist extension with the elbow in extension was the most common diagnostic test 
in LE patients. Respondents were also asked to report, in their opinion, (a) whether they 
had read an article about the conservative management of LE recently, (b) whether they 
had attended a course about the conservative management of LE during their careers, 
and (c) if they knew that more than 40 different treatments have been reported for the 
management of LE in the literature. For the purposes of the survey, the meaning 
“recently” was defined as four months or less before respondents receiving the 
questionnaire. 
 
5.3.1.3 Self-reports on their own clinical management of LE by respondents who 
work with LE using Cyriax physiotherapy, a supervised exercise programme and 
polarised polychromatic non-coherent light (Bioptron light)  
Respondents who reported that they used at least one of these three treatments to treat 
LE were then asked to report, in their opinion, (i) the aim; (ii) how many LE patients 
were managed in a clinical setting the last month; (iii) the treatment regimen (number of 
treatment sessions and frequency of treatment), the protocol (individual or standardised) 
and the compliance; (iv) the clinical outcome (short-term and long-term effects); (v) the 
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side effects and the contraindications; (vi) if the treatment was painful for patients; and 
(vi)  the cost (expensive or not) and the risk (time consuming or not) applications.  All 
these questions were asked related to the treatment the respondents used to treat LE. 
 
5.3.2 Pilot procedure 
A pilot study using the described above questionnaire was carried out in early 
November 2002. The number of subjects required for a pilot study is often dependent on 
circumstance and resource (Thomas and Nelson, 1996; Hicks, 1999; Domholdt, 2000; 
Berg and Latin, 2004). Georgoudis et al (2000) report that ten subjects is a satisfactory 
number. Since ten subjects has been used to run pilot studies for other questionnaire 
surveys, the present questionnaire was administered to ten physical therapists in Athens. 
The ten physiotherapists who were selected for the pilot study were drawn from the 
population for inclusion in the main study. The design of the questionnaire was 
subsequently discussed with the respondents and their comments noted. The results of 
the pilot study were not included in the final data analysis. 
 
All respondents returned the questionnaire. Seven out of ten questionnaires were fully 
completed. Based upon the comments received during the pilot study, limited rewording 
of a number of questions was thought necessary to improve clarity. The meaning of 
word “recently” had to be defined (question 9). It was also necessary to reword the 
questions that asked when respondents attended a course about the conservative 
treatment of LE (question 10) and who reproduced the pain in patients by digital 
palpation (question 6). No additional negative comments or feedback about the 
completion of the questionnaire were received during the pilot study. Respondents 
noted that the questionnaire included clear and concise instructions on how to complete 
it, using simple language and leaving adequate space for them to make comments. 
Finally, respondents mentioned that the questionnaire held their interest and was 
completed easily.  
 
5.3.3 Translation procedure 
In translating an assessment instrument to a different language, misrepresentation may 
arise and a multi-step translation and validation process is essential for truly successful 
translation. These steps include a forward translation, blind back translation and pilot 
testing (Cull, 1998).  
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As recommended by the European Organisation for Research and Treatment of Cancer 
(EORTC) in their manual “ EORTC quality of life study group: translation procedure” 
(Cull, 1998), for all translations, the translator(s) should be a native speaker of the 
language into which the questionnaire is being translated, with a high fluency in the 
other relevant language. The translation back to the original language should be 
undertaken independent of the forward translation, i.e. by a different translator, 
independent of the first (Cull, 1998).  
 
The present questionnaire did not follow this translation procedure. For the pilot and 
main study, it was written in English and translated into Greek (Appendix III) by the 
investigator of the project for the purposes of administering it to chartered 
physiotherapists in Athens.  
 
5.3.4 Survey procedure 
The mail addresses of the 660 Athens members of the Greek Physiotherapy Association 
were obtained and a random sample of 220 Athens physiotherapists (33.3%) were sent 
the questionnaire, accompanied by an invitation letter (Appendix IV) in mid-November 
of 2002.  
 
The questionnaire was designed to assure the confidentiality and anonymity of the 
responding physical therapists, since there was no coding to identify the questionnaires. 
Physical therapists completed the questionnaires and sent the completed questionnaires 
to the investigator using the self-addressed stamped envelope that was included. When 
the questionnaire was returned, the returned envelope was discarded maintaining the 
confidentiality and anonymity of the subjects’ responses to the questionnaire.  
 
Oppenheim (1992) suggests that questionnaires should be returned in a period of two 
weeks from the time they are distributed to participants. However, such a period of time 
is not long enough to provide a high response rate. Therefore, the investigator of the 
project chose to extend the deadline of the present study for two more weeks, giving an 
opportunity to the participants to return the questionnaires in four weeks (by mid-
December 2002) from the time which they received them. This deadline was extended 
in the hope of increasing the response rate. No questionnaires were received after the 
deadline of the four weeks. No follow-up reminders were sent to assure anonymity.  
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5.3.5 Data analysis 
Data was managed using descriptive statistical analysis (Hicks, 1999). One-way 
ANOVA was used to compare the mean professional experience of the groups.  
 
5.4 Results  
5.4.1 Response rate 
Of the 220 questionnaires, 150 (68%) were received by mid-December 2002. Overall, 
the response rate of the present study was 68% and can be considered as approaching 
very good. Currier (1990) states that returns of 40% to 50% or less are common, and a 
response rate of 60% is good and 70% is very good.  
 
Of the 150, 47 respondents (31.3%) reported that they did not work with patients who 
had LE. They were excluded from the analysis. Out of the remaining 103 respondents, 
35 (34%) who worked with LE patients reported that they never used Cyriax 
physiotherapy, a supervised exercise programme or polarised polychromatic non-
coherent light (Bioptron light) to treat LE. They were also excluded from the analysis. 
The remaining 68 respondents (66%) who worked with LE patients reported that they 
predominately used Cyriax physiotherapy (18, or 26.5%), a supervised exercise 
programme (43, or 63.2%) or polarized polychromatic non-coherent light (Bioptron 
light) (7, or 10.3%) to treat LE. Results of the analysis of these 68 completed 
questionnaires are presented below. Respondents’ flow through the survey is 
summarized in a flow chart (Figure 5.1). 
 
5.4.2 Background information  
The mean professional experience of respondents who work with LE using Cyriax 
physiotherapy, a supervised exercise programme or polarised polychromatic non-
coherent light (Bioptron light) was 15.93 (95%CI= 14.26-17.59) years (Table 5.1). 
There were no significant differences in mean professional experience between the 
groups (p>0.0005, One Way ANOVA, Table 5.1). Orthopaedic and sports medicine 
physiotherapy were the specialised areas of respondents. Out of the 68 respondents, 37 
(54.4%) were specialists in orthopaedic physiotherapy (Table 5.2) 
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5.4.3 Beliefs regarding signs, symptoms and management of LE  
Respondents were permitted to identify which term (such as LE, extensor tendonitis, 
lateral epicondylalgia, extensor tendinopathy and extensor tendinosis) they used to 
describe the TE condition. LE was the most common answer, reported by 45 out of 68 
respondents (66%) (Table 5.3) 
 
64 out of 68 respondents (94%) reported that the ECRB tendon is the most common 
affected structure on LE (Table 5.4). All respondents (68, or 100%) reported that LE 
patients complain of pain by digital palpation conducted by therapists on the affected 
site and by gripping. In addition, 57 out of 68 respondents (84%) reported that the 
resisted wrist extension with the elbow in extension is the most common diagnostic test 
in practice for LE patients (Table 5.4).  
 
Out of 68 respondents, 12 (17.5%) reported that they had read an article about the 
conservative management of LE recently (Table 5.5). Out of 68 respondents, 5 (7.5%) 
reported that they had attended a course about the conservative management of LE 
during their career (Table 5.5).  Finally, out of 68 respondents, 18 (26.5%) stated that 
they knew that more than 40 different treatments methods have been reported in the 
literature for the management of LE (Table 5.5).  
 
5.4.4 Self-reports on their own clinical management of LE  
Most respondents, irrespective of whether they used Cyriax physiotherapy, a supervised 
exercise programme or polarised polychromatic non-coherent light (Bioptron light) to 
treat LE, reported that the reduction of pain and the improvement of function, individual 
or combined, were the main aims of these treatments (Table 5.6). It should be noted that 
respondents had the option to give more than one answer. 
 
During the month prior to the survey, a total of 191 LE patients had been reported to be 
managed by the 68 respondents in a clinical setting with Cyriax physiotherapy, a 
supervised exercise programme or polarised polychromatic non-coherent light 
(Bioptron light) (Table 5.7). The supervised exercise programme was used more than 
the Cyriax physiotherapy and the polarised polychromatic non-coherent light (Bioptron 
light) in mean values (Table 5.7). 
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All respondents (68, or 100%) reported that they used a treatment regimen of 3 sessions 
of treatment per week for a four-week period to treat LE, irrespective of whether it was 
Cyriax physiotherapy, a supervised exercise programme or polarised polychromatic 
non-coherent light (Bioptron light). In addition, all respondents (68, or 100%) reported 
that they used a standardised treatment protocol during the treatment period to treat LE, 
irrespective of whether it was Cyriax physiotherapy, a supervised exercise programme 
or polarised polychromatic non-coherent light (Bioptron light).  
 
All respondents (18, or 100%) who predominately used Cyriax physiotherapy to treat 
LE and all respondents (7, or 100%) who predominately used polarized polychromatic 
non-coherent light (Bioptron light) to treat LE reported that they administered these two 
physiotherapy treatments only in a clinical setting. However, 21 out of 43 respondents 
(49%) who predominately used a supervised exercise programme to treat LE reported 
that an exercise programme could be performed by LE patients at home. 
 
All respondents (68, or 100%), irrespective of whether they used Cyriax physiotherapy, 
a supervised exercise programme or polarised polychromatic non-coherent light 
(Bioptron light) to treat LE, reported that these treatments were effective in the short-
term (one month after the end of treatment) and in the long-term (six months after the 
end of treatment). 
 
All respondents (68, or 100%) reported that they used a no-side-effects treatment to 
treat LE, irrespective of whether it was Cyriax physiotherapy, a supervised exercise 
programme or polarised polychromatic non-coherent light (Bioptron light).  
 
Out of 18 respondents, who predominately used Cyriax physiotherapy to treat LE, 12 
(66%) reported that this treatment had some contra-indications, of which the 
calcification of soft tissues was reported as the most common (Table 5.8). However, all 
respondents (43, or 100%) who predominately used the supervised exercise programme 
to treat LE and all respondents (7, or 100%) who predominately used polarized 
polychromatic non-coherent light (Bioptron light) to treat LE reported that these two 
treatments have no contra-indications in cases of LE.  
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All respondents (68, or 100%) reported that they used a pain-free treatment to treat LE, 
irrespective of whether it was Cyriax physiotherapy, a supervised exercise programme 
or polarised polychromatic non-coherent light (Bioptron light). 
 
All respondents (18, or 100%) who predominately used Cyriax physiotherapy and all 
respondents (43, or 100%) who predominately used a supervised exercise programme to 
treat LE reported that these two treatments were not expensive treatments for either 
physical therapists or patients. However, all respondents (7, or 100%) who 
predominately used polarized polychromatic non-coherent light (Bioptron light) to treat 
LE reported that this treatment was an expensive treatment not only for patients, but 
also for physiotherapists. 
 
All respondents (68, or 100%) reported that they did not use a time-consuming 
treatment to treat LE, irrespective of whether it was Cyriax physiotherapy, a supervised 
exercise programme or polarised polychromatic non-coherent light (Bioptron light). 
 
5.5 Discussion 
5.5.1 Principal (main) findings 
The primary aim of this questionnaire survey was to establish current clinical practices 
for Cyriax physiotherapy, a supervised exercise programme, and polarised 
polychromatic non-coherent light (Bioptron light) for the management of pain and 
functional impairment associated with LE based on the self-reports of Athens chartered 
physiotherapists who used these treatments in their clinical practice. This is the first 
questionnaire survey to address this question.  
 
Out of 103 respondents, 68 (66%) who worked with LE patients reported that they 
predominately used Cyriax physiotherapy, a supervised exercise programme, or 
polarised polychromatic non-coherent light (Bioptron light) to treat LE. Of those 68 
responses, the most common was the supervised exercise programme (43, or 63.2%) 
and the least common was the polarized polychromatic non-coherent light (Bioptron 
light) (7, or 10.3%).  It was reported that 191 LE patients were managed by the 68 
respondents in a clinical setting with one of these treatments during the month prior to 
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the survey. The supervised exercise programme was used more than the Cyriax 
physiotherapy and the polarised polychromatic non-coherent light (Bioptron light).  
 
The primary aim of these three treatments was reported to be the reduction of pain and 
improvement of function. The treatment regimen of these treatments was reported to be 
three sessions of treatment per week for a four-week period. The treatment protocol of 
these treatments was reported to be standardised during the treatment course. It was also 
reported that these treatments are characterized as not time-consuming, short-term (one 
month after the end of treatment) and long-term (six months after the end of treatment) 
effective treatments that do not cause side effects or increase of pain in patients during 
their application.  
 
In addition, it was reported that the supervised exercise programme was the only of the 
three treatments that could be performed at home. Furthermore, it was reported that 
Cyriax physiotherapy was the only one of the three treatments that had some 
contraindications. Finally, polarised polychromatic non-coherent light (Bioptron light) 
was reported to be the only treatment that was expensive for both physical therapists 
and patients. 
 
5.5.2 Strengths and weaknesses of study 
A weakness of the present survey is that it is based on self-reports made retrospectively. 
This can be a problem when respondents are asked to look back and estimate the 
frequency of a particular behaviour. To avoid this problem a valid and reliable 
questionnaire has to be designed. A questionnaire is valid when it measures what it 
claims to measure and is not subject to bias (Streiner and Norman, 1989). Reliable 
questionnaires yield consistent results from repeated samples and different researchers 
over time (McKinley et al., 1997; Boynton and Greenhalgh, 2004). Just because a 
questionnaire has been piloted on a few of your colleagues, used in previous studies, or 
published in a peer-reviewed journal does not mean it is either valid or reliable.  
 
Therefore, before administering a questionnaire, researchers have to be confident that 
the questionnaire is valid and reliable. However, in the present survey, the process of 
questionnaire development cannot ensure a high level of validity and reliability. 
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Unfortunately, this lack of a high level of validity and reliability is supported by the fact 
that the group of questions about beliefs of signs, symptoms and management of LE 
offers nothing to the aim of the study. These questions are therefore not discussed in 
this section. Nevertheless, the experience of respondents in diagnosis and management 
of LE was reported in the second section of the questionnaire. According to 
respondents’ answers it can be concluded that they could diagnose LE simply, easily 
and quickly but their level of recently informing (updating) in the management of LE, 
apart from the treatment that they used, seemed to be low.  
 
In addition, respondents who work with LE, irrespective of whether they used Cyriax 
physiotherapy, a supervised exercise programme, or polarised polychromatic non-
coherent light (Bioptron light) to treat LE, were asked to report if the treatment that they 
applied was harmful for clinicians’ hands (Question 19) and if any prophylactic 
measures were needed either for the therapists or for patients during its application  
(Questions 23 and 24). However, the findings of these questions are not presented in the 
results section because they were deemed not to be precise enough and were also not 
comparable. The answers to these excluded questions are included in Appendix V. 
Furthermore, these questions had not been asked of all respondents because the three 
treatments had different way of application (Chapter 3). 
 
This problem could have been avoided if a more valid and reliable questionnaire had 
been developed and a two-stage questionnaire survey had been carried out. Although no 
important negative comments received during the pilot study of the present 
questionnaire, just a pilot study is not enough to confirm the validity and reliability of a 
questionnaire. A valid and reliable questionnaire could be developed following the 
techniques outlined by Oppenheim (1992) and Sapsford (1999). These techniques 
include: interviews of potential participants to identify issues about the topic and so to 
develop questionnaire items; comparison the list with the issues identified during the 
interviews with published and unpublished similar questionnaires; comments from all 
participants interviewed during the development of questionnaire on its content in order 
to suggest additional issues or questions; development a bank of questions to produce 
multi-items scales, which are more reliable than single questions (Ware et al., 1978); 
administration of questionnaire by interview to potential participants. Questions which 
are confusing, ambiguous, or gave very skewed responses will be either removed, 
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rewritten, or replaced; two further postal pilot studies for clarity will be conducted 
maximizing the issues that reported by participants as important; a proportion of 
participants will be asked to complete a second questionnaire later the same day with 
the administration of questionnaire and return it by post as a test of test-retest reliability; 
some practitioners who are not otherwise involved in the development of questionnaire 
will be review the components of questionnaire to recheck validity of questionnaire; 
statistical tests calculating Cronbach's  coefficient and a matrix of Pearson's correlation 
coefficients.  
 
Later, in the first stage of a two stage questionnaire survey, a letter could be sent to all 
eligible participants to discover who predominately managed LE patients using Cyriax 
physiotherapy, using supervised exercise programmes or using polarised polychromatic 
non-coherent light (Bioptron light). For the second phase of the questionnaire survey, 
the questionnaire would be forwarded for completion to all those who predominately 
used one of the three physiotherapy treatments to manage LE. The questionnaire would 
be the same among the three groups with some modifications, for example, respondents 
who predominately used polarised polychromatic non-coherent light (Bioptron light) to 
treat LE would be asked in depth about prophylactics measures. Similar questions 
would be developed for the other groups. However, due to time and cost constraints, it 
was not possible to follow the above research design in the present survey.  
 
The validity and reliability of the questionnaire might seem to be in doubt because of 
these reservations. In light of the nature of the study, it would have been anticipated that 
Cyriax physiotherapy, supervised exercise programmes and polarised polychromatic 
non-coherent light (Bioptron light), as used for the management of LE, would be 
overstated in the responses to this questionnaire, because the first two treatments are 
two of the most common treatments for LE and the last one is a novel modality, 
attractive to practitioners working in rehabilitation settings. However, this did not occur, 
since 68 out of 150 respondents used one of these three treatments to treat LE. If so, 
given the response rate, the length of experience reported by respondents and the 
amount of detail in their answers, it may be confidently assumed that the above results 
present a representative view of current clinical practice of Cyriax physiotherapy, a 
supervised exercise programme and polarised polychromatic non-coherent light 
(Bioptron light) on LE at least as these treatments are applied in Athens. How much this 
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reflects usage in the rest of the Greece, Europe, or even the world, is yet to be seen by 
extending the research. 
 
5.5.3 Comparison with previously published literature  
Owing to a lack of comparable data, it is not possible to say whether the proportion of 
respondents who reported that they predominately used Cyriax physiotherapy, a 
supervised exercise programme, or polarized polychromatic non-coherent light 
(Bioptron light) to treat LE is high or low. The same conclusion about the number of LE 
patients who were managed during the last month in clinical settings using one of the 
three physiotherapy treatments must be drawn under consideration. The supervised 
exercise programme was the most commonly used treatment in practice. The most 
likely explanations for this are that the supervised exercise programme is a common 
physiotherapy treatment for a plethora of musculoskeletal disorders, no special training 
machines are needed, no specific “skills” from the physiotherapist are needed, more 
patients are familiar with it, and patients can understand that they are receiving a real 
treatment. Future surveys are needed to confirm these explanations and/or to add more. 
 
The possible treatment protocols for Cyriax physiotherapy, a supervised exercise 
programme, and polarised polychromatic non-coherent light (Bioptron light) on LE 
were reported in chapter 3. Although these three treatments are administered in totally 
different manner, it was reported that they have the same aim, to reduce pain and 
improve function. This answer was expected because this is the priority aim of 
physiotherapy management (Cook et al., 2001). 
 
The recommended regimen for Cyriax physiotherapy and polarised polychromatic non-
coherent light (Bioptron light) in the treatment of LE is three times per week for four 
weeks (Chapter 3). Such treatment regimens were used for these two treatments in the 
two preliminary clinical studies on overuse injuries that are similar to LE and were 
regularly presented to the clinic (Chapter 4). All respondents who predominately used 
one of these two treatments to treat LE reported in the present survey that they 
administered these treatments for LE three times per week for four weeks, supporting 
the findings of chapter 3. 
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On the other hand, the LE treatment regimen for a supervised exercise programme was 
not recommended in chapter 3 due to lack of available information. The most likely 
explanation for this may be that the exercise programmes were administered at home.  
The present survey found that half of respondents (21, or 49%) who predominately used 
supervised exercise programmes to treat LE reported that an exercise programme could 
be performed at home without the supervision of physical therapist. However, exercise 
programmes should be conducted under the supervision of physical therapists, because 
patients need a physiotherapist to monitor how the exercise programme is administered 
and how is progresses (Stasinopoulos and Johnson, 2004b). Supervised exercise 
programmes were used in the preliminary clinical trial in chapter 4 and in the 
subsequent controlled clinical trial in chapter 6. Nevertheless, the results of the present 
survey filled a knowledge gap in respect to the treatment regimen of supervised exercise 
programmes. All respondents who predominately used supervised exercise programmes 
to treat LE reported administering supervised exercise programmes three times per 
week for four weeks. Such a treatment regimen was used for the supervised exercise 
programme that was part of the preliminary patellar tendinopathy clinical study in 
chapter 4 (section 4.3). 
 
Therefore, it was decided that Cyriax physiotherapy, a supervised exercise programme 
and polarised polychromatic non-coherent light (Bioptron light) would be administered 
in the controlled clinical trial (Chapter 6) three times per week for four weeks. All 
respondents, irrespective of whether they used Cyriax physiotherapy, a supervised 
exercise programme, or polarised polychromatic non-coherent light (Bioptron light) to 
treat LE, reported that they used this treatment regimen. The previously reported 
regimen may be popular because of convenience with the clinical route/routine, or 
alignment with manufacturers’ recommendations, expert advice, and/or personal 
experience. Future surveys might reveal why all clinicians reported the same treatment 
regimen for three different treatments. Such research was beyond the scope of this 
project. 
 
Cyriax physiotherapy and a supervised exercise programme are individualized by 
patient verbal description of the pain experienced during the procedure (Chapter 3; 
Chapter 4). On the other hand, the respondents who predominately used one of these 
two treatments for LE reported in the present survey that the protocols of these two 
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treatments are standardised during the treatment course. This discrepancy occurred due 
to the design of the questionnaire. The questionnaire did not ask those respondents who 
predominately used one of these two treatments to treat LE whether the application of 
each of the components of these treatments should be standardised during the treatment 
period, that is, whether DTF should be administered in the same way to all patients 
during the treatment course or should be individualized in response to patients’ 
symptoms. This discrepancy would be avoided in a future survey. For the time being, 
the findings of chapter 3 are supported: the treatment protocols of Cyriax physiotherapy 
and supervised exercise programmes for LE cannot be standardised during the treatment 
period and are individualized by the patient’s description of pain experienced during the 
procedure. However, it is standard that these two treatments consist of two components 
during the treatment period. 
 
The rest findings of the present survey that related to the effectiveness (clinical 
effectiveness, side-effects, cost effectiveness, time effects and contraindications) of the 
three treatments will be discussed in chapter 7, when a clinical trial comparing the 
clinical value of Cyriax physiotherapy, a supervised exercise programme and polarised 
polychromatic non-coherent light (Bioptron light) on LE will be conducted in next 
chapter (Chapter 6). The findings of the present survey will be compared with the 
findings of the controlled clinical trial (Chapter 6) giving evidence to support or not the 
findings of the present project. 
 
5.6 Treatment protocols for Cyriax physiotherapy, a supervised 
exercise programme and polarized polychromatic non-coherent light 
(Bioptron light) for the treatment of LE 
The protocols for Cyriax physiotherapy, a supervised exercise programme, and 
polarised polychromatic non-coherent light (Bioptron light) for the management of LE 
were recommended in chapter 3. Some of these protocols were not effective in chapter 4 
but this may be due to the type of condition e.g. not LE. Chapter 5 matches treatment 
regimens of protocols in use for Cyriax physiotherapy and polarised polychromatic non-
coherent light (Bioptron light) with the treatment regimens of protocols recommended 
in literature discussed in chapter 3. In addition, chapter 5 adds information about the 
treatment regimen of the supervised exercise programme. The investigator cannot say 
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with certainty whether these recommended protocols are the optimal treatment 
protocols, because the optimal treatment protocol can only be developed by 
synthesizing different sources of information: all kinds of published trials, anecdotal 
reports from therapists, published reviews, published surveys that establish treatment 
protocol, etc. Due to a lack of such sources for information on these treatments, it can 
be concluded, based on the existing literature, that the protocols for these treatments are 
the most appropriate and/or the most successful. These treatments protocols will be 
therefore applied in the subsequently described controlled clinical trial (Chapter 6). 
 
5.6.1 Treatment protocol for Cyriax physiotherapy for the treatment of LE  
It was decided that Cyriax physiotherapy would be consisted of DTF and Mill’s 
manipulation administered three times per week for four weeks (Figure 3.3). Both 
components of Cyriax physiotherapy will be applied as described in chapter 3 (section 
3.4.3) and will be individualised by responding to the patient’s description of the pain 
experienced during the procedure.  
 
5.6.2 Ttreatment protocol for a supervised exercise programme for the treatment of 
LE 
It was decided that the supervised exercise programme would be consisted of slow 
progressive eccentric exercises of wrist extensors and static stretching exercises of 
ECRB administered three times per week for four weeks (Figure 3.10). Both 
components of the supervised exercise programme will be applied as described in 
chapter 3 (section 3.5.3) and will be individualised by responding to the patient’s 
description of the pain experienced during the procedure. 
 
5.6.3 Treatment protocol for polarised polychromatic non-coherent light (Bioptron 
light) for the treatment of LE 
A Bioptron 2 device (Figure 3.11) will deliver standardised polarised polychromatic 
non-coherent light (Bioptron light) therapy as described in chapter 3 (section 3.6.1) 
three times per week for four weeks (figure 3.15).  
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5.7 Conclusion 
Clinicians reported that they believed that Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) had the 
same aim (reduction of pain and improvement of function) and the same treatment 
regimen (three times per week for 4 weeks). It was also reported that these treatments 
are characterized as not time-consuming, short-term (1 month after the end of treatment) 
and long-term (6 months after the end of treatment) effective treatments that do not 
cause side-effects or increase of pain in patients during their application. Moreover, 
clinicians reported that (i) the supervised exercise programme could be performed at 
home; (ii) Cyriax physiotherapy had some contraindications; and (iii) polarised 
polychromatic non-coherent light (Bioptron light) was expensive for both physical 
therapists and patients. 
 
It appears that research in this area is warranted not only to substantiate the subjective 
findings of individual physiotherapists, but also to explore the possible clinical 
relevance of the three treatments. While cellular and animal models have their part to 
play and can provide much useful information in this respect, the work would be best 
completed in human subjects by conducting well-designed clinical trials. Such a clinical 
trial comparing the effects of Cyriax physiotherapy, a supervised exercise programme, 
and polarised polychromatic non-coherent light (Bioptron light) on LE is described in 
the next chapter. 
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Figure 5.1 
 
Flow chart of the survey 
 
Questionnaires sent 
n=220 
 
 
 
Replies 
n=150 
 
                                                   
 
 
 
Work with LE patients                                                       Do not work with LE patients 
            n=103                                                                                      n=47 
                                                                                                 (Excluded from analysis) 
 
 
 
 
 
 
 
 
Predominately used                                    Do not use Cyriax physiotherapy, a supervised exercise    
          n=68                                                 programme and polarised polychromatic non-   
                                                                   coherent light (Bioptron light) 
                                                                                n=35 
                                                                     (Excluded from analysis) 
 
 
 
 
 
 
 
 
 
Cyriax                       Supervised exercise            Polarised polychromatic non-coherent  
physiotehrapy            programme                         light (Bioptron light) 
    n=18                           n=43                                      n =7 
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Table 5.1 
 
Mean professional experience of respondents (years (95%CI)) 
 
 
  
Cyriax 
physiotherapy 
Supervised 
exercise 
programme 
Polarised polychromatic 
non-coherent light 
(Bioptron light) 
 
Mean professional 
experience  
 
14.61 (11.54-17.88) 
16.82 (14.61-
19.03) 
 
13.33 (7.91-18.75) 
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Table 5.2 
 
Specialised areas of respondents (n (%)) 
 
 
 Orthopaedic 
physiotherapy 
Sports medicine 
physiotherapy 
Cyriax physiotherapy 10 (55.5%) 8 (44.5%) 
Supervised exercise 
programme 
22 (51%) 21 (49%) 
Polarised polychromatic 
non-coherent light 
(Bioptron light) 
 
 
5 (71.4%) 
 
 
2 (28.6%) 
Total 37 (54.4%) 31 (45.6%) 
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Table 5.3 
 
Terms to describe the TE condition (n (%)) 
 
 
  
  
 
Cyriax 
physiotherapy 
 
Supervised 
exercise 
programme 
Polarised 
polychromatic non-
coherent light 
(Bioptron light) 
 
 
 
Total 
LE 12 (66.6%) 28 (65%) 5 (71.4%) 45 (66%) 
Extensor 
tendonitis 
 
5 (27.7%) 
 
10 (23%) 
 
0 
 
15 (22%) 
Lateral 
epicondylalgia 
 
1 (5.7%) 
 
3 (7%) 
 
1 (13.4%) 
 
5 (7.5%) 
Extensor 
tendinopathy 
 
0 
 
1 (2.3%) 
 
1 (13.4%) 
 
2 (3%) 
Extensor 
tendinosis 
 
0 
 
1 (2.3%) 
 
0 
 
1 (1.5%) 
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Table 5.4 
 
Signs and symptoms of LE (n (%)) 
 
 
  
 
 
Cyriax 
physiotherapy 
 
 
Supervised 
exercise 
programme 
Polarised 
polychromatic 
non-coherent 
light (Bioptron 
light) 
 
 
 
 
Total 
The most 
common 
affected site on 
LE is the 
ECRB tendon 
 
 
 
 
17 (94.3%) 
 
 
 
 
41 (95.4%) 
 
 
 
 
6 (85.7%) 
 
 
 
 
64 (94%) 
The most 
common 
diagnostic test 
in practice is 
the resisted 
wrist extension 
with the elbow 
in extension  
 
 
 
 
 
 
 
15 (83.2%) 
 
 
 
 
 
 
 
37 (86.1%) 
 
 
 
 
 
 
 
5 (71.4%) 
 
 
 
 
 
 
 
57 (84%) 
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Table 5.5 
 
Management of LE (n (%)) 
 
 
  
 
 
Cyriax 
physiotherapy 
 
 
Supervised 
exercise 
programme 
Polarised 
polychromatic 
non-coherent 
light (Bioptron 
light) 
 
 
 
 
Total 
Reading an 
article 
 
2 (11.3%) 
 
9 (21%) 
 
1 (14.3%) 
 
12 (17.5%) 
Attending a 
course 
 
0 
 
4 (9.3%) 
 
1 (14.3%) 
 
5 (7.5%) 
Knowing that 
more than 40 
treatments 
exists on LE 
 
 
 
4 (22.6%) 
 
 
 
12 (28%) 
 
 
 
2 (28.6%) 
 
 
 
18 (26.5%) 
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 Table 5.6 
 
Aims of Cyriax physiotherapy, a supervised exercise programme and polarised 
polychromatic non-coherent light for the treatment of LE (n (%)) 
 
 
  
 
 
Cyriax 
physiotherapy 
 
 
Supervised 
exercise 
programme 
Polarised 
polychromatic 
non-coherent 
light (Bioptron 
light) 
 
 
 
 
Total 
Reduce pain 2 (11%) 6 (14%) 3 (43%) 11 (16.1%) 
Improve 
function 
 
2 (11%) 
 
8 (19%) 
 
1 (14%) 
 
11 (16.1%) 
Reduce pain & 
improve 
function 
 
 
3 (17%) 
 
 
10 (23%) 
 
 
2 (29%) 
 
 
15 (22%) 
Repair 
connective 
tissue 
 
 
4 (22%) 
 
 
6 (14%) 
 
 
1 (14%) 
 
 
11 (16.1%) 
Reduce pain & 
repair 
connective 
tissue 
 
 
 
2 (11%) 
 
 
 
3 (7%) 
  
 
 
5 (7.35%) 
Improve 
function & 
repair 
connective 
tissue 
 
 
 
 
3 (17%) 
 
 
 
 
3 (7%) 
  
 
 
 
6 (8.82%) 
Reduce pain & 
improve 
function & 
repair 
connective 
tissue 
 
 
 
 
 
2 (11%) 
 
 
 
 
 
4 (9%) 
  
 
 
 
 
6 (8.82%) 
Improve blood 
flow 
  
2 (4.5%) 
  
2 (2.9%) 
Reduce pain & 
improve 
function & 
repair 
connective 
tissue & 
Improve blood 
flow 
  
 
 
 
 
 
 
1 (2.5) 
  
 
 
 
 
 
 
1 (1.45%) 
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Table 5.7 
 
Number of patients who were managed in a clinical setting with Cyriax 
physiotherapy, a supervised exercise programme and polarised polychromatic 
non-coherent light (Bioptron light) the month prior to the survey 
 
 
Treatment approaches N x (SD) Range 
Cyriax physiotherapy 52 2.88 (1.24) 1-5 
Supervised exercise programme 127 3 (1.4) 1-6 
Polarised polychromatic non-
coherent light (Bioptron light) 
 
12 
 
1.71 (0.75) 
 
1-3 
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Table 5.8 
 
Contraindications of Cyriax physiotherapy for the treatment of LE (n (%)) 
 
Participants Contraindications 
3 (25%) skin problem 
4 (33.3%) Infection 
5 (41.7%) calcification of the soft tissues 
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Chapter 6: A controlled clinical trial to compare the 
effectiveness of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light 
(Bioptron light) in the reduction of pain and in the 
improvement of function in patients with lateral epicondylitis 
 
6.1 Introduction 
Strong evidence for the short-term effectiveness of acupuncture for LE was presented in 
chapter 2. There was also strong evidence that four modalities, LPLL, ultrasound, 
ESWT, and pulsed electromagnetic field therapy were not effective physiotherapy 
treatments for the management of LE. There was insufficient evidence available for 
other treatments used for LE, such as iontophoresis and home exercise programmes, to 
judge their effectiveness. It was recommended that more evidence from clinical trials is 
needed for Cyriax physiotherapy, supervised exercise programmes, and polarised 
polychromatic non-coherent light (Bioptron light). It appears that treatment protocols 
for Cyriax physiotherapy, supervised exercise programmes, and polarised 
polychromatic non-coherent light (Bioptron light) are mainly derived from the views of 
advocates of these techniques, based on their personal experiences (Chapter 3) although 
the treatment protocol for Cyriax physiotherapy did not reduce the pain in patellar 
tendinopathy (Chapter 4; section 4.3). On the other hand, a supervised exercise 
programme was found to reduce pain of patellar tendinopathy. However, as the number 
of patients included in the patellar tendinopathy was small, the data should be 
interpreted cautiously. Polarised polychromatic non-coherent light (Bioptron light) was 
found to reduce nocturnal pain and paraesthesia of idiopathic CTS although it was not 
possible to attribute changes to the light per se because the study lacked a control group 
(Chapter 4; section 4.4). A questionnaire survey of the self-reporting of their use of 
these treatments by chartered physiotherapists in Athens revealed that they used 
protocols in their daily practice that were similar to those found in the literature 
(Chapter 5).  
 
In order to assess the effectiveness of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) for LE a 
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clinical trial was necessary. Relative effectiveness of outcome between treatments gives 
more clinically meaningful information since it provides therapists with information 
that can be used when choosing treatments (Halle et al., 1986). Absolute effectiveness, 
on the other hand, is useful in determining specific effects associated with individual 
treatments’ by comparing them to a placebo intervention. This does not provide 
information about the relative effects of a range of different treatments (Labelle et al., 
1992). From a clinical perspective information on relative effectiveness is more relevant 
to the practicing therapist. 
 
6.2 Aim 
The aim of this study was to investigate the relative effectiveness of Cyriax 
physiotherapy, a supervised exercise programme and polarized polychromatic non-
coherent light (Bioptron light), in the reduction of pain and improvement of function in 
patients with LE. 
 
6.3 Methods 
A controlled, monocenter trial was conducted in a clinical setting over 18-month period 
to assess the effectiveness of Cyriax physiotherapy, a supervised exercise programme, 
and polarised polychromatic non-coherent light (Bioptron light). A parallel-group 
design was employed because cross-over designs are limited in situations where patients 
are cured by the intervention and do not have the opportunity to receive the other 
treatments following cross-over (Johannsen et al., 1993). Three investigators were 
involved in the study: 1) The primary investigator who administered the treatments 
(DS); 2) a specialised rheumatologist (IS), who had over 25 years experience and who 
evaluated the patients to confirm the LE diagnosis, and 3) a physiotherapist (EK), who 
performed all baseline and follow-up assessments, and gained informed consent. All 
assessments were conducted by EK who was blind to the patients’ therapy group. EK 
had 15 years of experience in the management and assessment of musculoskeletal 
disorders including LE. EK interviewed each patient to ascertain baseline demographic 
and clinical characteristics including patient name, sex, age, duration of symptoms, 
previous treatment, occupation, affected arm and dominant arm (Appendix VI). 
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6.3.1 Sample size 
Abbott et al (2001) suggest that a sample size of twenty-five subjects per group is 
sufficient to demonstrate statistical clinical significance for all outcome measures on 
LE. Clinical effects of 20% had been reported as clinically meaningful in placebo-
controlled studies measuring pain relief and functional outcomes in response to 
physiotherapeutic interventions such as LPLL (Basford et al., 2000). In this study, 
baseline variance for pain and functional outcomes was set at 25%, in line with 
previously published data in this field (Dwars et al., 1990). Power calculations 
suggested that a sample size of 25 patients per group was sufficient to detect a 20% 
change in outcome measures assuming that variance was equivalent to 25% with 80% 
of power and a 5% significant level. The formula that used to estimate the appropriate 
sample size was: 
N=16σ2/d2 
where σ2=the variability of the data 
d2= the effect size 
For example in our trial σ=25 and d=20. Therefore the above formula is 
N=16(252)/(202)=16x625/400=25 
 
6.3.2 Participants and recruitment 
Patients suffering from lateral elbow pain were examined and evaluated in the 
Rheumatology and Rehabilitation centre located in Athens between January 2003 and 
January 2004. All patients lived in Athens, Greece, were native speakers of Greek, and 
were either self-referred or referred by their physician or physiotherapist. All patients 
were new cases to the clinic. 
 
6.3.3 Inclusion criteria 
Patients between 30 and 60 years old were included in the study if, at the time of 
presentation, they had been evaluated as having clinically diagnosed LE for at least 4 
weeks (1 month). Patients were included in the trial if they reported (i) pain on the facet 
of lateral epicondyle when palpated (Figure 1.2), (ii) less pain during resistance 
supination with the elbow in 90o of flexion rather than in full extension (Kraushaar and 
Nirschl, 1999) (Figure 1.7), and (iii) pain in at least two of the following four tests 
(Haker, 1993): 
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1. Tomsen test (Figure 1.3) 
2. Resisted middle finger test (Figure 1.4) 
3. Mill’s test (Figure 1.5) 
4. Handgrip dynamometer test (Figure 1.6) 
 
6.3.4 Exclusion criteria 
Patients were excluded from the study if they had one or more of the following 
conditions: (i) dysfunction in the shoulder, neck and/or thoracic region; (ii) local or 
generalized arthritis; (iii) neurological deficit; (iv) radial nerve entrapment; (v) bi-lateral 
lateral epicondylitis; (vi) limitations in arm functions; (vii) pregnancy; (viii) an installed 
pacemaker; (ix) the affected elbow had been operated on and (x) had received any 
conservative treatment for the management of LE in the preceding four weeks before 
entering the study (Vasseljen, 1992; Haker, 1993; Pienimaki et al., 1996; Runeson and 
Haker 2002; Kochar and Dogra, 2002; Hake et al., 2002a). 
 
6.3.5 Ethical considerations 
All patients received a written explanation of the trial (Appendix VII) prior to entry into 
the study. All patients gave signed informed consent (Appendix VIII) to participate in 
the study. The study was approved by the Leeds Metropolitan University Research 
Ethics Committee and access to patients was authorized by the manager of 
Rheumatology and Rehabilition centre. 
 
6.3.6 Sequential allocation 
The patients were allocated to three groups by sequential allocation. For example, the 
first patient with LE was assigned to the Cyriax physiotherapy group, the second patient 
with LE to the supervised exercise-programme group, the third patient with LE to the 
polarised-polychromatic-non-coherent-light (Bioptron light) group, the fourth patient 
with LE to the Cyriax physiotherapy group, the fifth patient with LE to the supervised-
exercise-programme group and so on.  
 
All patients were instructed to use their arm during the course of the study but to avoid 
activities that irritated the elbow such as shaking hands, grasping, lifting, knitting, 
handwriting, driving a car and using a screwdriver. Patients were informed to refrain 
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from taking anti-inflammatory medication throughout the course of study. Patient 
compliance to this request was monitored using a treatment diary.  
 
6.3.7 Treatment intervention  
All treatments were administered at the centre by a qualified physiotherapist with a 
certificate in orthopaedic medicine on Cyriax principles (DS) (Appendix I). Each 
treatment was given three times per week for four weeks.  
 
6.3.7.1 Cyriax physiotherapy 
Cyriax physiotherapy consisted of 10 minutes of DTF immediately followed by one 
intervention of Mill’s manipulation (Chapter 3, section 3.4.3, Figure 3.3). DTF was 
applied with the patient on a bed with the elbow on a pillow fully supinated and in 
ninety degrees of flexion with the therapist stood on the side of affected elbow. The 
inferior-lateral aspect of the lateral epicondyle was located and the area of tenderness 
identified. DTF was applied with the side of the thumb tip. The therapist applied 
pressure using the thumb in a posterior direction to the origin of ECRB tendon and this 
pressure was maintained whilst imparting DTF. The therapist held the other side of the 
elbow to establish counter pressure (Figure 3.1).  
 
Mill’s manipulation was applied with the patient positioned on a chair with a backrest 
and the therapist stood behind the patient. The patient’s arm was supported under the 
crook of the elbow with the shoulder joint abducted to ninety degrees and medially 
rotated. The forearm fell automatically into pronation. The thumb of therapist’s other 
hand was placed in the web space between the patient’s thumb and index finger and the 
patient’s wrist was fully flexed and the forearm was fully pronated. The hand 
supporting the crook of the elbow was moved on to the posterior surface of the elbow 
joint and whilst maintaining full wrist flexion and pronation, the patient’s elbow was 
fully extended. Then, a minimal-amplitude high-velocity thrust was applied by 
simultaneously side-flexing the therapist body away from his arms and pushing smartly 
downwards with the hand over the patient’s elbow (Figure 3.2).  
 
Cyriax physiotherapy treatment was individualised one the basis of the patient’s 
description of pain experienced during the procedure. 
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6.3.7.2 Supervised exercise programme 
The supervised exercise programme consisted of slow progressive eccentric exercises of 
wrist extensors and static stretching exercises of ECRB tendon (Chapter 3, section 
3.5.3, Figure 3.10). Three sets of 10 repetitions of slow progressive eccentric exercises 
of wrist extensors at each treatment session were performed with one-minute rest 
interval between each set. Static stretching exercises of ECRB tendon were repeated six 
times at each treatment session, three times before and three times after the eccentric 
exercises with a 30-second rest interval between each repetition.  
 
Eccentric exercises of wrist extensors were performed with elbow on bed in full 
extension, forearm in pronation, wrist in extended position (as high as possible) and the 
hand hanging over the edge of the bed (Figure 3.4). From this position patients flexed 
their wrist slowly counting to thirty (Figure 3.5), then returned to starting position with 
the help of the other hand (Figure 3.6). Patients were told to continue with the exercise 
even if they experienced mild pain. However, they were told to stop the exercise if the 
pain became disabling. When patients were able to perform the eccentric exercises 
without experiencing any minor pain or discomfort, the load was increased using free 
weights (Figures 3.7 and 3.8).  
 
Static stretching exercises of the ECRB tendon were performed with the help of the 
therapist. The therapist placed the elbow of patient in full extension, forearm in full 
pronation and the wrist in flexion and ulnar deviation according to the patient’s 
tolerance (Figure 3.9). This position was held for 30 to 45 seconds each time and then 
released.  
 
The supervised exercise programme treatment was individualised one the basis of the 
patient’s description of pain experienced during the procedure. 
 
6.3.7.3 Polarised polychromatic non-coherent light (Bioptron light) 
Polarised polychromatic non-coherent light (Bioptron light) therapy was administered 
using a Bioptron 2 device (Figure 3.11) to three locations for six minutes in each 
location, (i.e. 18 minutes in total) (Chapter 3, section 3.6.1, Figure 3.15). 
 
                                                                                                                            Chapter 6 
 
 
165 
The probe of the Bioptron 2 was held at a 90o angle 5-10 cm above the clean bare skin 
of the lateral condyle (i) from the upper surface (anterior) with the elbow in extension 
and the forearm in supination (Figure 3.12) and (ii) from the lateral surface with the 
elbow in 900 of flexion and the forearm in pronation (Figure 3.13). In addition, the 
probe of Bioptron 2 was held at a 90o angle 5-10 cm above the clean bare skin of the 
bellies of the extensors muscles of the wrist with the elbow in 900 of flexion and the 
forearm in mid-position of pronation-supination (Figure 3.14).  
 
The polarised polychromatic non-coherent light (Bioptron light) treatment was 
standardised during the treatment period. 
 
6.3.8 Outcome measures 
Pain, function and drop out rate were measured in the present study. Each patient was 
evaluated at the baseline (week 0), at the end of treatment (week 4), at one month (week 
8), at 3 months (week 16) and at six months (week 28) after the end of treatment.  
 
6.3.8.1 Pain 
Pain was measured on visual analogue scale (VAS), where 0 (cm) was “least pain 
imaginable” and 10 (cm) was “worst pain imaginable”. The pain VAS was used to 
measure the patient’s worst level of pain over the previous 24 hours prior to each 
evaluation (Appendix IX) and this approach has been shown to be valid and sensitive of 
the VAS (Stratford et al., 1987).  
 
6.3.8.2 Function 
Function was measured using a visual analogue scale (VAS), in which 0 (cm) was taken 
as “no function” and 10 (cm) as “full function”. Patients were instructed to report their 
overall level of elbow function over the previous 24 hours prior to each evaluation 
(Appendix IX). The validity and sensitivity of this measure has been shown by Stratford 
and his colleagues (1987). 
 
In addition, function was measured by pain-free grip strength (PFGS). PFGS is defined 
as the amount of force each patient is able to generate with an isometric gripping action 
before eliciting pain (Stratford et al., 1993). Force was measured in pounds with a Jamar 
hand dynamometer (Figure 6.1) that had adjustable handles to accommodate different 
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hand sizes. The arm was placed in a standardized position of elbow extension, forearm 
pronation and internal rotation of the upper limb such that the palmar aspect of the hand 
faced posteriorly with the upper limb placed by the patient’s side (Figure 6.2). Patients 
were then instructed to squeeze the dynamometer handles until they first experienced 
pain and then to release their grip (Haker, 1993; Vicenzino and Wright, 1995; 
Vicenzino et al., 1996; Abbott et al., 2001; Vicenzino et al., 2001; Smidt et al., 2002b; 
Tsui and Leng, 2002; Paungmali et al., 2003; Vicenzino et al., 2003). The attained grip 
force was subsequently recorded and the reading was not visible to the patient. Three 
measures of pain-free grip strength were recorded with a 30-second rest interval 
between each measurement and the mean value of these repetitions was calculated 
(Appendix X). This approach has been used in a plethora of previously published 
studies on LE (Chapter 2, Table 2.4). PFGS is a valid and sensitive measure for LE 
patients (Abbott et al., 2001). 
 
Furthermore, function was measured by an eight-item pain-free function questionnaire. 
The eight-item pain-free function questionnaire was first described by Stratford et al. 
(1987) who assessed the functional ability of patients to perform common movements 
that might cause elbow pain (Table 6.1). Patients answer the question: “Today, do you 
or would you have any elbow discomfort at all with any of the following activities?” 
Possible responses are: YES (Y) or NO (N) (Appendix XI).  
 
Function was also measured using global measure of improvement. The global measure 
of improvement required patients to choose a description of their status at the end of the 
treatment (week 4) and at the follow-ups (week 8, week 16, and week 28) from the 
following alternatives: worse, no change, somewhat better, much better and no pain in a 
scale of 1 to 5, where 1=worse and 5=no pain (Appendix XII) (Vasseljen, 1992; 
Vasseljen et al., 1992; Kochar and Dogra, 2002). 
 
6.3.8.3 Drop out rate 
A drop out rate was also used as an indicator of treatment outcome. Reasons for patients 
drop out were categorized as follows: (i) a withdraw without reason; (ii) not returned for 
follow-up; and (iii) request for an alternative treatment.  
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6.3.9 Data analysis 
The problem with pain and function on VAS is how to classify the data. Pain and 
function are subjective, so should these be called an ordinal scale? However, length 
measurement in centimeters is an interval/ratio scale, so how the issue can be resolved? 
There is no right answer here and it must be left to the investigator. However, as a 
general rule of data collection, it is usually advisable to use the most sophisticated level 
of measurement you can, since more detailed analysis can be performed (Hicks,1999). 
Therefore, it may be preferable to treat VAS as interval/ratio.  
 
The change from baseline was calculated for each follow-up for each outcome measure. 
Differences in this change pain on the VAS, change in function on the VAS and change 
in PFGS was calculated between the groups and was determined using a one-way 
analysis of variance (1-way ANOVA). Bonferroni post hoc comparisons were 
conducted when the results from the 1-way ANOVA were significant to determine how 
the three groups differed.  
 
The 1-way ANOVA was used and no the t test because this would violate an 
assumption concerning the established alpha level (0.05 in this case) The .05 level 
means 1 in 20 probability that a difference could be due to chance if the groups 
compared are independent. In this case, the groups are not independent because each 
group is compared more than once with every other group. Thus, we have increased the 
chances of making a type I error. ANOVA allows making any number of groups 
comparisons without violating the alpha level. 
 
For the same reasons, the t test did not use for post hoc comparisons. If t tests were used 
the probability of type I error would increase. Three t tests would be used in the present 
case rising the type I error to 15%. Several follow up tests protect the type I error. One 
of these is the Bonferroni that was used in the present statistical analysis. 
 
The Kruskal-Wallis test was used to determine whether there were significant 
differences between the groups in their responses to the eight-item pain-free function 
questionnaire and the global measure of improvement. To determine how the three 
groups differed, a Mann-Whitney test was used whenever the results from the Kruskal-
Wallis test were significant. These tests were used for the eight-item pain-free function 
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questionnaire and the global measure of improvement because the assumptions for the 
parametric tests were not met. The measurement level of the data in the eight-item pain-
free function questionnaire was in nominal level. The measurement level of the data in 
the global measure of improvement was in ordinal level. 
 
In the eight-item pain-free function questionnaire, the “NO” answers of participants was 
calculated by subtracting the results at baseline from those at follow-ups. A global 
measure of improvement was scored on a five-point scale, where 1 indicated  “worst” 
and the 5 indicated “no pain”. The results of the above outcome measure did not 
compare with the baseline (week 0), because this was first measured at week 4 (end of 
treatment). A 5% level of probability was adopted as the level for statistical 
significance. SPSS 11.5 statistical software was used for the statistical analysis. 
 
6.4 Results 
One hundred twenty one patients eligible for inclusion visited the clinic within the trial 
period. Twenty-five were unwilling to participate in the study and 21 did not meet the 
inclusion criteria described above (section 6.3.3). The other 75 patients were allocated 
by sequential allocation into one of the three possible groups: (1) Cyriax physiotherapy 
(n=25; 16 male, 9 female; mean age=40.44 years ±SD=5.61 years), (2) a supervised 
exercise programme (n=25; 15 male, 10 female; mean age=40.44 years ±SD=5.66 
years) and (3) polarized polychromatic non coherent light (Bioptron light) (n=25; 15 
male, 10 female; mean age=40.16 years ±SD=6.29 years) (Appendix XIII). Patient flow 
through the trial is summarized in a CONSORT flow chart (Figure 6.3).  
 
At baseline there were more males in the groups (17 in total). The mean age of patients 
was approximately 40 years and the duration of LE was approximately 5 months. LE 
was in the dominant arm in 90% of patients. There were no significant differences in 
mean age (p>0.0005, 1-way ANOVA) or the mean duration of complaints (p>0.0005, 1-
way ANOVA) between the groups. Patients had received a wide range of previous 
treatments (Table 6.2) (Appendix XIV). Drug therapy had been tried by 30-45%. Some 
4%-8% of patients were athletes (Table 6.3) (Appendix XV). 
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6.4.1 Pain 
Baseline pain on VAS was 6.96 (95%CI= 6.77-7.15) for the whole sample (n=75) 
(Table 6.4). There were no significant differences between the groups for baseline pain 
(p>0.05-1 way ANOVA, Table 6.4). The data passed the test for normality and 
subsequent data was analysed using parametric statistical tests (Appendix XVI).  
 
At week 4 there was a decline in VAS of approximately 4 units in all groups when 
compared to the pre-treatment baseline (p<0.0005, paired t-test, Table 6.5, Figure 6.4). 
There was a significant difference in the magnitude of reduction between the groups 
(p<0.0005-1-way ANOVA, Table 6.5), so post hoc tests were performed. The 
magnitude of reduction was significantly larger for the supervised exercise programme 
than for Cyriax physiotherapy (+0.60 VAS units) and polarised polychromatic non-
coherent light (Bioptron light) (+1.04 VAS units, p<0.05, Bonferroni, Table 6.5, Figure 
6.4). There was no significant difference between Cyriax physiotherapy and polarised 
polychromatic non-coherent light (Bioptron light) (+0.44 VAS units, p>0.05, 
Bonferroni, Table 6.5, Figure 6.4).  
 
Similarly, at week 8, 16 and 28 there were comparable magnitudes of reduction with 
larger reduction for the supervised exercise programme than for Cyriax physiotherapy 
and polarised polychromatic non-coherent light (Bioptron light) (p<0.05, Bonferroni, 
Table 6.5, Figure 6.4). There was a significant difference between Cyriax physiotherapy 
and polarised polychromatic non-coherent light (Bioptron light) at week 28 (p<0.05, 
Bonferroni, Table 6.5, Figure 6.4). 
 
6.4.2 Function 
6.4.2.1 Function on VAS 
Baseline function on VAS was 3.93 (95%CI= 3.74 - 4.13) for the whole sample (n=75) 
(Table 6.6). There were no significant differences between the groups for baseline 
function (p>0.05, 1 way ANOVA, Table 6.6). The data passed the test for normality and 
subsequent data was analysed using parametric statistical tests (Appendix XVII).  
 
At week 4 there was a rise in VAS of approximately 3 units in all groups when 
compared to the pre-treatment baseline (p<0.0005, paired t-test, Table 6.7, Figure 6.5). 
There was a significant difference in the magnitude of improvement between the groups 
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(p<0.0005, 1-way ANOVA, Table 6.7), so post hoc tests were performed. The 
magnitude of improvement was significantly larger for the supervised exercise 
programme when compared to Cyriax physiotherapy (+0.68 VAS units) and polarised 
polychromatic non-coherent light (Bioptron light) (+1.08 VAS units, p<0.05, 
Bonferroni, Table 6.7, Figure 6.5). There was no significant difference between Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) (+0.40 
VAS units, p>0.05, Bonferroni, Table 6.7, Figure 6.5).  
 
Similarly, at week 8, 16 and 28 there were comparable magnitudes of improvement with 
larger improvements for the supervised exercise programme than for Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) (p<0.05, 
Bonferroni, Table 6.7, Figure 6.5). There was no significant difference between Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) at any of 
the follow-up time points (p>0.05, Bonferroni, Table 6.7, Figure 6.5). 
 
6.4.2.2 Pain Free Grip Strength (PFGS) 
Baseline PFGS was 25.93 (95%CI= 25.00 – 26.87) for the whole sample (n=75) (Table 
6.8). There were no significant differences between the groups for baseline PFGS 
(p>0.05, 1- way ANOVA, Table 6.8). The data passed the test for normality and 
subsequent data was analysed using parametric statistical tests (Appendix XVIII).  
 
At week 4 there was a rise in PFGS of approximately 40 units in all groups when 
compared to the pre-treatment baseline (p<0.0005, paired t-test, Table 6.9, Figure 6.6). 
There was a significant difference in the magnitude of improvement between the groups 
(p<0.0005, 1-way ANOVA, Table 6.9), so post hoc tests were performed. The 
magnitude of improvement was significantly larger for the supervised exercise 
programme when compared to Cyriax physiotherapy (+7.12 PFGS units) and polarised 
polychromatic non-coherent light (Bioptron light) (+10.76 PFGS units, p<0.05, 
Bonferroni, Table 6.9, Figure 6.6). There was no significant difference between Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) (+3.64 
PFGS units, p>0.05, Bonferroni, Table 6.9, Figure 6.6).  
 
Similarly, at week 8, 16 and 28 there were comparable magnitudes of improvement, 
with larger improvements for the supervised exercise programme than for Cyriax 
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physiotherapy and polarised polychromatic non-coherent light (Bioptron light) (p<0.05, 
Bonferroni, Table 6.9, Figure 6.6). There was no significant difference between Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) at any of 
the follow-up time points (p>0.05, Bonferroni, Table 6.9, Figure 6.6). 
 
6.4.2.3 Eight-item pain-free function questionnaire 
The baseline of the eight-item pain-free function questionnaire was 0 for the whole 
sample (n=75, Table 6.10). There were no significant differences between the groups 
for baseline pain free function questionnaire (p>0.05, Kruskal-Wallis test ranks, Table 
6.10). The data was analysed using non-parametric statistical tests (Appendix XIX).  
 
At week 4 there was a rise in “no” responses to the pain-free function questionnaire for 
6 items in the Cyriax physiotherapy group and the supervised exercise programme 
group, and 5 items in the polarised-polychromatic-non-coherent-light (Bioptron light) 
group when compared to the pre-treatment baseline (Table 6.11, Figure 6.7). There was 
a significant difference in the magnitude of improvement between the groups 
(p<0.0005, Kruskal-Wallis test ranks, Table 6.11), so post hoc tests were performed. 
The magnitude of improvement was significantly larger for the supervised exercise 
programme when compared to Cyriax physiotherapy (0 pain free items) and polarised 
polychromatic non-coherent light (Bioptron light) (+1 pain free items p<0.05, Mann-
Whitney, Table 6.11, Figure 6.7). There was significant difference between Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) (+1 pain-
free items VAS units, p<0.05, Mann-Whitney, Table 6.11, Figure 6.7).  
 
Similarly, at week 8, 16 and 28 there were comparable magnitudes of improvement, 
with larger improvements for the supervised exercise programme than for Cyriax 
physiotherapy and polarised polychromatic non-coherent light (Bioptron light) (p<0.05, 
Mann-Whitney, Table 6.11, Figure 6.7). There was no significant difference between 
Cyriax physiotherapy and polarised polychromatic non-coherent light (Bioptron light) at 
any of the follow-up time points (p>0.05, Mann-Whitney, Table 6.11, Figure 6.7). 
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6.4.2.4 Global measure of improvement 
At week 4, 8, 16 and 28, the global measure of improvement was 4 (much better) on a 
5-point scale of improvement in all groups, where 1 meant worse and 5 meant no pain. 
The data was analysed using non-parametric statistical tests (Appendix XX).  
 
There were no comparable magnitudes of improvement between the groups at week 4 
and at any of the follow-up time points (p>0.05, Kruskal-Wallis test ranks). 
 
6.4.3 Drop out rate 
There were no drop out and all patients successfully completed the study.  
 
6.5 Discussion 
6.5.1 Principal findings 
The results obtained from this controlled clinical trial are novel, as to date there has 
been no data comparing the effectiveness of Cyriax physiotherapy, a supervised 
exercise programme and polarized polychromatic non-coherent light (Bioptron light) for 
pain and function in LE. 
 
When compared to the pre-treatment baseline, Cyriax physiotherapy, a supervised 
exercise programme and polarised polychromatic non-coherent light (Bioptron light) 
reduced pain and improved function at the end of the treatment and at any of the follow-
up time points. The supervised exercise programme produced the largest effect in the 
short, intermediate and long term. When compared to polarised polychromatic non-
coherent light (Bioptron light), Cyriax physiotherapy was also found to produce 
superior improvement on the pain-free function questionnaire immediately after 
treatment intervention (week 4) and superior pain relief at the six-month follow-up 
(week 28). There were no significant differences between the groups for the global 
measure of improvement. This lack of difference may indicate that a 5-point scale is not 
sensitive enough to detect minor changes. There were no drop-outs reported at the end 
of treatment or at any points of follow-ups.  
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6.5.2 Do the findings match previous knowledge? 
Although no previously published RCTs have examined the effectiveness of supervised 
exercise programmes for LE (Chapter 2), a home exercise programme has been used in 
some previously published clinical trials on LE (Pienimaki et al., 1996; Drechsler et al., 
1997; Svelnlov and Adolfsson, 2001; Kochar and Dogra, 2002; Smidt et al., 2002b; 
Struijs et al., 2003; Struijs et al., 2004). Nevertheless, a home exercise programme was 
the sole treatment in only one previously published RCT (Pienimaki et al., 1996; 
Chapter 2). A home exercise programme was only part of the treatment approach in 
other studies (Drechsler et al., 1997; Svelnlov and Adolfsson, 2001; Kochar and Dogra, 
2002; Smidt et al., 2002b; Struijs et al., 2003; Struijs et al., 2004), and therefore it was 
not possible to establish with certainty the degree to which the home exercise 
programme contributed to the overall results. 
 
In the only previously published RCT (Pienimaki et al., 1996) the home exercise 
programme was administered in a totally different manner than the supervised exercise 
programme employed in the present controlled clinical trial. The differences were not 
only in the environment in which the exercise programmes administered, at home in 
Pienimaki et al (1996) study and in a clinical setting in the present study, but also in the 
development of treatment protocol (type of exercises, intensity, frequency, duration of 
treatment). In all likelihood, Pienimaki and his colleagues did not evaluate the literature 
to establish recommended protocols based on therapists’ anecdotal reports, as was done 
in the present project (Chapter 3, section 3.5).  Nevertheless, although the protocol of 
the home exercise programme treatment administered by Pienimaki et al (1996) does 
not follow this author’s views (Chapter 3, section 3.5), research has to be continued to 
investigate the long-term effects of this treatment. In addition, there is clearly a need for 
a future clinical trial that would compare the effects of the present study supervised 
exercise programme treatment protocol with the home exercise programme treatment 
protocol used by Pienimaki et al (1996). 
 
Previously published trials (randomized and non-ransomised) found that a home 
exercise programme consisting of slow progressive eccentric and static stretching 
exercises reduced the pain in patellar (Chapter 4, section 4.3; Purdam et al., 2004) and 
Achilles tendinopathy (Niesen-Vertommen et al., 1992; Alfredson et al., 1998; Mafi et 
al., 2001; Silbernagel et al., 2001; Ohberg et al., 2004; Roos et al., 2004) respectively. 
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However, the home exercise programme was performed daily, once or twice per day, 
for about three months in all previously published studies. In contrast, the present 
controlled clinical trial and the preliminary clinical trial in chapter 4 (section 4.3) 
administered a supervised exercise programme three times per week for four weeks. 
Thus, it seems that the supervised exercise programme may give good long-term 
clinical results in a shorter period of time than the home exercise programme. The most 
likely explanation for this difference may be that a supervised exercise programme 
achieves a higher degree of patient compliance. Future studies to compare the effects of 
these two exercise programmes are required to confirm the findings of the present 
controlled clinical trial and of the preliminary clinical study in chapter 4 (section 4.3). 
 
There have been previously published trials of DTF (Stratford et al., 1989; Dwars et al., 
1990; Vasseljen, 1992; Drechsler et al., 1997; Smidt et al., 2002b; Struijs et al., 2003; 
Struijs et al., 2004) and Mill’s manipulation (Burton, 1988) administered separately for 
LE. However, in all previously published studies DTF and Mill’s manipulation were 
given as a part of a combined treatment approach and it was not possible to determine 
how much either component contributed to the results. The authors of all previously 
published studies did not report that Cyriax physiotherapy was administered, but 
components of Cyriax physiotherapy were administered as advocated by Cyriax 
(Chapter 3, section 3.4). Cyriax (1982) stated that, if clinicians intend to use Cyriax 
physiotherapy in treating patients with LE, it can only be considered Cyriax 
physiotherapy if DTF and Mill’s manipulation are used together (not separately) and the 
Mill’s performed immediately after the DTF (Chapter 3; section 3.4). Whether the two 
components of Cyriax physiotherapy are effective “sole” treatments must be confirmed 
by other researchers. 
 
The only previously published RCT that studied the effectiveness of Cyriax 
physiotherapy on LE administered in a manner identical to the present controlled 
clinical trial was conducted by Verhaar et al (1996). They found that Cyriax 
physiotherapy was a less effective treatment than steroid injection in short-term follow-
up (6 weeks after the end of treatment), but found no significant differences for the 
effectiveness of the treatments in the long-term follow-up (one year after the end of 
treatment). However, Verhaar and his colleagues (1996) did not conclude whether both 
treatments were effective or ineffective in the long-term follow-up, leaving the reader 
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with questions about their effectiveness. In contrast, Cyriax physiotherapy reduced pain 
and improved function, in the present controlled clinical trial, but it was less effective 
than the supervised exercise programme in the short, intermediate and long term. We 
cannot say with certainty that Cyriax physiotherapy is an effective treatment for LE 
because we did not use a placebo/sham (no treatment) group and the reduction of 
symptoms could have occurred just because of the natural fluctuations in healing. 
 
Research on the effectiveness of Cyriax physiotherapy on overuse injuries is sparse. 
Two studies showed poor outcomes for the effectiveness of Cyriax physiotherapy in 
patellar tendinopathy (Pallechia et al., 1994; Chapter 4, section 4.3) and one study 
showed similar results in iliotibial band friction syndrome (Schwellnus, 1992). 
However, these previously published studies had methodological shortcomings such as 
small sample size, lack of blinding (therapists, patients), lack of power analysis, invalid 
outcome measures, lack of follow-ups and lack of randomisation. Thus, definite 
conclusions about the effectiveness of Cyriax physiotherapy cannot be drawn. In 
addition, in all previously published studies, Cyriax physiotherapy consisted of 10 
minutes of DTF only, though, Cyriax physiotherapy for LE consists of DTF and Mill’s 
manipulation (Chapter 3, section 3.4). The possible explanations why Cyriax 
physiotherapy is applied in a different way between LE and rest tendinopathies will be 
discussed in chapter 7. 
 
Although novel modalities like polarised polychromatic non-coherent light (Bioptron 
light) are attractive to practitioners working in rehabilitation settings, the present 
controlled clinical trial was the first study to examine the effectiveness of light therapy 
using polarised polychromatic non-coherent light (Bioptron light) on LE. The 
preliminary clinical trial was also the only previously conducted clinical trial that 
assessed the effectiveness of this treatment in CTS, an overuse injury similar to LE that 
is regularly presented to the clinic (Chapter 4, section 4.4). The most likely explanation 
for this lack of trials is that polarised polychromatic non-coherent light (Bioptron light) 
has only become recently available in the physiotherapy area, though it is used routinely 
in our clinical practice the last 7-8 years. Both studies found that a course of polarised 
polychromatic non-coherent light (Bioptron light) treatments based on manufactures’ 
claims may improve patients’ symptoms on LE (pain and function) and CTS (nocturnal 
pain and paraesthesia) respectively.  The findings of these two trials encourage the 
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design of future well-designed RCTs that might produce strong evidence for the 
effectiveness of polarised polychromatic non-coherent light (Bioptron light) on overuse 
injuries. 
 
In contrast, there are several trials to assess the effectiveness of LPLL, the light therapy 
most commonly used in practice for the treatment of LE (Chapter 2, Table 2.4) and of 
other conditions similar to LE that are presented to the clinic. Chapter 2 found strong 
evidence that LPLL is an ineffective treatment on LE, but this modality cannot be ruled 
out as a target for research because this is a dose-response modality and the optimal 
treatment dosage (if any) for the management of LE and other conditions similar to LE 
has not yet have been determined. Even though LPLL and polarised polychromatic non-
coherent light (Bioptron light) are two forms of light therapy with biostimulative effects 
assisting tissue healing at cellular level, these two forms differ in their radiation 
characteristics (Chapter 3, Table 3.2). Therefore, the effects of LPLL on LE cannot be 
translated into those for polarised polychromatic non-coherent (Bioptron light). The 
effects of polarised polychromatic non-coherent light (Bioptron light) are yet to be 
confirmed by other researchers. 
 
6.5.3 Shortcomings of this controlled clinical trial 
The present study did not use a randomised design, a placebo (sham)/no treatment 
group was not included, what activities/other treatments patients might be getting when 
not in the clinic was not monitored and finally there was the lack of standardisation of 
treatment protocols for Cyriax physiotherapy and the supervised exercise programme. 
The shortcomings of the present trial will be discussed and answered in chapter 7 and 
will be compared with the shortcomings of the two preliminary clinical studies of 
chapter 4. 
 
6.6 Conclusion 
Cyriax physiotherapy, a supervised exercise programme, and polarised polychromatic 
non-coherent light (Bioptron light) reduced pain and improved function at the end of the 
treatment and at any of the follow-up time points. It is possible that these improvements 
were due to natural fluctuations in the symptoms and/or a placebo response. However, 
the supervised exercise programme produced the largest effect in the short, intermediate 
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and long term. This means that, choosing among these treatments, the supervised 
exercise programme should be the first treatment option for therapists when they 
manage LE patients. If it is not possible to administer the supervised exercise 
programme, Cyriax physiotherapy and polarised polychromatic non-coherent light 
(Bioptron light) may be suitable to reduce symptoms but further well designed RCTs 
are needed to confirm the effectiveness of the treatments in patients with LE.  
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Figure 6.1 
 
Jamar hand dynamometer 
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Figure 6.2 
 
Position of pain free grip strength measure 
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Figure 6.3 
 
Flow chart of the controlled clinical trial 
 
 All LE patients presenting the clinic (n=121) 
Unwillingness (n=25) 
 
Potential participants (n=96) 
 
 
Inclusion criteria 
Not meeting inclusion criteria (n=21) 
 
 
Eligible patients (n= 75) 
 
 
 
Sequential allocation (n=75) 
 
 
 
Cyriax physiotherapy (n=25)      Supervised exercise  programme (n=25)      Bioptron light (n=25) 
 
 
 
Completed trial (n=25) Completed trial (n=25) Completed trial (n=25) 
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Figure 6.4  
 
Pain over the previous 24 hours prior to each evaluation  (Mean (95%CI) VAS 
where 0= least pain imaginable and 10 = worst pain imaginable) 
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Figure 6.5 
 
Elbow function over the previous 24 hours prior to each evaluation  (Mean 
(95%) VAS where 0= no function and 10 = full function) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
week 0 week4 week8 week16 week28
Time period
F
u
n
c
ti
o
n
 o
n
 V
A
S
Cyriax
physiotherapy
Supervised exercise
programme
Bioptron light
F
u
n
c
ti
o
n
 o
n
 V
A
S
                                                                                                                         Chapter 6 
 183 
Figure 6.6 
 
PFGS (Mean (95%CI) pounds) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
week 0 week4 week8 week16 week28
Time period
P
F
G
S
 (
k
il
o
g
ra
m
s
)
Cyriax
physiotherapy
Supervised exercise
programme
Bioptron lightP
F
G
S
 (
k
il
o
g
ra
m
s
)
                                                                                                                         Chapter 6 
 184 
Figure 6.7 
 
Eight-item pain free function questionnaire (Median “no” responses where 0=no 
pain free function items and 8=only pain free function items) 
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Table 6.1 
 
Eight item pain free function questionnaire 
 
 
 
Activity YES NO 
Dressing yourself or pulling up your slacks   
Opening a jar or feeding yourself   
Washing yourself or wringing out a face 
cloth 
  
Household tasks (cleaning, lifting a chair, 
gardening) 
  
Opening doors   
Carrying objects with your involved hand   
Everyday activities   
Recreation or sporting activities   
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Table 6.2 
 
Previous treatments of participants (n (%)) 
 
 
  
 
Cyriax 
physiotherapy 
 
Supervised 
exercise 
programme 
  
 
 
Bioptron light 
LPLL  4 (16%) 4 (16%) 4 (16%) 
Drugs  10 (40%) 11 (44%) 9 (36%) 
Ultrasound  5 (20%) 3 (12%) 5 (20%) 
Iontophoresis  3 (12%) 2 (8%) 2 (8%) 
Heat  0 (0%) 2 (8%) 2 (8%) 
Injection  3 (12%) 3 (12%) 3 (12%) 
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Table 6.3 
 
Occupations of participants (n (%)) 
 
 
  
 
Cyriax 
physiotherapy 
 
Supervised 
exercise 
programme 
 
 
 
Bioptron light 
Housework  9 (36%) 7 (28%) 7 (28%) 
Manual work  7 (28%) 7 (28%) 8 (32%) 
Secreterial  8 (32%) 9 (36%) 8 (32%) 
Sport  1 (4%) 2 (8%) 2 (8%) 
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Table 6.4 
 
Pain over the previous 24 hours prior to each evaluation  (Mean (95%CI) VAS 
where 0= least pain imaginable and 10 = worst pain imaginable) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 week 0 week 4 week 8 week 16 week 28 
Cyriax 
physiotherapy 
 
6.96(6.61-7.31) 
 
2.84(2.51-3.17) 
 
2.60(2.33-2.87) 
 
2.40(2.11-2.69) 
 
1.96(1.61-2.31) 
Supervised 
exercise 
programme 
 
 
 
6.92(6.56-7.28) 
 
 
 
2.20(1.91-2.49) 
 
 
 
1.72(1.42-2.02) 
 
 
 
1.12(0.85-1.39) 
 
 
 
0.96(0.63-1.29) 
 Bioptron light 7(6.68-7.32) 3.32(3.04-3.60) 3.04(2.82-3.26) 2.84(2.64-3.04) 2.64(2.44-2.84) 
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Table 6.5 
 
Change in pain over the previous 24 hours prior to each evaluation from baseline 
(Mean VAS where 0= least pain imaginable and 10 = worst pain imaginable) 
 
 
  
 
 
 
 
Cyriax 
physiotherapy 
 
 
 
 
Supervised 
exercise 
programme 
 
 
 
 
 
Bioptron 
light 
1-way 
ANOVA 
on 
change in 
VAS 
from 
baseline 
 
Cyriax   
physiotherapy 
Vs 
Supervised 
exercise 
programme 
 
 
 
Cyriax   
physiotherapy 
Vs 
Bioptron light 
 
Supervised 
exercise 
programme 
Vs 
Bioptron 
light 
Week 4 -4.12 -4.72 -3.68 p<0.0005 +0.60 (*) -0.44 -1.04 (*) 
Week 8 -4.36 -5.20 -3.96 p<0.0005 +0.84 (*) -0.40 -1.24 (*) 
Week 16 -4.56 -5.80 -4.16 p<0.0005 +1.24 (*) -0.40 -1.64 (*) 
Week 28 -5.00 -5.96 -4.36 p<0.0005 +0.96 (*) -0.64 (*) -1.60 (*) 
*  The mean difference is significant at the .05 level 
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Table 6.6 
 
Elbow function over the previous 24 hours prior to each evaluation  (Mean 
(95%CI) VAS where 0= no function and 10 = full function) 
 
 
 week 0 week 4 week 8 week 16 week 28 
Cyriax 
physiotherapy 
 
3.92(3.48-4.36) 
 
7.12(6.69-7.55) 
 
7.32(6.99-7.35) 
 
7.68(7.40-7.96) 
 
7.8(7.48-8.12) 
Supervised 
exercise 
programme 
 
 
 
3.92(3.63-4.21) 
 
 
 
7.80(7.53-8.07) 
 
 
 
8.20(7.88-8.52) 
 
 
 
8.36(8.10-8.62) 
 
 
 
8.48(8.24-8.72) 
Bioptron light 3.96(3.66-4.26) 6.76(6.46-7.06) 7(6.73-7.27) 7.20(6.99-7.41) 7.32(7.12-7.52) 
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Table 6.7 
 
Change in elbow function over the previous 24 hours prior to each evaluation 
from baseline (Mean VAS where 0= no function and 10 = full function) 
 
 
  
 
 
 
Cyriax 
physiotherapy 
 
 
 
Supervised 
exercise 
programme 
 
 
 
 
Bioptron 
light 
1-way 
ANOVA 
on change 
in VAS 
from 
baseline 
Cyriax   
physiotherapy 
Vs 
Supervised 
exercise 
programme 
 
 
Cyriax   
physiotherapy 
Vs 
Bioptron light 
Supervised 
exercise 
programme 
Vs 
Bioptron 
light 
Week 4 +3.20 +3.88 +2.80 p<0.0005 -0.68 (*) +0.40 +1.08 (*) 
Week 8 +3.40 +4.28 +3.04 p<0.0005 -0.88 (*) +0.36 +1.24 (*) 
Week 16 +3.76 +4.44 +3.24 p<0.0005 -0.68 (*) +0.52 +1.20 (*) 
Week 28 +3.88 +4.56 +3.36 p<0.0005 -0.68 (*) +0.52 +1.20 (*) 
*  The mean difference is significant at the .05 level 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                         Chapter 6 
 192 
Table 6.8 
 
PFGS (Mean (95%CI) pounds) 
 
 
 week 0 week 4 week 8 week 16 week 28 
Cyriax 
physiotherapy 
25.8(23.77-
27.83) 
66.52(60.67-
72.37) 
67.48(61.93-
73.03) 
68.04(62.28-
73.80) 
69.04(63.32-
74.76) 
Supervised 
exercise 
programme 
 
 
25.92(24.14-
27.7) 
 
 
73.76(68.93-
78.59) 
 
 
75.6(70.77-
80.43 
 
 
76.68(72.36-
81) 
 
 
77.44(73.19-
81.69) 
Bioptron light 26.08(24.88-
27.28) 
63.16(60.69-
65.63) 
64.36(61.99-
66.73) 
65.46(63.4-
67.56) 
65.4(63.44-
67.36) 
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Table 6.9 
 
Change in PFGS from baseline (Mean pounds)  
 
 
  
 
 
 
 
Cyriax 
physiotherapy 
 
 
 
 
Supervised 
exercise 
programme 
 
 
 
 
 
Bioptron 
light 
1-way 
ANOVA 
on change 
in 
kilograms 
from 
baseline 
 
Cyriax   
physiotherapy 
Vs 
Supervised 
exercise 
programme 
 
 
 
Cyriax   
physiotherapy 
Vs 
Bioptron light 
 
 
Supervised 
exercise 
programme 
Vs 
Bioptron light 
Week 4 +40.72 +47.84 +37.08 p<0.0005 -7.12 (*) +3.64 +10.76 (*) 
Week 8 +41.68 +49.68 +38.28 p<0.0005 -8.00 (*) +3.40 +11.40 (*) 
Week 16 +42.24 +50.76 +39.38 p<0.0005 -8.52 (*) +2.84 +11.36 (*) 
Week 28 +43.24 +51.52 +39.32 p<0.0005 -8.28 (*) +3.92 +12.20 (*) 
*  The mean difference is significant at the .05 level 
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Table 6.10 
 
Eight-item pain free function questionnaire (Median “no” responses where 0=no 
pain free function items and 8=only pain free function items) 
 
 
 week 0 week 4 week 8 week 16 week 28 
Cyriax physiotherapy 0 6 6 6 6 
Supervised exercise 
programme 
 
 
0 
 
 
6 
 
 
7 
 
 
7 
 
 
7 
Bioptron light 0 5 6 6 6 
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Table 6.11 
 
Change in eight-item pain free function questionnaire from baseline (Median 
“no” responses where 0=no pain free function items and 8=only pain free function 
items) 
 
  
 
 
 
 
 
 
Cyriax 
physiotherapy 
 
 
 
 
 
 
Supervised 
exercise 
programme 
 
 
 
 
 
 
 
Bioptron 
light 
Kruskal-
Walis test 
rank 
on 
change in 
“no” 
responses 
from 
baseline 
 
 
 
Cyriax   
physiotherapy 
Vs 
Supervised 
exercise 
programme 
 
 
 
 
 
Cyriax   
physiotherapy 
Vs 
Bioptron light 
 
 
 
Supervised 
exercise 
programme 
Vs 
Bioptron 
light 
Week 4 +6 +6 +5 p<0.0005 0 (*) +1(*) +1 (*) 
Week 8 +6 +7 +6 p<0.0005 -1 (*) 0 +1 (*) 
Week 16 +6 +7 +6 p<0.0005 -1 (*) 0 +1 (*) 
Week 28 +6 +7 +6 p<0.0005 -1 (*) 0 +1 (*) 
*  The mean difference is significant at the .05 level 
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Chapter 7: Discussion 
 
7.1 Findings of the project 
LE is one of the most common lesions of the arm. LE is usually defined as a syndrome 
of pain in the area of the lateral epicondyle, the main complaints being pain and 
decreased function, both of which may affect activities of daily living and result in 
considerable morbidity and financial cost (Chapter 1). Many clinicians advocate a 
conservative approach as the treatment of choice for LE (Chapter 1). Physiotherapy is a 
conservative treatment that is usually recommended for LE patients (Chapter 1). A wide 
array of physiotherapy treatments have been recommended for the management of LE 
(Chapter 1). These treatments have different theoretical mechanisms of action, but all 
have the same aim, to reduce pain and improve function. Such a variety of treatment 
options suggests that the optimal treatment strategy is not known, and more research is 
needed to discover the most effective treatment in patients with LE. This lack of 
evidence may be related to the difficulty of establishing nomenclature, pathophysiology, 
etiology, epidemiology, diagnosis and conservative treatment of LE. Reviewing the 
literature, answers tried to present in the previously reported issues (Chapter 1). 
 
The term LE was used in the present thesis because this is the most common used term 
to describe this condition in medicinal literature. LE is a degenerative or failed healing 
tendon response characterised by the increased presence of fibroblasts, by increased 
amounts of proteoglycans and glycosaminoglycans, by vascular hyperplasia, and by 
disorganised collagen in the origin of ECRB, the most commonly affected structure. LE 
is generally a work related or sport related mechanical pain disorder usually caused by 
excessive quick, monotonous, repetitive activities, including eccentric contractions and 
gripping, of the wrist. Therefore, LE characterized as an overuse syndrome. The 
dominant arm is commonly affected, with a prevalence of 1–3% in the general 
population. Although LE occurs at all ages, the peak prevalence of LE is between 30 
and 60 years of age. The proportion of those afflicted by LE is not influenced by the sex 
of the patient, but the disorder appears to be of longer duration and severity in females. 
Even though the diagnosis of LE is simple, many conditions mimic LE pain, can be 
easily misdiagnosed as LE, and complicate the prospect for optimal treatment for LE.  
The diagnosis of LE can be confirmed by a plethora of diagnostic tests that reproduce 
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the pain. However, such a plethora of diagnostic tests suggests that the most variable 
and valid test for LE is not known and the most commonly diagnostic tests were used in 
our controlled clinical trial to identify LE patients (Chapter 6).  The history of patients 
and clinical examination are adequate in order to be diagnosed LE. Radiological 
investigation (MRI, ultrasound) can add information in diagnosis, but it is not routinely 
obtained probably due to high cost. Finally, conservative treatments including medicinal 
(injections and NSAIDs) and physiotherapy whose only role is to reduce inflammation 
may not prove helpful to treat patients with LE. Conservative physiotherapy treatments 
that reverse the pathophysiology of LE may be effective for the management of this 
condition.  
 
Labelle et al (1992) was the only published systematic review that examined the clinical 
effectiveness of physiotherapy in the management of LE until 2002. Several new RCTs 
have been published since, however, and an updated systematic review is required to 
evaluate the clinical effectiveness of available physiotherapy treatments. A systematic 
review was conducted in chapter 2 to establish the clinical effectiveness of treatments 
available to physiotherapists to manage the pain and functional impairment associated 
with LE. This information will provide future treatment strategies for LE in the present 
project. RCTs identified by a search strategy in six databases (until October 2002) were 
used in combination with reference checking. RCTs that included physiotherapy as sole 
treatment, patients with LE, and at least one of the clinically relevant outcome measure 
(pain and/or function) were selected. A qualitative analysis of the selected studies was 
conducted using the Chalmers’ scale. Chalmers’ scale was validated and tested for 
reliability by Berard et al (2000). A vote count trial was used to present the results using 
a rating system for level of evidence developed by Linton and Tulder (2001). This 
rating system consisted of four levels of scientific evidence: (i) Level A—Strong 
evidence (consistent findings from multiple RCTs); (ii) Level B--Moderate evidence 
(one RCT or consistent findings from multiple NRCTs); (iii) Level C—Limited 
evidence (only one NRCT); (iv) Level D—No evidence (no RCTs or NRCTs). As 
NRCTs were not included in this review, level C became irrelevant and therefore only 
three levels remained: strong, moderate and no evidence. Twenty-seven RCTs fulfilled 
the criteria and were included in the review. This review showed that there was strong 
evidence for the short-term effectiveness of acupuncture for LE. It also found that there 
was strong evidence that four physiotherapy modalities, LPLL, ultrasound, ESWT and 
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pulsed electromagnetic field therapy were not effective treatments on LE. Other 
treatments used for LE such as iontophoresis and home exercise programmes had 
insufficient evidence available to judge the results of their effectiveness. However, all 
the previously reported physiotherapy treatments for LE cannot be refuted or 
recommended as ideal treatment for LE, because the optimal treatment protocols are 
unknown. Additional well-designed RCTs are needed to provide definite conclusions 
for the effectiveness of these LE-treatment modalities. Finally, this review found no 
evidence for the effectiveness of Cyriax physiotherapy, supervised exercise programmes 
and polarised polychromatic non-coherent light (Bioptron light) for LE. Therefore, it 
was concluded to investigate the clinical use and effectiveness of Cyriax physiotherapy, 
supervised exercise programmes and polarised polychromatic non-coherent light 
(Bioptron light) as treatments for LE in the present project. It was the first time that 
such an effort was conducted in research. 
 
However, it was necessary to establish optimal protocols for Cyriax physiotherapy, 
supervised exercise programmes, and polarised polychromatic non-coherent light 
(Bioptron light) for the management of LE before a suitable clinical trial could be 
designed. Conducting a critical review of literature in chapter 3 the recommended 
treatment protocols for Cyriax physiotherapy, a supervised exercise programme, and 
polarised polychromatic non-coherent light (Bioptron light) were derived from the 
views of advocates of these treatments, based on their personal experience with the 
treatment and on the putative physiological mechanisms that the treatment addresses. 
Cyriax physiotherapy consists of 10 minutes of DTF and one instance of Mill’s 
manipulation, which is performed immediately after the DTF. The supervised exercise 
programme consists of slow progressive eccentric exercises of wrist extensors (3 sets of 
ten repetitions with 1-minute rest interval between each set) and of static stretching 
exercises of the ECRB tendon (3 repetitions before and 3 repetitions after the eccentric 
training for 30-45 each repetition with a 30-second rest interval between each 
procedure). The probe emitting polarised polychromatic non-coherent light (Bioptron 
light) should be held at a 900 angle (perpendicular) 5-10cm above the bare skin of the 
lateral condyle (anterior and lateral surface) and the bellies of extensors muscles of the 
wrist, for six minutes each position, 18 minutes totally. All treatments are administered 
in a clinical setting. The treatment regimen of Cyriax physiotherapy and polarised 
polychromatic non-coherent light (Bioptron light) is three times per week for four 
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weeks. The treatment regimen of supervised exercise programmes will be defined in 
chapter 5 by conducting a survey of existing practitioners’ reports of their use of a 
supervised exercise programme for the treatment of LE. Cyriax physiotherapy and 
supervised exercise programmes are individualised on the basis of the patient’s report of 
pain experienced during the procedure. A physiotherapist with certificate or diploma in 
Orthopaedic medicine based on Cyriax principles should be applied Cyriax 
physiotherapy. It has been postulated that Cyriax physiotherapy can be used for both 
symptomatic relief of pain and promotion of tissue healing. In clinical practice, exercise 
programmes are predominately used for the promotion of tissue healing. It has been 
reported that polarised polychromatic non-coherent light (Bioptron light) has 
biostimulative effects assisting tissue healing at the cellular level (Chapter 3). 
 
Two preliminary clinical trials to pilot the use of these treatment protocols on overuse 
injuries similar to LE that are regularly presenting to the clinic were performed in 
chapter 4. The first study was a controlled clinical trial that evaluated the effectiveness 
of Cyriax physiotherapy and a supervised exercise programme in patellar tendinopathy, 
commonly referred to as “jumper’s knee”. The second study was a prospective open, 
uncontrolled clinical trial that assessed the effectiveness of the polarised polychromatic 
non-coherent light (Bioptron light) treatment protocol in idiopathic CTS. The findings 
of these two preliminary clinical studies indicate that the supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) may reduce 
the symptoms in patellar tendinopathy and idiopathic CTS, respectively. Cyriax 
physiotherapy did not reduce the pain in patients with patellar tendinopathy. However, 
data of the previously reported trials should be interpreted cautiously, because the 
number of patients included in the patellar tendinopathy study was small and CTS trial 
lacked of a control group. Therefore, future well-designed studies are required to 
confirm and further explore these findings. 
 
As a preliminary to investigating the effectiveness of Cyriax physiotherapy, supervised 
exercise programmes, and polarised polychromatic non-coherent light (Bioptron light) 
in treating LE, a questionnaire survey was conducted to establish the current clinical 
practice of these protocols for the management of LE in chapter 5. This questionnaire 
was designed by the investigator of the present project to record the self-reports of 
chartered physiotherapists in Athens who were using these treatments in their clinical 
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practices, because there is lack of a validated existed questionnaire to fulfill the aim of 
the present survey. Of the 220 questionnaires, 150 were received. Results of the analysis 
of 68 completed questionnaires are presented. Of those 68 responses, the most common 
was the supervised exercise programme (43, or 63.2%) and the least common was the 
polarized polychromatic non-coherent light (Bioptron light) (7, or 10.3%). Clinicians 
reported that they believed that Cyriax physiotherapy, a supervised exercise programme 
and polarised polychromatic non-coherent light (Bioptron light) had the same aim 
(reduction of pain and improvement of function) and the same treatment regimen (three 
times per week for 4 weeks). It was also reported that these treatments are characterized 
as not time-consuming, short-term (1 month after the end of treatment) and long-term (6 
months after the end of treatment) effective treatments that do not cause side-effects or 
increase of pain in patients during their application. Moreover, clinicians reported that 
(i) the supervised exercise programme could be performed at home; (ii) Cyriax 
physiotherapy had some contraindications; and (iii) polarised polychromatic non-
coherent light (Bioptron light) was expensive for both physical therapists and patients. It 
may be confidently assumed that the above results present a representative view of 
current clinical practice of Cyriax physiotherapy, a supervised exercise programme and 
polarised polychromatic non-coherent light (Bioptron light) on LE at least as these 
treatments are applied in Athens. How much this reflects usage in the rest of the Greece, 
Europe, or even the world, is yet to be seen by extending the research. 
 
In order to assess the effectiveness of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) for LE a 
clinical trial was necessary. Such a controlled clinical trial was conducted in chapter 6. 
Cyriax physiotherapy, a supervised exercise programme, and polarised polychromatic 
non-coherent light (Bioptron light) reduced pain and improved function at the end of the 
treatment and at any of the follow-up time points. Whether this is due to placebo effects 
is not known. The supervised exercise programme produced the largest effect in the 
short, intermediate and long term. This means that, choosing among these treatments, 
the supervised exercise programme should be the first treatment option for therapists 
when they manage LE patients. If it is not possible to administer the supervised exercise 
programme, Cyriax physiotherapy and polarised polychromatic non-coherent light 
(Bioptron light) may be suitable. Further well designed RCTs are needed to confirm the 
effectiveness of these treatments in patients with LE. 
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7.2 Differences in the application of Cyriax physiotherapy, a 
supervised exercise programme and polarised polychromatic non-
coherent light (Bioptron light) between the two preliminary clinical 
studies on overuse injuries similar to LE (Chapter 4) and the main 
clinical trial on LE (Chapter 6) 
LE (Chapter 6) and patellar tendinopathy (Chapter 4) are similar conditions in the 
clinical behaviour and in histopathology (Khan et al., 2000a; Cook et al., 2000; Cook et 
al., 2001). However, Cyriax physiotherapy for these two conditions is applied in a 
different way. As already mentioned, Cyriax physiotherapy for LE consists of DTF and 
Mill’s manipulation, which is conducted immediately after the DTF (Chapter 3, section 
3.4.3). Cyriax physiotherapy in patellar tendinopathy and for other conditions similar to 
LE consists of DTF only. DTF in all previously reported conditions is applied with the 
same way, already described in chapter 3 (section 3.4.1). Mill’s manipulation is not 
conducted in patellar tendinopathy and for other conditions similar to LE. 
 
Someone might question why, for other conditions similar to LE, Cyriax physiotherapy 
should consist of DTF only and not of DTF plus Mill’s manipulation. The most likely 
explanation is that Mill’s manipulation is a technique that can be applied only for LE; it 
cannot be applied to other conditions that are similar to LE. Again, someone might 
question why a similar manipulative manoeuvre is not recommended for the 
management of these other overuse injuries similar to LE when trials showed poor 
outcomes for the effectiveness of Cyriax physiotherapy consisting of ten minutes of 
DTF only in patellar tendinopathy (Pallechia et al. 1994; Chapter 4, section 4.3) and in 
iliotibial band friction syndrome (Schwellnus et al. 1992). 
 
DTF and Mill’s manipulation showed positive effects on LE in the controlled clinical 
trial of present project (Chapter 6) and it is concluded that the effectiveness of Cyriax 
physiotherapy is based mostly on Mill’s manipulation. Therefore, the presence of Mill’s 
manipulation alone or in combination with DTF is important for the effectiveness of 
Cyriax physiotherapy. If a manipulation technique similar to Mill’s manipulation could 
be developed for other overuse injuries, the ineffective Cyriax physiotherapy treatment 
may become effective. Therefore, research is needed to find the optimal protocol of 
Cyriax physiotherapy in overuse injuries which is based on Cyriax’s views to date, 
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since no literature exists to contradict these views (Chapter 3) and future well designed 
RCTs may provide strong evidence for the effectiveness (absolute and relative) of this 
treatment. However, for the time being the treatment protocol of Cyriax physiotherapy 
for the management of LE consists of DTF and Mill’s manipulation and the treatment 
protocol of Cyriax physiotherapy for the management of patellar tendinopathy and rest 
overuse injuries consists of DTF only. 
 
The supervised exercise programme employed in the patellar tendinopathy study 
(Chapter 4) consisted of static stretching and eccentric exercises. The static-stretching 
exercises in the patellar tendinopathy study were administered as recommended for LE 
in chapter 3 (section 3.5.2.1) and followed in the controlled clinical trial (Chapter 6). 
The major difference in the application of static-stretching exercises between the two 
conditions was that, for LE, it was recommended stretching only the injured tendon 
(ECRB), whereas in patellar tendinopathy not only the injured tendon (quadriceps 
muscle is inserted into patellar tendon, which is the “injured” tendon in patellar 
tendinopathy) but also the tendons of the hamstrings were stretched. This occurred 
because, as already mentioned in the introduction section to the patellar-tendinopathy 
study (4.3.1), hamstrings and quadriceps are tight in patellar tendinopathy and this is 
one of the causes for the development of the condition. Therefore, by stretching the 
above two tendons, one of the causes of patellar tendinopathy was addressed, while 
helping in the management of patellar tendinopathy, reducing pain and improving 
function. However, future clinical studies could evaluate the effectiveness of exercise 
programmes consisting only of static stretching exercises of the quadriceps and by 
inference the patellar tendon in patients with patellar tendinopathy. 
 
The eccentric exercises in the patellar tendinopathy study (Chapter 4) were performed 
as recommended for LE in chapter 3 (section 3.5.1.1) and followed in chapter 6. 
However, there were two main differences between the administration of eccentric 
exercises administered for patellar tendinopathy and those eccentric exercises 
recommended for application in LE. Patients in the patellar-tendinopathy study 
performed three sets of 15 repetitions of eccentric exercises with two-minute rest 
between each set, whereas in our application to LE, three sets of 10 repetitions of 
eccentric exercises were recommended, with a one-minute rest between each set. 
 
                                                                                                                         Chapter 7 
 203 
In the patellar-tendinopathy study, patients performed 15 repetitions of eccentric 
exercises in each set, because this value was the mean value of clinicians’ practices (10 
repetitions in each set) and conducted clinical trials (Cannell et al., 2001) (20 repetitions 
in each set). In two recently published clinical trials on patellar tendinopathy, patients 
performed 15 repetitions in each set (Purdam et al., 2004; Young et al., 2005), the 
number of repetitions employed in the preliminary clinical study of chapter 4 (section 
4.3). However, due to a lack of clinical trials of supervised exercise programmes for LE 
(Chapter 2), it was recommended (Chapter 3) and followed in the controlled clinical 
trial (Chapter 6) 10 repetitions of eccentric exercises in each set for LE. 15 repetitions 
were chosen in patellar tendinopathy study because the patellar tendon is different from 
ECRB in anatomic morphology (length and width) and in function (tolerate greater 
forces). 
 
It was not considered a 1-minute rest between each set enough time for patients when 
they had performed 15 repetitions per set. Therefore it was recommended 2-minute rest 
between sets for the reasons, which were mentioned in chapter 3. However, there is lack 
of evidence to support the 2-minute rest between each set and we are relying on the 
investigator’s experience. The experience of therapists is an unreliable tool to determine 
either the effectiveness or the safety of a treatment (Ernst, 1995). Thus, well-designed 
future RCTs in patellar tendinopathy will be needed to support the 2-minute rest 
between each set. 
 
A Bioptron 2 device was used to deliver the polarised polychromatic non-coherent light 
(Bioptron light) in the idiopathic CTS clinical trial, as recommended in chapter 3 
(section 3.6) and followed in the controlled clinical trial (Chapter 6). Idiopathic CTS 
was chosen because this is the type of CTS that responds better in the treatment since it 
is not the cause of metabolic and endocrinal abnormalities. Although the CTS gives 
symptoms in the distribution of the median nerve, the median nerve becomes 
compressed when pathophysiological changes in the tendons of carpal tunnel occurred 
reducing the space within carpal tunnel. However, for LE, Bioptron 2 delivers polarised 
polychromatic non-coherent light (Bioptron light) in three positions and not in one, over 
the affected (injured) site, as for the other musculoskeletal conditions such as CTS 
(Chapter 3, section 3.6.1; Chapter 6). Although there is no evidence to explain why this 
should be, the most likely explanation relates to LPLL. 
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Polarised polychromatic non-coherent light (Bioptron light) is a form of light therapy 
and the other form of light therapy is the LPLL. The LPLL has been used in a total of 
nine trials on LE (Chapter 2). In some of these trials, the probe of LPLL was applied not 
only to the affected site, but also to acupuncture points around the lateral epicondylitis. 
The manufacturers may, based on these studies, claim that, for LE, Bioptron 2 will 
deliver polarised polychromatic non-coherent light (Bioptron light) in three positions, 
thus radiating the acupuncture points. However, further research is needed to discover if 
the recommended protocols, based on the manufacturers’ claims for the management of 
LE and CTS with Bioptron 2, are effective. 
 
7.3 Strengths and weaknesses of the clinical trials of the present 
project 
Methodological shortcomings such as lack of (i) adequate allocation concealment; (ii) 
blinding of participants and therapists increasing the possibility that expectations of 
patients and therapists might influence the outcome of the trials; (iii) standardised 
outcome measures; (iv) power analysis; (v) recruitment strategies; (vi) long term 
follow-up; (vii) reasons for drop-outs; and (viii) clear descriptions of interventions, 
were present in the studies covered in the systematic review of the present project 
(Chapter 2). In the above methodological shortcomings the absence of placebo 
(sham)/no treatment group can be added, as well as other activities/ treatments patients 
might be getting when not in the clinic and also ethical issues such as payment Vs non-
payment. It is presented below, how all these methodological shortcomings were 
addressed on the present project. 
 
As the conducted trials of the present project (Chapter 4; Chapter 6) were not RCTs, it 
is possible that some changes during the allocation procedure (such as some patients 
holding back and waiting until they were allocated to the supervised exercise 
programme) biased it towards the supervised exercise programme treatment, the most 
effective treatment in the present project. However, although no genuine randomisation 
procedure was followed in the trials, the use of sequential allocation to allocate patients 
to treatment groups allowed for a true cause-and-effect relationship to be demonstrated. 
During the use of sequential allocation the therapist who performed the treatments did 
not participate in the diagnosis of the condition and the patients did not have the right to 
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choose the treatment. Patients who wanted to follow a particular treatment approach did 
not participate in the studies. The randomisation would have done our studies more 
reliable, however the way that the sequential allocation was performed in our studies 
contributes to the reliability of our studies. 
 
No placebo (sham)/no treatment group was included in the trials of the present project 
(Chapter 4; Chapter 6). Without a placebo group it would be difficult to know what 
effect was attributed to the treatment and what amount the placebo was responsible for. 
Actually, there may be a placebo effect for any type of research treatment. Adding a 
placebo (sham)/no treatment group may have increased the quality of the trials of the 
present project. However, the reasons why a placebo (sham)/no treatment group was not 
used in this project are mentioned below. As these trials were conducted in an 
environment of private medicine where the patients might justifiably expect some 
therapeutic action, the withholding of treatment was considered unethical (Burton, 
1988). The placebo (sham)/no treatment group is important when the absolute 
effectiveness of a treatment is to be determined. Absolute effectiveness determines 
whether the clinical effectiveness of a treatment takes account of normal fluctuations in 
the patients’ symptoms. However, absolute effectiveness of such a technique based-
interventions is difficult to investigate, because a good and trustworthy placebo 
(sham)/no treatment control for Cyriax physiotherapy and exercise programmes appears 
to be difficult or impossible to develop due in part to difficulties in defining the active 
element of these treatments. In addition, there is strong evidence that LE and overuse 
injuries similar to LE are not self-limiting conditions and patients’ symptoms cannot be 
reduced without appropriate “active” treatment if these are persistent for more than two-
three weeks (Binder and Hazleman, 1983; Vasseljen, 1992; Haker et al, 1993; Verhaar 
et al., 1996; Solveborn, 1997; Sverlnov and Adolfsson, 2001). Finally, absolute 
effectiveness does not provide the therapists with information as to which is the most 
appropriate treatment for the management of a condition, in this case LE and similar 
conditions to LE. 
 
What activities/other treatments patients might be getting when not in the clinic was not 
monitored in the trials of the present project (Chapter 4; Chapter 6). Patients’ diaries 
suggested that patients were compliant to studies instructions’ although patients may 
have given incorrect details to please the investigators. For example, it was possible that 
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patients followed the treatment, but they took NSAIDs at the same time because 
physicians usually recommend this kind of common used treatment as the normal 
treatment for the management of musculoskeletal conditions, and the improvement of 
symptoms may be due to those medications. Therefore, ways should be found to 
measure how other treatments such as NSAIDs contribute to the improvement of 
symptoms. A possible solution for the previously reported issue is to include a control 
group of patients in a future trial that they will receive NSAIDs as the only treatment, 
even though the effectiveness of NSAIDs for the management of LE is controversial 
(Chapter 1). NSAIDs had been used as treatment by many patients before participating 
in the trials without positive results. 
 
It is generally accepted that blinding in studies of technique-based interventions is 
problematic (Thorsteinsson et al., 1990; Deyo et al., 1990). Double blinding is 
considered the “gold standard” in clinical trials for isolating this effect. Reports on 
physical therapy interventions that claim to have achieved double blinding rarely do 
provide details on how blinding was maintained or monitored throughout the trial 
(Chapter 2). In drug trials, the investigator can administer the treatment and record 
outcome measurements while remaining blinded. It is believed that a triple-blind 
method should be considered the “gold-standard” in physiotherapy trials (Johnson and 
Tabasam, 2003). Subject membership in a treatment group is concealed from the 
subject, the investigator recording outcomes, and the investigator administering the 
treatment. However, many of the interventions used in physical therapy including 
Cyriax physiotherapy and exercises programmes are technique-based interventions but 
the criteria for the gold standard cannot be achieved. If the criteria for the gold standard 
cannot be achieved then a gold standard perhaps does not exist at all. In the trials of the 
present project (Chapter 4; Chapter 6) blinding the investigator who was administering 
the treatment was problematic, if not impossible, because the investigator needed to be 
aware of the treatments in order to administer treatments appropriately. In a future trial 
the treatment approaches can be applied by therapists who will be irrelevant to the 
conducted study, because the presence of the main investigator of the present project 
(DS) in the treatments could influence the patients’ outcomes. The investigator who 
administered treatments was likely to have prior knowledge and expectations about 
treatment outcome, and this might influence the way in which treatment was given and 
thus biased the outcome. One approach could be to train an investigator who was naive 
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to the therapeutic strategy and outcome to administer treatment (Johnson and Tabasam, 
2003). However, due to the nature of Cyriax physiotherapy and supervised exercise 
programme this approach could not be achieved because the participating therapist 
needed to be familiar with the treatments being applied in order to maximize the 
treatment effectiveness. In studies on the effectiveness of massage therapy, for example, 
the researchers have attempted to use personnel with little or no training in massage 
therapy, but such studies have provided conflicting results (Menard, 2002). Blinding of 
patients was hampered in the trials of the present project (Chapter 4; Chapter 6) by the 
fact that, from the content of technique-based interventions included in the present 
project, the patients in most cases knew which treatment they received. Receiving such 
a treatment, patients might show an improvement in accordance with their expectations. 
Measures should have been taken in order to reduce the patients’ expectations. An 
approach with a placebo (sham)/no treatment group should have been useful to the 
present project, in case the above negative factors could have been overcome. However, 
blinding of patients by including a placebo group was not possible because a good and 
trustworthy placebo (sham) may be impossible to design due in part to difficulties in 
defining the active element of Cyriax physiotherapy and supervised exercise 
programmes. Therefore other measures might need to have been taken in order to 
reduce bias arising from the subject’s expectations, since knowledge on the part of the 
patients might influence the outcome of the present trials. One measure that was used in 
the present project was that during the process of selecting patients, the specialised 
rheumatologist asked the potential participants about their treatment preferences, and it 
was decided only to include patients with no strong preferences for or against the 
treatments included in the studies of the present project (Koes, 2004). In the same way, 
patients with extensive previous experiences with one of the investigated treatments 
were also excluded of the trials of the present project (Vicenzino et al., 2001; Koes, 
2004). In addition, communication and interaction (verbal and non-verbal) between the 
therapist and patient was kept to a minimum and behaviours sometimes used by 
therapists to facilitate positive treatment outcomes were purposefully avoided in the 
trials of the present project (Vicenzino et al., 1996). For example, patients were given 
no indication of the potentially beneficial effects of the treatments or any feedback on 
their performance in the pre- and post-application measurements. The only available 
method to include blinded outcome measurement is to use a blinded independent 
observer. This observer should assess the patient without knowledge of the assigned 
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therapy. In randomized clinical trials published in the last few years, this method seems 
to have become more common, since evaluator-blinding is the only one of the triple-
blind methods that is feasible. This approach was followed in the trials of the present 
project (Chapter 4; Chapter 6). 
 
Few studies have explicitly defined the exact identity of the treatment and this lack of 
specificity in definition is troubling. Many studies do not define or describe the specific 
technique used in the treatment protocol in sufficient detail and as a result, it is difficult 
for the reader to determine exactly what was done. Descriptions of treatment 
interventions should be more explicit, including clear descriptions of the techniques, 
dosage and progression, as well as training and experience requirements. Good 
descriptions make it easy for therapists to replicate study interventions. Such good 
descriptions of treatment protocols were presented in the trials of the present project 
(Chapter 4; Chapter 6). 
 
The question of standardisation is related to the issue of definitions. The lack of 
standardisation of treatment protocols for Cyriax physiotherapy and supervised exercise 
programmes might be a possible shortcoming of the clinical trials of the present project 
(Chapter 4; Chapter 6). However, in order that study findings could be generalized, it is 
essential that the type, intensity, frequency and duration of the treatment be sufficiently 
described in order to make it possible to replicate the therapy elsewhere (Koes, 2004; 
Trudel et al., 2004). It is not always necessary and/or feasible to develop a strict 
treatment protocol. In such cases, it is certainly permissable to work with some kind of 
treatment algorithm in which the steps in the treatment path depend on the outcome of a 
previous step (Koes, 2004). In any case, in the absence of a clear treatment protocol or 
algorithm, a clear description of the actual treatment applied in the study should be 
recorded and presented. Moreover, there may be ethical reasons for the lack of 
standardised protocols for Cyriax physiotherapy and supervised exercise programmes. 
Individualised Cyriax physiotherapy treatment protocol respect the patient’s physical 
and emotional boundaries, which may encourage higher rates of participation and 
greater adherence to compliance with the study protocol (Menard, 2002). An essential 
feature of the exercise programme is that the progression of static stretching and 
eccentric exercises should be based on the patients’ symptoms and not the time elapsed 
since the treatment started (Jensen and Di Fabio, 1989). 
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All previously published trials in Achilles and patellar tendinopathy (Niesen-
Vertommen et al., 1992; Alfredson et al., 1998; Mafi et al., 2001; Silbernagel et al., 
2001; Ohberg et al., 2004; Purdam et al., 2004; Roos et al., 2004), including the 
preliminary clinical trial in Chapter 4 (section 4.3), failed to define the “slowness” of 
eccentric exercises of the “injured” tendon. This failure may be due to the therapists’ 
belief that pain will not allow patients to perform the eccentric exercises quickly. In 
contrast, the “slowness” of eccentric exercises of wrist extensors tendons was defined in 
the clinical trial for the management of LE (Chapter 6). This definition helped the 
development of a successful treatment protocol for the supervised exercise programme, 
making it easy for therapists to replicate it and put it into practice. 
 
How confident are therapists that the treatment protocol they administer is the optimal 
treatment protocol for the management of a condition? Constructing the optimal 
treatment approach based on current evidence is difficult. There is confusion regarding 
protocols of treatments in the physiotherapy literature. Selection of physiotherapy 
treatments protocols in clinical trials seems to be circumstantial, and is either made at 
random based on manufacturers’ recommendations and the researchers’ empirical 
observations as demonstrated in chapter 3. There is a missing link between the 
increasing number of successful results from physiotherapy treatments in the laboratory 
and the mediocre results of clinical trials. If this gap can be filled, an optimal treatment 
protocol for physiotherapy interventions will be able to be found. Following this 
procedure, Bjordal and his colleagues (2001) found a dose-response pattern broadly 
resembling that of the LPLL laboratory trials. Having established the optimal protocol 
for a treatment, the challenge is to draw definite conclusions about the effectiveness of 
the treatment by using adequate methodology in research, thus assisting therapists to use 
the most successful treatment in their practices. 
 
An important issue in research design is determined by an adequate sample size. 
Although the sample size addresses more the precision of the estimation of effect rather 
than the validity of the study, it remains an important aspect of a trial (Koes, 2004). The 
patellar tendinopathy trial (Chapter 4; section, 4.3) was a preliminary pilot study with 
small sample size. The problem with small sample sizes is that the comparability of the 
study groups may be in danger. Only with increasing numbers of patients do we have 
some assurance that known, but also unknown, prognostic factors will be evenly 
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distributed over the study groups (Koes, 2004). However, in the main study of the 
present project on LE (Chapter 6) an adequate sample size was used (75 subjects totally, 
25 per group). To do this, the investigator of the present project performed a power 
analysis, which requires an estimate of the magnitude of effect the proposed 
intervention may have on the measured dependent variable. The lack of power analysis 
as occurred in the preliminary studies in chapter 4 becomes an important issue that fail 
to report any difference between interventions because of the risk of type II error 
(Wright and Vicenzino, 1997), i.e. it becomes difficult to determine whether the results 
are due to the fact that no treatment effect exists or to the fact that the study lacked 
sufficient statistical power to detect any small but clinically important therapeutic effect 
(Stratford et al., 1993). Abbott et al (2001) suggest that a sample size of twenty-five 
subjects per group as used in the controlled clinical study of the present project on LE 
(Chapter 6) is sufficient to demonstrate statistical clinical significance for outcome 
measures on LE. Related to the issue of sample size it is the question of prognostic 
homogeneous study populations. Homogenous study populations were used in the trials 
of the present project (Chapter 4; Chapter 6) using the criteria (inclusion/exclusion) that 
have been reported in previously published trials because heterogeneous study groups 
may hamper finding a treatment effect if, for instance, an intervention is effective only 
for one subset of the population. In this case the positive effect in this subgroup will be 
diluted due to the absence of effect in the complementary subgroups. 
 
The outcome assessment often includes a subjective rating of pain and functioning 
(Cook et al., 2001). The pain was only measured in the preliminary clinical studies 
(Chapter 4). Pain and function were measured in the main clinical study of this project 
on LE (Chapter 6), avoiding the previously reported shortcoming of the preliminary 
clinical studies (Chapter 4). Outcome measures of unknown validity were used in the 
preliminary clinical studies, since there are no studies to demonstrate which measures 
are variable and valid in patients with patellar tendinopathy (Chapter 4; section 4.3) and 
idiopathic CTS (Chapter 4, section 4.4), respectively. No electrophysiological 
examination was conducted in the long-term follow-up of the idiopathic CTS study 
(Chapter 4; section 4.4) due to high cost and the avoidance of patients to pass this 
painful lab examination for a second time. The outcome measures that were used in the 
main clinical trial on LE (Chapter 6) are valid and reliable. If more objective outcome 
measures such as MRI and/or ultrasound examinations had been used, the results of the 
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main trial of the present project (Chapter 6) would have been more valid and reliable. 
However, the lack of use of standardised outcome measurement has been an area of 
particular deficiency on LE as revealed in chapter 2. Self-report scales designed 
specifically for patients with LE are available and are likely to be most responsive to 
changes in LE symptoms (Stratford et al., 1987; Stratford et al., 1993; Overend et al., 
1999). The Patient-Rated Forearm Scale has pain and function (specific and usual 
activity) subscales, which are weighted equal to provide a global score. The eight-item 
Pain-free Function Questionnaire is a pain scale that focuses on pain with activity 
(Stratford et al., 1987). Both were developed with items specific to LE. Other self-report 
measures with sound psychometric properties such as the Disability of the Arm, 
Shoulder, and Hand Measure (DASH), VAS, and the McGill Pain Questionnaire might 
also contribute to a more comprehensive comparison of treatment interventions but are 
less specific to the present condition. In terms of measuring physical impairments, 
strength measures have been studied. PFGS has been shown to be reliable, valid, and 
responsive in this LE population (Stratford et al., 1987; Abbott et al., 2001). Pain 
threshold can be measured by algometry (Klaiman et al., 1998; Vicenzino et al., 2001; 
Vicenzino et al., 2003) although there is lack of validity and sensitivity of this outcome 
measure in LE patients. Structural changes in the tendon related to treatment 
intervention(s) can be shown by ultrasound examinations (Alfredson et al., 1998; 
Ohberg et al., 2004; Shalabi et al., 2004), but a specialist in ultrasound examinations is 
needed to help the investigator(s) identify structural changes. MRI of elbow joint 
confirms the effectiveness of physiotherapy treatments showing the structural changes 
in the tendon, but it is difficult to be performed because the cost is high and the help of 
a specialist in MRI examinations is also needed.  Adoption of a core set of outcome 
measures would facilitate future trials and allow for meta-analyses of smaller studies. 
Although a consensus process is advisable for this, a reasonable strategy at this time is 
that all studies should include outcome measures that do not need self-report responses; 
examples are PFGS, the pressure algometer, ultrasound and MRI examinations. If it is 
not possible to use these outcome measures in trials due to lack of available devices to 
measure PFGS and algometer pressure or due to a lack of qualified personnel to help 
investigator(s) with ultrasound and MRI examinations, self-reported scales should be 
used. The disadvantage of these self-reported scales is that patients may remember how 
they had experienced the condition during a previous evaluation and regress to the mean 
with their answers. 
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Recruitment strategies often not described in studies, made the results difficult to 
generalise (White and Park, 1999). Recruitment strategies were well described in the 
trials of the present project. However, the results of the trials of the present project 
should be interpreted cautiously, because some changes in the patient recruitment may 
have had an impact on the outcome of the study. The results might have been different 
whether (i) the trials were conducted in a hospital instead of in a private clinic; (ii) 
different inclusion/exclusion criteria had been used; (iii) the patients had paid for the 
treatment approach increasing their expectation for the outcome and (iv) the patients 
with psychological problems such as depression had included in the trials.  
 
Trials should always include long-term follow-ups at six months and over as followed 
in the main clinical study of this project on LE (Chapter 6) and in the preliminary 
clinical study in idiopathic CTS (Chapter 4; section 4.3), although patients are often 
interested in little more than a rapid recovery. If the initial advantage of a treatment 
maintains at long-term follow-up, definite conclusions for treatment effectiveness can 
be drawn. However, effects over the long term might be harder to detect due to, for 
example, recurrence of complaints. Loss to follow-up may also be substantial in trials of 
physiotherapy. Loss to follow-up relates to the number of patients participating in the 
outcome assessment (Koes, 2004). No loss of follow-up was reported in the main 
clinical study of the present project on LE (Chapter 6) and in the preliminary clinical 
studies on overuse injuries similar to LE (Chapter 4). It is obvious that, if there are large 
numbers lost to follow-up (>20%), the outcome of the study can be much influenced. 
Again, this is even more problematic if the loss to follow-up is selective (Koes, 2004). It 
is possible, however, to deal with selective follow-up in the analysis phase of a study. 
Additional analysis, for example a ‘worst case analysis’, could be carried out (Koes, 
2004). 
 
The normal process in our clinic when patients receive a treatment approach to improve 
their condition is to pay fees at the end of each treatment session. Patients who visited 
our clinic and participated in the trials of the present project (Chapter 4; Chapter 6) no 
fee was to be charged. This would have increased the possibility that patients with no 
true LE, patellar tendinopathy and idiopathic CTS had been included in the trials of the 
present project. However, the fact that all the previous reported conditions were 
diagnosed by a specialised rheumatologist with extensive experience in the area of 
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musculoskeletal conditions by means of the most commonly used diagnostic tests in 
practice, eliminated this possibility. In a future project, the diagnosis of these conditions 
can be confirmed using MRI and/or ultrasound examinations. MRI and/or ultrasound 
examinations were not used in the present project for the reasons mentioned previously. 
Furthermore, receiving a treatment (pay or not for it) patients have expectations to 
improve their condition. Measures to reduce patients’ expectations mentioned 
previously. The possibility that patients reported improvement at the end of treatment 
and at follow-ups in conducted studies in order to please the investigator cannot be 
discounted. However, none of the patients wanted to discontinue treatments included in 
the trials of the present project (Chapter 4; Chapter 6) in favor of conventional 
polytherapy as provided by the clinic and patients with patellar tendinopathy (Chapter 
4; section 4.3) who received Cyriax physiotherapy and pulsed ultrasound respectively 
continued to complain of pain at the end of the treatment and at any follow-up point, it 
may be assumed that the symptom reduction was an actual phenomenon in the trials of 
the present project and patients told the truth to investigator since their priority 
receiving a treatment was to reduce their symptoms and no to please the investigator. 
Finally, using the PFGS as an outcome measure in the main study of this project 
(Chapter 6), which is a valid, reliable and no self-reported outcome measure, supported 
the assumption that the symptom reduction was a real phenomenon. 
 
The patients who participated in all trials in the present project were examined and 
evaluated in the Rheumatology and rehabilitation centre, an environment of private 
medicine in Athens. The manager of this centre is the father of the investigator, a 
specialised rheumatologist. The investigator of the present project knew that he would 
have easy access to patients in his fathers’ clinic. It was decided to collect data in 
Greece. The university was informed about this decision from the beginning of the 
project (October 2001). Someone might believe that the manager of the clinic coerced 
patients to participate in the trials. It can be assumed that the previously reported issue 
was avoided since the standards of good practice such as those that are laid down in the 
Declaration of Helsinki were followed. Again, as the trials of the present project were 
conducted in a private clinic and no in a university lab or in a hospital someone might 
question about the way that the collected data would be stored. The data was stored 
securely at the investigator’s office, a place in the clinic with restricted access, 
protecting with this way the integrity of the data. 
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The quality score of the controlled clinical trial on LE (Chapter 6) is 52% on Chalmers 
scale. This score matches the scores of previously conducted trials on LE described in 
chapter 2. Lack of randomisation and blinding of patients and therapist are the main 
responsible methodological shortcomings for this quality score in the main clinical trial 
of the present project. Blinding of patients and therapist were not possible in this trial, 
as mentioned previously in this section. However, if blinding had been followed, the 
study would have been considered as high quality (more than 70%). Following this kind 
of allocation (sequential allocation) in the trial of Chapter 6, it was thought that the trial 
was a randomized one, because this allocation had been used in other trials as 
randomisation incorrectly (Burton, 1988; Dwars et al., 1990). When it was realized that 
a no randomized design was followed, it was late, since the trial had progressed a lot. If 
a randomized designed had been used in this trial the quality score of the study would 
have been more than 70% and the study would have been considered as high quality. 
Therefore, using randomisation instead of sequential allocation a future clinical trial 
should be conducted comparing the relative effectiveness of Cyriax physiotherapy, a 
supervised exercise programme and polarised polychromatic non-coherent light 
(Bioptron light) for the management of LE. However, the use of sequential allocation 
allowed for a true cause-and-effect relationship to be demonstrated in the present trial as 
mentioned previously. In addition, the quality score of patellar tendinopathy pilot trial 
(Chapter 4; section 4.3) and of preliminary prospective open idiopathic CTS clinical 
trial (Chapter 4; section 4.3) is 38% and 30% respectively on Chalmers scale. These two 
pilot studies had more methodological shortcomings than the main clinical trial of 
chapter 6, as mentioned previously and such scores were expected. Future well-
designed trials are needed to assess the effectiveness of the investigated treatments on 
the previously two reported conditions. 
 
7.4 Clinical implications  
A supervised exercise programme and polarised polychromatic non-coherent light 
(Bioptron light) reduced the symptoms in patellar tendinopathy and CTS respectively 
(Chapter 4), two overuse injuries that are similar to LE and are regularly presented to 
the clinic. The positive effects of these studies should be under consideration due to 
methodological shortcomings (see previous section). Cyriax physiotherapy was not an 
effective treatment in patellar tendinopathy (Chapter 4). The different way of Cyriax 
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physiotherapy application between LE and patellar tendinopathy may be responsible for 
the ineffectiveness of Cyriax physiotherapy in patellar tendinopathy as mentioned 
previously. Clinicians reported that they believed that Cyriax physiotherapy, a 
supervised exercise programme, and polarised polychromatic non-coherent light 
(Bioptron light) were effective treatments for LE in both the short term (one month after 
the end of treatment) and in the long term (6 months after the end of treatment) (Chapter 
5). The finding that the supervised exercise programme treatment is the most effective 
of the three treatments for LE means that, of the three treatments, it should be the first 
treatment option (Chapter 6). Cyriax physiotherapy and polarised polychromatic non-
coherent light (Bioptron light) may also be suitable treatments for the management of 
LE, because it was found that these two treatments may reduce pain and improve 
function in patients with LE (Chapter 6). Whether this is due to placebo effects or the 
patients’ expectations receiving a treatment is not known. To maximize the 
effectiveness of Cyriax physiotherapy treatment, physiotherapists should be experienced 
with Cyriax physiotherapy treatment and hold a certificate or diploma in orthopaedic 
medicine based on Cyriax principles.  
 
In addition, the choice of treatment should be based not only on clinical effectiveness, 
but also on clinical considerations such as which treatment is the most time efficient, 
which is the least expensive and which is the least invasive (Halle et al., 1986). 
Clinicians reported that they believed that the three treatments were not time-consuming 
procedures for them to apply (Chapter 5), probably due to the nature of clinical 
rote/routines. The application times investigated in the controlled clinical trial on LE 
(Chapter 6) produced the best results for the supervised exercise programme, but it is 
possible that Cyriax physiotherapy and polarised polychromatic non-coherent light 
(Bioptron light) may be more effective with longer application times. New treatments 
protocols will be developed modifying the application times that will be in contrast with 
the recommended protocols (Chapter 3). However, following this approach the optimal 
treatment protocol may be developed. 
 
Clinicians reported that they felt that the only expensive treatment was the polarised 
polychromatic non-coherent light (Bioptron light) (Chapter 5). This treatment is 
expensive because devices that deliver polarised polychromatic non-coherent light 
(Bioptron light) are costly. However, a benefit of polarised polychromatic non-coherent 
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light (Bioptron light) therapy is that physiotherapists place the device over the affected 
(injured) site and can then treat other patients simultaneously. In contrast, clinicians 
reported that Cyriax physiotherapy and a supervised exercise programme are not 
expensive treatments since no special equipment is required (Chapter 5). However, 
Cyriax physiotherapy and a supervised exercise programme must be administered under 
the supervision of a physiotherapist and the physiotherapist cannot treat other patients at 
the same time. But again, Cyriax physiotherapy must be administered by a 
physiotherapist who is experienced with this treatment and has a certificate or diploma 
in orthopaedic medicine based on Cyriax principles. Finally, the administration of 
Cyriax physiotherapy places considerable strain on physiotherapists’ hands and 
physiotherapists usually find this treatment exhausting. Any future trial should 
incorporate a cost-effectiveness analysis into the analysis of the compared treatments, 
since reduced costs are important issues for the recommendation of a treatment (White 
and Park, 1999).  
 
Cyriax physiotherapy, supervised exercise programmes and polarised polychromatic 
non-coherent light (Bioptron light) advocates reported that the application of these 
treatments for the treatment of LE caused no side effects (Chapter 3). In preliminary 
clinical trials (Chapter 4) and in the controlled clinical trial (Chapter 6), there were no 
adverse effects reported at the end of treatment or at any point during follow-up. The 
implication is that the treatments are both safe and effective in producing pain relief and 
function improvement. Clinicians also reported that these treatments cause no side 
effects in patients during their application (Chapter 5). However, in order to establish 
the safety of these treatments, it would be necessary to perform a RCT and survey to 
record only the side effects of these treatments, as it had been done for ESWT (Haake et 
al., 2002b) and acupuncture (MacPherson et al., 2001; White et al., 2001) respectively. 
A systematic review of a wide spectrum of published literature could also be carried out 
to evaluate the side effects of these treatments as it has also been done for acupuncture 
(Ernst and White, 2000).  
 
The application of Cyriax physiotherapy was the only one of the three treatments that 
had some contra-indications on LE (Chapter 3). In the conducted survey, respondents 
who predominately used Cyriax physiotherapy to treat LE reported that this treatment 
has some contra-indications on LE (Chapter 5). The way that these contraindications are 
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overcome has already been mentioned in chapter 3. However, studies similar to those 
were reported previously for side effects are needed to confirm the contra-indications of 
Cyriax physiotherapy on LE. There is a lack of such studies for the other physiotherapy 
treatments in the literature. 
 
Using the rating system for levels of evidence described in chapter 2, there is moderate 
evidence for the effectiveness of Cyriax physiotherapy, a supervised exercise 
programme and polarised polychromatic non-coherent light (Bioptron light) on LE. In 
addition to the reported treatments for LE in chapter 2 there is also Mulligan 
physiotherapy-mobilization with movement (Vicenzino and Wright, 1995; Vicenzino et 
al., 2001; Abbott et al., 2001; Paungmali et al., 2003), cervical mobilization (Vicenzino 
et al., 1996; Rompe et al., 2001; Cleland et al., 2004), wrist manipulation (Struijs et al., 
2003), neural tension technique (Drechsler et al., 1997), Rebox (Johannsen et al., 1993) 
and elbow taping (Vicenzino et al., 2003). These have been used in some trials, but the 
effectiveness of these treatments was not evaluated in the systematic review in chapter 2 
because these trials did not meet the inclusion criteria. None of these treatments can be 
recommended as first line treatment for LE because of insufficient evidence. Well-
designed RCTs are needed to draw definite conclusions about their effectiveness on LE. 
It is recommended that practitioners use the treatments techniques that have the 
strongest evidence supporting their outcomes. Given the lack of evidence on the relative 
benefits of these treatments options, therapists must construct a treatment plan and 
progression from these options based on clinical practicalities and experience. To obtain 
the best results, it is imperative that patients match to the characteristics and injury 
presentations of participants in specific treatment studies.  
 
7.5 Underlying mechanisms of investigated treatments 
One of the difficulties in establishing an optimal treatment for LE has been that the 
pathophysiology of this condition was unknown until recently (Chapter 1). It is now 
known that LE is a degenerative or failed-healing tendon response that is characterized 
by the increased presence of fibroblasts, by increased amounts of proteoglycans and 
glycosaminoglycans, by vascular hyperplasia and by disorganized collagen in the origin 
of the ECRB, the injured tendon (Chapter 1). Physiotherapy treatments that reverse the 
pathophysiology of LE may be effective for the management of this condition (Chapter 
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1). In contrast, chapter 2 found strong evidence only for the short-term effectiveness of 
acupuncture on LE, a symptomatic pain relief treatment. Although further research is 
needed to establish the effectiveness of acupuncture on LE, it is believed that this kind 
of treatment cannot offer long-term effectiveness because this treatment address the 
symptoms (pain) of LE rather than the cause of symptoms (pathophysiology changes of 
tendon). 
 
 The mechanisms behind the positive effects of Cyriax physiotherapy, a supervised 
exercise programme and polarised polychromatic non-coherent light (Bioptron light) as 
treatments for LE are not fully explained based on a number of hypotheses that are 
acceptable in the medicinal literature today (Chapter 3). The proposed mode of these 
treatments (Chapter 3) may cause changes in the pathophysiology of LE, giving one 
more explanation for the effectiveness of the three treatments. 
 
It has been postulated that Cyriax physiotherapy can be used for both sympromatic 
relief of pain and promotion of tissue healing (Chapter 3). The symptomatic relief of 
pain can be achieved through  (i) the gate control theory and (ii) the production of 
hyperemia (Chapter 3). The promotion of tissue healing can be achieved by (i) 
reorienting the collagen in a longitudinal fashion with the result of enhancing tensile 
strength because the more fibers stretch in accordance with the applied force the greater 
strains the tissue will tolerate and (ii) breaking down (rupturing) the strong cross-links 
or adhesions that have formed on the “injured” structure, tendon in this case (Chapter 
3).  
 
It is reported that supervised exercise programmes used for the promotion of tissue 
healing by (i) stimulating mechanoreceptors in tenocytes to produce collagen because 
the more fibers exist in the tendon the greater strains the tendon will tolerate; (ii) 
improving collagen alignment of the tendon and stimulate collagen cross-linkage 
formation, both of which increase the tensile strength (see previous paragraph); (iii) 
normalizing the high concentrations of glycosaminoglycans and (iv) leading to 
neovascularisation, the formation of new blood vessels, which improves blood flow in 
the area of injured (Chapter 3). 
 
                                                                                                                         Chapter 7 
 219 
It is claimed that polarised polychromatic non-coherent light (Bioptron light) has 
biostimulative effects assisting tissue healing (Chapter 3). The biostimulative effects of 
this intervention accelerate the cellular mechanisms and improve the tensile strength 
indirectly through the cell proliferation (especially fibroblasts), growth factor release 
and collagen synthesis enhancement (Chapter 3). It is also claimed that the radiation of 
polarised polychromatic non-coherent light (Bioptron light) may improve the blood 
supply (Chapter 3). 
 
Based on the previously reported evaluations, it is obvious that the proposed mechanism 
of action of the supervised exercise programme is the only of the three mechanisms that 
reverse the pathophysiology of LE in full, and therefore it may be explained why the 
supervised exercise programme was the most effective treatment in the present project. 
The recommended mode of action of the other two treatments, Cyriax physiotherapy 
and polarised polychromatic non-coherent light (Bioptron light), reverse the 
pathophysiology of LE partially and it was expected these two treatment to be less 
effective than the supervised exercise programme. Such as observations are expected for 
conditions similar to LE. 
 
7.6 Implications for future research 
Although completing this project constitutes an important step towards strengthening 
the evidence base, it is hoped that the findings obtained in the course of this project will 
inspire future studies ensuring that clinical practice is built on firm foundations of 
research evidence. 
 
 All treatments, that are used to treat LE including Cyriax physiotherapy, a supervised 
exercise programme and polarised polychromatic non-coherent light (Bioptron light), 
have to be shown to be effective if they are to be continued in future practice. The 
effectiveness of a treatment should be investigated when the optimal protocol of this 
treatment has been established. The optimal protocol for a treatment should be 
established by combining a wide spectrum of published literature (anecdotal reports 
from therapists, manufacturers’ claims, a variety of trials and reviews of literature, 
patient information sheets, etc) with self-report by therapists using this treatment in their 
clinical practice. Using the optimal treatment protocols, well designed RCTs that can 
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resolve the issues discussed should be conducted to determine the absolute effectiveness 
(e.g., against a placebo (sham)/ no treatment control) and relative effectiveness (e.g., 
against other treatments) of treatments in order to inform clinical decisions. RCTs 
appear to be a powerful research tool for answering questions on the effectiveness of 
interventions. Despite some problems with the conduct of RCTs, problems largely 
related to the blinding of patients and therapists, it is undoubtedly possible to carry out 
high-quality studies in this area. Of course, other types of research aimed at increasing 
the body of knowledge about treatments should also be carried out. Basic sciences, 
including animal studies and biomechanical work, are needed to develop new therapies 
and improve old therapies. However, only by the results of high-quality RCTs will be 
able to determine whether specific therapies are effective or not. When a wide range of 
differing treatment options are presented, as is the case for LE, comparisons of effects 
produced by different treatments can provide information about relative effectiveness 
and can inform decisions about treatment selection. 
 
Investigations using physiological variables should be carried to demonstrate how the 
treatments work. A cost-effectiveness analysis should be incorporated into future trials, 
because reduced costs are important issues for the recommendation of a treatment. The 
safety of treatments should be confirmed by RCTs and surveys that record only the side 
effects of treatments, with the side effects summarised by systematic reviews. 
 
In addition, research should be conducted that will help clinicians to understand the 
underlying nature of LE. A genuine understanding of the true nature of LE will make it 
easier to establish the most effective treatment to be used in clinical practice and 
produce a better prognosis for the condition. The pathophysiology of LE, which has 
been an obstacle to establishing effective treatments for the condition, is now more 
known. Further research is required to determine if this knowledge of the 
pathophysiology may be translated into clinical effectiveness and vice versa. Moreover, 
reviews of literature and surveys are recommended i) to develop a precise definition of 
LE; ii) to resolve the inconsistency of nomenclature; iii) to establish the etiology of LE 
and iv) to establish the epidemiology of LE. In addition, literature reviews, surveys and 
test-retest studies are needed to assess the validity and sensitivity of diagnostic tests for 
LE. 
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In conclusion, despite the need for further research to understand the nature of LE and 
the lack of optimal protocols to investigate the effectiveness of treatments, practitioners 
should be encouraged to use the treatments that have the strongest evidence supporting 
their outcomes. Cook et al (2001) suggest that physiotherapy treatments should be 
considered to be effective if they reduce the pain and improve function. Cyriax 
physiotherapy, a supervised exercise programme and polarised polychromatic non-
coherent light (Bioptron light) reduced pain and improved function at the end of the 
treatment and at any of the follow-up time points. It can be concluded that these three 
treatments are promising interventions for the management of patients with LE. 
However, the supervised exercise programme was clearly superior and should be used 
as a first treatment option when physiotherapists manage LE patients. The superiority of 
the supervised exercise programme is also confirmed from the proposed mode of action, 
that reverses the pathophysiology of LE (cause of symptoms) in full. If it is not possible 
the supervised exercise programme to be carry out, Cyriax physiotherapy and polarised 
polychromatic non-coherent light (Bioptron light) may be suitable with less positive 
effects since reduce the pathophysiology of LE partially. Further research is warranted 
to investigate and confirm the effectiveness of Cyriax physiotherapy, supervised 
exercise programmes and polarised polychromatic non-coherent light (Bioptron light) in 
the treatment of impairment and disability resulting from LE. 
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Questionnaire about management of Tennis Elbow 
 
 
1. How many years do you work as physiotherapist? 
 
2. In which area are you specialized? 
 
3. Do you work patients with Tennis elbow? (Circle your answer) 
 
            YES                NO 
 
If you answered NO in question 3, I would like to thank you for your 
participation, as you do not need to complete the rest questionnaire. If you 
answered YES in question 3, go on in question 4. 
 
Circle your answer to the following questions 4-12 
 
4. Which of the below terms is most commonly used instead of Tennis elbow? 
(Circle only one answer) 
 
             Lateral Epicondylitis 
    
             Lateral Epicondylalgia 
  
             Extensor Tendinosis 
 
             Extensor Tendinitis 
 
             Extensor Tendinopathy 
 
5. Do you believe that Extensor Carpi Radialis Brevis (ECRB) is the most common 
affected structure of Tennis elbow? 
 
                YES                 NO 
 
6. Do you believe that patients with Tennis elbow complain of pain by digital 
palpation conducted by therapist? 
 
                 YES                 NO 
 
7. Do you believe that patients with Tennis elbow complain of pain in gripping? 
 
                 YES                 NO 
 
8. Do you believe that the resisted wrist extension with the elbow in extension is the 
most common diagnostic test in patients with Tennis elbow? 
 
                 YES                 NO 
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9. Have you read an article about the conservative management of Tennis elbow 
recently (the last four months)? 
 
                 YES                 NO 
 
10. Have you attended a course about the conservative management of Tennis elbow 
during your career? 
 
                  YES                NO 
 
11. Do you know that more than 40 different treatment methods have been reported 
in order to treat patients with Tennis elbow? 
 
                    YES                NO 
 
12. Which of the below treatments do you use the most in order to treat patients with 
Tennis elbow in clinic? (Circle only one answer) 
 
                Cyriax Physiotherapy 
 
                Supervised exercise programme 
 
                Polarised polychromatic non-coherent light (Bioptron light)  
 
                None of the above treatments 
 
If you answered none of the above treatments, I would like to thank you for your 
participation.  
 
Circle your answer to the following questions, apart from questions 
15, 16, 28, 29, where you will answer in your own words 
 
13. Does this treatment have short-term effect? 
 
                      YES            NO 
 
14.  Does this treatment have long-term effect? 
 
                       YES            NO 
 
15.  How many times per week do patients follow this treatment? 
 
 
16.  How long do patients follow this treatment? (Your answer in months) 
 
 
17.  Do you use the same protocol for all patients? 
 
                       YES              NO  
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17a.  If you answered NO, refer when you vary the protocol 
 
 
 
 
      18.  Is painful this treatment for patients? 
 
                       YES                 NO 
 
19.  Is time-consuming this treatment? 
 
                       YES                 NO 
 
20.  Is harmful this treatment for clinician’s hands? 
 
                       YES                 NO 
 
21.  Is an expensive treatment for patients? 
 
                       YES                  NO 
 
22.  Is an expensive treatment for clinicians? 
 
                        YES                 NO 
 
23.  Do patients use any prophylactic measures? 
 
                         YES                NO 
 
23a. If you answered YES, refer 
 
 
 
24.  Do clinicians use any prophylactic measures? 
 
                          YES               NO 
 
24a. If you answered YES, refer 
 
 
 
25.  Does this treatment have any side effects in patients? 
 
                          YES               NO 
 
25a. If you answered YES, refer 
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26. Does this treatment have any contraindications? 
 
                          YES                NO 
 
26a. If you answered YES, refer 
 
 
 
 
     27. Can patients follow this treatment at their home? 
 
                         YES                NO 
 
     28.  Which is the aim of the treatment you use? 
 
 
 
 
 
29.  How many patients did you manage with this treatment last month? 
       
        
 
 
 
 
 
 
Thank you for your participation 
 
                                                                                                                       Appendix III 
 261 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX III 
 
Greek Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                       Appendix III 
 262 
Ερωτηματολόγιο για την αντιμετώπιση του αγκώνα των τενιστών 
 
1. Πόσα χρόνια δουλεύετε σα φυσικοθεραπευτής; 
 
2. Σε ποιο τομέα είστε εξειδικευμένος; 
 
3. Δουλεύετε ασθενείς με αγκώνα των τενιστών (Tennis Elbow); (Κυκλώστε την 
απαντησή σας) 
                
ΝΑΙ            ΟΧΙ 
 
Αν απαντήσατε ΟΧΙ στην ερώτηση 3, θα ήθελα να σας ευχαριστήσω για τη 
συμμετοχή σας, καθώς δε χρειάζεται να συμπληρώσετε το υπόλοιπο 
ερωτηματολόγιο. Αν απαντήσατε ΝΑΙ στην ερώτηση 3, συνεχίστε στην ερώτηση 4. 
 
Κυκλώστε την απάντηση σας στις παρακάτω ερωτήσεις 
 
4. Ποιον από τους παρακάτω όρους χρησιμοποιείτε κυρίως αντί για τον όρο αγκώνα 
των τενιστών (Tennis Elbow); (Κυκλώστε μόνο μια απάντηση) 
 
Επικονδυλίτιδα (Lateral Epicondylitis) 
Lateral epicondylalgia 
Τενόντωση 
Τενοντίτιδα 
Τενοντικό πρόβλημα (Tendinopathy) 
 
5. Πιστεύετε ότι ο βραχύς κερκιδικός εκτείνοντας του καρπού είναι η πιο συχνά 
τραυματιζόμενη περιοχή στους ασθενείς με αγκώνα των τενιστών (Tennis Elbow); 
 
ΝΑΙ                ΟΧΙ 
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6. Πιστεύετε ότι οι ασθενείς με αγκώνα των τενιστών (Tennis Elbow) παραπονιούνται 
για πόνο κατά τη ψηλάφιση από το φυσικοθεραπευτή; 
 
ΝΑΙ              ΟΧΙ 
 
7. Πιστεύετε ότι οι ασθενείς με αγκώνα των τενιστών (Tennis Elbow) παραπονιούνται 
για πόνο στις δραστηριότητες που απαιτούν σφίξιμο; 
 
ΝΑΙ              ΟΧΙ 
 
8. Πιστευέτε ότι η έκταση του καρπού με αντίσταση με τον αγκώνα σε έκταση είναι το 
πιο κοινό διαγνωστικό τεστ σε ασθενείς με αγκώνα των τενιστών (Tennis Elbow); 
 
ΝΑΙ              ΟΧΙ 
 
9. ΅Εχετε διαβάσει κάποιο άρθρο για τη συντηρητική αντιμετώπιση του αγκώνα των 
τενιστών (Tennis Elbow) πρόσφατα (τους τελευταίους 4 μήνες); 
 
ΝΑΙ              ΟΧΙ 
 
10. ΅Εχετε παρακολουθήσει κάποιο σεμινάριο για τη συντηρητική θεραπεία του αγκώνα 
των τενιστών (Tennis Elbow) κατά τη διάρκεια της καριέρας σας; 
 
ΝΑΙ              ΟΧΙ 
 
11. Γνωρίζετε ότι υπάρχουν παραπάνω από 40 θεραπείες για την αντιμετώπιση του 
αγκώνα των τενιστών (Tennis Elbow); 
 
ΝΑΙ              ΟΧΙ 
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12. Ποια από τις παρακάτω θεραπείες χρησιμοποιείτε κυρίως για την αντιμετώπιση των 
ασθενών με αγκώνα των τενιστών (Tennis Elbow) στην κλινική; (Κυκλώστε μόνο μια 
απάντηση) 
 
Cyriax φυσικοθεραπεία 
Επιβλεπόμενο πρόγραμμα ασκήσεων 
Πολωμένο φως 
Καμια από τις παραπάνω 
Αν απαντήσατε καμια από τις παραπάνω, θα ήθελα να σας ευχαριστήσω για τη 
συμμετοχή σας. 
 
Κυκλώστε την απαντησή σας στις παρακάτω απαντήσεις, εκτός από 
τις ερωτήσεις 15, 16, 28, 29 που θα απαντήσετε με δικά σας λόγια 
 
13. Η θεραπεία που χρησιμοποιείτε έχει βραχυπρόθεσμα αποτελέσματα; 
 
ΝΑΙ              ΟΧΙ 
 
14. Η θεραπεία που χρησιμοποιείτε έχει βραχυπρόθεσμα αποτελέσματα; 
 
ΝΑΙ              ΟΧΙ 
 
15. Πόσες φορές την εβδομάδα ακολουθούν οι ασθενείς τη θεραπεία; 
 
 
16. Πόσο καιρό οι ασθενείς ακολουθούν αυτή τη θεραπεία; (Η απάντηση σας σε μήνες) 
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17. Χρησιμοποιείτε το ίδιο πρωτόκολλο για όλους τους ασθενείς; 
 
ΝΑΙ              ΟΧΙ 
 
17α. Αν απαντήσατε ΟΧΙ, αναφέρετε πότε τροποποιείτε το πρωτόκολλο 
 
 
18. Είναι οδυνηρή αυτή η θεραπεία για τους ασθενείς; 
 
ΝΑΙ              ΟΧΙ 
 
19. Είναι χρονοβόρα αυτή η θεραπεία; 
  
ΝΑΙ              ΟΧΙ 
 
20. Είναι επιζήμια αυτή η θεραπεία για τα χέρια των φυσικοθεραπευτών; 
  
ΝΑΙ              ΟΧΙ 
 
21. ΅Είναι ακριβή η θεραπεία για τους ασθενείς; 
 
ΝΑΙ              ΟΧΙ 
 
22. ΅Είναι ακριβή η θεραπεία για τουςφυσικοθεραπευτές; 
 
ΝΑΙ              ΟΧΙ 
 
23. Χρησιμοποιούν οι ασθενείς προφυλακτικά μέτρα κατά την εφαρμογή της 
θεραπείας; 
 
ΝΑΙ              ΟΧΙ 
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23α. Αν απαντήσατε ΝΑΙ, αναφέρετε τα μέτρα 
 
 
 
 
24. Χρησιμοποιούν οι φυσικοθεραπευτές προφυλακτικά μέτρα κατά την εφαρμογή της 
θεραπείας; 
 
ΝΑΙ              ΟΧΙ 
 
24α. Αν απαντήσατε ΝΑΙ, αναφέρετε τα μέτρα 
 
 
 
 
 
25. ΅Εχει παρενέργειες η θεραπεία στους ασθενείς; 
 
ΝΑΙ              ΟΧΙ 
 
25α. Αν απαντήσατε ΝΑΙ, αναφέρετε τις παρενέργειες 
 
 
 
 
 
 
 
26. ΅Εχει αντενδείξεις η θεραπεία; 
 
ΝΑΙ              ΟΧΙ 
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26α. Αν απαντήσατε ΝΑΙ, αναφέρετε τις αντενδείξεις 
 
 
 
 
 
 
 
 
27. Μπορούν οι ασθενείς να ακολουθήσουν αυτή τη θεραπεία σπίτι τους; 
 
ΝΑΙ              ΟΧΙ 
 
28. Ποιος είναι ο σκοπός της θεραπείας που χρησιμοποιείτε; 
 
 
 
 
 
 
 
29. Πόσους ασθενείς με αγκώνα των τενιστών (Tennis Elbow) αντιμετωπίσατε με αυτή 
τη θεραπεία τον τελευταίο μήνα; 
 
 
 
 
Ευχαριστώ πολύ για τη συμμετοχή σας 
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RHEUMATOLOGY AND REHABILITATION CENTRE 
16 ORFANIDOU STREET, PATISSIA, ATHENS 11141,GREECE 
LEEDS METROPOLITAN UNIVERSITY 
Faculty: Health and Environment, School: Health Sciences 
City campus, Leeds LS1 3HE,U.K 
_____________________________________________________________________ 
November 14, 2002 
 
Dear Sir/Madam 
 
I am requesting your participation in a survey of physical therapy programmes in 
Greece to establish the clinical practice of three treatments, Cyriax physiotherapy, a 
supervised exercise programme and polarized polychromatic non coherent light 
(Bioptron Light), for the treatment of patients with lateral epicondylitis (tennis elbow). I 
believe that a compilation of information about the clinical use of these three 
interventions will be helpful to physical therapists as the currently clinical use of the 
three modalities will be established.  
 
The enclosed questionnaire takes an average of less than 15 minutes to complete. I 
would greatly appreciate your time in completing the questionnaire and returning it in 
the enclosed envelope by mid-December, 2002. If you would like a copy of the results, 
please complete the enclosed postcard and return it separately from the questionnaire. 
 
Thank you in advance for your consideration. If you have any questions or concerns 
about the study, please feel free to contact me at the address or telephone numbers 
listed. 
 
Sincerely, 
 
DIMITRIOS STASINOPOULOS 
PHYSIOTHERAPIST, M.SC, P.HD STUDENT, PGCRM, CERT CLIN. ED., CERT ORTH. 
MED. (CYRIAX) 
210 2015655 
210 2022500 
6944713312 
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Questionnaire data 
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Q1      Q2       Q4       Q5       Q6       Q7        Q8      Q9       Q10     Q11 
10 1 1 1 1 1 1 2 2 2 
12 1 1 1 1 1 1 2 2 1 
20 1 1 1 1 1 1 2 2 2 
26 2 2 1 1 1 1 2 2 2 
23 2 5 1 1 1 2 2 2 2 
13 2 1 1 1 1 1 2 2 1 
6 2 2 1 1 1 1 1 2 2 
11 1 1 1 1 1 1 2 2 2 
15 2 3 1 1 1 2 2 2 2 
20 1 1 1 1 1 1 2 2 2 
8 1 1 2 1 1 1 2 2 2 
12 2 2 1 1 1 1 2 2 1 
27 2 1 1 1 1 1 2 2 2 
9 1 3 1 1 1 1 2 2 2 
10 1 1 1 1 1 2 2 2 2 
11 2 1 1 1 1 1 2 2 2 
15 1 1 1 1 1 1 1 2 2 
15 1 1 1 1 1 1 2 2 1 
10 1 2 1 1 1 1 2 2 2 
6 1 1 1 1 1 1 2 2 2 
15 2 1 1 1 1 1 2 2 2 
23 2 1 1 1 1 1 2 2 1 
31 1 2 1 1 1 1 2 2 2 
8 1 1 1 1 1 1 2 2 2 
15 2 1 1 1 1 2 1 2 2 
16 1 4 1 1 1 1 2 2 2 
19 1 1 1 1 1 1 2 2 1 
22 2 1 1 1 1 1 2 2 2 
26 1 1 2 1 1 1 2 2 2 
28 1 2 1 1 1 1 1 2 2 
5 1 1 1 1 1 1 2 2 2 
9 2 1 1 1 1 1 2 2 1 
11 2 2 1 1 1 1 1 1 2 
13 1 1 1 1 1 1 2 2 2 
15 1 1 1 1 1 1 2 2 2 
22 1 1 1 1 1 1 1 2 2 
21 1 2 1 1 1 1 2 2 2 
20 2 1 1 1 1 1 2 2 1 
32 2 3 1 1 1 2 1 2 2 
6 1 1 1 1 1 2 2 1 2 
5 2 2 1 1 1 1 2 2 2 
11 1 1 1 1 1 1 2 2 1 
17 2 1 1 1 1 1 1 2 2 
21 1 1 1 1 1 1 2 2 2 
20 1 3 1 1 1 1 2 2 1 
10 2 1 1 1 1 1 1 1 2 
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15 2 1 1 1 1 1 2 2 1 
25 2 1 2 1 1 2 2 2 1 
25 2 1 1 1 1 1 1 2 2 
25 1 2 1 1 1 1 2 2 2 
27 1 1 1 1 1 1 2 2 1 
12 2 1 1 1 1 2 2 2 2 
15 2 1 1 1 1 1 2 2 2 
8 1 1 1 1 1 1 2 2 1 
5 2 1 1 1 1 1 1 2 2 
19 2 2 1 1 1 1 2 2 1 
20 1 2 1 1 1 1 2 1 2 
25 2 1 1 1 1 2 2 2 2 
15 2 3 1 1 1 1 2 2 1 
16 2 2 1 1 1 1 2 2 2 
16 1 4 1 1 1 1 2 2 2 
15 1 1 1 1 1 2 2 2 2 
21 1 2 2 1 1 1 2 2 2 
8 1 1 1 1 1 1 1 1 1 
9 1 1 1 1 1 1 2 2 2 
17 2 1 1 1 1 2 2 2 2 
15 1 2 1 1 1 1 2 2 1 
10 2 1 1 1 1 1 2 2 2 
 
In all these questions the first 18 answers related to Cyriax physiotherapy, the rest 43 
answers related to the supervised exercise programme and the final 7 answers related to 
polarised polychromatic non-coherent light (Bioptron light). 
 
In Q1 are presented the experience years of respondents. 
 
In Q2, 1= Orthopaedic area and 2=Sports medicine area. 
 
In Q4 1=Lateral epicondylitis 2=Extensor tendonitis 3=Lateral epicondylalgia 
4=Extensor tendinopathy and 5=Extensor tendinosis 
 
In Q5, Q6, Q7, Q8, Q9,Q10, Q11 1=YES and 2= NO 
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Q12    Q13     Q14     Q15      Q16     Q17     Q18     Q19     Q20     Q21     Q22 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
1 1 1 3 1 1 2 2 1 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
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2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
2 1 1 3 1 1 2 2 2 2 2 
3 1 1 3 1 1 2 2 2 1 1 
3 1 1 3 1 1 2 2 2 1 1 
3 1 1 3 1 1 2 2 2 1 1 
3 1 1 3 1 1 2 2 2 1 1 
3 1 1 3 1 1 2 2 2 1 1 
3 1 1 3 1 1 2 2 2 1 1 
3 1 1 3 1 1 2 2 2 1 1 
 
In Q12 1=Cyriax physiotherapy, 2= supervised exercise programme and 3=polarised 
polychromatic non-coherent light (Bioptron light). 
 
According to the previously reported division were answered the Q13, Q14, Q17-Q22 
where 1= YES and 2=NO and the same division was followed in the rest questions in 
the next pages. 
 
In Q15 the number 3 means 3 times per week and the answer was the same for the three 
groups. In Q16 the number 1 means 1 month and the answer was the same for the three 
groups. 
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Q23    Q24     Q25 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
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2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
2 2 2 
 
In Q23, Q24 and Q25, 2 means NO 
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Q26      Q26a 
2 
1 
1 
2 
1 
1 
2 
1 
1 
1 
2 
2 
1 
1 
2 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
skin prob 
infection 
infection 
skin prob 
 
cal sof tis 
 
cal sof tis 
 
skin prob 
cal sof tis 
cal sof tis 
 
infection 
infection 
cal sof tis 
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2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
 
In Q26, 1means YES and 2 means NO. In Q26a the YES answers of respondents who 
predominately used Cyriax physiotherapy to treat LE are presented. 
skin prob=skin problem 
cal sof tis= calcification of soft tissues 
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Q27               Q29 
2 . 3 
2 . 2 
2 . 1 
2 . 2 
2 . 3 
2 . 2 
2 . 5 
2 . 3 
2 . 3 
2 . 5 
2 . 5 
2 . 3 
2 . 4 
2 . 3 
2 . 2 
2 . 3 
2 . 2 
2 . 1 
2 . 6 
1 . 5 
2 . 3 
2 . 3 
1 . 3 
2 . 2 
1 . 4 
2 . 3 
1 . 3 
2 . 2 
1 . 5 
2 . 5 
1 . 2 
2 . 6 
2 . 1 
1 . 1 
1 . 2 
2 . 4 
2 . 3 
2 . 5 
1 . 4 
1 . 4 
1 . 3 
2 . 3 
1 . 2 
1 . 2 
2 . 2 
1 . 3 
2 . 1 
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1 . 4 
2 . 5 
1 . 5 
2 . 2 
1 . 3 
1 . 2 
2 . 2 
1 . 2 
2 . 2 
1 . 1 
2 . 2 
2 . 1 
1 . 2 
2 . 1 
2 . 2 
2 . 1 
2 . 2 
2 . 3 
2 . 2 
2 . 1 
2 . 1 
 
In Q 27, 1means YES and 2 means NO 
In Q29 are presented the patients that managed in a clinical setting the last month 
Q28 is in the next page 
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pain function function 
function pain pain 
pain/fun p/function p/function 
rep con rep con rep co 
 function pain 
pain pain pain 
pain/fun pain p/function 
rep con function 
pain/rep c p/function 
fun/rep co hyperem 
function pain/rep c 
rep con fun/rep co 
fun/rep co function 
pain/fun fuction 
rep con pain 
fun/rep co p/function 
pain/rep c p/function 
p/f/rep c hyperem 
p/f/rep c pain 
 fun/rep co 
 p/function 
 p/function 
 pain 
 function 
 pain/rep c 
 rep con 
 rep con 
 p/f/rep co 
 p/f/rep co 
 function 
 function 
 p/function 
 rep con 
 pain/rep c 
 fun/rep co 
 p/function 
 p/f/rep co 
 p/function 
 p/function 
 rep con 
 p/f/rep co 
 rep con 
 p/f/hyp/co 
Q28 Answers of respondents. The first column presents the answers of respondents who 
predominately used Cyriax participants to treat LE, the second column presents the 
answers of respondents who predominately used a supervised exercise programme to 
treat LE and the third column presents the answers of respondents who predominately 
used polarised polychromatic non-coherent light (Bioptron light) to treat LE. 
p=pain, hyper=hyperemia, f=Function, rep con=repair connective tissue 
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Descriptives 
 
  VAR00001   Statistic Std. Error 
Q1 1,00 Mean 14,61 1,453 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 11,54   
Upper Bound 
17,68   
5% Trimmed Mean 14,40   
Median 12,50   
Variance 38,016   
Std. Deviation 6,166   
Minimum 6   
Maximum 27   
Range 21   
Interquartile Range 10,00   
Skewness ,804 ,536 
Kurtosis -,320 1,038 
2,00 Mean 16,82 1,096 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 14,61   
Upper Bound 
19,03   
5% Trimmed Mean 16,68   
Median 16,00   
Variance 52,850   
Std. Deviation 7,270   
Minimum 5   
Maximum 32   
Range 27   
Interquartile Range 11,00   
Skewness ,125 ,357 
Kurtosis -,751 ,702 
3,00 Mean 13,33 2,108 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,91   
Upper Bound 
18,75   
5% Trimmed Mean 13,20   
Median 12,50   
Variance 26,667   
Std. Deviation 5,164   
Minimum 8   
Maximum 21   
Range 13   
Interquartile Range 9,25   
Skewness ,511 ,845 
Kurtosis -1,399 1,741 
 
Descriptive statistics for years of experience of respondents. 
1,00= Cyriax physiotherapy 
2,00= Supervised exercise programme 
3,00= Polarised polychromatic non-coherent light (Bioptron light) 
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 Descriptives 
 
    Statistic Std. Error 
 Mean 15,93 ,833 
95% Confidence 
Interval for 
Mean 
Lower Bound 14,26   
Upper Bound 
17,59   
5% Trimmed Mean 15,75   
Median 15,00   
Variance 47,144   
Std. Deviation 6,866   
Minimum 5   
Maximum 32   
Range 27   
Interquartile Range 11,00   
Skewness ,353 ,291 
Kurtosis -,696 ,574 
 
Descriptive statistics for years of experience for the whole sample 
 
  
 
 
 
One-way Anova 
  Sum of Squares df Mean Square F Sig. 
Between Groups 106,476 2 53,238 1,134 ,328 
Within Groups 3052,157 65 46,956     
Total 3158,632 67       
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APPENDIX VI 
 
Baseline assessment sheet 
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Date: 
 
Name: 
 
Sex: 
 
Age: 
 
Duration of symptoms: 
 
Previous treatment: 
 
Occupation: 
 
Affected arm: 
 
Dominant arm: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                      Appendix VII 
 286 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX VII 
 
Patient information sheet 
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DIMITRIOS I STASINOPOULOS 
Physiotherapist, M.Sc, PGCRM, 
RHEUMATOLOGY AND REHABILITATION CENTRE 
16 ORFANIDOU STREET, PATISSIA, ATHENS GREECE 
P.hD STUDENT LEEDS METROPOLITAN UNIVERSITY 
Faculty: Health and Environment, School: Health Sciences 
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PATIENT INFORMATION SHEET 
 
 
TITLE OF PROJECT: An investigation into the clinical use and clinical effectiveness 
of Cyriax physiotherapy, a supervised exercise programme and polarized polychromatic 
non-coherent light (Bioptron light) for the treatment of lateral epicondylitis. 
 
You are invited to participate in a research study, which forms part of my PhD 
training. The research study investigates the clinical effectiveness of Cyriax 
physiotherapy, a supervised exercise programme and polarised polychromatic non-
coherent light (Bioptron light) for the treatment of lateral epicondylitis, commonly 
referred to as tennis elbow (lateral elbow pain). Before entering this study you should be 
between 30 and 60 years old, have been complained of pain for at least a month, have 
been treated unsuccessfully for tennis elbow and have been either self-referred to our 
clinic or referred by your physician or physiotherapist to our clinic. Please inform the 
investigator if this is not the case. Participation in this study requires attendance in clinic 
at three 30-minute sessions per week for four weeks (a month). You would also be 
required to attend our clinic for a 10-minute assessment of your condition at one month 
after the end of treatment, three months after the end of treatment and six months after 
the end of treatment. You can withdraw from the study at any stage and without giving 
the reasons. 
 
If you agree to participate and are accepted in to the study you will be randomly 
allocated to receive ONE of three possible treatment interventions (i) Cyriax 
physiotherapy, (ii) a supervised exercise programme or (iii) polarised polychromatic 
non-coherent light (Bioptron light). 
 
Cyriax physiotherapy will consist of a 10-minute massage treatment applied by a 
qualified Cyriax therapist to the area around the elbow. The therapist will then 
straighten your arm using a short and quick movement. Occasionally the Cyriax 
physiotherapy can increase the pain during the treatment and if this happens you should 
immediately tell the therapist.  
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Treatment using the supervised exercise programme aims to increase the strength and 
flexibility of wrist extensors (muscles on the side of the elbow) muscles around the 
elbow. You will be shown how to perform the exercises and the therapist will provide 
guidance when you carry out the exercises. You will start with three sets of stretching 
exercises for 30-45 seconds at each session with 30-second rest interval between each 
procedure. This will be followed by 3 sets of 10 eccentric exercises, which last a few 
seconds each, with one-minute rest interval between each set. You will finish 
performing again three sets of stretching exercises. Performing these exercises minimal 
pain can be expected, but this type of pain is usually easily tolerated. 
Eccentric/stretching exercises will be conducted slowly in each session to reduce the 
risk of pain resulting from this treatment. If pain becomes too high during the exercises 
you should immediately tell the therapist who will make you stop the exercises and will 
appraise the situation with a view of stopping the experiment.  
 
Polarised polychromatic non-coherent light (Bioptron light) delivers light energy at 
intensities much lower than that achieved using therapeutic lasers. It will be applied 
over three sites around the painful area for six minutes at each site (a total of 18 minutes 
in each treatment). The polarised polychromatic non-coherent light (Bioptron light) 
probe will be positioned 5-10 cm above your skin and you are unlikely to feel any 
sensations from the probe or therapy. As a relatively new treatment there have been no 
reports in the literature of any adverse events arising from polarised polychromatic non-
coherent light (Bioptron light) given in this way. No any hypothetical effects can be 
found.  
 
Because it is not known whether these treatments are useful in tennis elbow it is 
possible that participation in this study will result in you receiving a treatment that does 
not directly help your condition. If there are no clear beneficial effects of treatment 
allocated to you at the first follow up measurement (one month after the end of 
treatment, week 8) then you will be offered an alternative form of treatment consisting 
of the standard care (polytherapy) for tennis elbow as provided by the clinic. Alternative 
treatment will be offered to every patient who will find the treatment interventions 
ineffective, but it is not compulsory to take up the alternative treatment, you can stay on 
the original treatment. 
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You are reminded that you can withdraw from the study at any point without 
consequence for further treatment, which will be free of charge for a month.  
 
During the study period we would like you to try to avoid activities that irritate the 
elbow such as gripping activities, and to try to refrain from taking pain reliving 
medication such as anti-inflammatory drugs like aspirin and ibuprofen or paracetamol. 
If you need for any reason to take medication we would like you to inform the 
investigator during your next visit to the clinic.  
 
During the study we will take measures of pain and function using a series of 
questionnaires. Grip strength will also be measured using a hand-held dynamometer 
which requires to grip and squeeze two handles until you feel the very first sensation of 
pain in the arm - at which point you will be asked to stop squeezing. This procedure is 
used routinely in physiotherapy and should not cause a new episode of pain.  
 
The treatment and measurements will be performed in our medical centre. The 
researcher, who is a qualified physiotherapist, will give treatments. Measurements will 
be performed by a physiotherapist during the course of study from baseline (week 0) to 
six-month follow-up (week 28), who will be blind to the patients’ therapy group and 
who will not treat you at all.  
 
Data resulting from this study will be used in my PhD thesis and in publications articles 
about this study. However, data will be coded and your identity will remain concealed 
at all times. You will not be identified in the reporting of any findings resulting from 
this study. All documentation will be held in a secure place where only the researcher 
has access and will be disposed carefully at the end of the study.  
 
Your participation in this study will help to inform physiotherapy practice so that 
patients with tennis elbow will receive effective treatment in the future. However, it is 
unlikely that the results of this study will be of direct benefit to yourself. 
 
If you have questions about this research or you feel your participation have been placed 
at risk, you can contact the investigator Dimitrios Stasinopoulos at 2015655. Your 
participation in this research is voluntary. If you elect to participate in the study, you 
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have the right to withdraw from the study at any time without giving a reason and 
without affecting your future care. You are not waiving any legal claims, rights, or 
remedies. You will receive a copy of this form. 
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APPENDIX VIII 
 
Informed Consent 
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CONSENT FORM 
 
Title of Project 
An investigation into the clinical use and clinical effectiveness of Cyriax physiotherapy, 
a supervised exercise programme and polarized polychromatic non-coherent light 
(Bioptron light) for the treatment of lateral epicondylitis. 
 
Please delete as applicable 
 
1. I have read the Patient Information Sheet.      YES/NO 
 
2.I have had the opportunity to ask questions and discuss the 
   research study.         YES/NO 
 
3. I am satisfied with the answer to my questions.     YES/NO 
 
4. I have received enough information about this study     YES/NO 
 
5. I have spoken to Mr. Stasinopoulos Dimitrios.                                 YES/NO 
 
6. I am understand that I am free to withdraw from the study at 
    any time without giving a reason and without affecting my  
    future care.             YES/NO 
 
7. I agree to take part in this research study.                                            YES/NO 
 
8. I am aware that I can withdraw at anytime without this having 
    any impact on my future treatment.                                                      YES/NO 
 
Signature 
Name (block capitals)                                                                              Date 
 
Signature of witness 
Name (block capitals)                                                                              Date  
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APPENDIX IX 
 
Pain and function on Visual Analogue Scale 
(VAS) (cm) 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                       Appendix IX 
 295 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How do you describe your level of pain and your function on an 11- point numerical 
rating scale, in which 0 (cm) means ´least pain imaginable` and ´no function` 
respectively and 10 (cm) means ´worst pain imaginable` and ´full function` respectively, 
in the last twenty-four hours? 
 
 
 
 
 
PAIN & FUNCTION ON VAS 
 
 0 week 4 week 8 week 16 week 28 week 
PAIN      
FUNCTION      
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APPENDIX X 
 
Pain Free Grip Strength (PFGS) (pounds) 
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Place your arm in a standardized position of elbow extension, forearm pronation and 
internal rotation of the upper limb such that the palmar aspect of the hand faced 
posteriorly with the upper limb placed by the subject’s side. Squeeze the dynamometer 
handles until they first experience pain and then to release their grip.  Repeat this three 
times with a 30-second rest interval between each measurement 
 
 
 
PAIN FREE GRIP STRENGTH (PFGS) (pounds) 
PFGS 0 week 4 week 8 week 16 week 28 week 
1 trial      
2 trial      
3 trial      
average      
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APPENDIX XI 
 
Eight-item pain free function questionnaire (“no” 
answers) 
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Today, do you or would you have any elbow discomfort at all with any of the following 
activities? 
 
 
Eight item pain free function questionnaire (‘no answers’) 
 
  
Y=YES          N=NO 
 
 
 
 
 
 
 
 
 
 
 
 
 0 week 4 week 8 week 16 week 28 week 
Activity      
Dressing yourself or pulling up your 
slacks 
     
Opening a jar or feeding yourself      
Washing yourself or wringing out a 
face cloth 
     
Household tasks (cleaning, lifting a 
chair, gardening) 
     
Opening doors      
Carrying objects with your involved 
hand 
     
Everyday activities      
Recreation or sporting activities      
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APPENDIX XII 
 
Global measure of improvement (5-point scale) 
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How do you feel today? 
 
 
Global measure of improvement (5-point scale) 
 
 4 week 8 week 16 week 28 week 
WORSE-1     
NO CHANGE-2     
SLIGHTLY BETTER-3     
MUCH BETTER-4     
NO PAIN-5     
 
 
                                                                                                                    Appendix XIII 
 302 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX XIII 
 
Participants’ characteristics 
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Cyriax physiotherapy 
 
SEX AGE Dur sym Aff Arm Dom arm 
male 32 2 1 1 
MALE 35 4 1 1 
MALE 46 5 1 1 
MALE 45 5 1 1 
female 31 1 1 1 
MALE 39 5 1 1 
female 40 2 1 1 
MALE 50 2 1 1 
female 47 10 1 1 
MALE 45 5 2 2 
female 37 4 1 1 
MALE 33 11 1 1 
MALE 38 16 1 1 
MALE 42 1 1 1 
MALE 42 9 1 1 
female 38 5 1 1 
MALE 39 5 2 2 
MALE 30 7 1 1 
female 45 4 1 1 
MALE 47 2 1 1 
female 48 5 1 1 
MALE 44 3 1 1 
female 43 7 2 2 
MALE 36 6 1 1 
female 39 3 1 1 
 
 
Age in years 
Dur sym= Duration of symptoms in months 
Aff Arm= Affected arm where 1=right arm and 2=left arm 
Dom Arm= Dominant arm where 1=right arm and 2=left arm 
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Supervised exercise programme 
 
SEX AGE Dur sym Aff Arm Dom Arm 
male 35 6 1 1 
male 45 5 1 1 
male 43 5 1 1 
male 44 4 1 1 
male 43 4 1 1 
male 49 7 2 2 
female 32 1 2 2 
female 36 3 1 1 
female 37 8 1 1 
male 38 10 1 1 
male 48 9 1 1 
female 41 8 2 1 
female 40 6 1 1 
male 48 4 1 1 
male 49 3 1 1 
male 36 6 1 1 
female 35 1 1 2 
female 48 2 2 1 
male 33 10 1 1 
male 32 7 1 1 
female 38 1 1 1 
female 36 5 1 1 
male 38 7 1 1 
male 39 5 1 1 
female 48 2 1 1 
 
 
 
Age in years 
Dur sym= Duration of symptoms in months 
Aff Arm= Affected arm where 1=right arm and 2=left arm 
Dom Arm= Dominant arm where 1=right arm and 2=left arm 
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Polarised polychromatic non-coherent light (Bioptron light) 
 
SEX AGE Dur sym Aff Arm Dom Arm 
male 40 3 2 2 
male 45 8 1 1 
male 48 9 1 1 
female 48 4 1 1 
female 49 6 1 1 
female 32 6 1 1 
female 31 5 1 1 
male 30 3 1 1 
male 36 7 1 1 
male 45 7 1 1 
male 42 2 2 2 
male 40 7 1 1 
male 38 5 1 1 
female 39 8 1 1 
female 36 4 1 1 
female 43 2 1 2 
male 43 3 2 1 
male 48 10 2 1 
male 31 8 1 2 
female 35 4 1 1 
male 39 2 1 1 
female 30 1 1 1 
male 49 7 1 1 
female 46 1 2 2 
male 41 6 1 1 
 
 
Age in years 
Dur sym= Duration of symptoms in months 
Aff Arm= Affected arm where 1=right arm and 2=left arm 
Dom Arm= Dominant arm where 1=right arm and 2=left arm 
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Patients’ characteristics 
 
 
  
 
 
Cyriax 
physiotherapy  
 
 
Supervised 
Exercise 
programme  
Polarised 
polychromatic 
non-coherent 
light (Bioptron 
light)  
Patients (n) 25 25 25 
Male/female (n) 16/9 15/10 15/10 
Mean age in years (SD) 40.44 (5.61) 40.44 (5.66) 40.16 (6.29) 
Mean duration of 
complaints in months 
(95%CI) 
5.16 (3.74-6.58) 5.16 (4.04-6.28) 5.12 (4.05-6.19) 
Dominant elbow affected 
(n) (%) 
25 (100%) 22 (88%) 21 (84%) 
 
 
 
 One Way ANOVA 
 
AGE  
  Sum of Squares df Mean Square F Sig. 
Between Groups 1,307 2 ,653 ,019 ,981 
Within Groups 2477,680 72 34,412     
Total 2478,987 74       
 
 
 
 
 One Way ANOVA 
 
DURATION of Symptoms 
  Sum of Squares df Mean Square F Sig. 
Between Groups ,027 2 ,013 ,002 ,998 
Within Groups 621,360 72 8,630     
Total 621,387 74       
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APPENDIX XIV 
 
Previous treatments of participants 
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drugs laser ultrasound 
drugs drugs ultrasound 
drugs drugs drugs 
ultrasound drugs drugs 
iontophoresis ultrasound drugs 
drugs iontophoresis injection 
laser heat iontophoresis 
drugs drugs laser 
laser drugs iontophoresis 
injection injection drugs 
iontophoresis laser heat 
ultrasound laser drugs 
ultrasound injection laser 
drugs drugs ultrasound 
injection laser drugs 
laser iontophoresis injection 
ultrasound ultrasound drugs 
drugs ultrasound laser 
drugs drugs injection 
drugs drugs drugs 
laser heat ultrasound 
injection drugs ultrasound 
iontophoresis drugs heat 
ultrasound injection drugs 
drugs drugs laser 
 
 
The first column presents the Cyriax physiotherapy participants’ answers, the second 
one highlights the supervised exercise programme participants’ answers and the last one 
presents the polarised polychromatic non-coherent light (Bioptron light) participants’ 
answers. 
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APPENDIX XV 
 
Occupations of participants 
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housework housework secreterial 
housework housework secreterial 
manual work housework manual 
housework manual manual 
secretarial manual housework 
secretarial secreterial secreterial 
housework housework secreterial 
housework housework housework 
secretarial manual housework 
manual work manual manual 
sport secreterial sport 
manual work secreterial sport 
manual work secreterial secreterial 
housework sport secreterial 
housework secreterial manual 
secretarial secreterial housework 
secretarial secreterial manual 
manual work housework housework 
secretarial manual secreterial 
housework housework secreterial 
manual work manual housework 
secretarial secreterial housework 
housework secreterial manual 
secretarial sport manual 
manual work manual manual 
 
 
The first column presents the Cyriax physiotherapy participants’ answers, the second 
one highlights the supervised exercise programme participants’ answers and the last one 
presents the polarised polychromatic non-coherent light (Bioptron light) participants’ 
answers. 
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APPENDIX XVI 
 
Raw data and statistical tests pain on VAS (cm) 
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Gr       0w       4w       8w      16w      28w 
1 7 3 3 3 2 
1 7 3 3 3 2 
1 8 4 3 3 3 
1 7 2 2 3 2 
1 6 3 3 3 3 
1 7 2 2 2 2 
1 7 2 2 2 2 
1 7 3 2 2 2 
1 7 2 2 3 3 
1 6 3 2 2 2 
1 6 3 2 2 1 
1 8 2 2 1 1 
1 8 5 4 4 3 
1 7 4 4 3 3 
1 7 3 3 2 2 
1 7 4 3 3 3 
1 6 2 2 3 3 
1 5 3 3 2 2 
1 9 3 3 2 2 
1 7 3 3 1 0 
1 7 2 2 2 1 
1 8 3 3 3 2 
1 7 2 2 2 1 
1 7 2 2 2 1 
1 6 3 3 2 1 
2 8 2 2 2 2 
2 8 3 2 2 2 
2 7 2 2 1 1 
2 6 1 0 0 0 
2 6 2 2 1 0 
2 7 2 1 1 0 
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2 6 2 2 1 0 
2 5 1 0 0 0 
2 7 2 2 1 1 
2 8 3 2 1 1 
2 7 3 2 1 1 
2 8 3 3 2 1 
2 7 2 2 2 1 
2 8 2 2 1 0 
2 7 1 1 1 1 
2 7 3 3 1 1 
2 6 1 1 1 0 
2 7 2 2 2 2 
2 8 3 2 2 2 
2 8 3 2 1 2 
2 7 2 1 1 2 
2 6 2 1 0 1 
2 6 3 2 0 0 
2 6 2 2 1 1 
2 7 3 2 2 2 
3 7 4 3 3 3 
3 7 3 3 3 3 
3 8 4 3 3 3 
3 8 5 4 3 3 
3 7 4 4 3 3 
3 7 3 3 3 3 
3 6 3 3 2 2 
3 6 3 2 2 2 
3 6 3 3 3 2 
3 5 3 3 3 2 
3 8 4 4 3 3 
3 8 3 3 3 3 
3 7 3 3 3 2 
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3 7 4 3 3 3 
3 8 4 4 4 3 
3 7 3 3 3 3 
3 7 3 3 3 3 
3 7 4 3 3 2 
3 6 2 2 2 2 
3 8 4 3 3 3 
3 7 3 3 3 3 
3 7 3 3 2 2 
3 7 3 3 3 3 
3 7 2 2 2 2 
3 7 3 3 3 3 
 
 
Gr= group 
0w= 0week 
4w=4week 
8w=8week 
16w=16week 
28w=28week 
In Group column the 1=Cyriax physiotherapy group, the 2= Supervised exercise 
programme group and the 3=Polarised polychromatic non-coherent (Bioptron light) 
group 
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Descriptives 
 
  GROUP   Statistic Std. Error 
PAIN0W 1 Mean 6,96 ,168 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,61   
Upper Bound 
7,31   
5% Trimmed Mean 6,96   
Median 7,00   
Variance ,707   
Std. Deviation ,841   
Minimum 5   
Maximum 9   
Range 4   
Interquartile Range ,50   
Skewness ,079 ,464 
Kurtosis ,980 ,902 
2 Mean 6,92 ,172 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,56   
Upper Bound 
7,28   
5% Trimmed Mean 6,96   
Median 7,00   
Variance ,743   
Std. Deviation ,862   
Minimum 5   
Maximum 8   
Range 3   
Interquartile Range 2,00   
Skewness -,262 ,464 
Kurtosis -,690 ,902 
3 Mean 7,00 ,153 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,68   
Upper Bound 
7,32   
5% Trimmed Mean 7,04   
Median 7,00   
Variance ,583   
Std. Deviation ,764   
Minimum 5   
Maximum 8   
Range 3   
Interquartile Range ,50   
Skewness -,610 ,464 
Kurtosis ,675 ,902 
PAIN4W 1 Mean 2,84 ,160 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 2,51   
Upper Bound 
3,17   
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5% Trimmed Mean 2,78   
Median 3,00   
Variance ,640   
Std. Deviation ,800   
Minimum 2   
Maximum 5   
Range 3   
Interquartile Range 1,00   
Skewness ,838 ,464 
Kurtosis ,726 ,902 
2 Mean 2,20 ,141 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 1,91   
Upper Bound 
2,49   
5% Trimmed Mean 2,22   
Median 2,00   
Variance ,500   
Std. Deviation ,707   
Minimum 1   
Maximum 3   
Range 2   
Interquartile Range 1,00   
Skewness -,307 ,464 
Kurtosis -,846 ,902 
3 Mean 3,32 ,138 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,04   
Upper Bound 
3,60   
5% Trimmed Mean 3,31   
Median 3,00   
Variance ,477   
Std. Deviation ,690   
Minimum 2   
Maximum 5   
Range 3   
Interquartile Range 1,00   
Skewness ,303 ,464 
Kurtosis ,329 ,902 
PAIN8W 1 Mean 2,60 ,129 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 2,33   
Upper Bound 
2,87   
5% Trimmed Mean 2,56   
Median 3,00   
Variance ,417   
Std. Deviation ,645   
Minimum 2   
Maximum 4   
Range 2   
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Interquartile Range 1,00   
Skewness ,606 ,464 
Kurtosis -,480 ,902 
2 Mean 1,72 ,147 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 1,42   
Upper Bound 
2,02   
5% Trimmed Mean 1,74   
Median 2,00   
Variance ,543   
Std. Deviation ,737   
Minimum 0   
Maximum 3   
Range 3   
Interquartile Range 1,00   
Skewness -,848 ,464 
Kurtosis ,994 ,902 
3 Mean 3,04 ,108 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 2,82   
Upper Bound 
3,26   
5% Trimmed Mean 3,04   
Median 3,00   
Variance ,290   
Std. Deviation ,539   
Minimum 2   
Maximum 4   
Range 2   
Interquartile Range ,00   
Skewness ,047 ,464 
Kurtosis ,981 ,902 
PAIN16W 1 Mean 2,40 ,141 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 2,11   
Upper Bound 
2,69   
5% Trimmed Mean 2,40   
Median 2,00   
Variance ,500   
Std. Deviation ,707   
Minimum 1   
Maximum 4   
Range 3   
Interquartile Range 1,00   
Skewness ,000 ,464 
Kurtosis -,024 ,902 
2 Mean 1,12 ,133 
95% 
Confidence 
Interval for 
Mean 
Lower Bound ,85   
Upper Bound 
1,39   
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5% Trimmed Mean 1,13   
Median 1,00   
Variance ,443   
Std. Deviation ,666   
Minimum 0   
Maximum 2   
Range 2   
Interquartile Range 1,00   
Skewness -,134 ,464 
Kurtosis -,557 ,902 
3 Mean 2,84 ,095 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 2,64   
Upper Bound 
3,04   
5% Trimmed Mean 2,83   
Median 3,00   
Variance ,223   
Std. Deviation ,473   
Minimum 2   
Maximum 4   
Range 2   
Interquartile Range ,00   
Skewness -,568 ,464 
Kurtosis 1,213 ,902 
PAIN28W 1 Mean 1,96 ,168 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 1,61   
Upper Bound 
2,31   
5% Trimmed Mean 2,00   
Median 2,00   
Variance ,707   
Std. Deviation ,841   
Minimum 0   
Maximum 3   
Range 3   
Interquartile Range 2,00   
Skewness -,378 ,464 
Kurtosis -,409 ,902 
2 Mean ,96 ,158 
95% 
Confidence 
Interval for 
Mean 
Lower Bound ,63   
Upper Bound 
1,29   
5% Trimmed Mean ,96   
Median 1,00   
Variance ,623   
Std. Deviation ,790   
Minimum 0   
Maximum 2   
Range 2   
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Interquartile Range 2,00   
Skewness ,073 ,464 
Kurtosis -1,351 ,902 
3 Mean 2,64 ,098 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 2,44   
Upper Bound 
2,84   
5% Trimmed Mean 2,66   
Median 3,00   
Variance ,240   
Std. Deviation ,490   
Minimum 2   
Maximum 3   
Range 1   
Interquartile Range 1,00   
Skewness -,621 ,464 
Kurtosis -1,762 ,902 
 
1= Cyriax physiotherapy group 
2= Supervised exercise programme group 
3= Polarised polychromatic non-coherent light (Bioptron light) group  
0W=0 week 
4W= 4 week 
8W= 8week 
16W= 16week 
28W= 28 week 
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Pain on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups at week 0 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups ,080 2 ,040 ,059 ,943 
Within 
Groups 
48,800 72 ,678   
Total 48,880 74    
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 Descriptives for pain on VAS for the whole sample at week 0 
 
    Statistic Std. Error 
PAIN0W Mean 6,96 ,094 
95% Confidence 
Interval for Mean 
Lower Bound 6,77   
Upper Bound 
7,15   
5% Trimmed Mean 6,99   
Median 7,00   
Variance ,661   
Std. Deviation ,813   
Minimum 5   
Maximum 9   
Range 4   
Interquartile Range 1,00   
Skewness -,236 ,277 
Kurtosis ,068 ,548 
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Normal distribution of pain on VAS data 
 
PAIN0W
9,08,07,06,05,0
40
30
20
10
0
Std. Dev = ,81  
Mean = 7,0
N = 75,00
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Paired t-test for pain on VAS from week 0 to week 4 
 
 Paired Samples Correlations 
 
  N Correlation Sig. 
Pair 1 GROUP & 
PAIN40 
75 ,193 ,097 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 GROUP 2,00 75 ,822 ,095 
PAIN40 -4,17 75 ,935 ,108 
 
 Paired Samples Test 
 
  
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 1 GROUP - 
PAIN40 
6,17 1,120 ,129 5,92 6,43 47,755 74 ,000 
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Pain on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 4 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 13,627 2 6,813 9,596 ,000 
Within 
Groups 
51,120 72 ,710   
Total 64,747 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean Difference 
(I-J) Std. Error Sig. 
2 1 -,60(*) ,238 ,042 
 3 -1,04(*) ,238 ,000 
3 1 ,44 ,238 ,207 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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Pain on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 8 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 20,027 2 10,013 15,432 ,000 
Within 
Groups 
46,720 72 ,649   
Total 66,747 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 -,84(*) ,228 ,001 
 3 -1,24(*) ,228 ,000 
3 1 ,40 ,228 ,250 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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Pain on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 16 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 36,560 2 18,280 27,697 ,000 
Within 
Groups 
47,520 72 ,660   
Total 84,080 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 -1,24(*) ,230 ,000 
 3 -1,64(*) ,230 ,000 
3 1 ,40 ,230 ,258 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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Pain on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 28 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 32,427 2 16,213 22,143 ,000 
Within 
Groups 
52,720 72 ,732   
Total 85,147 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 -,96(*) ,242 ,001 
 3 -1,60(*) ,242 ,000 
3 1 ,64(*) ,242 ,030 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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APPENDIX XVII 
 
Raw data and statistical tests of function on VAS 
(cm) 
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Gr       0w       4w       8w      16w      28w 
1 3 7 7 8 8 
1 3 8 8 8 8 
1 4 8 8 9 9 
1 3 7 7 8 8 
1 5 8 8 8 8 
1 5 7 7 8 8 
1 4 7 7 7 6 
1 3 6 7 7 7 
1 5 8 8 8 8 
1 5 9 9 9 9 
1 3 7 7 7 8 
1 3 6 7 8 7 
1 3 5 7 8 7 
1 4 7 7 7 8 
1 4 8 8 7 7 
1 5 8 8 8 8 
1 6 8 8 8 8 
1 3 6 7 8 9 
1 4 6 6 7 7 
1 3 6 6 7 8 
1 4 7 7 7 8 
1 5 8 7 7 7 
1 6 9 9 9 9 
1 3 6 6 7 8 
1 2 6 7 7 7 
2 4 8 8 9 9 
2 4 8 9 9 9 
2 3 8 8 8 8 
2 5 9 9 9 9 
2 5 8 9 9 9 
2 5 9 9 8 9 
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2 4 8 8 8 8 
2 4 7 9 9 9 
2 3 8 8 8 8 
2 4 8 8 8 8 
2 4 7 8 7 8 
2 4 8 8 8 7 
2 5 9 10 10 9 
2 3 7 8 8 8 
2 3 7 8 8 8 
2 3 7 7 8 8 
2 4 8 8 8 9 
2 4 8 9 9 9 
2 4 7 7 8 9 
2 3 8 8 9 9 
2 5 8 9 9 9 
2 4 8 8 8 9 
2 3 7 7 8 8 
2 4 8 8 8 8 
2 4 7 7 8 8 
3 5 8 8 8 8 
3 4 7 7 7 7 
3 4 7 7 7 7 
3 4 6 7 7 7 
3 3 6 6 7 8 
3 4 6 6 6 7 
3 4 7 7 7 7 
3 3 6 7 7 7 
3 3 6 6 7 7 
3 5 7 7 7 8 
3 3 6 6 7 7 
3 2 5 6 7 7 
3 4 7 7 7 8 
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3 4 7 7 7 7 
3 4 7 8 8 8 
3 4 6 7 7 7 
3 4 7 7 7 7 
3 4 7 7 7 7 
3 5 8 8 8 8 
3 4 7 7 7 7 
3 5 7 8 8 8 
3 4 7 7 7 7 
3 4 7 7 7 7 
3 5 8 8 8 7 
3 4 7 7 8 8 
 
 
Gr= group 
0w= 0week 
4w=4week 
8w=8week 
16w=16week 
28w=28week 
In Group column the 1=Cyriax physiotherapy group, the 2= Supervised exercise 
programme group and the 3=Polarised polychromatic non-coherent (Bioptron light) 
group 
 
 
 
 
 
 
 
 
 
 
                                                                                                                   Appendix XVII 
 332 
 Descriptives 
 
  GROUP   Statistic Std. Error 
FUN0W 1 Mean 3,92 ,215 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,48   
Upper Bound 
4,36   
5% Trimmed Mean 3,90   
Median 4,00   
Variance 1,160   
Std. Deviation 1,077   
Minimum 2   
Maximum 6   
Range 4   
Interquartile Range 2,00   
Skewness ,388 ,464 
Kurtosis -,776 ,902 
2 Mean 3,92 ,140 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,63   
Upper Bound 
4,21   
5% Trimmed Mean 3,91   
Median 4,00   
Variance ,493   
Std. Deviation ,702   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,00   
Skewness ,112 ,464 
Kurtosis -,816 ,902 
3 Mean 3,96 ,147 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,66   
Upper Bound 
4,26   
5% Trimmed Mean 4,00   
Median 4,00   
Variance ,540   
Std. Deviation ,735   
Minimum 2   
Maximum 5   
Range 3   
Interquartile Range ,00   
Skewness -,621 ,464 
Kurtosis ,991 ,902 
FUN4W 1 Mean 7,12 ,211 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,69   
Upper Bound 
7,55   
                                                                                                                   Appendix XVII 
 333 
5% Trimmed Mean 7,12   
Median 7,00   
Variance 1,110   
Std. Deviation 1,054   
Minimum 5   
Maximum 9   
Range 4   
Interquartile Range 2,00   
Skewness -,025 ,464 
Kurtosis -,765 ,902 
2 Mean 7,80 ,129 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,53   
Upper Bound 
8,07   
5% Trimmed Mean 7,78   
Median 8,00   
Variance ,417   
Std. Deviation ,645   
Minimum 7   
Maximum 9   
Range 2   
Interquartile Range 1,00   
Skewness ,202 ,464 
Kurtosis -,480 ,902 
3 Mean 6,76 ,145 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,46   
Upper Bound 
7,06   
5% Trimmed Mean 6,78   
Median 7,00   
Variance ,523   
Std. Deviation ,723   
Minimum 5   
Maximum 8   
Range 3   
Interquartile Range 1,00   
Skewness -,312 ,464 
Kurtosis ,312 ,902 
FUN8W 1 Mean 7,32 ,160 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,99   
Upper Bound 
7,65   
5% Trimmed Mean 7,30   
Median 7,00   
Variance ,643   
Std. Deviation ,802   
Minimum 6   
Maximum 9   
Range 3   
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Interquartile Range 1,00   
Skewness ,383 ,464 
Kurtosis ,034 ,902 
2 Mean 8,20 ,153 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,88   
Upper Bound 
8,52   
5% Trimmed Mean 8,18   
Median 8,00   
Variance ,583   
Std. Deviation ,764   
Minimum 7   
Maximum 10   
Range 3   
Interquartile Range 1,00   
Skewness ,244 ,464 
Kurtosis -,005 ,902 
3 Mean 7,00 ,129 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,73   
Upper Bound 
7,27   
5% Trimmed Mean 7,00   
Median 7,00   
Variance ,417   
Std. Deviation ,645   
Minimum 6   
Maximum 8   
Range 2   
Interquartile Range ,00   
Skewness ,000 ,464 
Kurtosis -,332 ,902 
FUN16W 1 Mean 7,68 ,138 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,40   
Upper Bound 
7,96   
5% Trimmed Mean 7,64   
Median 8,00   
Variance ,477   
Std. Deviation ,690   
Minimum 7   
Maximum 9   
Range 2   
Interquartile Range 1,00   
Skewness ,523 ,464 
Kurtosis -,688 ,902 
2 Mean 8,36 ,128 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 8,10   
Upper Bound 
8,62   
                                                                                                                   Appendix XVII 
 335 
5% Trimmed Mean 8,34   
Median 8,00   
Variance ,407   
Std. Deviation ,638   
Minimum 7   
Maximum 10   
Range 3   
Interquartile Range 1,00   
Skewness ,575 ,464 
Kurtosis ,549 ,902 
3 Mean 7,20 ,100 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,99   
Upper Bound 
7,41   
5% Trimmed Mean 7,21   
Median 7,00   
Variance ,250   
Std. Deviation ,500   
Minimum 6   
Maximum 8   
Range 2   
Interquartile Range ,50   
Skewness ,435 ,464 
Kurtosis ,490 ,902 
FUN28W 1 Mean 7,80 ,153 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,48   
Upper Bound 
8,12   
5% Trimmed Mean 7,82   
Median 8,00   
Variance ,583   
Std. Deviation ,764   
Minimum 6   
Maximum 9   
Range 3   
Interquartile Range 1,00   
Skewness -,244 ,464 
Kurtosis -,005 ,902 
2 Mean 8,48 ,117 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 8,24   
Upper Bound 
8,72   
5% Trimmed Mean 8,52   
Median 9,00   
Variance ,343   
Std. Deviation ,586   
Minimum 7   
Maximum 9   
Range 2   
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Interquartile Range 1,00   
Skewness -,592 ,464 
Kurtosis -,540 ,902 
3 Mean 7,32 ,095 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,12   
Upper Bound 
7,52   
5% Trimmed Mean 7,30   
Median 7,00   
Variance ,227   
Std. Deviation ,476   
Minimum 7   
Maximum 8   
Range 1   
Interquartile Range 1,00   
Skewness ,822 ,464 
Kurtosis -1,447 ,902 
 
 
1= Cyriax physiotherapy group 
2= Supervised exercise programme group 
3= Polarised polychromatic non-coherent light (Bioptron light) group  
0W=0 week 
4W= 4 week 
8W= 8week 
16W= 16week 
28W= 28 week 
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Function on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups at week 0 
 
One Way ANOVA 
 
 Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups ,027 2 ,013 ,018 ,982 
Within 
Groups 
52,640 72 ,731   
Total 52,667 74    
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 Descriptives for f function on VAS for the whole sample at week 0 
 
    Statistic Std. Error 
FUN0W Mean 3,93 ,097 
95% Confidence 
Interval for Mean 
Lower Bound 3,74   
Upper Bound 
4,13   
5% Trimmed Mean 3,93   
Median 4,00   
Variance ,712   
Std. Deviation ,844   
Minimum 2   
Maximum 6   
Range 4   
Interquartile Range 1,00   
Skewness ,128 ,277 
Kurtosis -,201 ,548 
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Normal distribution of function on VAS data 
 
 
FUN0W
6,05,04,03,02,0
40
30
20
10
0
Std. Dev = ,84  
Mean = 3,9
N = 75,00
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Paired t-test for function on VAS from week 0 to week 4 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 GROUP 2,00 75 ,822 ,095 
FUN40 3,29 75 ,749 ,087 
 
 Paired Samples Correlations 
 
  N Correlation Sig. 
Pair 1 GROUP & 
FUN40 
75 -,219 ,059 
 
Paired Samples Test 
 
  
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 1 GROUP - 
FUN40 
-1,29 1,228 ,142 -1,58 -1,01 -9,123 74 ,000 
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Function on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 4 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 14,907 2 7,453 20,144 ,000 
Within 
Groups 
26,640 72 ,370    
Total 41,547 74     
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 ,68(*) ,172 ,001 
 3 1,08(*) ,172 ,000 
3 1 -,40 ,172 ,069 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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Function on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 8 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 20,347 2 10,173 22,890 ,000 
Within 
Groups 
32,000 72 ,444   
Total 52,347 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 ,88(*) ,189 ,000 
 3 1,24(*) ,189 ,000 
3 1 -,36 ,189 ,181 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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Function on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 16 
 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 18,107 2 9,053 13,787 ,000 
Within 
Groups 
47,280 72 ,657   
Total 65,387 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 ,68(*) ,229 ,012 
 3 1,20(*) ,229 ,000 
3 1 -,52 ,229 ,079 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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Function on VAS for Cyriax physiotherapy, a supervised exercise programme and 
polarized polychromatic non-coherent light (Bioptron light) groups from week 0 to 
week 28 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 
18,107 2 9,053 12,402 ,000 
Within 
Groups 
52,560 72 ,730   
Total 70,667 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 ,68(*) ,242 ,019 
 3 1,20(*) ,242 ,000 
3 1 -,52 ,242 ,104 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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APPENDIX XVIII 
 
Raw data and statistical tests of PFGS (pounds) 
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Gr        0w       4w       8w      16w      28w 
1 22 45 49 50 50 
1 20 43 45 45 43 
1 25 57 56 55 55 
1 24 70 73 75 75 
1 23 78 80 80 82 
1 26 55 57 58 56 
1 25 70 75 76 75 
1 30 90 91 94 93 
1 22 60 60 63 63 
1 33 68 67 70 70 
1 25 78 75 75 75 
1 27 49 54 55 57 
1 28 45 47 52 54 
1 25 59 57 63 65 
1 29 70 72 75 77 
1 36 90 91 94 95 
1 40 90 88 86 86 
1 24 73 75 77 77 
1 25 75 75 77 78 
1 22 65 65 66 69 
1 21 49 52 50 54 
1 20 60 62 60 65 
1 20 67 65 51 53 
1 26 80 81 81 84 
1 27 77 75 73 75 
2 23 70 72 71 72 
2 24 73 74 75 75 
2 27 77 75 75 75 
2 21 55 59 62 65 
2 25 67 70 70 71 
2 22 68 72 75 77 
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2 25 59 63 65 63 
2 31 79 84 85 85 
2 25 63 66 65 65 
2 22 67 65 69 66 
2 24 79 86 84 85 
2 28 80 84 83 85 
2 27 78 80 85 85 
2 31 94 95 95 93 
2 34 97 95 94 95 
 2 40 103 107 104 105 
2 22 70 73 75 75 
2 25 69 70 74 75 
2 21 56 58 64 69 
2 25 67 65 66 67 
2 26 79 77 78 78 
2 27 82 83 83 85 
2 24 69 71 74 75 
2 25 73 77 76 77 
2 24 70 69 70 73 
3 26 60 62 61 61 
3 25 62 63 65 65 
3 30 70 71 70 70 
3 22 47 50 54 55 
3 24 67 69 68 67 
3 25 65 66 66 67 
3 25 66 68 69 70 
3 36 73 75 75 75 
3 26 59 62 64 65 
3 21 53 55 58 60 
3 26 60 61 64 65 
3 25 62 65 63 65 
3 28 68 70 74 74 
                                                                                                                 Appendix XVIII 
 348 
3 27 67 67 70 71 
3 28 66 68 70 73 
3 25 70 72 74 63 
3 24 57 59 63 65 
3 23 55 56 58 60 
3 25 68 68 65 65 
3 27 64 65 65 64 
3 26 66 66 63 63 
3 28 70 68 65 62 
3 25 62 60 64 66 
3 26 61 60 64 61 
3 29 61 63 65 63 
 
 
Gr= group 
0w= 0week 
4w=4week 
8w=8week 
16w=16week 
28w=28week 
In Group column the 1=Cyriax physiotherapy group, the 2=Supervised exercise 
programme group and the 3=Polarised polychromatic non-coherent (Bioptron light) 
group 
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Descriptives 
 
  GROUP   Statistic Std. Error 
PFGS0W 1 Mean 25,80 ,981 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 23,77   
Upper Bound 
27,83   
5% Trimmed Mean 25,38   
Median 25,00   
Variance 24,083   
Std. Deviation 4,907   
Minimum 20   
Maximum 40   
Range 20   
Interquartile Range 5,50   
Skewness 1,350 ,464 
Kurtosis 2,053 ,902 
2 Mean 25,92 ,862 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 24,14   
Upper Bound 
27,70   
5% Trimmed Mean 25,48   
Median 25,00   
Variance 18,577   
Std. Deviation 4,310   
Minimum 21   
Maximum 40   
Range 19   
Interquartile Range 3,50   
Skewness 1,763 ,464 
Kurtosis 3,864 ,902 
3 Mean 26,08 ,583 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 24,88   
Upper Bound 
27,28   
5% Trimmed Mean 25,87   
Median 26,00   
Variance 8,493   
Std. Deviation 2,914   
Minimum 21   
Maximum 36   
Range 15   
Interquartile Range 2,50   
Skewness 1,517 ,464 
Kurtosis 4,832 ,902 
PFGS4W 1 Mean 66,52 2,835 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 60,67   
Upper Bound 
72,37   
                                                                                                                 Appendix XVIII 
 350 
5% Trimmed Mean 66,50   
Median 68,00   
Variance 200,927   
Std. Deviation 14,175   
Minimum 43   
Maximum 90   
Range 47   
Interquartile Range 21,50   
Skewness -,010 ,464 
Kurtosis -,823 ,902 
2 Mean 73,76 2,339 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 68,93   
Upper Bound 
78,59   
5% Trimmed Mean 73,23   
Median 70,00   
Variance 136,773   
Std. Deviation 11,695   
Minimum 55   
Maximum 103   
Range 48   
Interquartile Range 12,00   
Skewness ,822 ,464 
Kurtosis ,855 ,902 
3 Mean 63,16 1,198 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 60,69   
Upper Bound 
65,63   
5% Trimmed Mean 63,48   
Median 64,00   
Variance 35,890   
Std. Deviation 5,991   
Minimum 47   
Maximum 73   
Range 26   
Interquartile Range 7,50   
Skewness -,817 ,464 
Kurtosis ,863 ,902 
PFGS8W 1 Mean 67,48 2,689 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 61,93   
Upper Bound 
73,03   
5% Trimmed Mean 67,40   
Median 67,00   
Variance 180,760   
Std. Deviation 13,445   
Minimum 45   
Maximum 91   
Range 46   
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Interquartile Range 18,50   
Skewness ,086 ,464 
Kurtosis -,878 ,902 
2 Mean 75,60 2,342 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 70,77   
Upper Bound 
80,43   
5% Trimmed Mean 74,96   
Median 73,00   
Variance 137,083   
Std. Deviation 11,708   
Minimum 58   
Maximum 107   
Range 49   
Interquartile Range 16,00   
Skewness ,909 ,464 
Kurtosis ,903 ,902 
3 Mean 64,36 1,149 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 61,99   
Upper Bound 
66,73   
5% Trimmed Mean 64,54   
Median 65,00   
Variance 32,990   
Std. Deviation 5,744   
Minimum 50   
Maximum 75   
Range 25   
Interquartile Range 7,50   
Skewness -,552 ,464 
Kurtosis ,383 ,902 
PFGS16W 1 Mean 68,04 2,790 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 62,28   
Upper Bound 
73,80   
5% Trimmed Mean 67,82   
Median 70,00   
Variance 194,540   
Std. Deviation 13,948   
Minimum 45   
Maximum 94   
Range 49   
Interquartile Range 22,00   
Skewness ,141 ,464 
Kurtosis -,865 ,902 
2 Mean 76,68 2,092 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 72,36   
Upper Bound 
81,00   
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5% Trimmed Mean 76,06   
Median 75,00   
Variance 109,393   
Std. Deviation 10,459   
Minimum 62   
Maximum 104   
Range 42   
Interquartile Range 14,00   
Skewness ,906 ,464 
Kurtosis ,640 ,902 
3 Mean 65,48 1,007 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 63,40   
Upper Bound 
67,56   
5% Trimmed Mean 65,56   
Median 65,00   
Variance 25,343   
Std. Deviation 5,034   
Minimum 54   
Maximum 75   
Range 21   
Interquartile Range 6,50   
Skewness -,022 ,464 
Kurtosis ,282 ,902 
PFGS28W 1 Mean 69,04 2,772 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 63,32   
Upper Bound 
74,76   
5% Trimmed Mean 68,99   
Median 70,00   
Variance 192,040   
Std. Deviation 13,858   
Minimum 43   
Maximum 95   
Range 52   
Interquartile Range 22,00   
Skewness ,028 ,464 
Kurtosis -,781 ,902 
2 Mean 77,44 2,060 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 73,19   
Upper Bound 
81,69   
5% Trimmed Mean 76,80   
Median 75,00   
Variance 106,090   
Std. Deviation 10,300   
Minimum 63   
Maximum 105   
Range 42   
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Interquartile Range 15,00   
Skewness ,895 ,464 
Kurtosis ,749 ,902 
3 Mean 65,40 ,949 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 63,44   
Upper Bound 
67,36   
5% Trimmed Mean 65,40   
Median 65,00   
Variance 22,500   
Std. Deviation 4,743   
Minimum 55   
Maximum 75   
Range 20   
Interquartile Range 6,00   
Skewness ,273 ,464 
Kurtosis ,135 ,902 
 
1= Cyriax physiotherapy group 
2= Supervised exercise programme group 
3= Polarised polychromatic non-coherent light (Bioptron light) group  
0W=0 week 
4W= 4 week 
8W= 8week 
16W= 16week 
28W= 28 week 
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PFGS for Cyriax physiotherapy, a supervised exercise programme and polarized 
polychromatic non-coherent light (Bioptron light) groups at week 0 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 
,987 2 ,493 ,029 ,971 
Within 
Groups 
1227,680 72 17,051   
Total 1228,667 74    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                 Appendix XVIII 
 355 
 Descriptives for PFGS for the whole sample at week 0 
 
    Statistic Std. Error 
PFGS0W Mean 25,93 ,471 
95% Confidence 
Interval for Mean 
Lower Bound 25,00   
Upper Bound 
26,87   
5% Trimmed Mean 25,57   
Median 25,00   
Variance 16,604   
Std. Deviation 4,075   
Minimum 20   
Maximum 40   
Range 20   
Interquartile Range 3,00   
Skewness 1,500 ,277 
Kurtosis 3,032 ,548 
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Normal distribution of PFGS data 
 
PFGS0W
40,0
37,5
35,0
32,5
30,0
27,5
25,0
22,5
20,0
40
30
20
10
0
Std. Dev = 4,07  
Mean = 25,9
N = 75,00
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Paired t-test for PFGS from week 0 to week 4 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 GROUP 2,00 75 ,822 ,095 
PFGS4
0 
41,88 75 9,792 1,131 
 
 Paired Samples Correlations 
 
  N Correlation Sig. 
Pair 1 GROUP & 
PFGS40 
75 -,153 ,191 
 
Paired Samples Test 
 
  
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 1 GROUP - 
PFGS40 
-39,88 9,951 1,149 -42,17 -37,59 -34,707 74 ,000 
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PFGS for Cyriax physiotherapy, a supervised exercise programme and polarized 
polychromatic non-coherent light (Bioptron light) groups from week 0 to week 4 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 1497,680 2 748,840 9,631 ,000 
Within 
Groups 
5598,240 72 77,753   
Total 7095,920 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 7,12(*) 2,494 ,017 
 3 10,76(*) 2,494 ,000 
3 1 -3,64 2,494 ,446 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                 Appendix XVIII 
 359 
PFGS for Cyriax physiotherapy, a supervised exercise programme and polarized 
polychromatic non-coherent light (Bioptron light) groups from week 0 to week 8 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 
1712,667 2 856,333 11,862 ,000 
Within 
Groups 
5197,920 72 72,193   
Total 6910,587 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 8,00(*) 2,403 ,004 
 3 11,40(*) 2,403 ,000 
3 1 -3,40 2,403 ,484 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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PFGS for Cyriax physiotherapy, a supervised exercise programme and polarized 
polychromatic non-coherent light (Bioptron light) groups from week 0 to week 16 
 
One Way ANOVA 
 
 
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 1747,547 2 873,773 13,208 ,000 
Within 
Groups 
4763,120 72 66,154   
Total 6510,667 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 8,52(*) 2,301 ,001 
 3 11,36(*) 2,301 ,000 
3 1 -2,84 2,301 ,663 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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PFGS for Cyriax physiotherapy, a supervised exercise programme and polarized 
polychromatic non-coherent light (Bioptron light) groups from week 0 to week 28 
 
One Way ANOVA 
 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Between Groups 1939,707 2 969,853 14,688 ,000 
Within 
Groups 
4754,240 72 66,031   
Total 6693,947 74    
 
 
Bonferroni post-hoc test 
 
(I) GROUP (J) GROUP 
Mean 
Difference (I-
J) 
Std. 
Error Sig. 
2 1 8,28(*) 2,298 ,002 
 3 12,20(*) 2,298 ,000 
3 1 -3,92 2,298 ,277 
*  The mean difference is significant at the .05 level 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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APPENDIX XIX 
 
Raw data and statistical tests of eight-item pain 
free function questionnaire (“no” answers) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                    Appendix XIX 
 363 
Gr       0w      4w        8w      16w      28w 
1 0 6 6 6 6 
1 0 5 6 7 7 
1 0 6 6 6 6 
1 0 4 5 5 5 
1 0 5 5 5 5 
1 0 7 7 7 7 
1 0 8 8 8 8 
1 0 6 6 6 6 
1 0 8 8 8 8 
1 0 6 6 6 6 
1 0 5 6 6 6 
1 0 4 4 6 6 
1 0 6 6 6 6 
1 0 4 5 5 5 
1 0 5 5 5 5 
1 0 7 7 7 7 
1 0 8 8 8 8 
1 0 8 8 8 8 
1 0 6 6 6 6 
1 0 4 4 5 5 
1 0 5 6 6 6 
1 0 4 4 5 5 
1 0 5 6 6 6 
1 0 6 6 6 6 
1 0 6 7 7 7 
2 0 6 6 7 7 
2 0 6 6 6 6 
2 0 6 7 7 7 
2 0 6 6 6 7 
2 0 6 6 7 7 
2 0 7 8 8 8 
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2 0 8 8 8 8 
2 0 8 8 8 8 
2 0 8 8 8 8 
2 0 6 6 6 8 
2 0 7 7 7 7 
2 0 6 6 6 6 
2 0 6 7 7 7 
2 0 6 6 8 8 
2 0 7 7 7 7 
2 0 8 8 8 8 
2 0 8 8 8 8 
2 0 8 8 8 8 
2 0 7 7 7 7 
2 0 5 7 7 7 
2 0 6 6 6 8 
2 0 4 6 7 7 
2 0 5 6 6 7 
2 0 7 7 7 7 
2 0 8 8 8 8 
3 0 5 5 6 6 
3 0 5 5 6 6 
3 0 4 6 6 7 
3 0 4 6 6 6 
3 0 5 5 6 6 
3 0 6 6 6 7 
3 0 6 7 7 7 
3 0 6 6 6 6 
3 0 7 7 7 7 
3 0 5 6 6 6 
3 0 5 6 6 6 
3 0 3 4 5 6 
3 0 6 6 6 6 
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3 0 4 6 6 6 
3 0 5 5 5 5 
3 0 5 6 6 6 
3 0 6 6 6 6 
3 0 6 6 6 6 
3 0 6 6 6 6 
3 0 4 4 5 6 
3 0 4 5 5 5 
3 0 4 6 6 6 
3 0 5 5 6 6 
3 0 5 6 6 6 
3 0 4 6 7 7 
 
 
Gr= group 
0w= 0week 
4w=4week 
8w=8week 
16w=16week 
28w=28week 
In Group column the 1=Cyriax physiotherapy group, the 2=Supervised exercise 
programme group and the 3=Polarised polychromatic non-coherent (Bioptron light) 
group 
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 Descriptives(a,b,c) 
 
  GROUP   Statistic Std. Error 
EIPFQ4 1 Mean 5,76 ,266 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,21   
Upper Bound 
6,31   
5% Trimmed Mean 5,73   
Median 6,00   
Variance 1,773   
Std. Deviation 1,332   
Minimum 4   
Maximum 8   
Range 4   
Interquartile Range 1,50   
Skewness ,364 ,464 
Kurtosis -,769 ,902 
2 Mean 6,60 ,224 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,14   
Upper Bound 
7,06   
5% Trimmed Mean 6,66   
Median 6,00   
Variance 1,250   
Std. Deviation 1,118   
Minimum 4   
Maximum 8   
Range 4   
Interquartile Range 2,00   
Skewness -,272 ,464 
Kurtosis -,431 ,902 
3 Mean 5,00 ,191 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 4,60   
Upper Bound 
5,40   
5% Trimmed Mean 5,00   
Median 5,00   
Variance ,917   
Std. Deviation ,957   
Minimum 3   
Maximum 7   
Range 4   
Interquartile Range 2,00   
Skewness ,000 ,464 
Kurtosis -,485 ,902 
EIPFQ8 1 Mean 6,04 ,241 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,54   
Upper Bound 
6,54   
5% Trimmed Mean 6,04   
Median 6,00   
Variance 1,457   
Std. Deviation 1,207   
Minimum 4   
Maximum 8   
Range 4   
Interquartile Range 2,00   
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Skewness ,072 ,464 
Kurtosis -,433 ,902 
2 Mean 6,92 ,172 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,56   
Upper Bound 
7,28   
5% Trimmed Mean 6,91   
Median 7,00   
Variance ,743   
Std. Deviation ,862   
Minimum 6   
Maximum 8   
Range 2   
Interquartile Range 2,00   
Skewness ,162 ,464 
Kurtosis -1,667 ,902 
3 Mean 5,68 ,150 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,37   
Upper Bound 
5,99   
5% Trimmed Mean 5,70   
Median 6,00   
Variance ,560   
Std. Deviation ,748   
Minimum 4   
Maximum 7   
Range 3   
Interquartile Range 1,00   
Skewness -,679 ,464 
Kurtosis ,586 ,902 
EIPFQ16 1 Mean 6,24 ,202 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,82   
Upper Bound 
6,66   
5% Trimmed Mean 6,21   
Median 6,00   
Variance 1,023   
Std. Deviation 1,012   
Minimum 5   
Maximum 8   
Range 3   
Interquartile Range 1,50   
Skewness ,524 ,464 
Kurtosis -,658 ,902 
2 Mean 7,12 ,156 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 6,80   
Upper Bound 
7,44   
5% Trimmed Mean 7,13   
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Median 7,00   
Variance ,610   
Std. Deviation ,781   
Minimum 6   
Maximum 8   
Range 2   
Interquartile Range 1,50   
Skewness -,220 ,464 
Kurtosis -1,280 ,902 
3 Mean 5,96 ,108 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,74   
Upper Bound 
6,18   
5% Trimmed Mean 5,96   
Median 6,00   
Variance ,290   
Std. Deviation ,539   
Minimum 5   
Maximum 7   
Range 2   
Interquartile Range ,00   
Skewness -,047 ,464 
Kurtosis ,981 ,902 
EIPFQ28 1 Mean 6,24 ,202 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,82   
Upper Bound 
6,66   
5% Trimmed Mean 6,21   
Median 6,00   
Variance 1,023   
Std. Deviation 1,012   
Minimum 5   
Maximum 8   
Range 3   
Interquartile Range 1,50   
Skewness ,524 ,464 
Kurtosis -,658 ,902 
2 Mean 7,36 ,128 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 7,10   
Upper Bound 
7,62   
5% Trimmed Mean 7,40   
Median 7,00   
Variance ,407   
Std. Deviation ,638   
Minimum 6   
Maximum 8   
Range 2   
Interquartile Range 1,00   
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Skewness -,473 ,464 
Kurtosis -,538 ,902 
3 Mean 6,12 ,105 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 5,90   
Upper Bound 
6,34   
5% Trimmed Mean 6,13   
Median 6,00   
Variance ,277   
Std. Deviation ,526   
Minimum 5   
Maximum 7   
Range 2   
Interquartile Range ,00   
Skewness ,176 ,464 
Kurtosis ,885 ,902 
 
a  EIPFQ0W is constant when GROUP = 1. It has been omitted. 
b  EIPFQ0W is constant when GROUP = 2. It has been omitted. 
c  EIPFQ0W is constant when GROUP = 3. It has been omitted. 
 
1= Cyriax physiotherapy group 
2= Supervised exercise programme group 
3= Polarised polychromatic non-coherent light (Bioptron light) group  
0W=0 week 
4W= 4 week 
8W= 8week 
16W= 16week 
28W= 28 week 
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“No” answers of eight-item pain free function questionnaire for Cyriax 
physiotherapy, a supervised exercise programme and polarized polychromatic 
non-coherent light (Bioptron light) groups at week 0 
 
Kruskal-Wallis test ranks 
 
GROUP N Mean Rank 
1 25 38,00 
2 25 38,00 
3 25 38,00 
Total 75  
 
 
Test statisticsa,b 
 
Chi-
Square 
,000 
df 2 
Asymp. 
Sig. 
1,000 
 
a  Kruskal Wallis Test 
 
b  Grouping Variable: GROUP 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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“No” answers of eight-item pain free function questionnaire for Cyriax 
physiotherapy, a supervised exercise programme and polarized polychromatic 
non-coherent light (Bioptron light) groups from week 0 to week 4 
 
Kruskal-Wallis test ranks 
 
GROUP N Mean Rank 
1 25 37,52 
2 25 51,40 
3 25 25,08 
Total 75  
 
 
Test statisticsa,b 
 
Chi-Square 18,286 
df 2 
Asymp. Sig. ,000 
 
a  Kruskal Wallis Test 
 
b  Grouping Variable: GROUP 
 
 
Mann-Whitney test 
 
      1 Vs 2 1 Vs 3 2 Vs 3 
Mann-Whitney U 195,500 214,500 93,000 
Wilcoxon W 520,500 539,500 418,000 
Z -2,348 -1,970 -4,388 
Asymp. Sig. (2-
tailed) 
,049 ,109 ,000 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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“No” answers of eight-item pain free function questionnaire for Cyriax 
physiotherapy, a supervised exercise programme and polarized polychromatic 
non-coherent light (Bioptron light) groups from week 0 to week 8 
 
Kruskal-Wallis test ranks 
 
GROUP N Mean Rank 
1 25 35,96 
2 25 52,64 
3 25 25,40 
Total 75  
 
 
Test statisticsa,b 
 
Chi-Square 18,899 
df 2 
Asymp. Sig. ,000 
 
a  Kruskal Wallis Test 
 
b  Grouping Variable: GROUP 
 
 
 
Mann-Whitney test 
 
      1 Vs 2 1 Vs 3 2 Vs 3 
Mann-Whitney U 179,500 259,500 102,000 
Wilcoxon W 504,500 584,500 427,000 
Z -2,715 -1,116 -4,395 
Asymp. Sig. (2-tailed) ,007 ,264 ,000 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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“No” answers of eight-item pain free function questionnaire for Cyriax 
physiotherapy, a supervised exercise programme and polarized polychromatic 
non-coherent light (Bioptron light) groups from week 0 to week 16 
 
Kruskal-Wallis test ranks 
 
GROUP N Mean Rank 
1 25 34,90 
2 25 54,16 
3 25 24,94 
Total 75  
 
 
Test statisticsa,b 
 
Chi-Square 23,276 
df 2 
Asymp. Sig. ,000 
 
a  Kruskal Wallis Test 
 
b  Grouping Variable: GROUP 
 
 
Mann-Whitney test 
 
      1 Vs 2 1 Vs 3 2 Vs 3 
Mann-Whitney U 159,000 276,000 87,000 
Wilcoxon W 484,000 601,000 412,000 
Z -3,105 -,795 -4,702 
Asymp. Sig. (2-tailed) ,002 ,427 ,000 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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“No” answers of eight-item pain free function questionnaire for Cyriax 
physiotherapy, a supervised exercise programme and polarized polychromatic 
non-coherent light (Bioptron light) groups from week 0 to week 28 
 
Kruskal-Wallis test ranks 
 
GROUP N Mean Rank 
1 25 35,88 
2 25 54,06 
3 25 24,06 
Total 75  
 
 
Test statisticsa,b 
 
Chi-Square 24,078 
df 2 
Asymp. Sig. ,000 
 
a  Kruskal Wallis Test 
 
b  Grouping Variable: GROUP 
 
 
 
Mann-Whitney test 
 
      1 Vs 2 1 Vs 3 2 Vs 3 
Mann-Whitney U 121,000 308,000 58,000 
Wilcoxon W 446,000 633,000 383,500 
Z -3,871 -,098 -5,245 
Asymp. Sig. (2-tailed) ,000 ,922 ,000 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
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APPENDIX XX 
 
Raw data and statistical test of global measure of 
improvement (5-point scale) 
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Gr       4w       8w      16w     28w 
1 3 3 3 3 
1 3 4 4 4 
1 4 4 4 4 
1 4 4 4 4 
1 5 5 5 5 
1 3 4 5 5 
1 5 5 5 5 
1 4 4 4 4 
1 4 5 5 5 
1 4 4 4 4 
1 3 3 3 3 
1 3 3 3 3 
1 5 5 5 5 
1 3 3 4 4 
1 5 5 5 5 
1 4 4 4 4 
1 4 5 5 5 
1 4 4 4 4 
1 5 5 5 5 
1 3 3 3 3 
1 3 4 4 4 
1 4 4 4 4 
1 5 5 5 5 
1 3 3 3 3 
1 4 4 4 4 
2 4 4 4 4 
2 4 4 5 5 
2 5 5 5 5 
2 3 4 4 4 
2 5 5 5 5 
2 4 4 4 4 
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2 4 4 4 4 
2 5 5 5 5 
2 3 3 4 4 
2 4 4 4 4 
2 4 4 4 4 
2 5 5 5 5 
2 3 3 4 4 
2 4 4 4 4 
2 4 4 4 4 
2 5 5 5 5 
2 3 4 4 5 
2 4 5 5 5 
2 4 4 4 4 
2 5 5 5 5 
2 5 5 5 5 
2 4 4 4 4 
2 4 4 4 4 
2 3 4 4 4 
2 5 5 5 5 
3 3 3 3 3 
3 3 4 4 4 
3 4 4 4 4 
3 4 4 4 4 
3 3 3 3 3 
3 5 5 5 5 
3 3 3 4 4 
3 4 4 4 4 
3 3 3 3 3 
3 4 4 5 5 
3 3 3 3 3 
3 5 5 5 5 
3 4 4 4 4 
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3 4 4 5 5 
3 4 4 4 4 
3 3 4 5 5 
3 3 3 3 3 
3 5 5 5 5 
3 3 3 3 5 
3 3 3 4 4 
3 4 4 4 4 
3 4 4 4 4 
3 3 3 3 3 
3 4 4 5 5 
3 4 4 4 4 
 
Gr= group 
4w=4week 
8w=8week 
16w=16week 
28w=28week 
3=somewhat better 
4=much better 
5=no pain 
In Group column the 1=Cyriax physiotherapy group, the 2=Supervised exercise 
programme group and the 3=Polarised polychromatic non-coherent (Bioptron light) 
group 
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Descriptives 
 
  GROUP   Statistic Std. Error 
RELIEF4W 1 Mean 3,88 ,156 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,56   
Upper Bound 
4,20   
5% Trimmed Mean 3,87   
Median 4,00   
Variance ,610   
Std. Deviation ,781   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,50   
Skewness ,220 ,464 
Kurtosis -1,280 ,902 
2 Mean 4,12 ,145 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,82   
Upper Bound 
4,42   
5% Trimmed Mean 4,13   
Median 4,00   
Variance ,527   
Std. Deviation ,726   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,00   
Skewness -,189 ,464 
Kurtosis -,971 ,902 
3 Mean 3,68 ,138 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,40   
Upper Bound 
3,96   
5% Trimmed Mean 3,64   
Median 4,00   
Variance ,477   
Std. Deviation ,690   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,00   
Skewness ,523 ,464 
Kurtosis -,688 ,902 
RELIEF8W 1 Mean 4,08 ,152 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,77   
Upper Bound 
4,39   
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5% Trimmed Mean 4,09   
Median 4,00   
Variance ,577   
Std. Deviation ,759   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,50   
Skewness -,138 ,464 
Kurtosis -1,179 ,902 
2 Mean 4,28 ,123 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 4,03   
Upper Bound 
4,53   
5% Trimmed Mean 4,31   
Median 4,00   
Variance ,377   
Std. Deviation ,614   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,00   
Skewness -,224 ,464 
Kurtosis -,445 ,902 
3 Mean 3,76 ,133 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,49   
Upper Bound 
4,03   
5% Trimmed Mean 3,73   
Median 4,00   
Variance ,440   
Std. Deviation ,663   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,00   
Skewness ,302 ,464 
Kurtosis -,612 ,902 
RELIEF16 1 Mean 4,16 ,149 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,85   
Upper Bound 
4,47   
5% Trimmed Mean 4,18   
Median 4,00   
Variance ,557   
Std. Deviation ,746   
Minimum 3   
Maximum 5   
Range 2   
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Interquartile Range 1,00   
Skewness -,274 ,464 
Kurtosis -1,076 ,902 
2 Mean 4,40 ,100 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 4,19   
Upper Bound 
4,61   
5% Trimmed Mean 4,39   
Median 4,00   
Variance ,250   
Std. Deviation ,500   
Minimum 4   
Maximum 5   
Range 1   
Interquartile Range 1,00   
Skewness ,435 ,464 
Kurtosis -1,976 ,902 
3 Mean 4,00 ,153 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,68   
Upper Bound 
4,32   
5% Trimmed Mean 4,00   
Median 4,00   
Variance ,583   
Std. Deviation ,764   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 2,00   
Skewness ,000 ,464 
Kurtosis -1,213 ,902 
RELIEF28 1 Mean 4,16 ,149 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,85   
Upper Bound 
4,47   
5% Trimmed Mean 4,18   
Median 4,00   
Variance ,557   
Std. Deviation ,746   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,00   
Skewness -,274 ,464 
Kurtosis -1,076 ,902 
2 Mean 4,44 ,101 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 4,23   
Upper Bound 
4,65   
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5% Trimmed Mean 4,43   
Median 4,00   
Variance ,257   
Std. Deviation ,507   
Minimum 4   
Maximum 5   
Range 1   
Interquartile Range 1,00   
Skewness ,257 ,464 
Kurtosis -2,110 ,902 
3 Mean 4,08 ,152 
95% 
Confidence 
Interval for 
Mean 
Lower Bound 3,77   
Upper Bound 
4,39   
5% Trimmed Mean 4,09   
Median 4,00   
Variance ,577   
Std. Deviation ,759   
Minimum 3   
Maximum 5   
Range 2   
Interquartile Range 1,50   
Skewness -,138 ,464 
Kurtosis -1,179 ,902 
 
Relief=Global measure of improvement 
1= Cyriax physiotherapy group 
2= Supervised exercise programme group 
3= Polarised polychromatic non-coherent light (Bioptron light) group  
4W= 4 week 
8W= 8week 
16W= 16week 
28W= 28 week 
1=worse 
2=no change 
3=somewhat better 
4=much better 
5=no pain 
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Global measure of improvement for Cyriax physiotherapy, a supervised exercise 
programme and polarized polychromatic non-coherent light (Bioptron light) 
groups at week 4 
 
Kruskal-Wallis test ranks 
 
 
 
 
 
 
 
 
 
 
Test statisticsa,b 
 
 
 
 
 
a. Kruskal-Wallis test 
b. Grouping variable: group 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROU
P N 
Mean 
Rank 
1 25 37,56 
2 25 44,20 
3 25 32,24 
Total 75   
Chi-Square 4,363 
df 2 
Asymp. Sig. ,113 
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Global measure of improvement for Cyriax physiotherapy, a supervised exercise 
programme and polarized polychromatic non-coherent light (Bioptron light) 
groups at week 8 
 
Kruskal-Wallis test ranks 
 
 
 
 
 
 
 
 
 
 
Test statisticsa,b 
 
 
 
 
 
a. Kruskal-Wallis test 
b. Grouping variable: group 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROU
P N 
Mean 
Rank 
1 25 39,18 
2 25 44,74 
3 25 30,08 
Total 75  
Chi-Square 4,168 
df 2 
Asymp. Sig. ,122 
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Global measure of improvement for Cyriax physiotherapy, a supervised exercise 
programme and polarized polychromatic non-coherent light (Bioptron light) 
groups at week 16 
 
Kruskal-Wallis test ranks 
 
 
 
 
 
 
 
 
 
 
Test statisticsa,b 
 
 
 
 
 
a. Kruskal-Wallis test 
b. Grouping variable: group 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROU
P N 
Mean 
Rank 
1 25 37,44 
2 25 43,60 
3 25 32,96 
Total 75  
Chi-Square 3,600 
df 2 
Asymp. Sig. ,165 
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Global measure of improvement for Cyriax physiotherapy, a supervised exercise 
programme and polarized polychromatic non-coherent light (Bioptron light) 
groups at week 28 
 
Kruskal-Wallis test ranks 
 
 
 
 
 
 
 
 
 
 
Test statisticsa,b 
 
 
 
 
 
a. Kruskal-Wallis test 
b. Grouping variable: group 
 
 
 
 
Group 1=Cyriax physiotherapy 
Group 2=Exercise programme 
Group 3=Polarised polychromatic non-coherent light (Bioptron light) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROU
P N 
Mean 
Rank 
1 25 36,32 
2 25 43,58 
3 25 34,10 
Total 75  
Chi-Square 3,102 
df 2 
Asymp. Sig. ,212 
